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Investigations into the role of the metabotropic glutamate receptor, mGluR5, 
in incentive learning and some behavioural and neurobiological effects of 
cocaine 
 
The metabotropic glutamate receptor, mGluR5, is densely expressed in brain 
regions involved in incentive learning processes. There is considerable evidence to 
suggest that following exposure to addictive drugs such as cocaine, adaptations in 
these brain areas may underlie the development and maintenance of behavioural 
responses related to addictive processes. The present thesis examines the role of 
mGluR5 in both incentive learning processes and some behavioural and 
neurobiological effects of cocaine. 
 
First, using a novel mutant mouse line in which mGluR5 is selectively knocked 
down in cells that express dopamine D1 receptors (D1R), I argue that this mGluR5 
population is critically important for specific incentive learning processes. By 
blocking mGluR5 in wild-type mice with a selective antagonist, I then propose 
mGluR5 as necessary for the acquisition, but not the expression of an incentive 
association. Next, I present data showing that mGluR5 on dopaminoceptive 
neurons are not necessary for the „conditioned rewarding‟ properties of cocaine, 
measured in the conditioned place preference model, but do contribute to the 
psychomotor activating effects of cocaine. Finally, I present an 
immunohistochemistry study that examines cocaine-induced activation of the 
extracellular-signal related kinase (ERK) pathway. In the mGluR5 knock-down 
mice, activation of the ERK pathway in the striatum is disrupted following an acute 
injection of cocaine. Given the importance of the ERK pathway in establishing and 
maintaining long term memories, I propose that disruption of this pathway could 
contribute, in part, to some findings reported in the present thesis. 
 
Taken together, this thesis will argue that signalling through mGluR5 on D1R 
expressing neurons is important for the formation of incentive associations, and 
may contribute to neural adaptations necessary for the development and 
maintenance of behavioural responses related to addictive processes.  
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1 
 
1 General introduction 
 
1.1 Overview 
 
Emotions are fundamental to a normal sense of well-being and can provide 
motivation for many tasks encountered in daily life. Associative learning processes 
represent a major component of emotion and motivation. In Pavlovian incentive 
learning, a neutral environmental stimulus that is predictive of reward (e.g. food, 
water or sex) can be attributed with motivational value enabling the stimulus itself 
to become attractive and wanted, reinforce new learning and/or energise goal-
directed action. While such learning has clear adaptive value, addictive drugs are 
proposed to interact and subvert the neural components of Pavlovian incentive 
learning. In this way, environmental stimuli that are predictive of drug experience 
may exert powerful control over behaviour and contribute to cardinal features of 
drug addiction, including relapse after an extended period of abstinence. A major 
goal of behavioural neuroscience is to uncover the neural mechanisms of reward 
processing and thereby provide new insight into the basis of clinical disorders like 
addiction. It is within this broad framework that the following thesis will investigate 
the role of the metabotropic glutamate receptor, mGluR5, in Pavlovian incentive 
learning and some behavioural and neurobiological effects of one addictive drug, 
cocaine. 
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1.2 Reward 
 
Obtaining and experiencing desirable objects like food, water or even the latest 
iPhone can be accompanied by complex emotional feelings such as pleasure or 
relief. Emotions experienced during rewarding events can provide motivation for 
many tasks encountered in daily life, but dysregulation of emotional and reward 
processing is a major feature in many affective disorders including depression, 
schizophrenia and addiction. A major focus of behavioural neuroscience research 
has been to explore the neural mechanisms of reward, not least with the hope of 
finding new therapeutic targets for affective disorders. However, to be successful in 
this goal, it is first necessary to consider what reward is. 
 
Reward is a difficult concept because it is used to refer to a wide-range of 
constructs including „reinforcement‟, „subjective states‟ and „incentive‟. Reward 
differs from reinforcement in a number of ways (reviewed in White, 1989). For 
example, the classical definition of a „reinforcer‟ as an event that increases the 
probability of the response that precedes it, makes no mention of subjective states 
(Robbins and Everitt, 1996). Indeed, reward can extend beyond solely the need for 
explicit subjective states experienced during the pursuit of the desired object and 
the final interaction with it (Robbins and Everitt, 1996; Dickinson and Balleine, 
2002; Berridge and Robinson, 2003; Schultz, 2006; Stephens et al., 2010). For 
example, as a consequence of Pavlovian incentive learning, initially neutral 
environmental stimuli that predict a desired goal can themselves become 
motivationally important (Berridge and Robinson, 1998). Thus, reward is not a 
unitary process, but can involve distinct emotional, incentive motivational and 
learning components. All of these components may be acting in concert to 
determine behaviour in the face of a rewarding event or a stimulus that has been 
associated with reward. Thus, for behavioural neuroscientists to fully appreciate 
the role of any neural mechanism in reward requires that reward is teased apart 
into its distinct components (Cardinal et al., 2002a; Berridge and Robinson, 2003; 
Yin et al., 2008). 
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A model advanced by Robinson and Berridge (Berridge and Robinson, 1998; see 
also Berridge and Kringelbach, 2008) provides a useful framework in which the 
components of reward can be deconstructed. These components consist of 1) 
Liking: defined as the affective component or hedonic impact of a reward (e.g. 
food), which includes core „liking‟ reactions, that can be unconsciously perceived, 
and explicit conscious experiences of pleasure. 2) Wanting: defined as motivation 
for reward, which includes incentive processes, that are not necessarily conscious, 
and conscious desires for incentives or cognitive goals and 3) Learning: which 
describes the ability to form associations, representations and make predictions 
about future rewards based on previous experiences, which involves explicit and 
cognitive predictions and implicit knowledge, as well as associative conditioning, 
such as Pavlovian and instrumental associations (Berridge and Kringelbach, 2008).  
 
Some experiments reported in this thesis will explore processes that fall within (and 
between) the incentive „wanting‟ and instrumental and Pavlovian associative 
„learning‟ domains as delineated by Berridge. For this reason, the following 
sections will review some basic concepts in instrumental and Pavlovian learning 
and some theories of motivation that are pertinent to this thesis. Aversive 
associative learning processes will not be formally considered here, although their 
role in regulating appetitive motivational processes is acknowledged (see 
Dickinson and Balleine, 2002 for further discussion). 
 
1.2.1 Instrumental learning 
An animal can come to influence its environment by learning that a response (R) it 
makes can produce an outcome (O) that is advantageous to its survival and should 
be repeated (positive reinforcement), and that, oppositely, some responses 
produce outcomes which are deleterious to survival and should be avoided 
(negative reinforcement and punishment) (reviewed in Bouton, 2007). The 
performance of reward-related actions are thought to reflect two distinct learning 
processes, one controlling the acquisition of goal-directed (R-O) actions and the 
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other the acquisition of S-R habits (Fig 1.1a; Adams and Dickinson, 1981; 
Dickinson et al., 1983; Dickinson and Balleine, 1994; Dickinson et al., 1995). Goal-
directed learning necessitates the acquisition of a response representation and a 
representation of the outcome produced by that action (Dickinson and Balleine, 
1994). Thus, an action is considered goal-directed when the initiation of the action 
is made with knowledge of the causal relationship between the action and its 
consequence (i.e. the contingency) and the current value of the outcome 
(Dickinson and Balleine, 1994). In habit learning, instrumental responses (R) are 
associated with stimuli (S) present during training and the reinforcer primarily 
serves to strengthen these S-R associations. The reinforcers do not themselves 
become encoded as a goal (Everitt and Robbins, 2006). Typically, as actions 
become well learned, they may become automatic behavioural responses triggered 
by the presentation of a stimulus (i.e. S-R habit), without any explicit relation to the 
outcome (Dickinson, 1985; Logan, 1998). It is sufficient for experiments reported 
later in this thesis to note that goal-directed and habitual actions can be 
distinguished by their relative sensitivity to devaluation of the outcome and to 
degradation of the action-outcome contingency (Balleine and O'Doherty, 2010). 
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Figure 1.1 Components of associative learning (a) Instrumental (1) and Pavlovian 
(2) conditioning and some interactions (3-5) are illustrated. CS, conditioned 
stimulus; US/O, unconditioned stimulus (Pavlovian conditioning) or outcome 
(instrumental conditioning); R, instrumental response; 3, Responses can be directly 
reinforced by a CS (conditioned reinforcement); 4, A CS can trigger an 
instrumental response (S-R habit); 5, A CS can motivate ongoing goal-directed 
actions (Pavlovian-instrumental transfer) (adapted from Bouton, 2007) (b) In 
stimulus substitution theory, a CS comes to elicit a reflex response which is 
identical to the unconditioned response generated to the US (e.g. salivation in 
response to food). (c) In stimulus-stimulus theory, a CS first generates a neural 
representation of the US, which determines the conditioned response that arises. 
(d) Multiple associations can form between the CS and features of the US, which 
determine how the CS can influence behaviour (redrawn from Delamater and 
Oakeshott, 2007).  
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1.2.2 Pavlovian learning 
When presented with an outcome, termed the unconditioned stimulus (US), an 
animal may exhibit responses that allow for an appropriate reaction to that 
outcome. The animal may also experience behavioural or physiological changes as 
a result of exposure to the outcome (the unconditioned response; UR). If a neutral 
stimulus is associated with the US, this stimulus may take on the properties of a 
„conditioned stimulus‟ (CS), which can subsequently evoke a conditioned response 
(CR) that resembles the UR, even when presented in the absence of the US. The 
formation of CS-US associations is central to Pavlovian conditioning (Fig. 1.1a) 
and the ability of a CS to elicit a CR is considered critical for behavioural 
adaptation to environmental events (Pavlov, 1927; Mackintosh, 1994). 
 
In the century that has followed Pavlov‟s seminal work on classical conditioning 
(Pavlov, 1927), many have questioned what is learned during the Pavlovian 
conditioning procedure, how such information is stored and represented in the 
brain and how Pavlovian associations interact with actions (e.g. Rozeboom, 1958; 
Rescorla, 1988; Cardinal et al., 2002a). Pavlov himself argued that a conditioned 
reflex would develop due to an acquired association between a representation of 
the CS and one of the US (Pavlov, 1927). However, this „stimulus-substitution‟ view 
(Fig. 1.1b) could not readily explain how CSs were observed to modulate 
behaviours in more complex ways (e.g. transfer effects observed by Estes, 1948), 
and made no reference to motivational components of associative learning. It was 
not until Konorski (1967) and other contemporary learning theorists that followed 
(e.g. Wagner and Brandon, 1989; Holland, 1990; Dickinson and Balleine, 1994; 
Berridge and Robinson, 1998; Delamater and Oakeshott, 2007), that Pavlovian 
conditioning was recognised as having the potential to allow for multiple 
independent associations to form between the representation of the CS and 
features of the US (i.e. stimulus-stimulus associations; Fig. 1.1c-d). 
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1.2.3 The ‘Konorskian’ model 
According to Konorski (1967), Pavlovian conditioning could be considered in two 
forms: preparatory and consummatory conditioning (reviewed in Dickinson and 
Balleine, 2002). Preparatory conditioning describes the acquisition of responses 
that are characteristic of the motivational class to which the US belongs, as 
determined by its autonomic (e.g. heart rate) and/or behavioural actions (e.g. 
approach and withdrawal). Consummatory conditioning refers to the acquisition of 
an association between the CS representation and a representation of the US that 
encodes its specific sensory-perceptual properties (e.g. salivation in response to a 
food US). By forming these distinct CS-US representations, a CS could elicit 
different CRs that, in part, also depended upon the nature of the CS itself 
(Konorski, 1967). 
 
How then does motivation feature in Pavlovian learning as described by Konorski? 
Konorski (1967) proposed that preparatory and consummatory CRs result from 
CSs activating a common motivational system by direct (preparatory CS  
motivational system) and indirect (consummatory CS  US representation  
motivational system) pathways. Critically, feedback excitation from the motivational 
system to the US representation was proposed to give rise to a Pavlovian „desire‟ 
(a term used by Dickinson and Balleine, 2002; but perhaps analogous to incentive 
„wanting‟ as defined by Berridge, 1996) that motivates behaviour. In an extension 
to the Konorski model, Dickinson and Dearing (1979) suggested that primary 
motivational states could gate the capacity of an excited US representation to 
activate the common appetitive motivational system. In this way, motivational state 
could influence motivational feedback onto the US representation and, in turn, the 
motivational impact of the CS (reviewed in Dickinson and Balleine, 2002). In 
summary, this the so-called „Konorskian‟ model (Fig. 1.2a) and a later version 
presented by Balleine (2005; Fig. 1.2b), proposed that both US-specific 
consummatory and general motivational preparatory associations can influence 
appetitive activation, which subsequently motivates goal-directed (instrumental) 
actions, but in distinct ways; either by generation of arousal or affect. As will be 
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evidenced later in this introduction, these preparatory and consummatory 
processes map well onto parallel learning processes that occur within, and 
probably between, sub-compartments of brain regions such as the amygdala 
(Balleine and Killcross, 2006) and ventral striatum (Shiflett and Balleine, 2010). 
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Panel B not shown due to copyright restrictions 
For panel, see Balleine, 2005, Fig. 3. 
Figure 1.2 A „Konorskian‟ model of appetitive motivational influences in Pavlovian 
learning (a) Preparatory CSs directly activate an appetitive motivational system 
and give rise to general motivational CRs. This pathway also allows for preparatory 
CSs to excite performance of consummatory CRs. Consummatory CSs first 
activate a representation of the US, which can acquire further „Pavlovian desire‟ by 
reciprocal connections with the appetitive system. However, this pathway is gated 
(blue box) by primary motivational state (e.g. hunger or thirst) (adapted from 
Konorski, 1967; Dickinson and Balleine, 2002). (b) (for panel,). A later model 
described by Balleine clearly incorporates the principles of the Konorskian model, 
with specific sensory associations (Se; i.e. consummatory) giving rise to affect, 
while general motivation associations (M; i.e. preparatory) giving rise to arousal, 
which can both influence goal-directed (instrumental) actions. Affect and arousal 
both activate a distributed appetitive (Ap) system and can be dissociated between 
different brain regions   
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1.2.4 The ‘Incentive Salience’ model 
Incentive motivation concepts that were first developed around the 1970s and 
1980s, most notably by Bolles (1972), Bindra (1974) and Toates (1986), closely 
followed principles of Pavlovian learning and provided an alternative account for 
how Pavlovian CSs could themselves serve as incentives to motivate behaviour 
(reviewed in Berridge, 2004). Bolles (1972) proposed that individuals were 
motivated by incentive expectancies, which he termed S-S* associations. In 
Pavlovian parlance, Bolles meant that the US (the S*) carried motivational value 
before learning had occurred, while the would-be CS (the S) did not. Thus, learning 
was required upon experience of S* to enable the acquisition of a predictive 
expectancy by the S. Bindra (1974) subsequently added to the expectancy account 
of Bolles that, as a consequence of classical conditioning, the CS could elicit the 
same incentive motivational state that had been generated by the reward itself 
(Bindra, 1974). Thus, the CS could be „liked‟ and „wanted‟, even when the US was 
not present, because it carried hedonic and affective qualities of the US. Finally, 
Toates (1986) proposed that primary drive states could also influence behaviour by 
enhancing the hedonic impact and incentive value of both the reward and the 
reward associated CS. For example, under conditions of thirst, the hedonic impact 
and incentive value of both a CS paired with water and of water itself would be 
enhanced. 
 
In the Bolles-Bindra-Toates accounts of incentive motivation, conditioned 
incentives had value because they were both „liked‟ (i.e. they produced pleasure) 
and „wanted‟ (i.e. they had incentive value) as a consequence of Pavlovian 
learning (reviewed in Berridge, 2004). Robinson and Berridge (1993; 1998), in their 
incentive salience model, further advanced incentive motivation theory to propose 
that „liking‟ and „wanting‟ processes are, in fact, neurobiologically separate and 
experimentally dissociable. Thus, it is the attribution of incentive salience „wanting‟ 
to a neutral perceptual or representational event (e.g. a cue) that determines the 
value of the incentive, controls instrumental behaviour directed toward obtaining it 
and enables neural representations of CSs to become highly salient, attractive and 
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desired (Berridge, 1996; Berridge and Robinson, 1998; Robinson and Berridge, 
2001). 
 
1.2.5 Summary 
I have introduced the idea that Pavlovian learning is not a unitary process but can 
result in multiple independent associations between internal representations of the 
CS and features of the US. The content of what is learned and even the nature of 
the reward-paired environmental stimulus can determine how the CS subsequently 
influences behaviour, which can occur in many ways beyond generating simple 
reflexive responses as was first envisioned by Pavlov (1927). Two prominent 
theories of motivation in appetitive Pavlovian conditioning have also been 
introduced. In the „Konorskian‟ model, CSs activate a general appetitive system 
that motivates goal-directed (instrumental) actions (Dickinson and Balleine, 2002). 
In this model, and subsequent extensions of it (see also Dickinson and Balleine, 
1994; Cardinal et al., 2002a; Balleine, 2005; Everitt and Robbins, 2005; Yin et al., 
2008) the strength of implicit stimulus-stimulus associations are emphasised and 
so too are effects of the S-R habits. In the incentive salience model of incentive 
motivation, CSs acquire incentive motivational value and emphasis is placed on 
the idea that CSs are „wanted‟ in their own right, and that incentive salience 
„wanting‟ can be dissociated from hedonic „liking‟ aspects of reward (Berridge and 
Robinson, 1998). From this point onward, I will use the phrase „Pavlovian incentive 
learning‟ in referring to learning that enables environmental stimuli associated with 
reward experience to influence behaviours. What is particularly interesting is that 
both theoretical standpoints reviewed here have made use of similar behavioural 
paradigms to assess Pavlovian incentive learning; which are sign-tracking (or 
approach towards the Pavlovian CS), conditioned reinforcement (CRf; response-
contingent CS presentations) and Pavlovian-instrumental transfer (PIT; response-
independent presentations of CSs). These three tests and some parameters that 
influence performance in them will be introduced in the following sections. 
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1.3 Behavioural models of Pavlovian incentive learning 
 
1.3.1 Sign-tracking  
When a localisable stimulus that is predictive of reward is presented, animals may 
come to approach and interact with it. I will use the term sign-tracking (Hearst and 
Jenkins, 1974) when referencing this phenomenon, while recognising that it has 
also been termed autoshaping (Brown and Jenkins, 1968), signal-centred 
behaviour (Jenkins et al., 1978) and conditioned (or Pavlovian) approach and 
contact behaviour (Peterson et al., 1972).  
 
Sign-tracking was first reported by Brown and Jenkins (1968), who noted that a 
hungry pigeon would peck at a light that was predictive of food delivery, even 
though pecks never affected grain delivery. Notably, pecking of the stimulus 
persisted even if this resulted in the omission of food delivery (Williams and 
Williams, 1969), indicating that sign-tracking is most likely driven by Pavlovian 
learning, rather than implicit instrumental associations that could form as a result of 
the co-occurrence of reward delivery with CS directed responding. Sign-tracking 
has been observed in mice (Mead and Stephens, 2003b), rats (Peterson et al., 
1972), monkeys (Sidman and Fletcher, 1968) and humans (Wilcove and Miller, 
1974). 
 
A number of factors influence the sign-tracking CR. The topography of the 
response (e.g. peck, sniff or lick) typically resembles that of the UR directed at the 
US indicating that sign-tracking is partly a reward-specific mechanism. For 
example, pigeons would make brief and forceful pecks at a stimulus predictive of 
food, but make relatively weak pecks accompanied by occasional licking or 
swallowing at a stimulus predictive of water (Wolin, 1968; Jenkins and Moore, 
1973). Where the US was intravenously delivered cocaine, rats approached and 
investigated the lever CS, but rarely contacted it, perhaps because no actions were 
required to consume the drug US (Uslaner et al., 2006). Similarly, the occurrence 
of sign-tracking responses may depend upon the nature of the CS (e.g. visual or 
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auditory) and whether the CS is a natural releaser for appetitive behaviour systems 
in that species (Cleland and Davey, 1983). In rats, manual or oral manipulability 
may be a property of appetitive CSs that is important for maintaining sign-tracking 
responses (Holland, 1980; Cleland and Davey, 1983) and successful studies in 
rats have used localizable stimuli including retractable or illuminated leavers (Stiers 
and Silberberg, 1974; Boakes, 1977), static stimulus lamps (Holland, 1980) and 
even restrained conspecifics (Timberlake and Grant, 1975). More recently, 
approach and contact responses have been recorded in rats using computer 
graphic CSs presented on touch-screen panels (Bussey et al., 1994). Taking 
advantage of the natural tendency for mice to explore with nose-pokes, sign-
tracking has been recorded in mice by placing a discrete visual CS within a hole 
and measuring nose-pokes into the CS-containing hole (Mead and Stephens, 
2003b). 
 
1.3.2 Conditioned reinforcement 
In addition to eliciting approach responses, the attribution of incentive salience to 
appetitive Pavlovian CSs allows them to act as a goal for instrumental behaviour 
(Mackintosh, 1974; Robbins, 1978). Conditioned reinforcers can influence 
behaviour in a number of powerful ways, such as maintaining actions over delays 
between delivery of the primary reinforcer, as modelled by second-order schedules 
of reinforcement (e.g. Kelleher, 1966; Mead and Stephens, 2003b; Wilson and 
Bowman, 2004), and supporting the acquisition of a novel instrumental action 
(Mackintosh, 1974). 
 
Experiments reported in Chapter 3 and chapter 4 of this thesis will focus on the 
acquisition of a novel instrumental response with CRf (Mackintosh, 1974). 
Extensive reviews on second-order schedules of reinforcement can be sought 
elsewhere (Everitt and Robbins, 2000; Schindler et al., 2002; Di Ciano and Everitt, 
2005). The acquisition of a novel instrumental response with the CRf method is 
particularly advantageous as the reinforcing properties of the CS can be examined 
in isolation from any prior association between the operant response and a primary 
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reinforcer (Di Ciano and Everitt, 2004a). In this procedure, an animal is first trained 
a Pavlovian (CS-US) association, in which a neutral stimulus (e.g. a light or sound) 
is paired with the delivery of a reinforcer (e.g. liquid or solid food). Following 
Pavlovian conditioning, a test of CRf is undertaken in which two novel levers are 
inserted into the conditioning chamber. Responses on one lever result in 
presentation of the previously food-paired stimulus (CS+), while responding on an 
alternate (control) lever is without consequence. The number of responses elicited 
on the CS+ lever, in comparison to the control lever, provides a measure of the 
acquired reinforcing quality of the CS+. While most commonly used with rats (e.g. 
Robbins, 1978), the acquisition of a novel instrumental response with CRf 
procedure has successfully been adopted for use in mice (Mead and Stephens, 
2003b; O'Connor et al., 2010). 
 
1.3.3 Pavlovian-instrumental transfer 
A third feature of appetitive Pavlovian CSs is that they can enhance goal-directed 
instrumental behaviour, termed Pavlovian-instrumental transfer (Estes, 1948; 
Lovibond, 1983), which may be considered ethologically as an example of a 
foraging behaviour (Galarce et al., 2007), and which others have referred to as 
conditioned motivation (Milton et al., 2008a) or cue-triggered wanting (Wyvell and 
Berridge, 2001). Although originally developed in rats, the PIT procedure has been 
adopted for use in mice (Mead and Stephens, 2003b; Yin et al., 2006a; Crombag 
et al., 2008a; O'Connor et al., 2010), monkeys (Henton and Brady, 1970) and 
humans (Hogarth et al., 2007; Talmi et al., 2008). In assessing this phenomenon, 
animals are first trained a Pavlovian association between presentation of a CS and 
the delivery of a primary reward (e.g., sucrose). Next, animals are trained to 
respond on a lever for the same primary reward experienced during conditioning, 
but in the absence of the CS. Finally, a test is undertaken in which the ability of the 
CS to enhance lever pressing in extinction is assessed. By performing the test 
under extinction conditions, neither primary nor secondary reinforcement occur, 
therefore enabling purely the response activating properties of CSs to be examined 
(Wyvell and Berridge, 2001). 
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In the experimental preparation described above, the training of a single CS-US 
(e.g. light  food) and R-O (e.g. left lever  food) association likely promotes a 
more general form of learning such that the CS exerts a more general 
enhancement of instrumental performance (termed general PIT). However, 
Pavlovian CSs can also exert a selective influence on instrumental performance 
(termed outcome-specific or selective PIT; Kruse et al., 1983). In the selective PIT 
procedure, an animal is first trained two separate CS-US associations (e.g. tone  
food pellet, light  sucrose liquid). For the instrumental training component, 
animals acquire a different operant response for each of the outcomes earned 
during the Pavlovian conditioning phase (e.g. left lever  food pellet, right lever  
sucrose). The effects of CS presentations on lever responding are then examined 
under extinction conditions. In selective PIT, the CS is observed to selectively 
enhance performance of the instrumental response associated with the same 
outcome. While most studies have examined either general or selective PIT within 
different experimental preparations (see Holmes et al., 2010 for an extensive 
review), Corbit and Balleine (2005) have described an elegant procedure in which 
general and outcome selective forms of PIT can be dissociated in the same 
experiment. 
 
The study of general or specific PIT necessitates that the animal first learns a 
Pavlovian CS-US association, but there exist a number of crucial differences in 
conditioning procedures used for PIT than those for Pavlovian approach and CRf. 
First, a long-duration CS (e.g. 2 min) is typically used for PIT, in contrast to a 
relatively short-duration CS (e.g. 10 sec) used in the study of Pavlovian approach 
and CRf. The duration of the CS can influence the temporal dynamics of the PIT 
effect (Holland and Gallagher, 2003) and more robust PIT is observed when using 
a longer-duration CS (Crombag et al., 2008a). It is proposed that longer-duration 
CSs are more likely to establish preparatory or drive conditioned responses, which 
can exert modulatory influence over behaviours. In contrast, short-duration CSs 
are more likely to establish specific consummatory conditioned responses 
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(Konorski, 1967; Wagner and Brandon, 1989; Holland and Gallagher, 2003). 
Second, in conditioning for PIT, reinforcer deliveries are made on a semi-random 
basis during CS presentations. This is important, since CSs not only encode 
sensory or motivational representations of the US, but can also signal its temporal 
occurrence (Delamater and Oakeshott, 2007). The semi-random US presentation 
ensures that any influence of Pavlovian appetitive CRs on instrumental responding 
are not limited to discrete portions of the CS interval (Holland and Gallagher, 2003; 
Holland, 2004). Finally, animals are typically provided with relatively fewer 
presentations of the unpaired CS in the conditioning sessions for PIT. In effect, the 
unpaired CS serves as a neutral CS, rather than an explicitly non-reinforced CS. 
The purpose of this conditioning parameter is to limit the contribution of 
experience-dependent suppression of responding in the transfer test that may 
occur when using a stimulus that has been extensively non-reinforced (Holland, 
2004). A truly novel stimulus is not used as a control stimulus, as this may result in 
unconditioned suppression of responding during the transfer test (Rescorla, 1967; 
Holland, 2004). 
 
The instrumental training parameters are another important factor in the PIT effect. 
A variable interval (VI) or random ratio (RR) schedule is commonly used in PIT 
training. Extensive training under such schedules encourages instrumental 
responding that is supported by stimulus-response (S-R) rather than response-
outcome (R-O) representations (Dickinson and Nicholas, 1983a, b; Dickinson et 
al., 1983; Dickinson et al., 1995). Thus, in general PIT, where transfer is most 
dependent upon the general motivational influence of the Pavlovian CS, the 
influence of the CS over instrumental responding is considered greatest when 
responding is least sustained by specific R-O representations (Holland, 2004). 
 
1.3.4 Summary 
Pavlovian incentive learning and some tests that can be used to explore the 
incentive motivational properties of CSs have been introduced from a theoretical 
and operational perspective. Understanding of the neural components of reward 
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processing has advanced significantly over the last twenty years, propelled by a 
greater understanding of neuroanatomy and by application of techniques that can 
be used to isolate discrete brain regions (e.g. lesioning), brain circuits (e.g. 
disconnection procedures) and neurotransmitters and receptors within those 
regions (e.g. behavioural pharmacology and genetics). The following sections will 
review studies that have investigated the neural components of the aforementioned 
behavioural models of Pavlovian incentive learning. In addition, studies that have 
examined the neural components of the acquisition and performance of an 
appetitive instrumental response will be reviewed, given the important role of 
instrumental processes in both CRf and, in particular, PIT. For each behavioural 
model, consideration will be given to what these studies tell us about the role of 
certain brain components in reward processing.  
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1.4 Neural components of reward 
 
1.4.1 Sign-tracking 
A series of lesioning experiments have identified interactions between the nucleus 
accumbens (NAcc) and its limbic cortical afferents in the acquisition of a sign-
tracking CR. Thus, sign-tracking is disrupted by selective excitotoxic lesions of the 
anterior cingulate cortex (ACC) (Bussey et al., 1997b), orbitofrontal cortex (OFC) 
(Chudasama and Robbins, 2003), NAcc core (Parkinson et al., 1999; Parkinson et 
al., 2000b; Cardinal et al., 2002b) and pre- but not post-training lesions of the 
central nucleus of the amygdala (CeN) (Parkinson et al., 2000a; Cardinal et al., 
2002b). A necessary role for ACCNAcc core projections in sign-tracking has 
been confirmed using a double disconnection procedure, involving a unilateral 
lesion of the NAcc core and a contralateral unilateral lesion of the ACC (Parkinson 
et al., 2000b). In addition, lesions of the subthalamic nucleus (STN), both prior to or 
following training, facilitate sign-tracking, possibly by increasing incentive salience 
attribution to the CS and/or US (Uslaner et al., 2008). In contrast, sign-tracking was 
unaffected by lesions of the posterior cingulate cortex, prelimbic cortex (PLC) and 
infralimbic cortex (ILC) (Bussey et al., 1997b; Chudasama and Robbins, 2003), 
NAc shell (Parkinson et al., 2000a; Parkinson et al., 2000b), basolateral amygdala 
(BLA) and dorsal or ventral subiculum (Parkinson et al., 2000a). 
 
Both dopamine and glutamate transmission are important for the acquisition and 
performance of sign-tracking responses. In the NAcc, dopamine depletions (Dalley 
et al., 2002; Parkinson et al., 2002) or antagonism of dopamine receptors (Di Ciano 
et al., 2001) impaired the acquisition and performance of sign-tracking. Using fast-
scan cycling voltammetry, dopamine signalling in the NAcc core has been 
confirmed as an integral part of CS-US incentive learning necessary for the 
development of a sign-tracking response (Flagel et al., 2010). With respect to 
glutamate, infusion of an AMPA/KA receptor antagonist into the NAcc core 
impaired the expression, but not the acquisition, of sign-tracking (Di Ciano et al., 
2001). In contrast, an NMDA receptor antagonist infused into the NAcc core 
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impaired the acquisition, but not the expression, of sign-tracking (Di Ciano et al., 
2001). Notably, the particular pattern of disruption following AMPA/KA receptor 
antagonism (that is, increased approaches to the CS-) was also observed following 
ACC lesions (Bussey et al., 1997a) but not NAcc lesions, where disrupted 
Pavlovian approach arose from a reduction in responding to the CS+ (Parkinson et 
al., 1999). ACC-dependent processes may therefore interact with the NAcc in 
controlling the performance of sign-tracking responses through AMPA/KA receptor 
dependent signalling mechanisms (Di Ciano et al., 2001). Consistent with a 
necessary role of AMPA receptors in the performance of sign-tracking, mice 
lacking the GluR1 (gria1 knock-outs), and GluR2 subunit (gria2 knock-out) showed 
reduced sign-tracking responses (Mead and Stephens, 2003b, a). Finally, early 
post-training intra-NAcc infusions of a dopamine D1 receptor (D1R) and NMDA 
receptor antagonist impaired sign-tracking, while similar infusions of a dopamine 
D2 (D2R) receptor antagonist were without effect (Dalley et al., 2005). 
 
So what do these lesioning, pharmacology and genetic studies tell us about the 
role of specific neural components in sign-tracking? The ACC plays a critical role in 
the formation of stimulus-reward associations, but perhaps not approach itself 
(Bussey et al., 1997a; Cardinal et al., 2002b), and provides a major source of 
projections to both the NAcc core and the CeN (Groenewegen et al., 1987; 
Groenewegen et al., 1999). The ACCNAcc core pathway is proposed to 
subserve associative learning processes (whether attentional, impulsive or 
memory-based) and provide direction to the behavioural response, in terms of 
helping the organism to discriminate between relevant and irrelevant cues (Bussey 
et al., 1997a; Bussey et al., 1997b; Everitt et al., 1999; Parkinson et al., 2000b; Di 
Ciano et al., 2001). The ACCCeN projection may allow for cortical control over 
autonomic, endocrine and behavioural reflexive components of emotional 
responses through projections from the CeN to the hypothalamus and brainstem 
(Swanson and Petrovich, 1998).  
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The CeN also receives information about appetitive stimuli from other inputs 
(including the BLA and thalamus) and projects to dopaminergic neurons of the VTA 
and STN (Fudge and Haber, 2000) and basal forebrain cholinergic neurons of the 
isodendritic core (Robledo et al., 1996; Han et al., 1997; Everitt et al., 1999). Thus, 
while there are no direct connections between the CeN and NAcc core, 
dopaminergic signalling in the CeN can markedly affect extracellular dopamine in 
the NAcc (Louilot et al., 1985; Simon et al., 1988). According to Everitt and 
colleagues, through these cholinergic and dopaminergic connections, the CeN may 
1) influence attentional processing necessary for the learning about CS-US 
associations, 2) provide information about appetitive stimuli to the NAcc that 
promotes behavioural activation and 3) supervise the strengthening of associations 
between environmental stimuli, encoded by cortical limbic glutamatergic inputs, 
and motivational process in the NAcc core (Everitt and Robbins, 1992; Everitt et 
al., 1999; Everitt et al., 2001; Cardinal et al., 2002b). A fourth possibility from an 
incentive salience perspective (Berridge and Robinson, 1998), and perhaps 
analogous to the second point above, would propose that the ability of the CeN to 
influence dopamine signalling in the NAcc core may contribute directly to incentive 
salience attribution. 
 
Glutamatergic and dopaminergic signalling are clearly critical within the cortical 
limbic striatal circuitry that converges on the NAcc core (Di Ciano et al., 2001; 
Flagel et al., 2010). Dopamine is proposed to play a major role in the attribution of 
incentive value to the reward paired CS (Yin et al., 2008; Flagel et al., 2010), 
distinct from its proposed role in reward prediction (Schultz et al., 1997). Both NAcc 
dopamine D1R and NMDA receptors appear necessary for the early consolidation 
of appetitive learning (Dalley et al., 2005), consistent with a role of these receptors 
in LTP and other forms of synaptic plasticity hypothesized to underlie associative 
learning (Pennartz et al., 1993; Kombian and Malenka, 1994; Kelley et al., 2003; 
Kelley, 2004). In contrast, AMPA receptors may be crucial for the performance of 
the sign-tracking CR, consistent with their role in the maintaining synaptic strength 
at excitatory synapses (Malenka, 2003; Kessels and Malinow, 2009). 
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1.4.2 Conditioned reinforcement 
In comparison to the neural circuitry mediating Pavlovian approach, lesion studies 
have identified a distinct (but convergent) neural circuitry mediating control over the 
acquisition of a new instrumental response by conditioned reinforcers. Thus, the 
OFC (Pears et al., 2003), BLA (Cador et al., 1989; Burns et al., 1993; Whitelaw et 
al., 1996; but see Alderson et al., 2000), ventral subiculum (Burns et al., 1993), 
STN (Baunez et al., 2002) and pedunculopontine nucleus (Inglis et al., 2000) 
contribute to CRf. In contrast, lesions of the ACC (Everitt et al., 2001), PLC (Burns 
et al., 1993) and medial PFC (Pears et al., 2003) and CeN (Robledo et al., 1996) 
are without effect. Notably, responding for CRf can be powerfully amplified by 
psychomotor stimulants (Robbins, 1978; Robbins et al., 1983; Taylor and Robbins, 
1984). This phenomenon critically depends upon dopamine (Taylor and Robbins, 
1986; Wolterink et al., 1993), glutamate (Burns et al., 1994) and possibly 
GABAergic transmission (Dixon et al., 2010) in the NAcc, and integrity of the 
ventral subiculum (Burns et al., 1993), NAcc shell (Parkinson et al., 1999) and CeN 
(Robledo et al., 1996). Lesions of the NAcc core, while not affecting the acquisition 
of CRf, result in a loss of selectivity over stimulant-induced potentiation of CRf 
(Parkinson et al., 1999). 
 
A role for dopamine and glutamate in the acquisition and performance of 
responding for CRf has been further explored with pharmacological and genetic 
approaches. Dopamine and glutamate signalling within the amygdala appears 
important for both the acquisition and performance of CRf (Hitchcott et al., 1997; 
Hitchcott and Phillips, 1997, 1998; Phillips et al., 2010). Prior to the CRf test, intra-
BLA, but not CeN, infusions of a D3R antagonist 7-OH-DPAT disrupted the 
acquisition of a new response with CRf (Hitchcott and Phillips, 1998). Pre-test, 
intra-BLA infusion of an AMPA antagonist CNQX reduced responding for a drug 
associated CRf, but also increased responding on the control CS reinforced lever 
(Hitchcott and Phillips, 1997). In the amygdala, NMDA receptors may play a critical 
role in memory reconsolidation that leads to responding for CRf (Milton et al., 
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2008b). In the ventral-subiculum, infusions of an AMPA/KA receptor antagonist 
CNQX selectively reduced responding for drug associated CRf (Hitchcott and 
Phillips, 1997). In the NAcc core, but not shell, responding reinforced by a cocaine-
paired CS was dependent upon AMPA/KA receptors (Di Ciano and Everitt, 2001). 
In contrast, blockade of NMDA receptors in either the NAcc core or shell were 
without effect (Di Ciano and Everitt, 2001). Confirming a role for AMPA receptors, 
CRf was impaired in GluR1 knock-out mice (Mead and Stephens, 2003b) but not in 
GluR2 knock-out mice (Mead and Stephens, 2003a). Moreover, point mutation of 
the GluR1-ser831 phosphorylation site in mice resulted in impaired responding for 
CRf, while mutation of the GluR1-ser845 phosphorylation site was without effect 
(Crombag et al., 2008c). 
 
Clearly then, the BLA, OFC and NAcc core are important for CRf, but what are the 
roles of these structures and signalling that occurs between them? First, dopamine 
transmission serves as a “gain amplification” signal, influencing the impact of the 
CS, but does not mediate responding for CRf per se (reviewed in Everitt et al., 
2001). This latter role is likely provided by cortical limbic glutamatergic inputs 
carrying information about conditioned reinforcers and converging onto the ventral 
striatum, which provides the “limbic-motor interface” (Mogenson et al., 1980). In 
this respect, the BLA appears to play a major role. The BLA projects to the OFC, 
NAcc core and NAcc shell (Wright et al., 1996) and is considered to form a fronto-
temporal system underlying more complex goal-directed behaviour (Everitt and 
Robbins, 1992; Schoenbaum et al., 1998; Everitt et al., 1999). Thus, the BLA is not 
necessary for Pavlovian conditioning per se, but may provide an affective 
representation of environmental stimuli to support more complex forms of goal-
directed behaviour (including CRf; Cador et al., 1989; Burns et al., 1993; Whitelaw 
et al., 1996; Setlow et al., 2002), but not the simple elicitation of a stimulus CR 
(Parkinson et al., 2000a). The ventral subiculum, with an ability to influence 
dopamine transmission in the NAcc (Brudzynski and Gibson, 1997; Floresco et al., 
1998), may provide a contextual background necessary for the potentiation of CRf 
(Everitt et al., 2001). Finally, a functional dissociation within the ventral striatum is 
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apparent, with the NAcc shell being involved in “vigour” of CRf, while “choice” or 
“direction” of the response involves the convergence of cortical limbic inputs at the 
NAcc core (Parkinson et al., 1999). 
 
1.4.3 Pavlovian-instrumental transfer 
The neural substrates mediating general PIT overlap with those described for 
Pavlovian approach. Thus, general PIT is disrupted by lesions of the CeN, but not 
the BLA (Hall et al., 2001; Holland and Gallagher, 2003) and lesions of the NAcc 
core, but not the NAcc shell (Hall et al., 2001) also disrupt general forms of PIT. 
Contrary to Pavlovian approach, there is no effect of ACC lesions on general PIT 
(Cardinal et al., 2003). A recent electrophysiology study suggests subsets of 
neurons in the PLC and OFC are involved in the integration of Pavlovian and 
instrumental information, which is fundamental to the general PIT effect 
(Homayoun and Moghaddam, 2009). 
 
The circuitry recruited for outcome specific PIT can be dissociated from that of 
general PIT. Thus, lesions of the BLA (Blundell et al., 2001; Corbit and Balleine, 
2005), but not the CeN (Holland and Gallagher, 2003; Corbit and Balleine, 2005), 
lesions of the NAcc shell, but not the core (Corbit et al., 2001) and post-training 
lesions of the OFC (Ostlund and Balleine, 2007), but not the PLC (Corbit and 
Balleine, 2003) disrupt specific PIT. Within the dorsal striatum, the dorsolateral 
striatum (DLS) appears vital for a CS to excite instrumental responding, while the 
dorsomedial striatum (DMS) is involved in the integration of CS-US associations 
with specific R-O associations to produce selective responding (Corbit and Janak, 
2007; but see Pielock et al., 2011). Using a double disconnection procedure, BLA-
NAc shell disconnection impairs the ability of outcome-specific CSs to bias 
instrumental actions during PIT, whereas BLA-NAcc core disconnection is without 
effect on selective PIT (Shiflett and Balleine, 2010). 
 
Like Pavlovian approach and CRf, a clear contribution of dopamine transmission 
for PIT has been recognised. Systemic administration of the dopamine antagonists 
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pimozide or cis-fluphenthixol were found to disrupt general PIT (Dickinson et al., 
2000). These findings may be attributable to blunted mesolimbic dopamine 
transmission, since PIT is also disrupted by antagonism of dopamine D1R and 
D2R in the NAcc core and shell (Lex and Hauber, 2008) and inactivation of the 
VTA (Murschall and Hauber, 2006; Corbit et al., 2007). Similar to the potentiation 
of CRf by psychomotor stimulants, intra-NAcc shell infusions of d-amphetamine 
potentiate general PIT (Wyvell and Berridge, 2000, 2001). The facilitation of PIT 
also occurs following intra-NAcc shell microinjections of corticotrophin releasing 
factor (Pecina et al., 2006). Selective PIT was intact in mice with knock-down of the 
dopamine transporter (Yin et al., 2006a), suggesting selective transfer may be 
independent of tonic dopamine levels (Yin et al., 2006a) and/or dopamine may be 
restricted to general excitatory effects of Pavlovian cues, with more specific 
motivational effects provided by other signals (Corbit and Balleine, 2005; El-
Amamy and Holland, 2007). 
 
Although glutamate transmission is likely involved in PIT, given the cortical limbic 
striatal circuitry recruited for PIT, there is some conflicting evidence on the 
particular molecular components involved. Systemic blockade of AMPA/KA and 
NMDA receptors were without effect on general PIT (Murschall and Hauber, 2005), 
while blockade of mGluR5 reduced general PIT (George et al., 2009). However, 
general PIT was impaired in GluR2 knock-out mice (Mead and Stephens, 2003a), 
but not GluR1 knock-out mice (Mead and Stephens, 2003b). Mutation of both 
GluR1-ser845 and GluR1-ser831 phosphorylation sites in mice resulted in a 
disruption of general PIT, but mutation of either site alone was without effect 
(Crombag et al., 2008b).  General PIT was intact in mice lacking NARP (Johnson 
et al., 2007b), a secreted neuronal product that clusters AMPA receptors and 
regulates excitatory synaptogenesis (O'Brien et al., 1999). In a test of selective 
PIT, CS enhanced responding was impaired in GluR1 knock-out mice (Johnson et 
al., 2007a). 
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Collectively, studies on the neural components of PIT indicate that general and 
selective forms recruit different neural circuits that ultimately enhance activity in the 
NAcc core and shell, respectively. Moreover, these studies support a necessary 
role of the BLA in providing more outcome-specific CS-US representations, while 
the CeN provides more general motivational control over goal-directed behaviour 
(Corbit and Balleine, 2005). The CeN may well influence general PIT through its 
ability to influence mesoaccumbens dopamine signalling, as discussed previously. 
The role of the OFC in PIT is consistent with the proposed role of this structure in 
using the acquired S-O associations to guide appropriate goal-directed behaviour 
(Pickens et al., 2005; Ostlund and Balleine, 2007; Schoenbaum et al., 2009). 
 
1.4.4 Instrumental learning 
The neural substrates mediating the acquisition and transition between goal-
directed and habitual responding have been discussed elsewhere (Belin et al., 
2009; Balleine and O'Doherty, 2010). Notably, the acquisition, but not the 
expression of goal-directed behaviour requires the prelimbic PFC (Corbit and 
Balleine, 2003; Killcross and Coutureau, 2003; Ostlund and Balleine, 2005) while 
the DMS (a striatal target of the prelimbic PFC) contributes to both the learning and 
expression of goal-directed behaviour (Yin et al., 2005). In contrast, the DLS 
appears critically important for the transition to habit based responding (Yin et al., 
2004, 2006b). 
 
There is ample evidence to implicate dopamine and glutamate signalling within the 
cortical limbic striatal circuitry the acquisition and/or performance of a simple (R-O) 
appetitive instrumental response. Instrumental learning is disrupted by D1R 
antagonism in the NAcc core (Hernandez et al., 2005), the BLA and CeN 
(Andrzejewski et al., 2005) and the ventral, but not dorsal subiculum (Andrzejewski 
et al., 2006). With regard to glutamate, instrumental learning is disrupted by pre-
trial antagonism of NMDA receptors in the mPFC (Baldwin et al., 2000), BLA and 
CeN (Andrzejewski et al., 2004; McKee et al., 2010), posterior lateral striatum 
(Andrzejewski et al., 2004) and the medial striatum (McKee et al., 2010). In 
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contrast, NMDA antagonism in the OFC (McKee et al., 2010), dorsal or ventral 
subiculum (Baldwin et al., 2000) and the anterior dorsal striatum (Andrzejewski et 
al., 2004) were without effect on the acquisition of an instrumental response. Co-
infusion of a D1R and NMDA antagonist in the NAcc core strongly impaired the 
acquisition of instrumental responding, but were without effect when infused 
separately, highlighting the importance of dopamine-glutamate interactions in the 
learning of an instrumental response (Smith-Roe and Kelley, 2000). The 
contribution of NMDA and D1R receptors in the NAcc core to the acquisition, but 
not the performance of an instrumental response has been confirmed (Kelley et al., 
1997; Baldwin et al., 2000; Hernandez et al., 2005). Finally, post-training 
interference with protein synthesis in the NAcc core impairs the acquisition of an 
instrumental response, further implicating synaptic alterations within this region as 
important for the consolidation of instrumental memories (Baldwin et al., 2002; 
Hernandez et al., 2002). 
 
1.4.5 Summary 
I have presented a review of studies that have investigated neural components of 
sign-tracking, CRf and PIT and of appetitive instrumental responding. The neural 
substrates underlying each behavioural model of Pavlovian incentive learning are 
distinct, but also show some commonality (Table. 1.1). Taken together, the studies 
reviewed in this section point to a critical importance for Pavlovian incentive 
learning of dopamine signalling in the striatum converging with excitatory 
glutamatergic inputs arising from limbic cortical regions such as the amygdala, 
prefrontal cortex and hippocampus (Fig. 1.3). Within each of these major nodes are 
further subdivisions (e.g. the BLA and CeN of the amygdala and the NAcc shell 
and core of the ventral striatum) that play functionally distinct roles in reward 
processing (Fig. 1.3). Lesions of specific subdivisions within these nodes can leave 
the function of other subdivisions intact, indicating that many neural components of 
reward processing learning convey parallel and independent information. This 
general theme is in accordance with neuroanatomical and theoretical models that 
support the existence of parallel and interactive neural networks in reward 
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processing (Haber et al., 2000; Cardinal et al., 2002a; Haber, 2003; Balleine and 
Killcross, 2006; DeLong and Wichmann, 2007; Belin et al., 2009; Kringelbach and 
Berridge, 2009; Balleine and O'Doherty, 2010). The striatum, broadly divisible into 
ventral and dorsal parts, is clearly an important interface between Pavlovian and 
instrumental processes. Is it now useful to introduce some details on the micro-
circuitry of the ventral striatum, to further appreciate its role as the „limbic-motor 
interface‟ (Mogenson et al., 1980).  
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Table 1.1 A summary of some brain regions involved in Pavlovian incentive 
learning processes. Lesion studies have identified an overlapping neural circuitry 
involved in different tests of Pavlovian incentive learning. Note that the picture 
presented here is rather simplified, since pharmacology manipulations of 
dopaminergic and glutamatergic signalling in each region are not incorporated. 
Green boxes, lesions disrupt behaviour; Grey, lesions are without effect; Pre, pre-
training, but not post-training, lesions disrupt behaviour; F, Area necessary for 
psychostimulant facilitation of CRf. For complete details and references, see text.  
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Figure 1.3 Neural circuitry of Pavlovian incentive learning. Glutamatergic (red) 
projections from the amygdala, hippocampus and prefrontal cortex arrive onto the 
striatum and are integrated with dopamine signals (blue) from the ventral midbrain. 
Reciprocal dopamine - GABA (black) connections between the midbrain and 
striatum result in a series of spiralling loops that allows more ventral parts of the 
striatum to influence more dorsal regions (DMS and DLS). The roles of each region 
in Pavlovian incentive learning can be briefly ascribed as follows: Hippocampus, 
contextual information; BLA, sensory specific information (producing affect); CeN, 
general motivation (producing arousal); VTA, incentive salience attribution and/or 
reward-prediction error learning; Prefrontal cortex, executive control and 
contingency / outcome representation; Dorsal striatum, control of instrumental 
actions; be they goal directed (DMS) or habit based (DLS); NAcc shell, 
consummatory CRs / hedonic URs; NAcc core, preparatory CRs / sign-tracking. 
Outputs of the striatum are illustrated in more detail in Figure 1.4 (adapted from; 
Everitt and Robbins, 2005; Yin et al., 2008).  
NAcc 
shell
NAcc
core
Dorsal 
striatum
SNc
(ventral>dorsal)
VTA 
(medial>lateral)
Hippocampus
Prefrontal cortex
BLA
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1.5 The ventral striatum 
 
The striatum can be broadly divided into ventral and dorsal parts (reviewed in 
Meredith et al., 2008; Humphries and Prescott, 2010; Sesack and Grace, 2010), 
although other reviewers have suggested that divisions of the striatum are best 
considered across a ventromedial to dorsolateral gradient (Voorn et al., 2004). The 
dorsal regions of the striatum (i.e. DMS and DLS) receive information from motor 
and somatosensory cortical inputs and have clear importance for controlling goal-
directed and habit-based instrumental actions (Balleine, 2005; Faure et al., 2005; 
Yin et al., 2006b; Yin et al., 2008; Balleine and O'Doherty, 2010). Here I will focus 
on the ventral part (i.e. the accumbens), which can be further divided into the NAcc 
shell and NAcc core regions (Zaborszky et al., 1985; Meredith et al., 1992; Brog et 
al., 1993; Sesack and Grace, 2010) and which serves as a „hub‟ of the limbic 
network, playing a central role in Pavlovian incentive learning processes. 
 
1.5.1 Afferents 
The ventral striatum receives most of its excitatory glutamatergic input from 
allocortical regions including the hippocampus and amygdala and neocortical areas 
including the prefrontal cortex (Heimer et al., 1991; Heimer and Van Hoesen, 2006; 
Meredith et al., 2008). Dopamine input to the ventral striatum comes from the VTA 
and the SN (Beckstead et al., 1979; Brog et al., 1993). There are few strong 
inhibitory afferents to the NAcc, although there is evidence for reciprocal GABA 
projections from the VP, other parts of the basal forebrain and the VTA (reviewed 
in Sesack and Grace, 2010). The NAcc shell also receives a projection from 
hypocretin neurons in the lateral hypothalamus (Peyron et al., 1998), which may 
have inhibitory actions on NAcc neurons (Martin et al., 2002). Serotonin and non-
serotonin afferents from the dorsal raphe nucleus, and small norepinephrine 
projections from the locus coeruleus (LC) and the nucleus of the solitary tract, also 
input to the NAcc, the latter mainly to the NAcc shell (reviewed in Sesack and 
Grace, 2010). 
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Both glutamatergic and dopaminergic inputs appear differentially distributed 
between the NAcc core and shell compartments. For example, the ventral 
subiculum of the hippocampus projects primarily to the NAcc shell, while the more 
dorsal parts of the subiculum innervate the core (Meredith et al., 2008). Similarly, 
inputs from the amygdala strongly innervate the NAcc shell, but innervate only 
small compartments (the patches or striosomes) of the core (Ragsdale and 
Graybiel, 1988; Wright et al., 1996). Glutamatergic projections to the shell from the 
cortical regions arise from infralimbic, central and lateral orbital cortices, while 
projection to the NAcc core arise from more dorsal regions of the prefrontal cortex, 
such as the ventral and dorsal prelimbic and anterior cingulate cortices (reviewed 
in Yin et al., 2008). With respect to dopamine, the medial shell receives the most 
dense dopaminergic innervation (Voorn et al., 1986), with inputs to the NAcc shell 
arising almost exclusively from the VTA (Brog et al., 1993). In contrast, the NAcc 
core receives dopaminergic projections from both the VTA and SN (Brog et al., 
1993). More specifically, dopamine neurons from the SNc project to „patch‟ 
compartments in the ventral striatum (Gerfen et al., 1987), while dopaminergic 
neurons from the VTA terminate ventromedially in the NAcc shell and in medial 
parts of the core (Brog et al., 1993). How these different glutamatergic and 
dopaminergic inputs are fully integrated throughout the ventral and dorsal striatum 
is still under investigation, but the possibility exists that inputs from different regions 
can synapse onto the same principal neurons of the striatum, as has been 
demonstrated for inputs from the ventral subiculum and BLA and inputs from the 
PFC and BLA (French and Totterdell, 2002, 2003). Such connectivity may be 
critical for allowing hippocampal and BLA afferents to gate prefrontal influences on 
accumbens neurons (O'Donnell and Grace, 1995; O'Donnell et al., 1999; Grace, 
2000) 
 
1.5.2 Efferents 
The major projections of the ventral striatum are GABAergic and connect with the 
VP, SN, VTA, hypothalamus and brainstem (reviewed in Sesack and Grace, 2010). 
The NAcc core projects mainly to the dorsolateral portion of the VP, the 
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entopenduncular nucleus and the SNr (Sesack and Grace, 2010). The NAcc shell 
innervates regions including the ventromedial part of the VP, SNc and VTA. 
Inhibitory projections from the NAcc shell to the VTA influence DA cells that, in 
turn, project to the NAc core, which give rise to a medial to lateral series of 
„spiralling‟ projections which allow ventral regions of the striatum to influence 
transmission in more dorsal, motor-related, striatal regions (Heimer et al., 1991; 
Haber et al., 2000; Haber, 2003; Ikemoto, 2007). 
 
1.5.3 Medium spiny neurons 
The principle neurons in the striatum were first described as medium in size and 
densely spiny (Ramón y Cajal, 1911). Medium spiny neurons (MSNs) use GABA 
as their primary neurotransmitter, express neuropeptides, and comprise 90-95% of 
the total neuronal population of the striatum (Kita and Kitai, 1988; Meredith et al., 
2008). However, MSNs are far from homogenous in morphology, the organisation 
of their inputs, the peptides and receptors they express and regions that they 
project to (Gerfen et al., 1990; Meredith et al., 2008; Bertran-Gonzalez et al., 
2011). Morphologically, the cell bodies of MSNs are smaller in the ventral striatum 
than in the dorsal striatum, but the spine densities are similar (Meredith et al., 
1992). However, in the medial shell, MSNs are smaller still and have fewer 
dendritic arbors and spines compared to MSNs in other striatal regions. Thus, it is 
estimated that MSNs in the medial shell have 80% less surface for synaptic contact 
than MSNs in the dorsal striatum (Meredith et al., 1992). With regard to 
organisation of inputs, MSNs receive glutamate input at synapses on the “head” of 
the spine (Kemp and Powell, 1971), while dopamine terminals generally contact 
with the “neck” of the spine (Bolam, 1984; Freund et al., 1984). This so-called „triad 
of elements„ is believed to enable dopamine signals to influence the efficacy of the 
glutamatergic signal (reviewed in Dani and Zhou, 2004). But, in the NAcc core, 
only about half of dopaminergic inputs contact with spine necks and in the medial 
shell, approximately one third of dopaminergic terminals make contact with spines 
(Zahm, 1992). In more medial and caudal regions of the ventral striatum, more 
dopaminergic contacts are found on dendrites of MSNs (Zahm, 1992). 
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1.5.4 Direct and indirect pathways 
What receptors and peptides do MSNs express and where do they project to? 
These topics have been a matter of some debate and there may be ventral / dorsal 
striatal divisions that are not yet fully understood (for review see Voorn et al., 2004; 
Sesack and Grace, 2010; Bertran-Gonzalez et al., 2011). Current evidence 
suggests that MSNs can be segregated into approximately equal numbers based 
on the target of their main axon (Beckstead and Cruz, 1986). MSNs that form the 
„direct‟ striatonigral pathway project mainly to the SNr and express the D1R as well 
as the neuropeptides dynorphin and substance P (Hong et al., 1977; Mroz et al., 
1977). MSNs that form the „indirect‟ striatopallidal pathway connect to the SNr 
through successive synaptic relays in the VP and STN, and express primarily 
D2Rs and enkephalin (Finley et al., 1981; Gerfen and Young, 1988; Gerfen et al., 
1990). Uncertainty remains as to the identity and strength of connections on 
postsynaptic neurons to which MSNs project, but techniques such as optogenetics 
are beginning to prove useful in this area of research (e.g. Chuhma et al., 2011). 
 
Finally, it is important to recognize that MSNs make contact not only with neurons 
outside of the striatum but also within it (Chang and Kitai, 1986; Chuhma et al., 
2011). There exist MSN–MSN connections, which may allow for lateral inhibition 
within the NAcc, of which unidirectional (D1R-D1R or D2R-D2R) collaterals are 
most common and D2RD1R collaterals are more abundant than D1RD2R 
(Taverna et al., 2005; Taverna et al., 2008). MSNs may also connect with striatal 
inter-neurons, which together comprise < 5% of all striatal neurons, that include 
cholinergic tonically active neurons (TANs), fast-spiking interneurons (FSIs) and 
low-threshold spiking GABAergic inter-neurons (Kawaguchi et al., 1995). 
 
1.5.5 Summary 
Some of the connective intricacies of the striatum have been highlighted. The key 
points from this section are that, first, the striatum receives extensive dopaminergic 
inputs from the ventral midbrain and glutamatergic inputs from cortical and limbic 
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regions (Fig. 1.3). Second, how these inputs are integrated is not completely 
understood, but dopaminergic synapses are often well placed at the neck of spines 
on MSNs to modulate information encoded by glutamatergic inputs connecting at 
the spine head. Third, MSN projections from the striatum are broadly divisible into 
the direct pathways which connect with the ventral midbrain and express 
predominantly dopamine D1Rs and indirect pathways, which first connect with the 
ventral pallidum and express predominantly dopamine D2Rs (Fig. 1.4). Fourth, a 
series of ascending spiral loops between the striatum and midbrain allow the 
ventral striatum to influence activity in more dorsal striatal regions (Fig. 1.3). 
Finally, local connections amongst MSNs and striatal inter-neurons are likely 
critical for regulating overall striatal activity. 
 
A challenge remains to understand how various components of the striatum 
interact at a network level in Pavlovian incentive learning processes (discussed 
further in Berridge, 2004; Voorn et al., 2004; Goto and Grace, 2008; Yin et al., 
2008; Belin et al., 2009). The ventral striatum can be considered as a „hub‟ for 
associative Pavlovian learning, while the dorsal striatum is a „hub‟ for integrating 
sensorimotor actions. That neurons from the VTA and SNc project differently 
between ventral and dorsal parts of the striatum has led some to propose that the 
mesoaccumbens pathway may have a role more restricted in acquiring the value of 
stimuli during Pavlovian learning, while the nigrostriatal pathway may be more 
critical for learning the value of actions (Yin et al., 2008). However, it is important to 
remember that both striatal regions likely operate in parallel in „real world‟ 
situations in which actions may lead to the presentation of conditioned incentives 
and where conditioned incentives may be encountered that, in turn, promote 
actions. Serial, dopamine-dependent connectivity linking the ventral striatum to 
more dorsal regions is proposed to offer a neural substrate for how incentive 
motivation can link to cognitive processes, with glutamate afferents onto the ventral 
striatum acting to push control in this circuitry toward more dorsal sites (Belin et al., 
2009). 
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The neural circuitry of Pavlovian incentive learning is clearly important for adaptive 
behaviours, but its role in clinical disorders, and in particular drug addiction, is 
increasingly appreciated. In the next section, I will introduce some of the work 
which supports a role of Pavlovian incentive learning and its neural components in 
addiction-related behaviours.  
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Figure not shown due to copyright restrictions 
For figure, see Seack and Grace, 2010, Fig. 2. 
 
Figure 1.4 Outputs of the ventral striatum. Hypothetical direct and indirect output 
pathways whereby the NAcc core and shell may disinhibit or inhibit, respectively, 
adaptive motor pathways. Note that in this figure exist direct projections (i.e. D1R 
expressing) to the ventral mid brain, and indirect projections (i.e. D2R expressing) 
to the midbrain via the pallidum and subthalamic nucleus. Only major projections 
are shown. Red indicates inhibitory structures and pathways, whereas green 
indicates excitatory connections. BF Hypoth: basal forebrain and hypothalamus, 
MD Thal: mediodorsal thalamic nucleus, NAc: nucleus accumbens, PFC: prefrontal 
cortex, SNr: substantia nigra zona reticulata, STN: subthalamic nucleus, VP dl/vm: 
ventral pallidum, dorsolateral/ventromedial, VTA: ventral tegmental area (Sesack 
and Grace, 2010)  
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1.6 Drug addiction and Pavlovian incentive learning 
 
“A number of detoxified cocaine users in our clinic population report experiencing 
intense arousal and cocaine craving when they encounter „reminders‟ of their 
previous cocaine use: the sight of cocaine-using friends or locations, the use of 
alcohol, the sight of white bread, crumbs on the carpet, even the sight of talcum 
powder while changing a child‟s diaper... In our view, these cocaine „reminders‟ are 
essentially classically conditioned stimuli which have acquired their „reminder 
power‟ through repeated pairings with cocaine‟s pharmacologic effects over the 
natural course of a patient‟s drug use.” (taken from Childress et al., 1988) 
 
Drug addiction is defined as a chronic relapsing disorder characterised by loss of 
control over drug intake and compulsive drug taking despite adverse 
consequences (Everitt and Robbins, 2005; Koob and Le Moal, 2006). A cardinal 
feature of drug addiction is the high likelihood of relapse, even after long periods of 
abstinence from drug taking (DeJong, 1994). Early views of drug addiction 
emphasised motivation to take drugs because of their initial hedonic effects and to 
continue take drugs to avoid negative effects associated with drug withdrawal 
(Koob and Le Moal, 1997; Koob and Le Moal, 2006). However, as exemplified in 
the clinical observations above made by Childress and colleagues (1988) of 
detoxified drug users who were probably no longer experiencing withdrawal, a role 
for drug-associated cues is now appreciated in both the maintenance of drug 
seeking and taking and in precipitating relapse (Stewart et al., 1984; Robinson and 
Berridge, 1993; Everitt et al., 2001; Hyman and Malenka, 2001). 
 
Addictive drugs, such as cocaine, and drug-paired CSs closely interact with and 
can persistently alter the neural systems involved in Pavlovian incentive learning 
(reviewed in Berke and Hyman, 2000; Hyman and Malenka, 2001; Kelley, 2004; 
Hyman et al., 2006; Kauer and Malenka, 2007; Belin et al., 2009). For example, 
cocaine-associated stimuli have been found to activate dorsolateral striatum and 
limbic cortical areas in humans (Childress et al., 1999; Garavan et al., 2000; 
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Volkow et al., 2006) and non-contingent presentations of drug CSs are able to 
increase dopamine release in the NAcc core, but not the shell of rats (Ito et al., 
2000). Moreover, repeated d-amphetamine exposure can facilitate appetitive 
Pavlovian learning (Harmer and Phillips, 1998, 1999) and, within the striatum, 
exposure to addictive drugs can dramatically alter dopamine and glutamate 
signalling (Di Chiara and Imperato, 1988; White et al., 1995; White and Kalivas, 
1998; Wolf, 1998; Ungless et al., 2001; Kalivas, 2004; Wolf and Ferrario, 2010), 
can cause persistent alterations in neuronal morphology (Robinson and Kolb, 
2004; Crombag et al., 2005) and alter how information is processed and how 
actions are controlled at a network level (Schoenbaum and Setlow, 2005; 
Takahashi et al., 2007; Belin and Everitt, 2008). As a result of these (and many 
more) neurobiological changes caused by drug experience, drug-associated cues 
are proposed to become particularly effective in triggering drug-taking habits 
(Everitt and Robbins, 2005; Belin et al., 2009), or may become pathologically 
„wanted‟ due to a sensitisation of incentive salience attribution (Robinson and 
Berridge, 1993). 
 
In the following sections I will introduce the incentive-sensitisation model (Robinson 
and Berridge, 1993), given the experiments on behavioural sensitisation reported 
later in this thesis (Chapter 5). It is also valuable to introduce some ideas on how 
such CSs may operate in controlling addiction-related behaviours. 
 
1.6.1 Incentive-sensitisation 
Incentive motivation theory (see section 1.2.4) proposes that environmental stimuli 
associated with rewards can acquire incentive salience as a consequence of 
classical conditioning processes. Within the context of drug addiction, incentive-
sensitisation theory provides an account of how addictive drugs, through their 
ability to activate and cause persistent neural adaptations in „reward-related‟ brain 
areas, result in drugs and associated stimuli exerting increasingly powerful control 
over drug seeking and taking behaviour in some individuals (Robinson and 
Berridge, 1993, 2000, 2001, 2003, 2008). The four major points of the incentive 
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sensitisation, outlined by Robinson and Berridge (2001) are that 1) potentially 
addictive drugs cause long-lasting alterations in the brain 2) brain systems altered 
include those normally involved in incentive motivation and reward 3) these neural 
adaptations result in reward systems being sensitised to drug effects and drug 
associated stimuli and 4) these systems do not mediate pleasure or euphoric drug 
effects, but do mediate the incentive salience „wanting‟ component of reward. 
Importantly, the incentive-sensitisation model proposes that drugs and drug 
associated stimuli may be wanted more and more even if the affective/hedonic 
qualities of drugs are experienced less and less. Thus, „liking‟ components of 
reward, from the incentive-sensitisation perspective, are neither necessary nor 
sufficient for drug addiction to develop (Robinson and Berridge, 2001). 
 
Measuring the psychomotor activating effects of addictive drugs has been a 
primary method of assessing sensitisation, based on the assumption that neural 
components underlying behavioural sensitisation overlap with those involved in 
reward processing (Robinson and Becker, 1986; Wise and Bozarth, 1987; 
Robinson and Berridge, 1993, 2000). It is worthwhile pointing out some parameters 
of behavioural sensitisation and consider what some of these may tell us about 
how this phenomenon reflects addiction-related processes (reviewed in Robinson 
and Berridge, 2001). Behavioural sensitisation is dose-dependent (Kalivas et al., 
1988), typically requires repeated, intermittent drug experience (Robinson and 
Becker, 1986) but can also follow repeated exposure to food (Le Merrer and 
Stephens, 2006). Sensitisation in remarkably persistent (Robinson and Becker, 
1986), can occur with drug self-administration (Phillips and Di Ciano, 1996) and 
shows individual differences in susceptibility (Robinson and Berridge, 2001; Flagel 
et al., 2008). Individual variation seen in the development of sensitisation have 
been found to correlate with individual variation seen in incentive salience 
attribution and is proposed to reflect differences in vulnerability or resistance to 
drug addiction and other compulsive behavioural disorders (Flagel et al., 2008; 
Flagel et al., 2009; Robinson and Flagel, 2009). Sensitisation is also strongly 
influenced by associative learning that involves circumstances surrounding drug 
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experience (Robinson et al., 1998). Thus, while sensitisation of neural systems can 
occur non-associatively, the expression of behavioural psychomotor sensitisation 
critically depends upon stimuli (such as the context) associated with drug 
experience (Pert et al., 1990; Anagnostaras and Robinson, 1996). This feature 
may reflect the role of drug-associated contexts in precipitating relapse (Robinson 
and Berridge, 2001). In addition, whether the environment is novel or familiar (i.e. a 
home environment) can also influence the development of sensitisation (Badiani et 
al., 1995; Crombag et al., 1996; Browman et al., 1998b, a; Crombag et al., 1999). 
 
1.6.2 Sign-tracking 
How might conditioned incentives influence addiction-related behaviour? Drug-
paired CSs can elicit approach toward them (Uslaner et al., 2006) and, in real-
world situations, individuals may be brought into close proximity with sources 
where drugs can be found, which may in turn influence the propensity to relapse 
(Stewart et al., 1984; Tiffany, 1990; Robinson and Berridge, 1993; Tomie, 1996; Di 
Chiara, 1998; Everitt and Robbins, 2005). Although sign-tracking effects have long 
been thought important for addiction-related behaviours, it has only been with 
recent methodological developments that sign-tracking toward drug-paired CSs 
has been demonstrated in animals (Krank, 2003; Kearns and Weiss, 2004; Uslaner 
et al., 2006; Cunningham and Patel, 2007). 
 
1.6.3 Conditioned reinforcement 
In many aspects of addiction-related behaviours, conditioned reinforcers may play 
a critical role. First, conditioned reinforcers may maintain drug-seeking between 
periods when drugs are not available, as modelled using the second-order 
schedule of reinforcement (Kelleher, 1966; Arroyo et al., 1998; Schindler et al., 
2002; Mead and Stephens, 2003b; Wilson and Bowman, 2004; Di Ciano and 
Everitt, 2005). Indeed, drug-seeking for psychostimulants is particularly sensitive to 
omission of conditioned reinforcement during second-order schedules (Goldberg et 
al., 1981). Second, following extinction of an instrumental drug-seeking response, 
conditioned reinforcers are observed to reinstate instrumental responding on the 
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previously drug-paired lever (de Wit and Stewart, 1981; Kruzich et al., 2001; 
Highfield et al., 2002; Shalev et al., 2002; Shaham et al., 2003). This „extinction-
reinstatement model of drug seeking‟ may reflect the observation that humans 
frequently relapse after prolonged abstinence from drug taking. Third, conditioned 
reinforcers are able to support the acquisition of a new instrumental response (Di 
Ciano and Everitt, 2004a), which may model the learning of new behavioural 
strategies for obtaining drugs by drug addicted individuals (Everitt and Robbins, 
2005). Whether these three differing operational roles of conditioned reinforcers 
are also neurobiologically separable remains to be determined (Stephens et al., 
2010). Finally, as has been discussed previously, psychostimulants can markedly 
enhance responding for CRf maintained by CSs associated with natural rewards 
(see section 1.4.2). Everitt and Robbins (2005) propose that this feature of 
psychostimulants may be a critical component that contributes to their reinforcing 
effects; by analogy, this could be one reason why certain drugs are repeatedly 
taken for their ability to enhance enjoyment of music and other social experiences. 
 
1.6.4 Pavlovian-instrumental transfer 
PIT like processes may be considered as important in invigorating efforts to seek 
out, to consume or to „want‟ drugs (Berridge and Robinson, 2003; Everitt and 
Robbins, 2005) and it is noteworthy that PIT effects have been shown for smokers 
working to gain cigarettes and money (Hogarth et al., 2007). To date, PIT like 
processes have not been observed with drug-associated CSs in animals. In fact, 
unexpected drug-CS presentations are found to suppress rather than enhance 
drug-seeking (Di Ciano and Everitt, 2003), which may be due to distracting effects 
of the highly salient „wanted‟ cues (Robinson and Berridge, 1993; Belin and Everitt, 
2008). 
 
1.6.5 Summary 
The present section has introduced the idea that environmental cues associated 
with addictive drugs, through associative learning processes, are proposed to 
subsequently influence drug taking, seeking and relapse in ways that reflect normal 
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Pavlovian incentive learning processes (i.e. sign-tracking, CRf and PIT). There has 
been some debate as to whether the effects of drug-associated cues arise 
because of „aberrant learning‟ (Tiffany, 1990; Berke and Hyman, 2000; Everitt et 
al., 2001); in terms of strengthened stimulus-stimulus associations or dominant 
effects of S-R habits (discussed in Robinson and Berridge, 2003). Everitt and 
Robbins (2005) propose that habit does not refer to a procedural skill, but rather a 
persistent and repetitive initiation of an activity (e.g. drug-seeking). The incentive-
sensitisation model argues that S-S associations are not pathologically strong, that 
learning itself is normal and learning alone cannot generate compulsive behaviour 
(Robinson and Berridge, 2001, 2003). Rather, Robinson and Berridge (1993, 2000, 
2001, 2003, 2008) assert that the motivational impact of drug-associated CSs 
themselves are elevated due to sensitisation of systems (particularly mesolimbic 
and mesocorticolimbic dopamine systems) that control incentive salience „wanting‟ 
attribution. However, food can also support behavioural sensitisation that shows 
many commonalities with drug sensitisation (Le Merrer and Stephens, 2006), 
suggesting that behavioural sensitisation alone cannot account for a dominance of 
drug-seeking behaviour supported by drug associated cues (Stephens, 2006). 
Nevertheless, the role of drug associated CSs and Pavlovian learning processes 
are likely of critical importance for many features of addiction, including the 
maintenance of drug-seeking and taking and of relapse after periods of abstinence. 
 
I have now discussed at length Pavlovian incentive learning, its neural components 
and its relevance to drug addiction. Throughout this introduction an important and 
often necessary role of dopamine and glutamate signalling has been identified. In 
the final part of this introduction, the importance of glutamate signalling and the 
metabotropic glutamate receptor, mGluR5, will be further considered. 
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1.7 A focus on glutamate 
 
Mesolimbic and mesostriatal dopamine has gained prominence as the 
neurotransmitter of reward-related learning (Schultz, 1997; Schultz et al., 1997; 
Berridge and Robinson, 1998; Wise, 2004; Flagel et al., 2010). However, as has 
been highlighted throughout this introduction, glutamatergic afferents to the 
striatum and glutamate signalling within this and other reward-related structures, 
including the amygdala, are clearly important for Pavlovian incentive processes 
(e.g. Hitchcott and Phillips, 1997; Baldwin et al., 2000; Di Ciano et al., 2001; Di 
Ciano and Everitt, 2001; Mead and Stephens, 2003b, a; Andrzejewski et al., 2004; 
Dalley et al., 2005; Crombag et al., 2008b; Crombag et al., 2008c; Milton et al., 
2008b; McKee et al., 2010). In addition, dopamine outflow from the ventral 
midbrain is heavily influenced by glutamatergic inputs from the prefrontal cortex, 
ventral hippocampus and amygdala (reviewed in Sesack and Grace, 2010).  
 
Many of the studies reviewed thus far point to dissociable roles of specific 
glutamate receptors in the ventral striatum, with NMDA receptors generally seen as 
necessary for the acquisition of learning (e.g. Kelley et al., 1997; Dalley et al., 
2005), and AMPA receptors playing a more prominent role in the performance of 
acquired associations (e.g. Di Ciano et al., 2001). This theme has led a number of 
reviewers to propose that sculpting of synapses on striatal MSNs during reward-
related learning may be critical for determining how these neurons subsequently 
respond to salient events (e.g. reward-associated CSs) and that glutamatergic 
mechanisms, acting in partnership with dopamine, may be critical for instigating 
and maintaining these experience-dependent neuroplastic changes (Kelley et al., 
2003; Svenningsson et al., 2004; Dalley et al., 2005; Valjent et al., 2005; Meredith 
et al., 2008; Wolf and Ferrario, 2010). Moreover, glutamatergic signalling, and 
alterations of it following exposure to addictive drugs, may be a key component 
underlying much addiction-related behaviour (Kalivas and Duffy, 1998; Kalivas, 
2000; Vanderschuren and Kalivas, 2000; Kalivas, 2004; Wolf et al., 2004; Conrad 
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et al., 2008; Engblom et al., 2008; Kalivas and O'Brien, 2008; Kalivas, 2009; 
Mameli et al., 2009). 
 
In the following sections, I will briefly introduce some receptors of the glutamatergic 
neurotransmitter system and consider some features that underwrite their central 
role in synaptic plasticity, considered as the cellular correlate of learning and 
memory (Bliss and Lomo, 1973; Morris et al., 1986). Finally, I will introduce 
metabotropic glutamate receptors with a focus on group I mGluRs. Some 
electrophysiology and behavioural evidence will be reviewed that points to this 
receptor family as playing a central role in striatal synaptic plasticity and which 
indicates that mGluR5, in particular, could play an important role in Pavlovian 
incentive learning processes and the behavioural effects of addictive drugs, 
including cocaine. 
 
1.7.1 Ionotropic NMDA and AMPA receptors 
NMDA receptors, named after the selective agonist N-methyl-D-aspartate, are 
multimeric complexes formed of subunits belonging to three related families (NR1-
3), with NR1 and NR2 required for subunit function (reviewed in Monaghan et al., 
2005). An important feature of NMDA receptors is that they are both ligand gated 
and voltage gated, with voltage dependency due to blockade of NMDA receptor 
channels by Mg2+ ions at negative membrane potentials (Mayer et al., 1984; 
Nowak et al., 1984). NMDA receptors are highly permeable to Ca2+, Na+ and K+ 
ions. Calcium permeability through NMDA receptors allows for the activation of 
intracellular signalling cascades; a feature that advocates NMDA receptors as 
critical for triggering experience-dependent plasticity (Monaghan et al., 2005). 
Indeed, NMDA receptor activation is critical for many forms of LTP (a long lasting 
enhancement of the synaptic response following high frequency stimulation of an 
afferent input) that have been observed in brain tissue (Collingridge and Bliss, 
1995; Nicoll and Malenka, 1999), and also for the opposing phenomenon of LTD (a 
long lasting reduction in synaptic strength following low-frequency stimulation of an 
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afferent). Whether NMDA activation results in LTP or LTD may also depend, in 
part, upon the NMDA receptor subunit composition (Hrabetova et al., 2000). 
 
AMPA receptors, named after the selective agonist α–amino-3-hydroxy-5-
methylisoxazole-4-propionate, consist of four subunits (GluR1-4) and the 
composition of these subunits can dramatically alter the pharmacological and 
functional properties of the receptor. Notably, while agonist binding reveals a pore 
in AMPA receptors that can flux NA+ ions and allow for depolarisation of the cell, 
GluR2 lacking AMPA receptors can also flux Ca2+, which leads to more robust 
changes in cellular activation (reviewed in Monaghan et al., 2005; Derkach et al., 
2007; Shepherd and Huganir, 2007). AMPA receptors can also be phosphorylated 
at multiple sites on the intracellular C-terminal domain of their subunits, which 
allows for rapid and dynamic changes in the electrophysiological, morphological 
(e.g. trafficking and clustering) and biochemical (e.g. synthesis and subunit 
composition) properties of these receptors (reviewed in Wang et al., 2005; Santos 
et al., 2009). The correct trafficking of AMPA receptors is critical for the expression 
and maintenance of synaptic plasticity, with LTP generally requiring incorporation 
of new AMPA receptors at synapses, and LTD requiring removal of synaptic AMPA 
receptors (the mechanisms underlying AMPA trafficking have been extensively 
reviewed elsewhere; Song and Huganir, 2002; Bredt and Nicoll, 2003; Collingridge 
et al., 2004). 
 
1.7.2 Metabotropic glutamate receptors 
Metabotropic glutamate receptors (mGluR) are categorised into three groups, 
based on similarities in agonist pharmacology, primary sequence and associated 
G-protein effector coupling; Group I (mGluR1 and mGluR5), Group II (mGluR2 and 
mGluR3) and Group III (mGluR4, mGluR6, mGluR7 and mGluR8) (Alexander et 
al., 2008). The mGluRs share a common structure of a large bi-lobed extracellular 
N-terminal domain, seven putative trans-membrane spanning domains separated 
by short intra- and extracellular loops, and a variable length cytoplasmic carboxyl-
terminal domain (Fig. 1.5; Abe et al., 1992; Conn and Pin, 1997; Cartmell and 
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Schoepp, 2000; Kew and Kemp, 2005). Activation of mGluRs can trigger a 
cascade of intracellular events that indirectly alter neuronal excitability and can 
also produce relatively slow and delayed synaptic currents (reviewed in Ossowska, 
2005). 
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Figure not shown due to copyright restrictions 
For figure, see Conn and Pin, 1997, Fig. 4. 
 
Figure 1.5 Schematic representation of an mGluR. The mGluRs share a common 
structure of a large bi-lobed extracellular N-terminal domain that contains the 
glutamate (Glu) biding site, seven putative trans-membrane spanning domains 
separated by short intra- and extracellular loops that together mediate G protein 
activation, and a variable length cytoplasmic carboxyl-terminal domain which 
regulates receptor activity and targeting by interactions with proteins including 
calmodulin, Homer and PICK1. Positive and negative allosteric modulators bind to 
the heptahelical transmembrane domain (adapted from Conn and Pin, 1997).  
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1.7.3 Group I mGluRs 
1.7.3.1 Function 
Group I mGluRs positively couple via pertussis toxin-insensitive G protein (Gq/11) to 
phospholipase Cβ (PLCβ), modulating cellular activity through secondary 
messenger cascades associated with increased phosphoinositide hydrolysis and 
calcium mobilization (Abe et al., 1992; Conn and Pin, 1997; Kew and Kemp, 2005). 
Activation of mGluR5a induces oscillations of intracellular calcium (Nash et al., 
2001), whereas mGluR1a activation produces a single peak of intracellular calcium 
followed by a plateau (reviewed in Ossowska, 2005). Calcium mobilisation 
following group I mGluR activation can occur in a number of ways, including 1) 
production of ionositol 1,4,5-trisphosphate (IP3) due to PLCβ activation, with 
resultant release of Ca2+ from internal stores via IP3 receptors located on the 
endoplasmic reticulum (Fagni et al., 2000), 2) release of Ca2+ from internal stores 
via ryanodine-sensitive receptors (Fagni et al., 2000) and 3) Ca2+ influx through 
voltage dependent L-type calcium channels in the plasma membrane (Fagni et al., 
2000; Ossowska, 2005). Calcium signalling by group I mGluRs is likely to involve 
Homer proteins, which can physically bridge these receptors to internal calcium 
stores (Tu et al., 1998). In a partly calcium independent manner, Group I mGluRs 
can positively link to the extracellular signal-regulated kinase (ERK) cascade 
(Peavy and Conn, 1998; Thandi et al., 2002), which has numerous functions in  
experience-dependent plasticity, for example, by regulating gene expression, cell 
proliferation and AMPA receptor trafficking (Adams and Sweatt, 2002; Boudreau et 
al., 2007; Patterson et al., 2010). 
 
1.7.3.2 Localisation 
In the CNS, distribution of group I mGluRs is widespread. Regarding mGluR5 (Fig. 
1.6), Immunohistochemistry of mGluR5 protein and in situ hybridization of mGluR5 
mRNA has identified intense expression predominantly in the telencephalic 
regions; including the cerebral cortex, hippocampus, subiculum, the olfactory bulb, 
dorsal and ventral striatum and the lateral septal nucleus (Abe et al., 1992; 
Shigemoto et al., 1993; Testa et al., 1994; Romano et al., 1995). Electron 
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microscopic immunocytochemistry has indicated that mGluR5 is primarily localised 
postsynaptically in the striatum (Shigemoto et al., 1993) and on post-synaptic 
dendritic spines and shafts in the cortex and hippocampus (Romano et al., 1995; 
Shigemoto et al., 1997). Typically, group I mGluRs are found in a perisynaptic zone 
that surrounds the ionotropic receptors (Luján et al., 1996). To a lesser extent, 
Group I mGluRs may be found pre-synaptically on glutamatergic (Herrero et al., 
1992; Thomas et al., 2000), cholinergic (Marti et al., 2001; Feligioni et al., 2003) 
and noradrenergic (Parodi et al., 2006) nerve endings (but see Cartmell and 
Schoepp, 2000 for review). 
 
The distribution of mGluR1 and mGluR5 largely overlap, although the relative 
expression of either receptor varies markedly amongst brain regions. Thus, the 
density of mGluR5 is considerably higher than mGluR1 in the basal ganglia and 
the CA1, CA3 and dentate gyrus of the hippocampus (Spooren et al., 2001). 
Expression of mGluR1 in the Purkinje cell layer of the cerebellum is high, but this 
area is almost devoid of mGluR5 (reviewed in Ossowska, 2005).  
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Figure not shown due to copyright restrictions 
For figure see Shigemoto et al 1993, Fig 2 
 
Figure 1.6 Localisation of mGluR5 receptors in the adult rat brain. (a) Negative 
image of a parasagittal section showing mGluR5 immunoreactivity. Abbreviations: 
Sp, Spinal trigeminal nucleus; Cb, Cerebellum; IC, Inferior colliculus; Hi, 
Hippocampus; Th, thalamus; St, Striatum; Cx, Cerebral cortex; Ac, accumbens 
nucleus; AO, Anterior olfactory nucleus; AOB, Accessory olfactory bulb, MOB: 
main olfactory bulb. Bar = 4 mm (taken from Shigemoto et al., 1993)  
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1.7.3.3 Pharmacology 
Synthetic ligands for the mGluRs can be divided into competitive ligands which 
interact with the bi-lobed orthosteric agonist binding site and a relatively newer 
class of non-competitive ligands that interact with the transmembrane heptahelical 
domain, and which function as positive and negative allosteric modulators 
(reviewed in Kew and Kemp, 2005). Regarding competitive ligands, the most 
potent group I mGluR agonist, that displays reasonable selectivity over AMPA 
receptors and group II and III mGluRs, is (S)-3,5-dihydroxyphenylglycine [(S)-
DHPG] (Schoepp et al., 1999), which exhibits low micromolar potency at mGluR1 
and 5 (Kew and Kemp, 2005). The compound (R,S)-2-chloro-5-
hydroxyphenylglycine (CHPG) is also a low-potency agonist at rat recombinant 
mGluR5 and is selective over mGluR1 (Doherty et al., 1997). Selective mGluR1 
competitive antagonists have also been developed, which include (R,S)-1-
aminoindan-1-5-dicarboxylic acid (AIDA) (Pellicciari et al., 1995). 
 
Non-competitive mGluR5 antagonists have proven particularly valuable in 
understanding the physiological role of these receptors thanks to their useful in 
vivo pharmacokinetic profiles. Notably, 2-methyl-6-(phenylethynyl)-pyridine (MPEP) 
is a potent ligand of mGluR5 (IC50 = 37nM at human mGluR5a) and exhibits 
inverse agonism (Gasparini et al., 1999), while 3-[2-methyl-1,3-thiazol-4-
yl)ethynyl]pyridine (MTEP) exhibits improved selectively and CNS bioavailability 
over MPEP (Cosford et al., 2003). It is worthwhile noting that a number of positive 
allosteric modulators of group I mGluRs have also been identified, which may be 
particularly useful in reducing the potential for receptor desensitisation and 
tolerance effects associated with other ligands (reviewed in Kew and Kemp, 2005). 
 
1.7.3.4 Role in plasticity 
Group I mGluRs are well positioned at post-synaptic excitatory synapses to 
regulate neuronal excitability (reviewed in Ossowska, 2005) and to facilitate or 
induce both LTP and LTD of synaptic strength, although the cellular mechanisms 
through which these effects are achieved may vary amongst brain regions 
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(reviewed in Anwyl, 1999; Bellone et al., 2008; Anwyl, 2009; Luscher and Huber, 
2010). Commonly, activation of group I mGluRs is associated with a persistent 
weakening of glutamatergic synapses (i.e. mGluR-LTD), which typically involves a 
pre-synaptic expression mechanism mediated by retrograde endocannabinoid 
signalling (Gerdeman and Lovinger, 2001; Sung et al., 2001; Robbe et al., 2002). 
However, mGluR-LTD can also occur independently of endocannabinoid signalling 
(Rouach and Nicoll, 2003) and can be expressed post-synaptically (Huber et al., 
2000; Snyder et al., 2001; Nosyreva and Huber, 2005). 
 
In the dorsal and ventral striatum, group I mGluRs are densely expressed on both 
D1- and D2-MSNs (Tallaksen-Greene et al., 1998) and can influence synaptic 
plasticity in both striatal regions and on both MSN populations (Surmeier et al., 
2009; Luscher and Huber, 2010). In the dorsal striatum, mGluR-LTD is prevented 
on D1-MSNs of the direct pathway in the presence of dopamine, while mGluR-LTD 
on D2-MSNs of the indirect pathway is promoted (Kreitzer and Malenka, 2007; 
Shen et al., 2008). Both LTD mechanisms involve post-synaptic mGluRs, involve 
endocannabinoid signalling and are expressed pre-synaptically (reviewed in 
Luscher and Huber, 2010). 
 
Within the ventral striatum, CB1 receptors are also present on glutamatergic 
corticostriatal afferents and activation of post-synaptic mGluR5 is both necessary 
and sufficient to produce retrograde endocannabinoid signalling, resulting in LTD 
through stimulation of these pre-synaptic CB1 receptors (termed 'eCB-LTD'; Robbe 
et al., 2002; Uchigashima et al., 2007). Notably, eCB-LTD in the NAcc is abolished 
following a single administration of cocaine (Fourgeaud et al., 2004). It is not 
known how dopamine regulates mGluR-dependent eCB-LTD in the ventral striatum 
and the relative contributions of mGluR1 and mGluR5 to mGluR-LTD in the ventral 
and dorsal striatum are not fully understood. Some evidence suggests that 
mGluR1 is the primary receptor mediating mGluR-LTD in the striatum (Gubellini et 
al., 2001), while both mGluR5 and mGluR1 may be necessary for corticostriatal 
LTP (Gubellini et al., 2003). In either case, mGluR-LTD would seem necessary to 
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balance activity between the direct and indirect pathways, which is normally 
dominated by an inhibition (i.e. LTD) of the indirect pathway (Surmeier et al., 
2007). It is also noteworthy that mGluR5 participates in retrograde cannabinoid 
signalling in the BLA (Zhu and Lovinger, 2005) and, at excitatory synapses in the 
mouse prefrontal cortex, retrograde endocannabinoid signalling plays an important 
role in mediating LTD, with some evidence pointing to involvement of mGluR5 
(Lafourcade et al., 2007). 
 
In addition to altering pre-synaptic glutamate release through endocannabinoid 
signalling, post-synaptic group I mGluRs can closely interact with other post-
synaptic receptors to influence neuronal plasticity. For example, both mGluR5 and 
dopamine D1Rs, but not D2Rs, may be involved in LTP that occurs in the NAcc 
core following high-frequency stimulation of glutamatergic inputs (Schotanus and 
Chergui, 2008), while mGluR5 is found to potentiate NMDA responses in striatal 
MSNs following stimulation of corticostriatal afferents (Pisani et al., 2001). In some 
brain regions (such as the hippocampus and VTA), mGluR-LTD can arise through 
alterations in post-synaptic AMPA receptor trafficking (Huber et al., 2000; Mameli 
et al., 2007; Luscher and Huber, 2010), which involves rapid local synthesis of 
proteins that include activity-regulated cytoskeletal associated protein (Arc; Park et 
al., 2008), microtubule associated protein 1b (MAP1b; Davidkova and Carroll, 
2007) and striatal enriched tyrosine phosphatase (STEP; Moult et al., 2006; Zhang 
et al., 2008). At least in the VTA, mGluR-LTD requires the rapid synthesis of 
GluR2, which forms GluR2-containing AMPA receptors that are built within minutes 
and replace synaptic GluR2-lacking (calcium permeable) AMPA receptors (Mameli 
et al., 2007). Notably, mGluR-LTD is only observed in the VTA after synapses have 
been potentiated by cocaine exposure, suggesting that group I mGluRs may play a 
protective role by „depotentiating‟ synapses (Bellone and Luscher, 2005, 2006; 
Mameli et al., 2007). Finally, interactions with the ERK-MAPK and PI3K-mTOR 
intracellular signalling pathways provide a mechanism through which group I 
mGluRs can alter translational regulation and induce plasticity (reviewed in 
Luscher and Huber, 2010). 
54 
 
 
1.7.3.5 Role in behaviour 
Much of what is known about the role of group I mGluRs in behaviour has come 
from studies using the selective mGluR5 antagonists MPEP and MTEP. Both 
compounds have been shown to display anxiolytic and antidepressant activity 
(Ballard et al., 2005; Li et al., 2006; Belozertseva et al., 2007; Stachowicz et al., 
2007; George et al., 2009), to reverse L-dopa induced dyskinesia in rodent models 
of Parkinson‟s disease (Dekundy et al., 2006; Levandis et al., 2008), to modulate 
nociceptive transmission (Neugebauer, 2002; Zhu et al., 2005; Osikowicz et al., 
2008) and to modulate the reinforcing effects of drugs of abuse (Table 1.2), as 
discussed further below (and reviewed elsewhere; Carroll, 2008; Markou, 2009; 
Olive, 2009). Recent evidence also suggests that positive allosteric modulators of 
mGluR5 may provide a novel approach for the development of antipsychotic and 
precognitive agents (Liu et al., 2008). Thus, it appears that mGluR5 contributes to 
a variety of behavioural and emotional processing functions, which is in 
accordance with the predominant expression of mGluR5 within the limbic system. 
 
In a now seminal study, mGluR5 knock-out mice were found not to self-administer 
cocaine and were insensitive to cocaine‟s locomotor stimulating effects 
(Chiamulera et al., 2001). Following this report, numerous studies have used 
mGluR5 antagonists to further understand the role of this receptor in animal 
models of addiction-related behaviours and behavioural effects of addictive drugs. 
Thus, by example of cocaine, mGluR5 antagonism has been shown to disrupt the 
acute psychomotor activating effects of cocaine (McGeehan et al., 2004), to block 
the acquisition and/or expression of cocaine sensitisation (Dravolina et al., 2006; 
Veeneman et al., 2010), to disrupt the acquisition of cocaine CPP (McGeehan and 
Olive, 2003) (but see Herzig and Schmidt, 2004), and to attenuate reinstatement of 
drug seeking by cocaine-associated cues and by a cocaine prime (Backstrom and 
Hyytia, 2006; Kumaresan et al., 2009). Indeed, mGluR5 antagonists have been 
shown to disrupt the reinforcing effects of addictive substances from a variety of 
pharmacological classes, as assessed using the drug self-administration paradigm 
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(Table 1.2). Interestingly, mGluR5 antagonism had no effect on the reinstatement 
of food seeking by a food-paired cue (Bespalov et al., 2005; Gass et al., 2008; 
Kumaresan et al., 2009), although reinstatement of seeking induced by a 
discriminative cue paired with sweetened, condensed milk was attenuated by 
MTEP (Martin-Fardon et al., 2009). 
 
Taken together, these studies suggest that mGluR5 may be intimately involved in 
appetitive learning processes for both „natural‟ and/or „drug‟ rewards. However, it 
remains uncertain as to whether mGluR5 plays an exclusive role in primary and/or 
secondary reinforcement and, in fact, little work has been done to tease apart the 
role of mGluR5 in specific Pavlovian incentive learning processes (although see 
George et al., 2009). Furthermore, attempts to clarify the exact contribution and 
neuroanatomical location of mGluR5 in regulating responses to addictive drugs or 
reward-paired CSs have been complicated by the fact that pharmacological tools, 
such as MPEP, may induce anhedonia following intracerebral administration 
(Backstrom and Hyytia, 2007), or may possess intrinsic reinforcing properties (van 
der Kam et al., 2009b) and also because of the widespread expression of mGluR5 
in the brain (Shigemoto et al., 1993). 
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Table 1.2 Review of mGluR5 antagonist effects on drug self-administration. Abbreviations: NHP, Non-human primate; M, male; F, female; 
FR, fixed-ratio; PR, progressive ratio; i.m. intra muscular; i.v. intra venous; i.p. intra peritoneal; MED: minimum effective dose; ↓ indicates 
decrease in self-administration  
Drug Reference Species
Sub species / 
Strain Sex Schedule
mGluR5 
antagonist
Doses 
(mg/kg)
Admi
n 
Route
Pre-
dose 
time 
(min)
Outcome 
(MED; 
mg/kg)
Cocaine (Platt et al., 2008) NHP Squirrel Monkey M FR10 MPEP 0.1-1.8 i.m. ↓ (0.3)
(Lee et al., 2005) NHP Squirrel Monkey M/F FI(FR) MPEP 0.1-1.0 i.m. 5 ↓ (0.3)
(Tessari et al., 2004) Rat Wistar M FR2 MPEP 1.0-10 i.v. 30 ↓ (10)
(Paterson et al., 2005) Rat Wistar M PR MPEP 1.0-9.0 i.p. 30 ↓ (9)
(Kenny et al., 2005) Rat Wistar M FR1 MPEP 1.0-9.0 i.p. 30 ↓ (3)
(Osborne et al., 2008) Rat SD M FR1 MTEP 0-3 i.p. 30 ↓ SA (1)
(Gass et al., 2008) Rat SD M FR1/PR MTEP 0-3 ↓
Ethanol (Cowen et al., 2005) Rat Fawn Hooded M FR3 MTEP 2 i.p. 20 ↓ (2)
(Cowen et al., 2005) Rat Alc Prefering (iP) M FR3 MTEP 0.5-2 i.p. 20 ↓ (1)
(Besheer et al., 2008) Rat Alc Prefering (P) M PR MPEP 1.0-10 i.p. ↓ (3)
(Schroeder et al., 2005) Rat Alc Preferring (P) M MPEP 1.0-10 ↓ (3)
(Cowen et al., 2007) Mouse C57BL/6 M FR1 MTEP 5-40 i.p. 20 ↓ (20)
(Lominac et al., 2006) Mouse C57BL/6J M FR4 MPEP 1.0-30 i.p. 30 ↓ (10)
(Hodge et al., 2006) Mouse C57BL/6J M FR1 MPEP 1.0-10 i.p. 0 ↓ (3)
Heroin (van der Kam et al., 2007) Rat Long Evans FR10 MPEP 1.25-20 i.p. 30 ↓ (20)
Ketamine (van der Kam et al., 2007) Rat Long Evans FR3 MPEP 1.25-20 i.p. 30 ↓ (5)
Nicotine (Tessari et al., 2004) Rat Wistar M FR2 MPEP 1.0-10 i.v. 30 ↓ (10)
(Palmatier et al., 2008) Rat Sprague Dawley M FR1(VS/lever) MPEP/MTEP 0-12/0-4 i.p. ↓ (6 & 2)
(Liechti et al., 2007) Rat Wistar M FR5 MPEP 1.0-9.0 i.p. 30 ↓ (6)
(Paterson et al., 2005) Rat Wistar M PR MPEP 1.0-9.0 i.p. 30 ↓ (9)
(Paterson, et al., 2003) 
(Markou, et al., 2004) Rat Wistar M FR5 MPEP 1.0-9.0 i.p. 30 ↓ (3)
Methamph
etamine
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1.7.4 Summary 
Reward processing is multifaceted, but associative learning represents one major 
component that allows an organism to recognise and appropriately respond to 
environmental stimuli that are predictive of reward experience. Reward-associated 
stimuli can influence behaviour in many ways that are considered to reflect the 
formation of distinct CS-US associations. Investigations into the neural substrates 
of Pavlovian incentive learning have identified a forebrain circuitry involving cortical 
limbic and striatal regions, with glutamatergic and dopaminergic signalling 
recognised as important in both the formation of distinct reward-related memories 
and in determining responding to reward-associated stimuli. The striatum, with its 
ventral and dorsal parts, is a key integration point for dopaminergic signalling 
arising from the ventral midbrain with glutamatergic inputs from cortical and limbic 
regions. Outputs from the striatum to motivational and motor systems can be 
broadly distinguished into two neuronal populations that form the direct striatonigral 
(D1-MSNs) and indirect striatopallidal (D2-MSNs) pathways. A challenge remains 
to understand how reward experience might sculpt activity in these functionally 
distinct pathways, which could determine how these pathways, and presumably the 
organism in turn, respond to reward-associated stimuli. Moreover, understanding 
how addictive drugs interact with the neural mechanisms of Pavlovian incentive 
learning may provide insight to how drug associated stimuli come to influence 
drug-seeking, taking and relapse in addiction. 
 
Within this context, mGluR5 is particularly interesting. From histology and 
electrophysiology studies, group I mGluRs appear ideally positioned to contribute 
to experience-dependent neuroplastic changes in reward-related brain areas, 
either through modulation of pre-synaptic neurotransmitter release, post-synaptic 
intracellular signalling cascades and/or post-synaptic activity of D1Rs, NMDA and 
AMPA receptors. With the advent of useful in vivo tools, behavioural studies have 
identified mGluR5 as important for appetitive learning for „natural‟ and/or „drug‟ 
rewards. However a number of interesting questions remain unanswered. First, it is 
not clear which component(s) of reward processing mGluR5 is involved in, such as 
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liking and/or incentive salience attribution or Pavlovian and/or instrumental 
learning. Second, with regard to Pavlovian incentive learning, it is not clear whether 
mGluR5 contributes to general motivational and/or outcome specific learning and 
whether mGluR5 could be involved in learning necessary to support sign-tracking, 
CRf and/or PIT. Third, it is not clear whether mGluR5 could play a role in the 
acquisition of reward-related associations and/or the expression of control over 
behaviour by reward-associated stimuli. Fourth, it is not clear where in the brain 
mGluR5 might contribute to reward processing, although the striatum would seem 
like one obvious candidate given the particularly high expression of mGluR5 in this 
region. Fifth, if striatal mGluR5 contributes to reward-related learning, it would be of 
interest to understand the relative contributions of mGluR5 located on MSNs of the 
D1R direct striatonigral pathway or the D2R indirect striatopallidal pathway. Finally, 
it would be of further value to understand the effect of addictive drugs on signalling 
mediated by mGluR5 which, combined with a better understanding of the role of 
mGluR5 in reward processing, may provide some insight to how drug-associated 
stimuli come to influence addiction-related behaviours. 
 
As outlined in the following sections, experiments reported in this thesis will aim to 
address some of these issues using behavioural pharmacology techniques 
combined with immunohistochemistry and immunoblotting in novel mouse line in 
which mGluR5 has been selectively knocked-down on cells that express dopamine 
D1Rs (termed mGluR5KD-D1 mice; Novak et al. 2010).  
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1.8 Aims and structure of this thesis 
 
1.8.1 Chapter 2 
Chapter 2 investigates the basic phenotype of mGluR5KD-D1 mice. Particular 
attention is paid to taste, vision and auditory function and motor activity. Intact 
function of these sensory and motor systems will be required to undertake more 
complex behavioural tasks in mGluR5KD-D1 mice. In addition, there is much 
evidence to support a role of mGluR5 in anxiety-related behaviours (e.g. Spooren 
et al., 2000b), thus potential alterations in anxiety-related behaviours in mGluR5KD-
D1 mice will be assessed using three tests of unconditioned anxiety; open-field, 
light-dark box and elevated plus-maze. The experiments reported in this chapter 
therefore aim to discover any basic deficits in mGluR5KD-D1 mice that should be 
considered when undertaking and interpreting data from other experiments 
reported in this thesis. 
 
1.8.2 Chapter 3 
Chapter 3 explores Pavlovian incentive learning in mGluR5KD-D1 mice. Given the 
dense expression of mGluR5 in „reward-related‟ brain areas (Shigemoto et al., 
1993; Sesack and Grace, 2010) and its established role in synaptic plasticity 
(Bellone et al., 2008), considered as the cellular correlate of learning and memory 
(Kelley, 2004), it is reasonable to propose that mGluR5 may have a critical role in 
appetitive Pavlovian learning. To investigate this possibility, cohorts of mGluR5KD-
D1 mice will be trained a Pavlovian association between a food reward and a simple 
stimulus (such as a tone or light). The ability of mGluR5KD-D1 mice to learn about 
the predictive properties of the food-paired CS will be assessed in tests of 
discriminated approach. The ability of the CS to acquire incentive motivational 
value, such that it can reinforce, attract and motivate behaviour will be assessed in 
tests of CRf, sign-tracking (Pavlovian approach) and PIT, respectively. To further 
probe neural function in mGluR5KD-D1 mice, the ability of cocaine to facilitate CRf 
will be examined. 
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1.8.3 Chapter 4 
The aim of Chapter 4 is to investigate whether the CRf deficit in mGluR5KD-D1 mice 
reported in Chapter 3 reflected a failure of these mice to learn an incentive 
association between an environmental stimulus and a food reward (i.e. an 
acquisition deficit) and/or a failure of the conditioned incentive to subsequently 
exert control over behaviour (i.e. an expression deficit). Since mGluR5 is 
constitutively knocked-down in mGluR5KD-D1 mice, the experiments in Chapter 4 
will take a pharmacology approach to investigate this question. Thus, wild-type 
mice will be injected with the mGluR5 antagonist, MTEP, to block mGluR5 function 
during the learning of a Pavlovian association and/or a test of CRf. In this way, the 
role of mGluR5 in the acquisition and/or expression of predictive and incentive 
properties of a reward-paired CS will be assessed. 
 
1.8.4 Chapter 5 
Findings from chapter 3 and 4 both implicate mGluR5 in the acquisition of incentive 
associations that subsequently enable a CS paired with a “natural” reward (food) to 
control behaviour. Environmental stimuli associated with addictive drugs, such as 
cocaine, are proposed to exert powerful control over behaviours because of the 
effects of such drugs on the neural circuitry that mediates incentive learning and 
memory processes (Robinson and Berridge, 1993; Nestler, 2001; Kelley, 2004; 
Hyman et al., 2006). If incentive Pavlovian learning is disrupted in mGluR5KD-D1 
mice, it is reasonable to propose that some behavioural effects of cocaine, which 
reflect cocaine-induced neuronal adaptations within reward-related brain areas, 
may also be disrupted in mGluR5KD-D1mice. Thus, Chapter 5 will use mGluR5KD-D1 
mice to explore the contribution of mGluR5 on dopaminoceptive neurons to 
cocaine conditioned reward, measured with the CPP task, and to behavioural 
sensitisation. 
 
1.8.5 Chapter 6 
Experiments in Chapter 5 reveal that the acute psychomotor activating effects of 
cocaine are significantly attenuated in mGluR5KD-D1 mice when compared to their 
61 
 
wild-type counterparts. If some acute behavioural effects of cocaine, which involve 
glutamate and dopamine signalling in the striatum, are diminished, it may be 
expected that some neurobiological effects of cocaine are also disrupted in the 
striatum of mGluR5KD-D1 mice. The experiments of Chapter 6 explore this possibility 
using immunohistochemistry and immunoblotting techniques to measure cocaine-
induced activation of the ERK1/2 pathway in the striatum of mGluR5KD-D1 mice. 
This pathway appears critical for influencing transcriptional regulation proposed to 
underlie the long term effects of addictive drugs (Girault et al., 2007). In addition, 
both cocaine and group I mGluRs are well known to regulate trafficking of AMPA 
receptors, a feature also considered important for neuroplastic changes underlying 
addiction-related behaviours (Snyder et al., 2001; Bellone and Luscher, 2005; 
Zhang et al., 2008; Wolf and Ferrario, 2010). The second series of experiments 
reported in Chapter 6 aim to explore, with immunoblotting, the extent to which loss 
of mGluR5 on dopaminoceptive neurons disrupts rapid changes in AMPA receptor 
trafficking and function in the striatum that occur following acute cocaine exposure. 
Finally, it must be remembered that while the experiments of this chapter tell us 
something about the role of mGluR5 on dopaminoceptive neurons in neuroplastic 
changes that may contribute to behavioural effects of cocaine, they may also serve 
to highlight deficits in neuroplasticity following loss of mGluR5 on these neurons 
that could contribute to incentive learning deficits in mGluR5KD-D1 mice reported in 
Chapter 3 of this thesis. 
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2 Basic phenotyping of mGluR5KD-D1 mice 
 
2.1 Introduction 
 
Advances in molecular genetics have led to a revolution in our ability to explore the 
function of individual genes in physiology and behaviour. From the introduction of 
the inbred mouse stain in the 1900s to the development of transgenic (Jaenisch, 
1976) and genetically mutated mice (Thomas and Capecchi, 1987), powerful tools 
now exist to examine genetic components of more complex behavioural traits that 
characterise many human disorders. The mapping of animal genomes (Lander et 
al., 2001; Waterston et al., 2002) has facilitated the ability to insert or remove 
genes or modify their expression levels in a cell-type and time-point specific 
manner. However, with these advancements comes an important caveat. Genes 
do not work in isolation and mutation of a single gene or transgene insertion can 
have many effects beyond those anticipated by the investigator. The observable 
characteristics (that is, the phenotype) of a novel mouse line must therefore be well 
understood before more advanced behavioural analyses are undertaken. 
 
The aim of this chapter will be to characterise the basic phenotype of a novel 
mouse line in which mGluR5 has been selectively knocked-down on cells that 
express dopamine D1 receptors by use of RNA interference technology. Before 
introducing these experiments in further detail (section 2.1.3 of this chapter), it is 
first necessary to appreciate some general concepts in generating transgenic mice 
and the use and limitations of RNA interference technology, which is a relatively 
recent addition to the neuroscientist toolbox. In addition, the mGluR5KD-D1 mouse 
and its biological characterisation (as reported in Novak et al., 2010) will be 
introduced. 
 
2.1.1 Transgenic mice in behavioural neuroscience 
Tremendous progression within molecular biology, genetics and behavioural 
neuroscience has uncovered great complexity in the genetic control of human 
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behaviour. One gene can influence multiple phenotypic traits (termed, pleiotropy; 
Hodgkin, 1998), indicating that genes and their associated proteins do not work in 
isolation but are part of a complex network of interactions. For example, 
transcriptional silencing of the FMR1 gene, arising from an unstable trinucleotide 
(CGG) repeat expansion mutation (Verkerk et al., 1991), can result in physical 
perturbations, attentional deficits, stereotypic movement, anxiety, autism, 
susceptibility to epilepsy and language and learning impairments that characterise 
Fragile X syndrome (Bagni and Greenough, 2005; Mercaldo et al., 2009). 
Meanwhile, psychiatric disorders such as drug addiction, depression or 
schizophrenia can reflect the interaction of multiple genes and signals that control 
their expression (termed, epigenetics; Nestler, 2000; Tsankova et al., 2007). Gene-
behaviour and gene-gene interactions are also influenced by environmental 
factors, which add another layer of complexity in determining behavioural output 
under normal and aberrant states (Feder et al., 2009; Bale et al., 2010). If we are 
to successfully parse the genetic components of human behaviours, a model 
organism is required in which individual genes can be readily manipulated, 
environment factors carefully controlled and individual behaviours that contribute to 
complex behavioural traits examined. 
 
A variety of experimental species have been adopted by behavioural geneticists. 
Genomic alterations of species traditionally used to examine developmental 
processes, including the nematode Caenorhabditis elegans, fruit fly Drosophila 
melanogaster, and zebrafish Danio rerio have recently been used to study the 
genetic basis of associative learning processes (Glanzman, 2005; Ardiel and 
Rankin, 2010; Sison and Gerlai, 2010) and of more complex behavioural disorders 
such as Parkinson‟s disease (Schmidt et al., 2007; Flinn et al., 2008; Botella et al., 
2009). While these species are cost effective and their genes can be rapidly 
manipulated, the translation of findings to mammalian systems can prove difficult 
(Yin et al., 2007). In contrast, rodents share ~99% of their genes with humans 
(Waterston et al., 2002) and the rat is perhaps one of the best characterized 
laboratory species with regard to its physiology, neurobiology, pharmacological 
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responses and behavioural repertoire. Until recently, the development of 
genetically modified rats was precluded by the failure to generate germline 
competent rat embryonic stem (ES) cells (Buehr et al., 2008; Li et al., 2008; Voigt 
and Serikawa, 2009). In contrast, mouse pluripotent ES cells were successfully 
isolated in 1981 (Evans and Kaufman, 1981), which allowed for modifications of 
the mouse genome to be transmitted through the mouse germline (Capecchi, 
1989). Around the same time, the first transgenic mouse was generated by the 
stable integration of foreign DNA into the genome using pronuclear microinjection 
(Brinster et al., 1981; Gordon and Ruddle, 1981; Wagner et al., 1981). When 
combined with behavioural tasks, many of which were initially developed for use 
with rats, the genetically modified mouse offers a powerful model system for 
understanding the genetic components of complex behavioural traits. 
 
2.1.1.1 Generation of transgenic mice and some limitations 
The application of mutant mice for the exploration of gene function is dependent, in 
part, upon methodologies available to manipulate the genome (Branda and 
Dymecki, 2004). The techniques used to generate mutant mice have become 
increasingly sophisticated since their original description in the early 1980s and 
today, literally thousands of modified strains are available to the researcher 
(Yoshiki et al., 2009; Ringwald and Eppig, 2010). It is beyond the scope of this 
thesis to address the many molecular techniques that enable generation of mice 
with deletions, insertions, inversions or exchanges of chromosomal DNA with high 
fidelity and regional and temporal specificity of expression. Indeed, a number of 
reviews thoroughly discuss generation of mice by homologous recombination of ES 
cells, including site-specific recombination (for example, Cre/loxP and Flp-FRT), 
knock-out, knock-in and conditional gene inactivation techniques (Picciotto and 
Wickman, 1998; Brusa, 1999; Misra and Duncan, 2002; Branda and Dymecki, 
2004; Castrop, 2010). In addition to these „designer‟ mutant technologies, the 
contribution of phenotype-driven strategies in mice for identifying the genetic basis 
of behavioural traits, such as mapping of spontaneous or induced single gene 
mutations in inbred strains and QTL analysis, also deserves mention (reviewed in 
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Lander and Botstein, 1989; Paigen, 2003b, a; Peters et al., 2007). A more detailed 
consideration of the features and potential limitations of transgenic mice generated 
by pronuclear microinjection using RNA interference (RNAi) is warranted however, 
as this approach was used to generate the mGluR5KD-D1 strain (Novak et al., 2010). 
 
The generation of transgenic mice by pronuclear microinjection first requires the 
design of a transgene expression cassette, which is then cloned into a vector, 
purified, microinjected into the pronuclei of fertilized eggs and reimplanted into the 
oviducts of a pseudo-pregnant foster mother. Newborn mice that carry the 
transgene are referred to as founders of the transgenic line and, all being well, the 
transgene is passed onto progeny in Mendelian fashion (Brusa, 1999; Auerbach, 
2004). Clearly, the entire process is not quite as straightforward as the two 
sentence description just provided. Many factors contribute to the success of 
generating the novel transgenic mouse line, which include the design of the 
transgene cassette and the genetic material that is incorporated into the genome. 
 
The transgene expression cassette typically contains two major components; the 
transcription unit of a gene of interest and regulatory elements that control its 
expression, which are cloned into a vector such as a bacterial or yeast artificial 
chromosome (BAC or YAC) (Auerbach, 2004). A reporter gene can also be 
incorporated into the cassette, allowing for expression of the transgene to be 
readily identified. Reporter gene examples include lacZ, which is detected by 
assaying for β-galactosidase, and Green Fluorescent Protein (GFP; or its 
enhanced version, EGFP), which can be visualized without need for a substrate 
(Chalfie et al., 1994).  
 
The regulatory elements (promoter/enhancer) of the transgene cassette can 
provide regional specificity of transgene expression. For example, use of a small 
fragment of the gene promoter for tyrosine hydroxylase confers selectivity of 
transgene expression to dopaminergic neurons (Liu et al., 1997), while larger 
promoter fragments can drive gene expression in all catecholaminergic cells (Min 
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et al., 1994). Careful selection of neural-specific promoters can therefore offer 
greater precision for investigating the function of a specific gene and an associated 
protein within a brain region that cannot be so easily isolated with lesioning 
approaches or in which pharmacology is neither available or regionally or cell-type 
selective. Promoters can also confer temporal specificity of transgene expression. 
For example, a transgene with a promoter of the NR2B subunit would be 
expressed in neurons of the forebrain and cerebellar granule cells from embryonal 
to early stages of postnatal development, but would then be selectively repressed 
in the cerebellum after the second week (Monyer et al., 1994). Further control over 
transgene expression is afforded by inducible promoters, such as tetracycline-
responsive promoters (Gossen and Bujard, 1992; Mayford et al., 1996), which 
enable the switching on and/or off of a promoter with an external stimulus. Tissue 
specific transgene removal and activation can also be achieved using the Cre 
recombinase system (Schwenk et al., 1995; Auerbach, 2004). 
 
There are some important limitations associated with the use of pronuclear 
microinjection for generation of transgenic mice. A significant issue is that the 
efficiency of production of founder mice that appropriately express the transgene is 
low. First, microinjection can result in genetic mosaicism if the transgene is 
integrated during or after a round of replication in the fertilized egg (Palmiter et al., 
1984). Second, random insertion of the transgene into the genome may result in 
transgene expression being influenced not only by the number of transgene 
copies, but also by genomic sequences that flank the integration site(s) (termed, 
positional effects; Palmiter et al., 1982; Overbeek et al., 1986). For example, 
transgene expression may be dramatically reduced or abolished if the transgene is 
inserted into a transcriptionally inactive region of the genome. Alternatively, 
flanking sequences may contain regulatory elements of neighboring genes that act 
on the transgene promoter as an enhancer, resulting in ectopic expression 
(Auerbach, 2004). Moreover, if a transgene is inserted into a transcriptionally active 
region, it may interrupt the normal expression of an endogenous gene and produce 
effects on phenotype ranging from inconsequential to lethal but, most importantly, 
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which are independent of the particular function of the transgene. Third, as with all 
approaches that seek to modify the mouse genome, compensation effects from 
other genes can result in rescued function of the mutated gene and may mask any 
phenotypic deficit due to a mutation. Finally, irrespective of any positional or 
compensation effects, the mutant mice phenotype will always be a result of the 
mutated gene and interactions with background genes. Since behavioural traits 
vary amongst mouse strains, the genetic background of the strain used to 
construct the modified mouse must always be considered when assessing 
behavioural traits (Gerlai, 1996; Crawley et al., 1997; Crawley, 2007). 
 
2.1.1.2 RNA interference technology and some limitations 
The inclusion of a gene of interest in the transgene cassette has traditionally 
restricted the pronuclear microinjection approach to „gain of function‟ studies (with 
respect to time, place and/or level of gene expression). For example, in middle to 
advanced stages of Alzheimer‟s disease, galanin fibers and terminals are found to 
hyper-innervate cholinergic neurons of the nucleus basalis of Meynert (Chan-
Palay, 1988). The potential consequences of galanin hyper-function for learning 
and memory processes have been explored, in part, by the use of transgenic mice 
that over-express galanin throughout the CNS using a platelet-derived growth 
factor promoter (Diez et al., 2000; Kuteeva et al., 2005), or where galanin over-
expression is confined to adrenergic neurons by use of a dopamine β-hydroxylase 
promoter (Steiner et al., 2001). In many scenarios, however, a more revealing 
experiment is provided by the „loss of function‟ study, which has traditionally been 
achieved by genetic disruption using ES cell technology. The identification of RNAi 
and the ability to deliver RNAi technology into mammalian cells using a transgene 
cassette has changed this situation and provided a new way to study gene function 
in transgenic mice (Hannon, 2002; Bartel, 2004; Prawitt et al., 2004; Gao and 
Zhang, 2007; Kunath, 2008). 
 
The first demonstration of RNAi came from studies in C. elegans where introducing 
double-stranded RNA (dsRNA) homologous to a specific gene resulted in the post-
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translational silencing of that gene (Fraser et al., 2000). The cellular mechanism 
through which silencing is achieved is particularly interesting. Initially, the dsRNA is 
recognized by a nuclease enzyme, named Dicer, and processed into small double-
stranded molecules, termed small interfering RNA (siRNA). Next, siRNA is 
unwound by an RNA-induced silencing complex (RISC), which then finds 
homologous target mRNAs complementary to the siRNA sequence and cleaves 
these mRNAs (Martinez et al., 2002; Tijsterman and Plasterk, 2004). This 
response to dsRNA is considered a likely self-defense mechanism against viral 
invasion (Gao and Zhang, 2007). In mammalian cells, a similar response to dsRNA 
is observed, except that the end result is silencing of all protein encoding RNAs 
and, eventually, cell death via apoptosis (Meurs et al., 1990). However, it was later 
discovered that short (21 nt) RNA duplexes could induce RNAi in cultured 
mammalian cells without eliciting global gene silencing (Elbashir et al., 2001). 
Another major breakthrough for RNAi was the discovery that animal cells naturally 
express short (~22 nt) RNAs, termed micro-RNA (miRNA; Lagos-Quintana et al., 
2001; Lee and Ambros, 2001), that arise from the processing of long primary 
miRNA precursors (pri-miRNA) (Bartel, 2004). These micro-RNAs play an 
important role in regulating gene expression through blocking translation, or 
inducing degradation of target mRNA (Bartel, 2004). Exploitation of these collective 
findings allowed molecular biologists to stably induce RNAi in mammalian cells, 
first using expression vectors that expressed the RNA duplex as small hairpin RNA 
(shRNA), which is likely processed to siRNA within the cell (Brummelkamp et al., 
2002), followed by the use of artificial miRNA-expressing vectors (Silva et al., 
2005). The stable expression of RNAi in transgenic mice (Peng et al., 2006) is now 
becoming more commonplace, providing an alternate approach to targeted gene 
disruption in delineating gene function. Moreover, in comparison to conditional 
gene deletion, RNAi can be used with only one mouse line, and offers the potential 
to be used, in modified forms, in other organisms where targeted mutagenesis is 
not feasible. 
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There are, of course, some important limitations of the RNAi technology for 
generation of transgenic mice. First, knock-down of expression is never complete 
and residual expression of an RNAi-targeted gene is expected (Gao and Zhang, 
2007). However, this limitation may be seen as advantageous where null mutations 
are associated with lethality. Second, RNAi is useful for modulating the level of 
gene expression, but cannot be used for other genetic manipulations (e.g. point 
mutations). Third, not all cell types can perform RNAi, and the efficiency of cells 
that can varies widely amongst cell types (Peng et al., 2006). Fourth, the genetic 
material used to produce RNAi may have off-target effects, such as degradation of 
non-target mRNA (Castrop, 2010). Finally, whether a transgenic RNAi effect is 
permanent remains to be determined, since it is possible that an shRNA transgene 
could be shut down during development or turned off through epigenetic 
modifications (Gao and Zhang, 2007). 
 
2.1.1.3 Characterising a new transgenic mouse 
Because of the potential complications that may arise in the generation of 
transgenic mice and use of RNAi, phenotyping screens provide an important and 
necessary step in understand traits related to transgene function or unexpected 
abnormalities (Crawley, 2007). Phenotyping screens also complement the rigorous 
assessment by molecular biologists of transgene expression and the potential for 
compensatory or off-target effects in founder lines. Findings of gross phenotypic 
differences between genotypes can be used to optimise animal husbandry and/or 
the design of subsequent behavioural tests. Indeed, only when the basic 
phenotype has been characterised can conclusions from advanced behavioural 
tests be made with assurance that an exciting finding is not simply due to 
interference from unexpected behavioural traits. 
 
The majority of phenotyping screens have adapted protocols from those originally 
described by Irwin (1968), which incorporated some 50 categories of observations. 
More recently, the SHIRPA consortium described an observation battery for mutant 
mice that consists of three levels of testing, starting with preliminary observations 
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(for example, muscle function) and progressing to more detailed assessments of 
behaviour and physiology (for example, feeding, anxiety, histology and magnetic 
resonance imaging) (Rogers et al., 1997). Whatever combination of assessments 
are chosen, the first point of phenotyping is to ensure that the mutant line is 
generally healthy, since ill mice will likely behave aberrantly in the simplest 
behavioural test. This initial inspection often includes assessments of sensory 
capabilities and basic neurological reflexes, such as the righting reflex. Any gross 
physical deficits will similarly impair performance in many behavioural tests. Once 
these compulsory observations have been completed, subsequent tests can be 
selected to determine adequate function for performance in specific behavioural 
tasks or to test specific hypotheses regarding gene function (Crawley, 2007). For 
example, undertaking the Morris water-maze task would require that mice could 
adequately swim and observations of motor activity would be necessary. Similarly, 
phenotyping screens for strains with mutations known to affect neuronal excitability 
might focus on observations of convulsions, locomotor activity and handling 
reactivity. Any deficits found within a particular domain can then be investigated 
further. 
 
2.1.2 Introducing the mGluR5KD-D1 mouse 
To explore the role of mGluR5 in mediating appetitive behaviours and 
neurobiological responses to cocaine, we use a novel mouse line in which mGluR5 
has been selectively knocked-down in cells that express the dopamine D1R. The 
generation and characterization of these mGluR5KD-D1 mice has recently been 
described (Novak et al., 2010). Cell-type specific knock-down of mGluR5 is 
achieved using a BAC-based construct in which a conventional RNA-polymerase II 
promoter (the D1R-promoter) drives the expression of artificial miRNAs that target 
mGluR5 RNA. The coding sequence for green fluorescent protein (GFP) is 
introduced in tandem with the miRNAs, enabling expression of the construct to be 
easily tracked (Fig. 2.1a-b). 
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Extensive characterization of these mice has confirmed the selectivity of transgene 
expression to cells that express the dopamine D1R (Novak et al., 2010). Thus, 
immunostaining of GFP in brains from mGluR5KD-D1 mice identified an expression 
pattern that fits with that described for D1Rs, including strong expression in the 
dorsal striatum and nucleus accumbens (Fig. 2.1c) (Novak et al., 2010). A more 
detailed examination of the striatum confirmed that the transgene (GFP) was 
expressed in ~53% of the striatal neurons (NeuN; Fig. 2.1d). Furthermore, 
expression of the transgene was confined to MSNs (identified by immunostaining 
against DARPP-32) (Fig. 2.1e) but the transgene was not expressed in D2-MSNs 
(identified by immunostaining against preproenkephalin; ppEnk) (Fig. 2.1e), 
showing that expression is restricted to D1-MSNs. Confirmation that transgene 
expression reduced the abundance of mGluR5 transcript was provided by in situ 
hybridization. In the striatum, mGluR5-positive cells were reduced, while the 
staining-intensity of cells still expressing mGluR5 was not reduced (Fig. 2.1f), 
indicating strong mGluR5 knock-down selectively in the targeted cells. The 
abundance of mGluR5 transcript was reduced to ~40% in the homogenised 
striatum (Fig. 2.1g) with the corresponding protein reduced to ~50% compared to 
levels in wild-type mice (Fig. 2.1h). Since the expression of the construct is 
restricted to D1-MSNs (Fig. 2.1e), knock-down efficiency was estimated to be 
~90% in the targeted cells. There was no significant reduction of mGluR5 mRNA in 
the cerebral cortex or in the hippocampus of mGluR5KD-D1 mice, which may 
suggest that the D1R-promotor is less strong in these regions or that D1 and 
mGluR5 are not expressed in the same neuronal populations (Novak et al., 2010). 
 
In addition to enabling selective knock-down of mGluR5 in cells that express 
dopamine receptors, the RNAi approach used for generation of mGluR5KD-D1 mice 
is particularly impressive. First, previous use of RNAi have identified that high 
levels of short RNAs may result in perturbed cellular homeostasis due to over-
saturating exportin 5 and thus blocking the processing of endogenous short RNAs 
(Grimm et al., 2006). This is not the case for the mGluR5KD-D1 mice, where 
maturation of short RNAs is normal (Novak et al., 2010). Most likely, previously 
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reported problems were caused by the use of tools resulting in very high levels of 
short RNAs, such as strong RNA polymerase III promoters or the use of shRNAs 
instead of artificial miRNAs (Boudreau et al., 2009). Second, while use of miRNAs 
may knock-down mRNAs other than mGluR5, this does not appear problematic in 
mGluR5KD-D1 mice where abundance of mRNAs with partial complementarity to the 
miRNAs was not affected (Novak et al., 2010). Third, no evidence has been found 
for a reduction in the knock-down efficiency of the mutation across generations (up 
to 12 generations over 3 years of breeding; personal communication with Dr. J. 
Rodriguez). Finally, the successful use of artificial miRNAs driven by cell-type 
specific promoters had previously only been reported for interference with other 
genes in nurse cells (Rao et al., 2006). Together with a very recent report (Garbett 
et al., 2010), the mGluR5KD-D1 line shows this approach can also be used 
successfully in the brain. 
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Figure not shown due to copyright restrictions 
For figure, see Novak et al., 2010, Fig. 1. 
 
Figure 2.1 Neurobiological characterisation of mGluR5KD-D1 mice. (a) Design of the 
transgene expressing GFP as a marker and two interfering RNAs (iRNAs). This 
construct was inserted after the translational start of the gene encoding the 
dopamine D1 receptor in a bacterial artificial chromosome. (b) Sequences of 
iRNAs. Interfering sequence is depicted in bold. Red arrows indicate targeted 
regions of mGluR5 mRNA. (c) Expression of the transgene in mGluR5KD-D1 mice 
(KD) as detected by immunohistochemistry for GFP in a sagittal brain section. 
Higher magnification showing difference between staining of cell bodies in the 
caudate putamen (CPu) and its projections to ventral midbrain nuclei (VMN). (d) 
The transgene (GFP; green) is expressed in ~53% of the striatal neurons (NeuN; 
red;  indicates examples of GFP-positive neurons and ► indicates examples of 
GFP-negative neurons). (e) The expression of the construct is selective for D1-
MSNs. Thus, expression is limited to MSNs (DARPP-32; blue) and absent from 
D2-MSNs (labeled by red immunofluorescent labelling of pre-pro enkephalin; 
ppEnk). Examples of GFP-expressing () and non-GFP-expressing (►) MSNs. (f) 
Expression of mGluR5 in the striatum as shown with in situ hybridization. (g), 
Knock-down assessment by quantitative PCR (n = 5-8, p = 0.0027) and (h), 
western-blotting with representative blot example shown (n = 4, p = 0.0112). Data 
is presented as mean + S.E.M., p-value of t-test (*p < 0.05, **p < 0.01). Scale bars 
20 μm. Cx, cortex; CPu, caudate putamen (dorsal striatum); VMN, ventral midbrain 
nuclei; Acb, nucleus accumbens (taken from Novak et al., 2010). 
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2.1.3 Phenotyping of mGluR5KD-D1 mice 
In regard to the initial phenotyping of mGluR5KD-D1 mice that will be undertaken in 
the present chapter, a conventional screening approach as discussed above will be 
adopted. Initial observations will examine basic health and neurological reflexes to 
ensure no gross abnormalities that would otherwise preclude undertaking of more 
advanced behavioural tests. Body weights of adult mice will be also assessed, 
which provides a reliable indicator of factors affecting growth (Crawley, 2007). 
Tests of sensory function will assess visual and auditory function, since 
conditioning studies necessitate that mice can adequately see and hear the 
conditioned stimuli. Similarly, mutant mice must be able to detect a palatable food, 
since the majority of tests described in this thesis will use food-based 
reinforcement paradigms. The sucrose two-bottle choice paradigm will be used 
primarily to assess taste perception. 
 
Following these initial assessments, close attention will be paid to motor activity. In 
addition to providing information regarding physiological function, a change in 
locomotor activity could also result from general ill health in mutant mice. 
Assessment of motor function is also necessary to permit the use of many 
behavioural tasks reported in this thesis. For example, if motor function is impaired, 
a mouse may be unable to coordinate actions necessary to explore an operant 
chamber, to lever press or to collect a small food pellet from a receptacle. Efforts to 
evaluate the psychomotor stimulating effects of cocaine or performance in a 
conditioned-place preference chamber (see Chapter 5) may also be confounded by 
any genotype differences in baseline locomotor activity. Locomotor assessments 
are particularly important with respect to mGluR5KD-D1 mice, given the widespread 
expression of mGluR5 within the basal ganglia motor circuitry, including the STN 
(Awad et al., 2000) and SNr (Hubert et al., 2001; Smith et al., 2001), and the 
potential for co-expression of the D1R in these nuclei (Smith and Villalba, 2008). 
 
The final series of tests will look at anxiety-related behaviours. Soon after one of 
the first non-competitive mGluR5 antagonists (MPEP) was developed, a role for 
75 
 
mGluR5 in anxiety-related behaviours was established in rodents (Gasparini et al., 
1999; Spooren et al., 2000b). The anxiolytic effects of MPEP have been 
demonstrated using several unconditioned (for example, social interaction, stress-
induced hyperthermia, elevated plus-maze and marble burying) and conditioned 
tests (for example, Geller-Seifter, Vogel conflict and fear potentiated startle) 
(Spooren et al., 2000b; Tatarczynska et al., 2001; Brodkin et al., 2002b; Brodkin et 
al., 2002a; Pietraszek et al., 2005; Paterson et al., 2010). Critically, anxiolytic 
effects of MPEP occurred at doses that did not alter locomotor activity 
(Tatarczynska et al., 2001), did not show psychotomimentic effects (Spooren et al., 
2000b) and did not impair working memory or spatial learning (Ballard et al., 2005). 
Similarly, the more potent mGluR5 antagonist, MTEP also demonstrated efficacy in 
several anxiety-related models in rodents (Cosford et al., 2003; Klodzinska et al., 
2004; Pietraszek et al., 2005; Varty et al., 2005), and lacked side effects seen with 
benzodiazepines, such as sedation or ethanol interactions (Busse et al., 2004). 
Surprisingly few studies have examined the anxiety phenotype of mice in which 
mGluR5 has been genetically modified, and those few reports offer conflicting 
findings. In mGluR5 knockout mice, attenuated anxiety-related behaviours have 
been reported using stress-induced hyperthermia (Brodkin et al., 2002b) and open-
field tests (Olsen et al., 2010), but not in the elevated plus-maze or a light-dark box  
(Olsen et al., 2010). Thus, it is of value to examine anxiety-related behaviours in 
mGluR5KD-D1 mice not only to add to our knowledge of the role of mGluR5 in 
anxiety per se, but also given the potential symmetry between anxiety phenotypes 
and performance in appetitive learning and memory tasks that are reported in 
subsequent chapters of this thesis (Pecina et al., 2006; George et al., 2009). 
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2.2 Materials and methods 
 
2.2.1 Animals 
mGluR5KD-D1 mice were generated as previously described (Novak et al., 2010). In 
brief, shRNAs were designed and first tested in cell culture for knock-down 
efficiency of mGluR5 mRNA. Synthetic oligos were inserted into an artificial micro-
RNA context and the construct recombined into a bacterial artificial chromosome 
(BAC) that harbored the mouse D1R gene (as described in Parkitna et al., 2009). 
Following purification of the BAC and removal of vector sequences, the transgene 
was injected into the pronuclei of fertilized oocytes from C57BL/6n mice. 
Experimental animals were generated by backcrossing of mGluR5KD-D1 transgenic 
mice to a C57BL/6n line (Novak et al., 2010). mGluR5KD-D1 and wild-type littermate 
mice used in the present experiments were gifted from Dr. J. Rodriguez Parkitna 
(DKFZ, Heidelberg, Germany) or obtained from a breeding colony subsequently 
established at the University of Sussex. 
 
Mice (n = 85/89, WT/KD; at least 8 weeks old prior to experiment start) were 
maintained on a 12:12 h light-dark cycle (lights on at 07:00 h) under controlled 
temperature (21 ± 2 °C) and humidity conditions (50 ± 5%). Animals were housed 
in groups of two or three in polycarbonate cages, except for the sucrose 
consumption experiment where mice were singly housed. Water was available ad 
libitum in the holding room. Unless otherwise stated, mice were placed onto a 
restricted feeding regime designed to maintain body weights at ~85% of free-
feeding weight at least 7 days prior to the experiment start. In this way, any 
phenotypic differences between genotypes could be used more readily to 
understand any differences in performance during subsequent behavioural tests 
where food restriction was employed. Experiments took place during the light-
phase. All procedures were performed in accordance with the United Kingdom 
1986 Animals (Scientific Procedures) Act, following institutional ethical review. 
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It is worthwhile to note here that wild-type littermates provide the most appropriate 
control for a mutant phenotype, since phenotype is influenced by many intrauterine 
and postnatal environmental factors such as parental care, temperature, noise, 
lighting, humidity, circadian cycle, cage cleaning, cage type, colony size and age at 
weaning (Crawley, 2007). Because the RNAi mutation exerts a dominant effect 
(Castrop, 2010), heterozygous mGluR5KD-D1 mice were used in all experiments 
such that disruption of any gene function as a result of random transgene insertion 
could potentially be compensated by the presence of an intact gene copy on the 
other allele. Heterozygous mice and wild-type littermate controls were obtained 
from the breeding of heterozygous and wild-type parents. 
 
2.2.2 Genotyping 
2.2.2.1 DNA extraction 
Ear punches were taken and incubated for 2 hours at 55oC followed by 15 min at 
95oC in 20 μl of a 1 mg/mL proteinase K solution (Roche Diagnostics, Burgess Hill, 
West Sussex, UK) in a 20 mM Tris-HCl (Sigma-Aldrich, Dorset, UK) and 10 mM 
EDTA (Sigma-Aldrich) buffer. The digested sample was then diluted with 80 μl of 
purified water. 
 
2.2.2.2 PCR 
mGluR5KD-D1 mice were identified using primers (ACGTAAACGGCCACAAGTTC, 
AAGTCGTGCTGCTTCATGTG) that amplified a 180bp sequence of the GFP-
encoding region of the inserted transgene. Control primers 
(CCATTTGCTGGAGTGACTCTG, TAAATCTGGCAAGCGAGACG), derived from 
the Dicer gene, amplified a 370bp sequence and were included to confirm 
efficiency of the PCR reaction (Fig. 2.2). Each PCR reaction contained 0.5 μl of 
sample DNA, 0.5 μl of each primer and 22.5 μl of a PCR mix containing Taq 
polymerase, dNTPs and an agarose loading dye (Mega Mix-Blue; Microzone Ltd., 
Haywards Heath, West Sussex, UK). Using a thermal cycling PCR machine (G-
Storm; GRI Ltd., UK), the PCR sample was incubated at 95oC for 5 min, followed 
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by 35 cycles of: 95oC for 30 sec, 60oC for 1 min and 72oC for 1 min. Samples were 
then held at 72oC for 10 min. 
 
 
 
 
 
 
 
 
 
 
 
 
2.2.2.3 DNA Detection 
DNA gel electrophoresis was performed using a gel made from 2% agarose (High 
Res standard agarose; AGTC Bioproducts Ltd., Hessle, UK) in 1x TAE buffer (242 
g/L Tris-base; 57.1 mL/L acetic acid; 500 mL/L of 50 M EDTA; all Sigma-Aldrich; in 
dH2O) supplemented with 0.004% ethidium bromide (50 mg/mL stock; Sigma-
Aldrich). Gels were loaded with ~12 μl of each post-PCR sample and run in 1x TAE 
buffer for 30 min at 140 volts prior to imaging under UV light. 
 
2.2.3 Gross appearance, auditory and visual function and neurological 
reflexes 
Procedure: Mice (n = 12/12, WT/KD; fed ad libitum) were first exposed to a battery 
of assessments (adapted from Crawley, 2007) designed to assess gross 
appearance, simple sensory responses (auditory and visual) and neurological 
reflexes. Assessments were made in a quiet and low lit room designated for 
behavioural studies. The test order of mice (wild-type or knock-down) was 
randomised and the experimenter was unaware of the mouse genotype. Gross 
appearance was first assessed by observation of mice within their home cages and 
 
Figure 2.2 Example western blot for genotyping of mice. 
KD mice were identified by a band (180 bp) confirming 
presence of the transgene that results in mGluR5 knock-
down selectively in dopamine D1R-expressing cells. The 
presence of a control band (370 bp) confirmed the 
efficiency of the PCR reaction. 
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included the following; 1) Whiskers present: presence of whiskers, 2) Bald patches: 
missing fur, 3) Exopthalmia: bulging of eyes, and 4) Piloerection: erection of fur. A 
basic assessment of auditory function was then provided by making a loud 
clapping noise within close proximity to the mouse. Auditory function was 
confirmed by a Preyer startle reflex (movement of the body or ear twitch response). 
Assessment of visual function was provided by the visual placing test (Heyser, 
2003). The mouse was held by its tail ~15 cm from a table surface and lowered 
toward the surface. Visual function was confirmed if the mouse extended its 
forepaws to make contact with the approaching surface. 
 
After assessments of gross appearance, auditory and visual function, the following 
reflexive assessments were undertaken in the same mice; 1) Air puff: a puff of air 
was directed toward the back of the mouse using an empty spray bottle. A 
response was recorded as normal if mice turned in reaction to the air puff, 2) 
Touch escape: the experimenter attempted to pick up the mouse. A normal 
response was observed if the mouse made attempts to escape, 3) Eye blink: the 
corner of the eye was touched with a clean cotton swab. A normal response was 
defined as an eye blink in response to the cotton swab, 4) Ear twitch: the ear was 
touched with a clean cotton swab. A normal response was defined as an ear twitch 
in response to the cotton swab, 5) Whisker touch: whiskers were touched with a 
cotton swab. A normal response was defined as a brief cessation of whisker 
movement in response to the cotton swab, 6) Wire suspension test: Mice were 
placed on a wire-grid, which was then inverted for 60 seconds. A normal response 
was recorded if mice remained attached to the wire-grid for the duration of the test, 
7) Righting reflex: mice were placed onto their back. A normal response was 
recorded if mice resumed a righting posture unaided, and finally 8) Splay reflex: 
mice were placed into an empty polycarbonate cage which was then moved from 
side to side and up and down. A normal response was recorded if mice elicited a 
postural reflex to maintain an upright, balanced position. 
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2.2.4 Body weight 
Procedure: Mice (n = 12/12, WT/KD; as used in assessments above) were placed 
onto a restricted feeding regime designed to maintain body weights at 
approximately 85% of free-feeding weight. This was achieved by the provision of 
~2 standard lab chow pellets (B&K Feeds, Hull, UK) per mouse per day. To 
determine whether weights differed between genotypes under basal or restricted 
feeding conditions, mouse body weight (g) was recorded every 48 hours for 6 days 
prior to and 6 days following the start of food restriction. Additional recordings were 
made at 32-36 days after the start of food restriction. Under restricted feeding 
conditions, body weights were recorded immediately prior to daily feeding. 
 
2.2.5 Sucrose consumption 
Apparatus: A two-bottle choice paradigm was used to assess sucrose 
consumption. The experiment was conducted in the home-cage using two bottles 
inserted into the front of the cage. Chow, which was normally placed into a recess 
at the front of the cage, was instead placed on the floor of the cage. 
 
Procedure: Mice (n = 12/12, WT/KD) were individually housed to enable accurate 
recordings of consumption to be obtained from each mouse. To habituate mice to 
the drinking bottles, both bottles were filled with water for the first three days. For 
the choice phase of the experiment, one bottle was filled with water and the second 
with varying concentrations of sucrose (1%, 3%, 10% or 20% w/v; Tate & Lyle, 
Nottingham, UK). Presentation order of sucrose may be important for determining 
consumption in some strains but not in the majority of others (Lewis et al., 2005). 
Here, sucrose concentrations were presented in increasing order so that 
preference for a higher concentration of sucrose did not develop before being 
presented with a lower sucrose concentration. When comparing preference 
amongst different solutions (for example, sucrose, saccharin and water), testing for 
at least 4 days at each concentration of solution has been considered most 
sensitive for detecting any differences between strains (Tordoff and Bachmanov, 
2002). However, shorter durations of exposure are considered sufficient for 
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detecting strain differences in intake when using multiple concentrations of the 
same solution (Glendinning et al., 2002; Lewis et al., 2005). In the present test, 
consumption of sucrose and water was measured every 24 hours over 3 days at 
each concentration. Chow was placed on the floor of the cage at the same time 
when bottles were weighed and/ or replenished. Although chow intake was not 
recorded in the current study, it is recognised that chow intake during the test can 
vary as a function of sucrose concentration in an effort to maintain caloric 
homeostasis in some strains, but not others (Lewis et al., 2005). The left and right 
positions of the bottles were reversed daily to control for any side preference. In 
addition to measuring daily sucrose and water intake (mL/Kg), a sucrose 
preference score was calculated by dividing sucrose intake by total fluid intake (i.e. 
sucrose plus water intake). 
 
2.2.6 Activity in a novel environment 
2.2.6.1 Locomotor activity 
Apparatus: Locomotor activity was first assessed using nine circular runways. 
Each runway was constructed from a black open-ended plastic tube (24.5 cm dia. x 
25.5 cm), inside which was fixed a similar smaller tube (10.5 cm dia. x 25.5 cm) 
thereby creating a 6.5 cm wide circular runway (Fig. 2.3a). Runways were set on a 
translucent Perspex platform (122 x 89 x 1 cm) mounted 127 cm above the floor. 
Illumination of runways was achieved by 4 fluorescent tubes (T4, 30 watt) 
positioned behind a second Perspex sheet suspended 17 cm above the runways. 
A camera (Fire-i; UniBrain, San Ramon, California, USA), which interfaced with a 
PC, was situated on the floor beneath the runways and captured the location of 
mice (Fig. 2.3b). Images were recorded and the distance travelled (m) by mice 
calculated using a PC running MATLAB (version R2007a; MathWorks, Cambridge, 
UK).  
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Figure 2.3 Apparatus used for behavioural phenotyping of mice. (a) Schematic of a 
circular runway used for locomotor assessment. (b) Video tracking of mice in 
circular runways. (c) Open-field arena used for the assessment of spontaneous 
activity in a novel environment. (d-f) For assessing anxiety-related behaviours: (d) 
Open-field arena indicating the outer (O), middle (M) and inner (I) areas. (e) Light-
dark box indicating the light area illuminated by an overhead lamp and the dark 
area accessed by an opening in the dividing partition. (f) Elevated plus-maze 
indicating a closed and open arm and the middle area. A camera (not shown) was 
positioned to record mouse activity in each apparatus. Panel a provided by Simon 
Nilsson  
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Procedure: Mice (n = 28/31, WT/KD) were habituated to the circular runways 
across five once-daily 1 hour sessions. In this way, activity in a novel environment 
(session 1) and habituation between daily sessions (sessions 1-5) could be 
compared between genotypes. Multiple groups of mice were run each day, 
although each group contained mice from both genotypes. The runways and 
Perspex platform were cleaned between each group. Mice were assigned to the 
same runway for all sessions. Note that mice reported in this experiment were 
subsequently used for cocaine locomotor studies (reported in Chapters 5 and 6). 
 
2.2.6.2 Spontaneous nose-poking 
Apparatus: Exploratory behaviour in a novel environment, indexed by nose-
poking, was assessed using eight standard mouse conditioning chambers (15.9 x 
14 x 12.7 cm; Med Associates, Vermont, USA; see section 3.2.3 for further 
description). Each chamber was fitted with a recessed food magazine (ENV-303M, 
Med Associates) situated at the centre of one side wall. Two nose-poke ports 
(ENV-313M, Med Associates) were inserted into the wall opposite to the magazine. 
Infra-red beams detected head entries into each of the three apertures. The 
recording of beam breaks and their time of occurrence was performed using Med-
PC IV (Med Associates). 
 
Procedure: Mice (n = 24/24, WT/KD) were placed into the conditioning chambers 
and nose-poking activity recorded during a single 30 minute session. Multiple 
groups of mice were run each day, although each group contained mice from both 
genotypes. 
 
2.2.6.3 Spontaneous activity in an open-field 
Apparatus: A more detailed analysis of spontaneous activity was undertaken in a 
novel open-field arena (39 x 39 x 42 cm), constructed from white acrylic and 
layered with sawdust (Fig. 2.4c). A video camera (Sony B&B CCD-HAD), 
connected to a videocassette recorder (Sony SLV-SE70), was mounted directly 
above the arena. 
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Procedure: Mice (n = 12/12, WT/KD; used also for the nose-poking assessment) 
were allowed to explore the area for 30 minutes. The test order of mice (wild-type 
or knock-down) was alternated, the arena cleaned and the sawdust replaced 
between each recording session. Video recordings were subsequently scored by 
an observer unaware of the mouse genotype. Specifically, locomotor activity was 
assessed by measuring the duration of the following activity levels: 1) Static: No 
ambulatory movement and no exploratory movement (e.g. sleeping), 2) 
Static/Exploratory: No ambulatory movement but exploratory movement (e.g. static 
and sniffing or rearing), 3) Forward movement: ambulatory movement around the 
arena, and 4) Excited movement: rapid movement, such as wild circular running or 
jumping. The duration of more specific exploratory behaviours was also measured: 
1) Wall rearing: rearing (both forelimbs removed from the floor and extension of the 
body) with support from the wall, 2) Centre rearing: rearing without support from 
the wall, 3) Grooming: body care movements using mouth or paws, and 4) Digging: 
excavation of the sawdust with paws or head. 
 
2.2.7 Anxiety-related behaviours 
2.2.7.1 Open-field arena 
Apparatus: The open-field arena (50 x 50 x 25.5 cm; Fig 2.3d) was constructed 
from grey Perspex. The arena floor was marked into 10 x 10 cm squares that 
defined the „outer‟ (16 squares), „middle‟ (8 squares) and „inner‟ (1 square) areas. 
A video camera (Sony B&W CCD-HAD), connected to a videocassette recorder 
(Sony SLV-SE70), was mounted directly above the arena. The surface of the 
apparatus was under an illumination of 115–157 lx, provided by a 40W bulb 
located 80cm above the apparatus. 
 
Procedure: Mice (n = 12/12, WT/KD; those used for assessment of gross 
appearance, auditory and visual function and neurological reflexes) were placed 
into the inner area of the open-field at the start of the test session, and allowed to 
freely explore the arena for 5 minutes. The test order of mice (wild-type or knock-
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down) was alternated and the arena cleaned between each test. Video recordings 
were subsequently scored for the amount of time mice spent in each area. A 
measure of gross locomotor activity was provided by counting crosses over lines 
that marked each 10 x 10 cm square. 
 
2.2.7.2 Light-dark box 
Apparatus: The light-dark box (Fig. 2.3e) consisted of two partitioned areas. The 
„light‟ area (27 x 27 x 30 cm) had an open top and was painted white. A lamp (60 
watt) positioned 30 cm above the light area provided illumination in the range of 
380-470 lx at the floor of the light area. The „dark‟ area was smaller in size (27 x 18 
x 30 cm), painted black and was fully enclosed. Mice could move between areas 
through an opening (7.5 x 7.5 cm) in the partitioning wall. Access to the opening 
was controlled by a removable panel. A video camera (Sony B&W CCD-HAD), 
connected to a videocassette recorder (Sony SLV-SE70), was mounted directly 
above the light-dark box. 
 
Procedure: Mice (n = 9/10, WT/KD; fed ad libitum) were placed into the light area 
at the start of the test session. The panel was then removed, allowing mice free 
access between the light and dark areas. Mice were allowed to explore the light-
dark box for 5 minutes. The test order of mice (wild-type or knock-down) was 
alternated and the apparatus cleaned between each test. Video recordings were 
subsequently scored for the amount of time mice spent in each area. The latency 
to the first escape from the light area and the latency to re-enter the light area were 
also measured. A measure of gross locomotor activity was provided by counting 
transitions between the light and dark areas. 
 
2.2.7.3 Elevated Plus-Maze 
Apparatus: The elevated plus-maze (raised 45 cm above the floor; Fig. 2.3f) was 
constructed form black acrylic and consisted of four arms (30 x 5 cm) connecting at 
right angles to a middle platform (5 x 5 cm). Two opposing arms were enclosed by 
a 15 cm high wall (the „closed‟ arms), while the other arms were not enclosed (the 
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„open‟ arms). The open arms of the maze were under illumination of 40-48 lx. A 
video camera (Sony B&W CCD-HAD), connected to a videocassette recorder 
(Sony SLV-SE70), was mounted directly above the plus-maze. 
 
Procedure: Mice (n=8/10, WT/KD; also used in the light-dark box experiment) 
were placed into the middle area of the maze at the start of the test session and 
allowed to explore the plus-maze for 5 minutes. The test order of mice (wild-type or 
knock-down) was alternated and the plus-maze cleaned between each test. Video 
recordings were subsequently scored for the amount of time mice spent in each 
area. A measure of gross locomotor activity was provided by counting transitions 
between each area of the plus-maze. 
 
2.2.8 Statistical Analysis 
Assessments of gross appearance, auditory and visual function and neurological 
reflexes were qualitative and not subject to formal statistical analysis. All other data 
were initially assessed for normality (Shapiro-Wilk test; assumption violated when p 
≤ 0.05) and homogeneity of variance (Levene‟s test, assumption violated when p ≤ 
0.05), to permit use of parametric tests. For most tests, data were first analysed by 
mixed-factor analysis of variance (ANOVA), with genotype (WT, KD) as a between-
subjects factor. Details of the within-subjects factors used for the analysis of data 
by ANOVA are provided in the results section. Where significant (p ≤ 0.05) main 
effects or interaction terms were found, further analysis was performed using 
ANOVA. Individual between genotypes comparisons were performed using an 
independent samples two-tailed t-test. Findings were considered indicative of a 
trend where p ≤ 0.1. For within-subjects ANOVA, the Greenhouse-Geisser 
correction was used where the assumption of sphericity was violated (Mauchly‟s 
test, p ≤ 0.05). Statistical analysis was performed with SPSS Statistics v.17 (IBM, 
Somers, New York, USA). All figures show group mean (± SEM).  
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2.3 Results 
 
2.3.1 Gross appearance, auditory and visual function and neurological 
reflexes 
Mutant mice were indistinguishable from their wild-type counterparts when gross 
appearance, auditory and visual function and neurological reflexes were assessed. 
Specifically, all mice assessed had whiskers present and did not present with bald 
patches, expothalmia or piloerection. All mice responded to a loud noise (e.g. 
jumped or twitched) and directed forelimbs in anticipation of an approaching 
surface, suggesting intact auditory and visual function, respectively. A variety of 
other neurological assessments failed to find any difference in responses between 
WT and KD mice (see Table 2.1 for summary). 
 
2.3.2 Body weight 
Body weights in adult mice (Fig. 2.4) did not differ between genotypes measured 
prior to the implementation of a restricted feeding regime (from days -6 to -2 prior 
to food restriction; main effect of Genotype, not significant (NS); Genotype x Day 
interaction, NS). After the restricted feeding regime had commenced, body weights 
declined at a similar rate in both genotypes (days 2 to 6 from restriction start; main 
effect of Genotype, NS; Day, F(2,44) = 38.637, p < 0.001; Genotype x Day 
interaction, NS). Weights did not differ between genotypes after an extended 
period of food restriction (days 32-36 from restriction start; main effect of 
Genotype, NS; Genotype x Day interaction, NS).  
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Table 2.1 Basic assessments of gross appearance, sensory responses and 
neurological reflexes. KD mice were indistinguishable from WT mice in their 
general appearance, responses to auditory and visual stimuli and neurological 
reflexes assessed using a variety of simple tests. The procedure for each test and 
normal responses are defined in the methodology (n = 12/12, WT/KD).  
Genotype WT KD 
Gross Appearance 
Whiskers present (%) 
Bald Patches (%) 
Exophthalmia (%) 
Piloerection (%) 
 
100 
0 
0 
0 
 
100 
0 
0 
0 
Sensory Responses 
Auditory reflex (%) 
Visual response (%) 
 
100 
100 
 
100 
100 
Reflexive Responses 
Air puff (%) 
Touch escape (%) 
Eye blink (%) 
Ear twitch (%) 
Whisker touch (%) 
Wire suspension (%) 
Righting reflex (%) 
Splay Reflex (%) 
 
100 
100 
100 
100 
100 
100 
100 
100 
 
100 
100 
100 
100 
100 
100 
100 
100 
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Figure 2.4 Body weights measured prior to and during food restriction. Body 
weights did not differ between adult WT and KD mice either prior to (days -6 to -2) 
or following (days 2-6 and 32-26) the implementation of a restricted feeding regime 
(n = 12/12, WT/KD).  
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2.3.3 Sucrose consumption 
Prior to the two-bottle sucrose choice test, baseline water intake (ml/kg/24 h; 
averaged from intake recorded over the final two days of habituation to the water 
bottles) was lower in KD mice, although this effect did not reach significance (t = 
1.723, df = 22, p = 0.099; Fig. 2.5a).  
 
During the two-bottle choice phase of the experiment, both genotypes drank more 
from the bottle containing sucrose than the water bottle at all sucrose 
concentrations. In both genotypes, sucrose intake (ml/kg/24 h; averaged from the 
final two days of testing at each sucrose concentration) described an „inverted-u‟ 
profile with consumption progressively increasing from 1-10 % sucrose and 
decreasing at 20% sucrose (Fig. 2.5a). These observations were confirmed by an 
initial analysis of intake across all sucrose concentrations (1-20%) using a mixed-
factor ANOVA, with Bottle (sucrose, water) as a within-subjects factor. Intake 
differed according to the bottle type (main effect of Bottle, F(1,22) = 81.97, p < 
0.001), but not between genotypes (main effect of Genotype, NS; Genotype x 
Bottle interaction, NS). A subsequent analysis of sucrose intake alone by mixed-
factor ANOVA, with Concentration (1-20%) as a within-subjects factor, confirmed 
that sucrose intake varied with sucrose concentration (main effect of 
Concentration, F(3,66) = 23.67, p < 0.001), although this intake profile did not differ 
between genotypes (main effect of Genotype, NS; Concentration x Genotype 
interaction, NS). 
 
A plot of absolute sucrose consumption (i.e., g/Kg/24 h; Fig. 2.5b) revealed that the 
amount of sucrose consumed increased between 1-10% sucrose and approached 
a plateau between 10-20% sucrose (main effect of Concentration, F(3,66) = 93.64, 
p < 0.001), likely reflecting satiety. This consumption profile did not differ between 
genotypes (main effect of Genotype, NS; Concentration x Genotype interaction, 
NS). 
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Finally, calculation of sucrose preference (that is, sucrose intake divided by total 
fluid intake) revealed that preference increased in line with the sucrose 
concentration in both genotypes, although overall sucrose preference was lower in 
mutant mice (Fig. 2.5c). These observations were confirmed by analysis of 
preference scores by mixed-factor ANOVA (main effect of Concentration, F(3,66) = 
9.04, p = 0.001; Genotype, F(1,22) = 5.17, p < 0.05; and Concentration x Genotype 
interaction, NS). 
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Figure 2.5 Measures of sucrose and water intake during a two-bottle choice 
paradigm. (a) Mice from both genotypes drank more from the sucrose bottle than 
the water bottle at all sucrose concentrations. Baseline intake of water from prior to 
sucrose testing is shown (BL). Each point represents the group mean intake of 
sucrose or water, averaged from measurements taken over two consecutive days. 
(b) The quantity of sucrose consumed is shown (c) Preference for sucrose 
(sucrose intake / total fluid intake) at each concentration is shown. Sucrose intake 
and consumption did not differ between genotypes, although the overall sucrose 
preference score was lower in mutant mice (n = 12/12, WT/KD).  
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2.3.4 Activity in a novel environment 
2.3.4.1 Locomotor activity 
In both genotypes upon exposure to the novel circular runway environment, activity 
(indexed by the distance travelled; m) was greatest during the first 10 minute 
period of the 1 hour session and declined over each subsequent 10 minute period 
(Fig. 2.6a; main effect of Period, F(5,285) = 69.79, p < 0.001; Period x Genotype 
interaction, NS). Notably, activity in KD mice during this first session was 
significantly reduced in comparison to their wild-type counterparts (main effect of 
Genotype, F(1,57) = 6.75, p < 0.05). Both genotypes habituated to the apparatus 
with repeated exposure to the runway over five once-daily 1 hour sessions (Fig. 
2.6b). Habituation was confirmed by a significant reduction in activity over the five 
sessions in each genotype (WT: main effect of Session, F(4,108) = 8.36, p < 0.001; 
KD: main effect of Session, F(4,120) = 3.54, p < 0.01). During the fifth session (Fig. 
2.6c), activity declined across each 10 minute period of the session in both 
genotypes (main effect of Period, F(5,285) = 19.37, p < 0.001; Period x Genotype 
interaction, NS), but there was no difference in overall activity between genotypes 
(main effect of Genotype, NS).  
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Figure 2.6 Locomotor activity in a circular runway. Mice were exposed to the 
locomotor apparatus over five once-daily 1 hour sessions. (a) During the first 
session (i.e. when presented as a novel environment), locomotor activity in both 
genotypes was greatest at the start of the 1 hour session, but declined over each 
subsequent 10 minute period. Activity in KD mice was significantly reduced in 
comparison to WT mice. (b) Mean total activity from each daily 1 hour session is 
shown. Both genotypes habituated to the circular runway, although activity in KD 
mice was reduced during the first session. ANOVA findings reflected this 
observation (main effect of Session, F(4,228) = 12.19, p < 0.001; Genotype, 
F(1,57) = 4.99, p < 0.05; Session x Genotype interaction, F(4,228) = 2.35, p = 
0.08) (c) In the fifth locomotor session, activity did not differ between genotypes 
during any of the 10 minute periods (n = 28/31, WT/KD). 
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2.3.4.2 Spontaneous nose-poking 
In the spontaneous nose-poking test, no difference was found between genotypes 
in the total number of nose-pokes made during the 30 minute session (Fig. 2.7a; t 
= 0.92, df = 46, p > 0.05). A plot of the time-course of nose-poke responses across 
each 10 minute period of the session (Fig. 2.7b) did not reveal any difference 
between genotypes in the response profile (Period x Genotype interaction, NS; 
main effect of Genotype, NS). There was no difference between genotypes in the 
latency to the first nose-poke response (t = -0.31, df = 46, p > 0.05; Fig. 2.7c).  
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Figure 2.7 Spontaneous nose-poking in a novel environment. (a) There was no 
difference between genotypes in the mean total number of nose-pokes made 
during the 30 minute session. (b) Nose-poke activity remained stable over each 10 
minute period of the session (main effect of Period, NS) and this response profile 
did not differ between genotypes. (c) The mean latency to the first nose-poke of 
the session did not differ between genotypes (n = 24/24, WT/KD).  
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2.3.4.3 Spontaneous activity in an open-field 
The final assessment of activity was provided by recording behaviours of mice 
during a single 30 minute session in a novel open-field environment. The mean 
total duration of four levels of activity (static, static/exploratory, forward movement, 
excitatory movement) were first compared between genotypes (Fig. 2.8a). In both 
genotypes, the majority of session time was occupied by static/exploratory 
movement, followed by forward movement. Consistent with findings from the 
circular runway experiment, forward movement duration was significantly reduced 
in KD mice in comparison to WT mice (t = 2.08, df = 22, p < 0.05). Conversely, 
static/exploratory duration was increased in KD mice, although a between 
genotype comparison did not reach statistical significance (t = -1.78, df = 22, p = 
0.089). 
 
Time course plots of each activity level (Fig. 2.8c) were also consistent with 
findings from the circular runways. In both genotypes, forward movement duration 
decreased across each 10 minute period of the session (Fig. 2.8c, panel iii) while 
static/exploratory duration increased (Fig. 2.8c, panel ii). Static and excitatory 
movement duration did not differ over the course of the session, nor between 
genotypes (Fig. 2.8c, panels i and iv, respectively). These observations were 
confirmed by mixed-factor ANOVA, with each 10 minute bin represented as the 
within-subjects factor of Period (see Table 2.2 for ANOVA results). 
 
From video recordings of the same 30 minute session, an analysis of more specific 
activities (wall rearing, centre rearing, grooming and digging) was also undertaken. 
In both genotypes, centre rearing occupied most session time, followed by wall 
rearing and digging (Fig. 2.8b). Between genotype comparisons of total activity 
duration identified a significant increase in centre rearing duration in KD mice (t = -
2.14, df = 22, p < 0.05). Time-course plots of these more specific activities 
indicated that, in both genotypes, centre rearing duration increased while digging 
duration decreased over each 10 minute period of the session (Fig. 2.8d). Wall 
rearing and grooming duration not differ over the course of the session, nor 
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between genotypes. These findings were confirmed by mixed-factor ANOVA, 
which also identified a significant overall increase in centre rearing duration in KD 
mice (see Table 2.2 for ANOVA results). 
 
  
Spontaneous 
Activity 
Period 
F(2,44) 
Period x 
Genotype F(2,44) 
Genotype 
F(1,22) 
Static/No 
Movement 
7.24 2.86
§ 1.73 
Static/Exploratory 44.20*** 0.64 3.16
§ 
Forward Movement 57.83*** 0.44 4.34* 
Excitatory 
Movement 
3.32* 0.009 1.39 
    
Wall Rearing 0.39 0.15 1.78 
Center Rearing 9.75*** 0.20 4.57* 
Grooming 0.80 0.27 1.08 
Digging 9.13*** 0.19 1.39 
 
Table 2.2 ANOVAs for time-course profiles of spontaneous activity in an 
open-field. Factors: Period (3 x 10 minute Bin of the 30 minute session); 
Genotype (WT, KD). ***p < 0.001, *p < 0.05, §p < 0.1 
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Figure 2.8 Spontaneous activity in an open-field. (a) The mean total duration of 
four levels of activity classified as static (S), static/exploratory (S/E), forward 
movement (FM) and excited movement (EM) are shown. In comparison to WT 
mice, forward movement duration was significantly reduced in KD mice, while 
static/exploratory movement tended to be increased. (b) Figure shows the mean 
total duration of four specific activities classified as rearing at the wall (W-Rear), 
rearing away from the wall (C-Rear), grooming (Groom) or digging (Dig). Rearing 
away from the wall duration was significantly increased in KD mice. (c) The time 
0
5
10
15
20
25
S S/E FM EM
WT
KD
p<0.1
*
Activity
D
u
ra
ti
o
n
 (
m
in
)
0
2
4
6
8
WT
KD
*
W-Rear C-Rear Groom Dig
Activity
D
u
ra
ti
o
n
 (
m
in
)
0
2
4
6
8
10
1 2 3
i.S
KD
WT
10 min Bin
D
u
ra
ti
o
n
 (
m
in
)
0
2
4
6
8
10
1 2 3
iii.FM
10 min Bin
0.0
0.5
1.0
1.5
2.0
2.5
1 2 3
KD
WT
i.W-Rear
10 min Bin
D
u
ra
ti
o
n
 (
m
in
)
0.0
0.5
1.0
1.5
2.0
2.5
1 2 3
iii.Groom
10 min Bin
0
2
4
6
8
10
1 2 3
ii.S/E
10 min Bin
0
2
4
6
8
10
1 2 3
iv.EM
10 min Bin
0.0
0.5
1.0
1.5
2.0
2.5
1 2 3
ii.C-Rear
10 min Bin
0.0
0.5
1.0
1.5
2.0
2.5
1 2 3
iv.Dig
10 min Bin
a b
c
d
100 
 
course for each level of activity is shown. (d) The time course for each specific 
activity is shown. *p < 0.05, t-test comparison between genotypes (n = 12/12, 
WT/KD).  
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2.3.5 Anxiety-related behaviours 
2.3.5.1 Open-field arena 
During the 5 minute assessment of anxiety-related behaviours in an open-field 
arena, both genotypes spent more time in the outer area than the middle or inner 
areas of the arena (Fig. 2.9a). These findings were confirmed by mixed-factor 
ANOVA, with Area (outer, middle, inner) included as a within-subjects factor (main 
effect of Area, F(2,44) = 2386.22, p < 0.001; Genotype, NS). However, mutant 
mice spent a greater amount of time in the middle area than their wild-type 
littermates (Genotype x Area interaction, F(2,44) = 4.17, p < 0.05; between 
genotype comparison of time in middle area, t = -2.16, df = 22, p < 0.05). Although 
KD mice also spent less time in the outer area than WT mice, this comparison was 
not quite statistically significant (t = 2.03, df = 22, p = 0.055). Locomotor activity in 
the test session, assessed by crosses over lines that identified areas of the open-
field, did not differ between genotypes (t = 0.79, df = 22, p > 0.05; Fig. 2.9b). 
 
2.3.5.2 Light-dark box 
During the 5 minute test in the light-dark box, both genotypes spent more time in 
the dark area than the light area. The time in each area did not differ between 
genotypes (Fig. 2.10a). These findings were confirmed by mixed-factor ANOVA, 
with Area (light, dark) included as a within-subjects factor (main effect of Area, 
F(1,17) = 34.27, p < 0.001; Genotype, NS; Genotype x Area interaction, NS). In 
both genotypes, the latency to the first escape from the light area was shorter than 
the latency to the first re-entry into the light area (Fig. 2.10b; main effect of 
Latency, F(1,17) = 18.82, p < 0.001). Latency events did not differ between 
genotypes (main effect of Genotype, NS; Latency x Genotype interaction, NS). 
Locomotor activity in the test, assessed by the total number of transitions between 
light and dark areas, tended to be reduced in KD mice, although this effect did not 
reach statistical significance (t = 1.94, df = 17, p = 0.07; Fig. 2.10c). 
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Figure 2.9 Anxiety-related behaviours in an open-field arena. (a) In the 5 minute 
session, both genotypes spent most time in the outer area of the open-field than 
the middle or inner areas. Mutant animals spent significantly more time in the 
middle area of the open field than WT littermate controls (b) Locomotor activity, 
assessed by crosses over lines that identified the areas of the open field, did not 
significantly differ between genotypes. *p < 0.05, t-test comparison between 
genotypes (n = 12/12, WT/KD).  
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Figure 2.10 Anxiety-related behaviours in a light-dark box. (a) During the 5 minute 
test, both genotypes spent more time in the dark area than the light area. This 
effect did not reliably differ between genotypes. (b) There was no difference 
between genotypes in the latency to the first transition from the light area to the 
dark area (Escape), or in the latency to the first return to the light area from the 
dark area (Re-Entry). (c) Locomotor activity, indexed by the total number of 
transitions between the light and dark areas, tended to be reduced in KD mice. §p < 
0.1 between-genotype t-test comparison (n = 9/10, WT/KD). 
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2.3.5.3 Elevated plus-maze 
During the 5 minute test, mice from both genotypes spent most time in the closed 
arms of the elevated plus-maze than the open arms or the adjoining middle area. 
The time in each area did not differ between genotypes (Fig 2.11a). These findings 
were confirmed by mixed-factor ANOVA, with Area (open, closed, middle) included 
as a within-subjects factor (main effect of Area, F(2,32) = 122.95, p < 0.001; 
Genotype, NS; Genotype x Area interaction, NS). Locomotor activity in the 5 
minute test, assessed by transitions between each of the three areas, did not differ 
between genotypes (t = 0.660, df = 16, p > 0.05; Fig. 2.11b). So called ethological 
„risk assessment behaviours‟, such as stretch-attend postures and head-dips over 
the edges of the open sides were recorded, but the occurrence of these behaviours 
were insufficient to permit meaningful analysis. 
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Figure 2.11 Anxiety-related behaviours in an elevated plus-maze. (a) During the 5 
minute test, mice from both genotypes spent more time in the closed arms of the 
plus-maze than in the open arms or middle area that connected the arms. This 
activity profile did not differ between genotypes. (b) Locomotor activity, assessed 
by the total number of transitions between each of the three areas, did not differ 
between genotypes (n = 8/10, WT/KD).  
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2.4 Discussion 
 
The present experiments examined the phenotypic traits of a novel mouse line in 
which cell-type specific RNA interference was used to selectively knock-down 
mGluR5 in cells that express the dopamine D1R. These mGluR5KD-D1 mice were 
indistinguishable from their wild-type littermates in gross appearance, simple tests 
of auditory and visual function and a variety of assessments of reflexive responses. 
Body weights in adult mice did not differ between genotypes under ad libitum or 
restricted feeding conditions. Mutant animals showed a preference for sucrose and 
were able to adjust their intake according to the sucrose concentration. However, 
locomotor activity experiments revealed that activity in a novel environment was 
reduced in mutant mice. Tests of anxiety-related behaviours suggested that mutant 
mice may have a reduced anxiety phenotype, but this effect was not reliably 
observed among the different tests employed. 
 
The first series of assessments included an evaluation of general health and 
neurological reflexes. While these tests may appear crude, they can provide 
valuable information regarding gene function or unexpected effects that could 
severely constrain the interpretation of findings from more complex behavioural 
experiments. Poor body condition could indicate illness, inadequate diet, premature 
weaning, aberrant grooming or fighting amongst littermates. Impaired neurological 
reflex responses could have pointed to serious motor dysfunction including motor 
neuron degeneration. For example, the hanging wire test reflects motor strength 
and can be used to detect neuromuscular abnormalities, since balance and grip 
strength is required for the mouse to remain suspended from the inverted wire 
cage (Crawley, 2007). These tests were particularly relevant for mGluR5KD-D1 mice 
because mGluR5 is widely expressed in at many levels of the and peripheral 
neural circuitry involved in motor control central (Tallaksen-Greene et al., 1998; 
Alvarez et al., 2000; Awad et al., 2000; Hubert et al., 2001). The possibility for co-
expression of the D1R in these areas could have resulted in disruption of motor 
control due to corresponding knock-down of mGluR5. For example, mGluR5 is 
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expressed within the ventral horn of the spinal cord, albeit at lower levels than the 
dorsal horn (Alvarez et al., 2000; Tomiyama et al., 2001; Ma et al., 2006). There is 
also some evidence for D1R-like expression in the ventral horn (Dubois et al., 
1986; Zhu et al., 2007) and behavioural data pointing to a role of spinal D1R in the 
control over rhythmic movement generation (Lapointe et al., 2009). That we found 
no difference between mGluR5KD-D1 and control mice in these basic assessments 
of health and neurological reflexes provides the first indication that loss of mGluR5 
in mutant mice does not result in gross abnormalities that could restrict the use of 
these mice in more complex behavioural paradigms. 
 
The use of visual and auditory stimuli for conditioning experiments reported in 
subsequent chapters of this thesis would necessitate that mGluR5KD-D1 mice could 
adequately see and hear. Vision was assessed using the visual placing test 
(Heyser, 2003). While blind mice perform poorly in this test (Pinto and Enroth-
Cugell, 2000), normal performance recorded in mGluR5KD-D1 mice does not 
necessarily infer normal visual function. It is possible that performance in this task 
could be maintained despite some degree of impaired vision. However, it is also 
worth noting that mGluR5KD-D1 mice typically moved directly from the light area to 
the dark area in the light-dark box test, indicating sufficient vision to identify the 
escape route from the light area. Published electrophysiology data, considered to 
provide the most sensitive and accurate measure of visual activity (Pinto and 
Enroth-Cugell, 2000), also fails to support a major role of mGluR5 in visual function 
(Cirone et al., 2002). Meanwhile, auditory function was provided by assessing the 
Preyer startle reflex. Akin to the visual placing test, a normal Preyer reflex cannot 
be taken as indicative of entirely normal auditory function (Astbury and Read, 
1982; Horner and Barkway, 1986). However, there is a paucity of literature 
examining the role of mGluR5 in auditory function and expression of mGluR5 
protein is low in the dorsal cochlear nucleus (Petralia et al., 1996), a major brain 
centre for the integration of auditory information. Collectively, the lack of evidence 
for impaired visual or auditory function in mGluR5KD-D1 mice provides support for 
the use of visual and auditory stimuli for conditioning experiments. 
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The sucrose two-bottle choice test was used to primarily as an index of taste 
perception. However, sucrose consumption is a complex behaviour influenced by 
separate and dissociable orosensory and post-ingestive mechanisms (Sclafani, 
1995) and can also reflect hedonic states (Papp et al., 1991; Stephens et al., 
2010). With the experimental design used here, it is not possible to identify which 
factor was primarily responsible for driving sucrose consumption in mutant and 
control mice. However, the use of food restriction in the present test likely results in 
sucrose consumption being largely driven by the requirement for energy 
homeostasis (Hayward et al., 2002). Notably, sucrose consumption did not differ 
between genotypes and was high in both WT (4.8-28.6 mL @ 10% sucrose) and 
KD (3.9-25.5 mL @ 10% sucrose) mice, consistent with what has previously been 
reported in other C57BL/6 strains  (Lewis et al., 2005). Although we were unable to 
determine a minimum threshold for detection of sucrose (subsequent studies would 
ideally test lower concentrations of sucrose), mGluR5KD-D1 mice displayed a clear 
preference for sucrose at all concentrations tested. Thus, despite the complex 
nature of the task, the study at least demonstrates that taste functions such as 
simple detection and discrimination are not impaired in mutant mice under 
conditions of restricted feeding that would be used throughout behavioural tests in 
subsequent chapters of this thesis. 
 
Other studies of sucrose consumption have reported that mice initially consume 
little sucrose upon first exposure, but gradually develop a sucrose preference over 
subsequent days (Amico et al., 2005). This neophobic response can be a useful 
indicator of memory and taste perception, since it reflects the ability to store 
representations of an experienced taste so that it can be retrieved on subsequent 
encounters and infers the ability to identify and respond differently to novel versus 
familiar tastes (Vogt and Rudy, 1984). The present study found no evidence for 
neophobia in either wild-type or mutant mice, as sucrose consumption in both 
genotypes did not significantly increase across the days of exposure to each 
sucrose concentration (data not shown). Absence of a neophobic response in the 
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present study may reflect rapid acclimatisation to sucrose due to the relatively low 
sucrose concentration first experienced (approximately 10 fold lower than typically 
used to examine neophobia) and/or heightened motivation due to food restriction 
overriding a neophobic response. Alternatively, the interval between 
measurements of sucrose intake (once every 24 hours) may have lacked 
sensitivity for detecting a neophobic response that may have occurred during initial 
exposure to the sucrose bottle. Indeed, 24 hour measurements take no account of 
meal size, rate of consumption, meal frequency or circadian rhythms. 
 
An important finding in the two-bottle test was that sucrose preference was 
reduced in mGluR5KD-D1 mice, which was a function of increased water intake at 
the 10% sucrose concentration. The reason for altered intake of water is not 
entirely clear, but could reflect altered metabolic function in mutant mice. 
Metabotropic glutamate receptors are involved in hormone secretion in the 
endocrine pancreas (Brice et al., 2002). Indeed, mGluR5 is expressed at the cell 
surface of clonal beta-cells and in purified insulin-containing granules and is 
required for an optimal insulin response to glucose (Storto et al., 2006). Given that 
pancreatic cells also possess characteristics of dopamine producing cells (Mezey 
et al., 1996) and dopamine-D1 receptors may be expressed by beta-cells (Rubi et 
al., 2005), it is plausible that mGluR5 is knocked-down in these cells, resulting in 
disrupted pancreatic signalling. Decreased intake of sucrose and increased water 
intake by animals with experimentally induced diabetes in a two-bottle choice test 
has been reported previously (Maller and Hamilton, 1968; Hiji, 1969). This pattern 
of intake is considered a strategy by which diabetic animals dilute the osmotic load 
of concentrated sugar solutions (Tepper and Friedman, 1991). Although we have 
not examined pancreatic expression of mGluR5 or assessed pancreatic function 
directly in mGluR5KD-D1 mice, a „diabetic mouse‟ hypothesis seems unlikely. First, 
water intake measured during the habituation phase of the two-bottle choice 
experiment tended to be lower in mutant mice, which is inconsistent with a 
polydipsia phenotype typically observed in diabetic animals (Tepper and Friedman, 
1991). Second, mutant mice attained free-feeding body weights comparable to 
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their wild-type littermates and were able to tolerate a restricted feeding regime, 
which is also inconsistent with diabetic phenotypes of hyperphagia and weight loss 
(Tepper and Friedman, 1991). 
 
Three tests were used specifically to examine locomotor behaviour in mutant mice. 
In a circular runway, a clear reduction in activity was found in mutant mice during 
the first test session (that is, when the test environment was novel). A more 
detailed assessment of activity in a novel open-field arena indicated this genotype 
difference likely arose from a reduction in ambulatory movement and, conversely, a 
tendency for an increase in the duration of static/exploratory behaviour in KD mice. 
One possibility is that decreased ambulatory movement in mutant mice was due to 
competing aberrant behaviours, such as stereotypy (that is, repetitive, invariant, 
and perseverative motor patterns that do not appear directed toward a purposeful 
action). Although stereotypy was not formally assessed in the current studies, 
mutant mice did not show elevated levels of grooming or digging. Similarly, 
static/exploratory or excitatory movement duration, which would have captured 
stereotyped movements (for example, wild-running, circling, excessive grooming, 
stereotyped sniffing, head bobbing), did not significantly differ between genotypes. 
After a period of habituation, baseline activity in the circular runways did not differ 
between genotypes, consistent with findings of no genotype difference in activity 
when monitored in the home-cage (personal communication with Dr. B. Halbout). 
Taken together, these data suggest that the locomotor responsiveness to novelty is 
attenuated in mutant mice, rather than general locomotor activity per se. 
 
The spontaneous nose-poking task was also used as a measure of exploratory 
behaviour in a novel environment, taking inspiration from hole-board exploration 
paradigms that exploit of the tendency of mice to poke their noses into holes in a 
wall or floor (Boissier et al., 1964). In contrast to findings from the circular runway 
and the open-field, no difference was found between genotypes in exploratory 
behaviour that was indexed by nose-poking. This lack of difference may indicate 
that the behavioural measure (nose-poking) was not sufficiently sensitive to detect 
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locomotor differences between genotypes. Alternatively, the nose-poke response 
may have been simply unaffected in mutant mice, while motor behaviours reduced 
in the circular runway and open-field (for example, ambulatory activity) were more 
heavily influenced by mGluR5 loss on D1 expressing cells. Finally, if differences in 
motor activity between genotypes were correlated to the anxiogenic potential of the 
test environment, this would be consistent with a lack of difference between 
genotypes in the nose-poking test, which was conducted in the relatively small, 
dark and enclosed space of the conditioning chamber. 
 
Locomotor activity in a novel environment, although commonly associated with 
dopaminergic signalling, requires the function of many central and peripheral 
systems (Picciotto and Wickman, 1998). It is well beyond the scope of this thesis to 
determine precisely where disruption has occurred in this particular network in 
mGluR5KD-D1 mice, although this point will be given further consideration in the 
discussion in Chapter 5 and also the General Discussion of this thesis. For now, it 
is sufficient to recognise that this particular phenotypic trait must be considered 
when discussing data generated from subsequent behavioural tests, given the 
potential for non-specific effects associated with reduced locomotor activity under 
certain conditions. 
 
Three tests were used to examine anxiety-related behaviours in mutant mice. The 
first test used one of the oldest and simplest (at least in design) measures of 
rodent emotional behaviour, the open-field (Hall, 1934, 1936). A number of 
behaviours recorded in a novel and inescapable open-field are proposed as indices 
of heightened emotionality and/or anxiety, including decreased ambulation, 
increased defecation, thigmotaxis (the proportion of time spent close to the wall) 
and decreased rearing (Archer, 1973; Walsh and Cummins, 1976; Crawley et al., 
1997). In the present test, mutant mice spent significantly more time in the middle 
part of the arena than wild-type mice. Although rearing was not assessed in this 
open-field test, increased rearing was observed in mutant mice in the smaller 
open-field arena used to assess spontaneous activity. Together, these data 
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support a reduced anxiety-like phenotype in mGluR5KD-D1 mice. However, this 
conclusion was not robustly supported when anxiety-related behaviours were 
examined in two other tests of unconditioned behaviour, namely the light-dark box 
(Crawley and Goodwin, 1980; Crawley et al., 1981; Bourin and Hascoet, 2003) and 
the elevated plus-maze (Pellow et al., 1985; Pellow and File, 1986; Stephens et al., 
1986; Lister, 1987). Both tests similarly exploit the naturalistic conflict between the 
tendency of mice to explore a novel environment and the aversive properties of an 
open space (Crawley, 1985; Belzung and Griebel, 2001). In the light-dark box, 
mutant mice did spend more time in the (anxiogenic) light area than wild-type 
controls, but this effect did not reach significance. In the elevated plus-maze, no 
difference in exploratory behaviour was observed between genotypes. The 
contrasting findings amongst the three tests are not easily reconciled, but could 
reflect different genetic components underlying performance in each of the 
paradigms (Crawley and Goodwin, 1980; Crawley et al., 1981; Mathis et al., 1994; 
Dawson and Tricklebank, 1995; Mathis et al., 1995). 
 
An important consideration for interpreting findings from the tests of anxiety-related 
behaviours is that all are heavily dependent upon locomotor activity. In the light-
dark box, there was a tendency in mutant mice for a reduction in the number of 
transitions between areas (a measure considered by some to be a more sensitive 
measure of anxiety-related behaviour than time in each area (Crawley, 1985)), 
although no genotype difference in activity was detected in the open-field or the 
elevated plus-maze. The failure to find a significant difference in activity in these 
tests could have been due to the sensitivity of the measures used and/or the 
relatively short duration of the tests. For example, the number of area transitions in 
the elevated plus-maze is reported to be a relatively insensitive measure of drug-
induced changes in locomotor activity (Dawson et al., 1995). Since mice 
experienced all tests under novel environment conditions, the potential for 
differences in locomotor activity between genotypes contributing to an apparent 
reduced anxiety phenotype cannot be completely discounted. 
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If mGluR5 on D1R expressing cells contributes to anxiety related behaviours, it is 
likely that the overall contribution is small. Reports on the role of mGluR5 in anxiety 
propose multiple brain areas that may be involved in the anxiolytic-like effects of 
mGluR5 antagonists. First, the anxiolytic-like effects of mGluR5 antagonists may 
reflect their ability to reduce extracellular noradrenaline in the frontal cortex, as the 
noradrenergic locus coeruleus is an important mediator of stress responses and 
may contribute to affective disorders (Page et al., 2005). Second, the mGluR5 
antagonist MTEP is reported to produce a dose-dependent increase in serotonin in 
the frontal cortex, and the anxiolytic-like effects of MTEP may necessitate 
activation of the serotonin system (Stachowicz et al., 2007). Third, MTEP reduced 
anxiety-related measures in the elevated plus-maze when injected directly into the 
lateral-septal nucleus (Molina-Hernandez et al., 2006), an area that likely regulates 
mood and motivation through connections with the mesocorticolimbic dopamine 
system (Sheehan et al., 2004). Finally, the anxiolytic effects of MPEP in non-
conditioned tests of anxiety may by mediated by block of mGluR5 in the BLA 
and/or CeN, resulting in reduced glutamate transmission within the BLA and 
reduced glutamate output from the CeN (Perez de la Mora et al., 2006). Clearly, to 
determine whether function in any or all of these neural systems are impaired in 
mGluR5KD-D1 mice would require many years of investigation. For now, it is 
sufficient that the potential for a reduced anxiety-phenotype in mutant mice will be 
considered alongside any other findings reported in this thesis. 
 
Finally, it must be acknowledged that all of the assessments reported here were 
undertaken in adult male mice during the light phase and phenotype/genotype 
interactions may have also arisen as a function of age, gender or time of day. For 
example, Huntington‟s disease transgenic mice show reduced impaired motor 
activity that progressively worsens with age (Mangiarini et al., 1996). Just one 
example of gender differences is provided by the observation that female mice of 
some strains typically consume greater volumes of sweet solutions than male mice 
(Stockton and Whitney, 1974; Ramirez and Fuller, 1976). Although all of these 
factors would be of interest to explore in mGluR5KD-D1 mice, it must also be noted 
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that subsequent experiments of this thesis would be conducted during the light-
phase in adult male mice. Thus, the experimental parameters employed in the 
current chapter allowed for basic phenotype differences to be used more readily in 
understanding any further genotype differences that could emerge from 
experiments reported in the following chapters of this thesis. 
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3 Appetitive learning in mGluR5KD-D1 mice 
 
3.1 Introduction 
 
As a consequence of associative learning, an environmental stimulus paired with 
reward experience (a conditioned stimulus; CS) can not only acquire predictive 
properties that serve to signal the availability and/or location of the reward 
(discriminated approach or goal-tracking; Boakes, 1977), but may also acquire 
incentive properties that enable CSs to attract (auto-shaping or sign-tracking; 
Brown and Jenkins, 1968), directly reinforce (conditioned reinforcement; 
Mackintosh, 1974) or energise (Pavlovian-instrumental transfer; Estes, 1948) 
appetitive behaviours (see also Flagel et al., 2009; Robinson and Flagel, 2009). 
While the predictive and incentive functions of CSs have clear adaptive value, the 
neural systems that mediate the learning of incentive properties (the acquisition) 
and the CSs‟ subsequent effects on behaviour (the expression) are proposed to be 
subverted by drugs of abuse (Everitt et al., 2001; Kelley, 2004; Hyman et al., 
2006). Thus, contemporary theories of drug addiction ascribe particular importance 
to the role of drug-paired CSs in maintaining drug taking and triggering relapse 
(Stewart et al., 1984; Robinson and Berridge, 1993; Everitt et al., 2001). The 
powerful influence of CSs over the consumption of natural rewards (e.g. cue-
potentiated feeding; Zambie, 1973; Weingarten, 1983) has similarly led to the 
proposition that food-paired CSs may contribute to the development and 
maintenance of certain eating disorders and obesity (Holland and Petrovich, 2005; 
Le Merrer and Stephens, 2006; Volkow et al., 2008). 
 
The neural circuitry underlying incentive learning and control over appetitive 
behaviours by CSs involves, in part, convergence within the striatum of 
dopaminergic projections from the ventral tegmental area (VTA) and substantia 
nigra (SN), with glutamatergic inputs originating in the prefrontal cortex (PFC), 
hippocampus and amygdala (Schultz et al., 1997; Robbins and Everitt, 2002; 
Cardinal and Everitt, 2004; Goto and Grace, 2008). Glutamate signalling through 
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ionotropic AMPA and NMDA receptors in the ventral striatum appear particularly 
important for mediating the control over certain appetitive behaviours by CSs (for 
example, sign-tracking responses; Di Ciano et al., 2001). However, much less is 
known about the role of metabotropic glutamate receptors in these incentive 
learning processes. 
 
The group I metabotropic glutamate receptor, mGluR5, is found throughout the 
CNS, but is most densely expressed in the striatum, cortex and hippocampus 
(Romano et al., 1995). Typically located postsynaptically on dendritic spines and 
concentrated at perisynaptic sites (Shigemoto et al., 1993; Luján et al., 1996), 
mGluR5 plays a central role in different forms of synaptic plasticity, including long 
term potentiation (LTP; see Anwyl, 2009 for review) and long term depression 
(LTD; see Bellone et al., 2008 for review), that are thought to be involved in a 
variety of learning and memory processes (Kelley, 2004; Malenka and Bear, 2004; 
Hyman et al., 2006). Mechanisms by which group I mGluRs influence synaptic 
plasticity include control over presynaptic transmitter release via retrograde 
endocannabinoid signalling (Robbe et al., 2002) and changes in postsynaptic 
sensitivity to excitatory input through alterations in AMPA receptor expression 
(Snyder et al., 2001; Bellone and Luscher, 2005; Mameli et al., 2007; Jo et al., 
2008; Zhang et al., 2008; Kelly et al., 2009). Thus, mGluR5 appears ideally 
positioned to mediate incentive learning processes necessary for the acquisition of 
predictive and/or incentive properties by reward-paired CSs which enable them to 
influence appetitive behaviours. 
 
In the striatum, mGluR5 is expressed on both striatonigral and striatopallidal 
projecting MSNs (Tallaksen-Greene et al., 1998) that are characterised, in part, by 
predominant expression of dopamine D1R or D2R receptors, respectively (Gerfen 
et al., 1990; Bertran-Gonzalez et al., 2011). MSNs provide the sole striatal output 
to motivational and motor systems (Goto and Grace, 2008), but the role of mGluR5 
on these functionally distinct neurons for incentive learning processes is not clear. 
Although systemic administration of an mGluR5 antagonist can disrupt behaviours 
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maintained by a reward-paired CS (e.g. Backstrom et al., 2004), pharmacological 
approaches inevitably lack the selectivity required for understanding the 
contribution of mGluR5 on distinct neuronal populations within the same brain 
locus, such as D1- and D2-MSNs within the striatum. In addition, the only 
published report to examine the role of striatal mGluR5 in behaviours maintained 
by a drug-paired CS was unsuccessful (Backstrom and Hyytia, 2007). In this study, 
the mGluR5 antagonist MPEP was reported to decrease cocaine seeking relative 
to baseline, but only because similar effects were seen following vehicle injections 
in the same within-subjects design. The authors suggested this may reflect 
conditioned anhedonic effects associated with MPEP (Backstrom and Hyytia, 
2007). The mGluR5KD-D1 mouse model therefore offers a valuable tool to examine 
the contribution of mGluR5 on cells that express the dopamine D1R (including 
striatal D1-MSNs) to incentive learning processes. 
 
In this regard, the following experiments will see mGluR5KD-D1 and wild-type mice 
exposed to tests that aim to examine the role of mGluR5 on D1R expressing 
neurons in predictive and incentive elements of appetitive learning. Mice will first 
be trained a purely Pavlovian association between the presentation of a discrete 
stimulus (e.g. a light) and the delivery of a food pellet. Learning about the 
predictive properties of the food-paired CS will be indexed by discriminated 
approach responses during training and, more formally, by tests of discriminated 
approach conducted in the absence of food delivery (i.e. extinction conditions). To 
assess incentive learning in mGluR5KD-D1 and wild-type mice, three fundamental 
(but neurobiologically distinct; Cardinal et al., 2002a) properties of an incentive CS 
will be examined; the ability of a CS to 1) elicit approach toward it (sign-tracking), 
2) reinforce the learning of a new response (CRf) and 3) energize ongoing 
instrumental actions (PIT). Two pharmacology tests will be used to further probe 
the role of mGluR5 in incentive learning. First, mGluR5KD-D1 and wild-type mice will 
receive injections of cocaine prior to CRf tests. This experiment will inform about 
the contribution of mGluR5 on D1R expressing cells to the neural circuitry 
underlying psychostimulant potentiation of CRf. Second, wild-type mice will receive 
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injections of an mGluR5 antagonist, MTEP, prior to tests of CRf. In this experiment, 
the role of mGluR5 in the expression of control over behaviour by a conditioned 
incentive can be examined. Finally, two satiety-induced devaluation tests will be 
reported. The first devaluation test will assess whether mice can update the value 
of the CS elicited representation of the US. The second test will assess whether 
instrumental responding, after the PIT test, is goal-directed or habit based.  
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3.2 Materials and Methods 
 
3.2.1 Animals 
Mice (n = 40/45, WT/KD; male and at least 8 weeks old prior to experiment start) 
were maintained on a 12:12 h light-dark cycle (lights on at 0700 hours) under 
controlled temperature (21 ± 2 °C) and humidity conditions (50 ± 5%). Animals 
were housed in groups of two or three per cage. Water was available ad libitum in 
the holding room. At least 7 days prior to the experiment start, mice were placed 
onto a restricted feeding regime designed to maintain body weights at ~85% of 
free-feeding weight. Experiments took place during the light-phase. All procedures 
were performed in accordance with the United Kingdom 1986 Animals (Scientific 
Procedures) Act, following institutional ethical review. 
 
3.2.2 Drugs 
Cocaine hydrochloride (Macfarlan Smith, Edinburgh, Scotland, UK) was dissolved 
in 0.9% saline. The non-competitive mGluR5 antagonist, 3-((2-methyl-1,3-thiazol-4-
yl)ethynyl)pyridine (MTEP; Sequoia Research Products, Pangbourne, UK), was 
dissolved in 10% v/v Tween 80 : 90% water. Injections were administered at a 
volume of 10 ml/kg i.p. 
 
3.2.3 Apparatus 
Behavioural training and testing were performed in eight standard mouse 
conditioning chambers (15.9 x 14 x 12.7 cm; Med Associates, Vermont, USA). 
Each chamber was housed within a sound attenuating and light-resistant cubicle, 
fitted with an exhaust fan that served both to ventilate the unit and mask any 
external noise. The front access panel, ceiling and rear wall of the conditioning 
chambers were constructed from clear Plexiglas and the side walls consisted of 
removable aluminium panels. Each chamber was fitted with a pellet dispenser 
system that delivered 20 mg food pellets (5TUL, Cat no. 1811142; Test Diets, 
Indiana, USA) into a recessed food magazine situated at the centre of one side 
wall (Fig. 3.1a). A retractable response lever was located on either side of the food 
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magazine and an LED stimulus light was positioned approximately 8 cm above 
each lever (Fig. 3.1a-b). A tone generator (2.9 KHz, 5 dB above background) was 
situated between the stimulus lights (Fig. 3.1a). On the wall opposite to the food 
magazine was located the house light and, for the Pavlovian approach tests, two 
nose-poke holes that each contained an LED stimulus light (Fig. 3.1c) Infra-red 
beams detected head entries into the food magazine and the nose-poke holes. 
Conditioning chambers were controlled and responses recorded using Med-PC IV 
(Med Associates). 
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Figure 3.1 Apparatus for conditioning studies (a) The front wall of the conditioning 
chamber is shown, with the Plexiglas door that provides access to the chamber 
open. A waste tray filled with sawdust is located below the grid floor. (b) The two 
levers are extended into the chamber. (c) The rear wall of the conditioning 
chamber is shown. For the Pavlovian approach test, two nose-pokes are inserted 
into the chamber. In one nose-poke a stimulus light is presented (CS+ nose-poke), 
while no stimulus is presented in the control (Ctrl) nose-poke. 
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3.2.4 Procedural note 
Four different groups of mice were used for the following experiments. An outline of 
the experiments conducted within each group (1-4) is provided (Fig. 3.2). Where 
multiple tests were conducted in the same group, Pavlovian reconditioning 
sessions were provided between tests to maintain baseline conditioning 
performance. 
 
3.2.5 Magazine training 
To familiarize all mice with the food used for conditioning studies, a small amount 
of the food was given to mice in their home cage. Mice also received a single, 30 
min, magazine training session in which food pellets were delivered once every 60 
 
Figure 3.2 Experimental outline for conditioning studies. Four groups of WT 
and KD mice were used for the present experiments. All groups first 
received a magazine training session followed by Pavlovian conditioning. 
Further reconditioning sessions, represented by the block arrows, were 
provided between tests. Group 1 was used to examine sign-tracking (ST), 
conditioned reinforcement (CRf) and cocaine facilitation of CRf (Coc+CRf). 
Group 2 was used to examine CRf. Wild-type mice (open arrows) from this 
group were then used to examine the effect of MTEP on CRf (MTEP+CRf). 
WT and KD (black arrows) mice were then both assessed for discriminated 
approach (DA). Group 3 was used for conditioned reinforcement (CRf) and 
devaluation of DA (Dev+DA). Group 4 was used to examine Pavlovian-
instrumental transfer (PIT) and devaluation of instrumental responding under 
extinction (Dev+Ext). 
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sec, on average (range of 25 to 95 sec; M = 60 sec). No levers, nose-pokes or 
stimuli (e.g. tone or cue lights) were present during the magazine training session. 
 
3.2.6 Group 1 
Procedure overview: Mice (n = 12/12, WT/KD) were first trained a Pavlovian 
association between a discrete visual stimulus and the delivery of a food pellet. 
Following Pavlovian conditioning sessions, the ability of the food-paired stimulus to 
elicit approach toward it (sign-tracking) and to reinforce a novel instrumental 
response (CRf) was examined. Finally, I examined whether cocaine would facilitate 
responding for CRf in wild-type and mutant mice. 
 
3.2.6.1 Pavlovian conditioning 
Mice received eleven, once-daily, 30 min Pavlovian conditioning sessions in which 
16 presentations of a 10 sec stimulus paired with food delivery (CS+; cue lights 
flashing at 1 Hz) occurred. A single food pellet was delivered 5 sec after CS+ 
onset. Each CS+ presentation was separated by a variable, no-stimulus, inter-trial 
interval (ITI; range of 80 to 120 sec; M = 100 sec). A number of measures were 
used to inform about learning in Pavlovian conditioning sessions, 1) Magazine 
entries / min: the rate of magazine entries during CS+ presentations and the ITI, 2) 
% Magazine entries: the distribution of magazine entries between stimulus and ITI 
periods, calculated as ((#CS+ entries / CS+ time) / ((#CS+ entries / CS+ time) + 
(#ITI entries / ITI time))) x 100), 3) Discriminated approach responses: the number 
of magazine entries made during the first 5 sec interval that occurred after CS+ 
onset but before food delivery, and 4) Retrieval latency: the mean latency to enter 
the food magazine after CS+ onset. Note that when a mouse did not enter the 
magazine during a CS+ trial, a time of 10 sec was designated as the retrieval 
latency for that trial. 
 
3.2.6.2 Sign-tracking 
For the 45 min sign-tracking test, conducted 24 h after the final conditioning 
session, two nose-poke holes were inserted into the conditioning chamber (Fig. 
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3.1c). Access to the food magazine was blocked in order to minimize the potential 
for competition between discriminated approach and sign-tracking responses. In 
one nose-poke hole, 15 x 1 min presentations of a flashing cue light (that is, the 
CS+) occurred. Each CS+ presentation was separated by a 2 min, no-stimulus, ITI. 
No stimulus presentations occurred in the second (control) nose-poke hole and no 
food was delivered during the test. The assignment of nose-poke holes (left or 
right) as CS+ and control was counterbalanced within each genotype. Entries into 
each nose-poke were recorded during CS+ presentations, thus providing a 
measure of Pavlovian approach responses toward the CS+. Entries into the nose-
poke ports during the ITI were recorded to provide an indication of overall activity 
during the test. 
 
3.2.6.3 Conditioned reinforcement 
The 45 min CRf test commenced with insertion of both response levers into the 
operant chamber. A single response on one lever (termed, the CS+ lever) resulted 
in a 1.5 sec presentation of the flashing cue lights (that is, the CS+), whereas a 
single response on the alternate lever (the control lever) had no scheduled 
consequence. For half of the animals, the left lever was assigned as the CS+ lever 
and the right lever was the control lever. The remaining animals received the 
reverse lever-outcome pairings. The number and time of occurrence of responses 
on both levers were recorded. No food was delivered during the test. 
 
3.2.6.4 The effect of cocaine on responding for conditioned reinforcement 
Mice were injected with cocaine (0, 3, 10 or 20 mg/kg i.p.) immediately prior to CRf 
tests (undertaken as described 3.2.6.3.). Each mouse received all doses of 
cocaine and vehicle in a Latin-square design. One or two reconditioning sessions 
(as described 3.2.6.1) were provided between each CRf test. 
 
3.2.7 Group 2 
Procedure overview: Since findings from the CRf test in group 1 could have been 
influenced by experience of the sign-tracking test first, a second group of mice (n = 
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12/12, WT/KD) underwent identical Pavlovian training that was immediately 
followed by a CRf test. Next, the role of mGluR5 in mediating responding for CRf 
was further explored by injecting WT mice from this group with the mGluR5 
antagonist, MTEP, prior to additional CRf tests. Finally, the ability of the food-
paired stimulus to serve as a predictor of food delivery (discriminated approach) 
was examined in both WT and KD mice. A number of discriminated approach tests 
were performed to understand whether mice were using the stimulus light or 
perhaps another cue (such as the sound of the food pellet delivery) as a signal of 
oncoming food delivery. 
 
3.2.7.1 Pavlovian conditioning 
Pavlovian conditioning was undertaken as described (3.2.6.1) 
 
3.2.7.2 Conditioned reinforcement 
Conditioned reinforcement was undertaken as described (3.2.6.3) 
 
3.2.7.3 The effect of MTEP on responding for conditioned reinforcement 
Wild-type mice were injected with MTEP (0, 3, 10 or 20 mg/kg i.p.) 15 minutes prior 
to CRf tests (undertaken as described 3.2.6.3). Each mouse received all doses of 
MTEP in a Latin-square design. One or two reconditioning sessions (as described 
3.2.6.1) were provided between each CRf test. Mutant mice did not undergo this 
experiment, since they did not demonstrate any CRf in the first test. One WT 
mouse that failed to elicit any responses during the first CRf test was excluded 
from this test, leaving a group size of n = 11. 
 
3.2.7.4 Discriminated approach 
Mice (n = 12/12, WT/KD) were given five discriminated approach tests, each of 
which was 15 minutes in duration. Each test contained 8 x 10 sec trials, with each 
trial separated by a fixed 100 sec ITI. The type of trial in each test was either 1) 
CS+, US: 10 sec presentation of the CS+, with delivery of a single food pellet 5 sec 
after CS+ onset (i.e. normal Pavlovian conditioning parameters), 2) CS+, Noise: 10 
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sec presentation of the CS+, with the sound of the food pellet delivery 5 sec after 
CS+ onset. The sound of the food pellet delivery was recreated by activating the 
food magazine and allowing the food pellet to fall into a metal receptacle located 
outside of the conditioning chamber. 3) CS+: 10 sec presentation of the CS+ only, 
4) Noise: the sound of the food pellet delivery occurring 5 sec after the end of each 
100 sec ITI, or 5) No: no stimuli were presented during the 10 sec trial period. Note 
that only one type of trial was present in a test. The order of the five discriminated 
approach tests was presented in a Latin-square design. One or two reconditioning 
sessions (as described in 3.2.6.1) were provided between each test. Magazine 
entry rates were recorded during each 10 second trial and the intervening ITIs. 
 
3.2.8 Group 3 
Procedure overview: Because recent evidence suggested that responding for 
sensory reinforcement may contribute significantly to responding for CRf where 
only one conditioned stimulus is used (Winterbauer and Balleine, 2007), a third 
group of mice (n = 9/12, WT/KD) was trained a Pavlovian association with one 
stimulus paired with food delivery and a second stimulus unpaired with food. A test 
of CRf followed in which responding on one lever led to presentation of the food 
paired stimulus and responding on a second lever resulted in presentation of the 
unpaired stimulus. A test of discriminated approach was also undertaken in these 
mice. However, this test contained a devaluation component that would inform 
about ability of the mice to use the CS for gaining access to an internal 
representation of the associated outcome (Holland, 2004). 
 
3.2.8.1 Pavlovian conditioning 
Mice received eleven, once-daily, Pavlovian conditioning sessions in which 16 
presentations of a stimulus paired with food delivery (CS+) and 16 presentations of 
a stimulus paired with no outcome (CS-) occurred. The order of stimulus 
presentations was entirely random and each stimulus was separated by a variable 
no-stimulus ITI (range of 80-120 sec; M = 100 sec). For half of the mice, a constant 
tone (80 dB, 2,900 Hz; 10 sec) served as the CS+ and flashing cue lights (1 Hz; 10 
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sec) served as the CS-. The remaining animals received the reverse pairings. A 
single food pellet was delivered 5 sec after CS+ onset. The measures used to 
inform about learning in Pavlovian conditioning sessions were as described 
(3.2.6.1), with the modification that magazine entries / min and the % Magazine 
entries calculation now took into account magazine entries during both CS+ and 
CS- periods. 
 
3.2.8.2 Conditioned reinforcement 
The 45 min test commenced with insertion of both response levers into the operant 
chamber. A single response on one lever resulted in a 1.5 sec presentation of the 
CS+, whereas a single response on the alternate lever resulted in a 1.5 sec 
presentation of the CS-. For half of the mice, the left lever was designated the CS+ 
lever and the right lever the CS- lever. This contingency was reversed for 
remaining mice. No food was delivered during the test. The number of lever 
responses and their time of occurrence was recorded. 
 
3.2.8.3 The effect of satiety on discriminated approach responses 
The discriminated approach test contained 8 presentations of the 10 sec CS+ and 
8 presentations of the 10 sec CS-. The order of stimulus presentations was entirely 
random and each stimulus was separated by a fixed 100 sec ITI. No food was 
delivered during the test. Magazine entry rates were recorded during each CS+ 
and CS- trial. All mice were exposed to two discriminated approach tests, with two 
reconditioning sessions (as described in 3.2.8.1) provided between each test. For 1 
hour prior to the first test, half of the mice within each genotype received ad libitum 
access to standard lab chow in their home cage (termed, the „valued‟ conditioned), 
while the other half received ad libitum access to the food pellets used for 
conditioning studies (termed, the „devalued‟ condition), also within their home 
cages. For the second discriminated approach test, mice were exposed to the 
opposite feeding condition. To confirm whether food consumption had occurred, 
body weights of mice were recorded before and after the 1 hour feeding period. 
 
128 
 
3.2.9 Group 4 
Procedure overview: Mice (n = 7/9, WT/KD) were first trained a Pavlovian 
association between a stimulus paired with food delivery and a second stimulus 
unpaired with food. Following lever training for food reinforcement, the ability of the 
food-paired stimulus to motivate on-going instrumental responding was examined 
in the Pavlovian-instrumental transfer test. Lever responding under extinction was 
then examined in these mice, which included a devaluation component to inform 
whether instrumental responses were goal-directed or habit based.  
 
3.2.9.1 Pavlovian conditioning 
Mice received twelve, once-daily, 30 min Pavlovian conditioning sessions in which 
four presentations of a 2 min stimulus paired with food delivery (CS+; an 
intermittent tone or flashing house light) occurred. Each stimulus event was 
separated by a variable, no-stimulus, ITI (range of 225 to 375 sec; M = 300 sec). 
Mice then received a further six 45 min conditioning sessions, in which two 
presentations of a 2 min stimulus paired with no outcome (CS-; the alternative 
stimulus) occurred, along with four reinforced presentations of the CS+. The order 
of stimulus presentations was randomly determined and each stimulus was 
separated by a variable, no-stimulus, ITI (range of 205 to 395 sec; M = 300 sec). 
Four food pellets were delivered during each CS+ presentation. Pellet delivery was 
equally likely to occur in each 10 sec time bin throughout the CS+, although a 
minimum time of 10 sec separated each pellet delivery. Magazine entry rates 
(magazine entries / min) were recorded and the distribution of magazine entries (% 
magazine entries) calculated for the two stimulus periods (CS+, CS-). 
 
3.2.9.2 Instrumental training 
Following Pavlovian conditioning sessions, mice were trained to lever press for 
food during once-daily sessions. Each food self-administration session 
commenced with the insertion of two levers. Responses on one lever (the active 
lever) resulted in food pellet delivery, while responses on the alternative lever (the 
inactive lever) had no scheduled consequence. Instrumental training sessions 
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terminated after 30 food pellets had been obtained, or 30 min had elapsed. Initially, 
mice were trained to respond under a fixed-ratio 1 (FR1) schedule of reinforcement 
followed by progressively leaner variable-interval (VI) schedules, until responding 
in both genotypes was stable (that is, less than 20% variation in active lever 
response rates between training sessions) under a VI60 sec schedule of 
reinforcement. 
 
3.2.9.3 Pavlovian-instrumental transfer 
The PIT test commenced with the insertion of both levers and for the first 5 min, no 
stimuli were presented. This period was followed by 4 presentations of the 2 min 
CS+ and 4 presentations of the 2 min CS-, occurring in an alternating order. 
Whether the CS+ or CS- occurred first was randomly determined. Each stimulus 
presentation was preceded by a 2 min, no stimulus ITI. No food was delivered 
during the test. An elevation score was calculated to assess changes in active 
lever response rate during CS+ and CS- presentations (elevation score = lever 
responses during CS+ or CS- presentations minus lever responses during the no-
stimulus ITI period prior to CS+ or CS- presentations, respectively). 
 
3.2.9.4 The effect of satiety on extinction responding 
The 10 min extinction test commenced with insertion of both levers into the 
chamber. Responses on levers were recorded but were without consequence. All 
mice were exposed to two tests, with one instrumental training session (as 
described 3.2.9.2) provided between tests. For 1 hour prior to the first test, half of 
the mice within each genotype received ad libitum access to the food pellets used 
for conditioning studies in their home cage (termed, the „devalued‟ condition), while 
the other half received no food (termed, the „valued‟ conditioned). For the second 
extinction test, mice were exposed to the opposite condition. 
 
3.2.10 Statistical analysis 
All test data were initially assessed for normality (Shapiro-Wilk test; assumption 
violated when p ≤ 0.05) and homogeneity of variance (Levene‟s test, assumption 
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violated when p ≤ 0.05). To permit analysis by parametric tests, appropriate 
transformations were undertaken to transform skewed distributions closer to a 
normal distribution and to reduce heterogeneity of variance (Cardinal and Aitken, 
2006). Specifically, for lever responding during CRf tests (groups 1 and 2), 
magazine entries during the discriminated approach test (group 3) and lever 
responding during the devaluation test (group 4), data were square root 
transformed (Y‟=√Y). Most data (see exceptions below) were first analysed by 
mixed-factor analysis of variance (ANOVA), with genotype (WT, KD) as a between-
subjects factor. Details of the within-subjects factors used each ANOVA are 
provided in the results section. Where significant (p ≤ 0.05) main effects or 
interaction terms were found, further analysis was performed using ANOVA and 
post-hoc comparisons by t-test. Findings were considered indicative of a trend 
where p ≤ 0.1 and Bonferroni corrections were applied for multiple comparisons. 
For within-subjects ANOVA, the Greenhouse-Geisser correction was used where 
the assumption of sphericity was violated (Mauchly‟s test, p ≤ 0.05). 
 
For nose-pokes during the sign-tracking test (group 1) and magazine entries during 
the MTEP on CRf test (group 2), data were not amenable to transformation and 
were analysed by non-parametric tests. Specifically, the comparison of CS+ and 
control nose-pokes within each genotype was made by Wilcoxon Signed-Rank 
test, while comparisons of nose-pokes between genotypes was made by Mann-
Whitney U test. The time course of magazine entries during the MTEP on CRf test 
were analysed by Friedman test. All figures show group mean (± SEM).  
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3.3 Results 
 
3.3.1 Group 1 
3.3.1.1 Pavlovian conditioning 
Both wild-type and mutant mice acquired Pavlovian conditioning; that is, they came 
to enter the food magazine during presentation of the stimulus paired with food 
delivery (the CS+), but largely ignored the food magazine during the no-stimulus 
(ITI) period when food delivery never occurred. Four measures of magazine activity 
were used to compare the acquisition of Pavlovian conditioning between 
genotypes (Fig. 3.3a-d). Analyses of these data was undertaken by mixed-factor 
ANOVA that included Session (1-11) and Period (CS+, ITI) as within-subjects 
factors. 
 
Magazine entries / min: In both genotypes, the absolute rate of magazine entries 
across conditioning sessions increased during CS+ presentations, but decreased 
during the ITI period (Fig. 3.3a). An initial analysis of entries in both periods 
confirmed that magazine entry rates over the conditioning sessions significantly 
differed depending upon the Period identity (main effect of Period, F(1,22) = 70.05, 
p < 0.001; Period x Session interaction, F(10,220) = 37.34, p < 0.001), but not 
between genotypes (Period x Session x Genotype interaction, not significant (NS)). 
A subsequent analysis of magazine entries in both genotypes, first for the CS+ 
period only, confirmed that entry rates in the CS+ period increased over 
conditioning sessions (main effect of Session, F(10,220) = 26.42, p < 0.001), but 
this effect did not differ between genotypes (Session x Genotype interaction, NS). 
Overall CS+ magazine entry rates tended to be lower in mutant mice, but this effect 
did not reach significance (main effect of Genotype, F(1,22) = 3.51, p = 0.074). 
Magazine entry rates during the ITI period decreased over conditioning sessions 
(main effect of Session, F(10,220) = 8.94, p < 0.001) in both genotypes (Session x 
Genotype interaction, NS). Overall magazine entry rates during the ITI were 
reduced in mutant mice (main effect of Genotype, F(1,22) = 5.532, p < 0.05). 
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% Magazine entries: The proportion of total entries made into the food magazine 
during CS+ presentations significantly increased over conditioning sessions (main 
effect of Session, F(10,220) = 34.55, p < 0.001) in both genotypes (Session x 
Genotype interaction, NS), such that magazine entries occurred almost exclusively 
during the CS+ period (Fig. 3.3b). There was no overall difference in % magazine 
entries between genotypes (main effect of Genotype, NS). 
 
Discriminated approach responses: By recording magazine entries in the 5 sec 
interval following CS+ onset but prior to food delivery, it was possible to determine 
whether mice were learning to use the CS+ as a predictor of food delivery. In both 
genotypes, the number of entries into the magazine during this 5 sec interval 
significantly increased over conditioning sessions (main effect of Session, 
F(10,220) = 9.14, p < 0.001), in both genotypes (Session x Genotype interaction, 
NS). This overall response profile did not differ between genotypes (main effect of 
Genotype, NS; Fig. 3.3c). 
 
Retrieval latency: The average time at which mice from both genotypes first 
entered the food magazine following onset of the CS+ decreased across 
conditioning sessions (main effect of Session, F(10,220) = 37.51, p < 0.001; 
Session x Genotype interaction, NS) and approached the time of food delivery (that 
is, 5 sec after CS+ onset; Fig. 3.3d). Although overall retrieval latencies tended to 
be reduced in mutant mice, in comparison to wild-types, this effect did not reach 
statistical significance (main effect of Genotype, F(1,22) = 3.97, p = 0.059).  
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Figure 3.3 Group 1: Pavlovian conditioning (a) In both genotypes, the number of 
entries into the food magazine increased across conditioning sessions during 
presentation of a stimulus paired with food (CS+), while entries during the no-
stimulus period (ITI) decreased. (b) The number of magazine entries made during 
presentation of the CS+, relative to the total number of magazine entries in the 
session (% Magazine entries), increased over conditioning sessions in both 
genotypes. (c) The number of magazine entries made during the first five seconds 
of CS+ onset (i.e. before food delivery), increased over conditioning sessions in 
both genotypes. (d) The average time of the first entry into the food magazine 
following CS+ onset (retrieval latency) decreased over conditioning sessions and 
approached the time of food (US) delivery (n = 12/12, WT/KD)  
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3.3.1.2 Sign-tracking 
When the CS+ was presented in a nose-poke (the CS+ nose-poke), both 
genotypes in group 1 preferentially approached the location of the CS+ in 
comparison to a second (control) nose-poke in which no stimulus was presented 
(Fig. 3.4a; comparison of CS+ and control nose-pokes within each genotype; WT, 
Z = -2.67, p < 0.01; KD, Z = -2.21, p < 0.05). However, mutant mice made 
significantly fewer CS+ approaches than wild-type mice (U = 37, Z= -2.06, p = 
0.045). Mutant mice tended to make fewer approaches into the control nose poke 
than wild-type mice, although this effect did not reach statistical significance (U = 
40, Z = -2.131, p = 0.068). 
 
During the period between CS+ presentations (ITI), nose-poking rates in the CS+ 
and control holes did not differ within each genotype (Fig. 3.4b; WT, Z = -0.46, p = 
0.65; KD, Z = -0.21, p = 0.83), although overall rates of nose-poking were reduced 
in mutant mice (comparison between genotypes for the CS+ nose-poke, U = 43.5, 
Z = -1.68, p = 0.1; control nose-poke, U = 34, Z = -2.22, p < 0.05).  
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Figure 3.4 Group 1: Sign-tracking test (a) When the CS+ was presented in a nose-
poke hole, both genotypes preferentially approached the CS+ nose-poke (CS+) 
than an alternate (control; Ctrl) nose-poke in which no stimulus presentations 
occurred. However, KD mice made significantly fewer CS+ nose-pokes than WT 
mice. Nose-pokes in the Ctrl hole tended to be reduced in mutant mice. (b) During 
the period between stimulus presentations (ITI), nose poking rates in the CS+ and 
Ctrl holes did not differ in either genotype, although overall rates over nose-poking 
tended to be reduced in mutant mice in comparison to wild-types. **p < 0.01, *p < 
0.05, within-genotype comparison of CS+ and Ctrl nose-poke responses. #p < 0.05, 
§p < 0.1, between-genotype comparison of CS+ or Ctrl nose-poke responses (n = 
12/12, WT/KD) 
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3.3.1.3 Conditioned reinforcement 
Mice from both genotypes in group 1 demonstrated CRf; that is, responding was 
preferential for a CS+ reinforced lever over an alternate control lever on which 
responses were met with no consequence (Fig. 3.5a). Analysis of lever responding 
by mixed-factor ANOVA, with Lever (CS+, Control) as a within-subjects factor, 
confirmed that responding varied depending on the lever identity (main effect of 
Lever, F(1,22)= 5.27, p < 0.05) in both genotypes (Genotype x Lever interaction, 
NS). This analysis also indicated no overall difference in lever responding between 
genotypes (main effect of Genotype, NS). Although both genotypes responded 
more on the CS+ paired lever than the control lever, post-hoc comparisons of CS+ 
and control lever responding indicated that this conditioned reinforcement effect 
was not particularly robust in either genotype (WT, t = 1.82, df = 11, p = 0.095; KD, 
t = 1.465 , df = 11 , p = 0.171). 
 
3.3.1.4 The effect of cocaine on responding for conditioned reinforcement 
Data from one mutant mouse were excluded from analysis (CS+ lever responses 
following 10 mg/kg cocaine exceeded the group mean responses + 2.5 x S.D.), 
leaving group sizes of n = 12/11 for WT/KD mice, respectively. Cocaine, at a dose 
of 10 mg/kg, potentiated responding for CRf in wild-type mice, but not in mutant 
mice (Fig. 3.5b). An initial analysis of lever responding in both genotypes by mixed-
factor ANOVA, with Lever (CS+, Control) and Dose (0-20 mg/kg) included as 
within-subjects factors, confirmed that lever responding varied according to the 
lever identity (main effect of Lever, F(1,21) = 17.18, p < 0.001). This analysis also 
identified that lever responding varied amongst cocaine doses and between 
genotypes (main effect of Dose; F(3,63) = 5.91, p < 0.01; Lever x Genotype 
interaction, F(1,21) = 3.46, p = 0.077; Lever x Dose x Genotype interaction, F(3,63) 
= 6.34, p < 0.01). Further analyses were undertaken to explore these effects. 
 
The next analyses examined lever responding in each genotype separately, across 
all cocaine doses. Wild-type mice showed an overall preference for the CS+ lever 
(main effect of Lever, F(1,11) = 11.72 , p < 0.01), and lever responding varied with 
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cocaine dose (Lever x Dose interaction, F(3,33) = 6.95, p < 0.05). Mutant mice also 
showed an overall preference for the CS+ lever (main effect of Lever, F(1,10) = 
7.58, p < 0.05), but lever responding did not vary with dose (Lever x Dose 
interaction, NS). 
 
The third level of analyses examined CS+ and control lever responding separately 
in each genotype across all cocaine doses. In wild-type mice, responding varied 
with cocaine dose for the CS+ lever (main effect of Dose, F(3,33) = 7.05, p = 0.01) 
and the control lever (main effect of Dose, F(3,33) = 8.89, p < 0.01). In mutant 
mice, responding varied with cocaine dose for both the CS+ lever (main effect of 
Dose, F(3,30) = 3.68, p < 0.05) and the control lever (main effect of Dose, F(3,30) 
= 5.35, p < 0.05). Subsequent comparisons confirmed that 10 mg/kg cocaine 
facilitated CS+ lever responding in wild-type mice (10 mg/kg vs. vehicle, t = -2.70, 
df = 11, p = 0.021). Moreover, the effect of cocaine in wild-type mice was specific 
to the CS+ lever, since control lever responding was significantly decreased 
following 10 mg/kg cocaine (10 mg/kg vs. vehicle, t = 2.77, df = 11, p = 0.020). The 
facilitation effect did not occur at a higher cocaine dose. In fact, CS+ lever 
responding was significantly decreased in wild-type mice at 20 mg/kg cocaine (20 
mg/kg vs. vehicle, t = 2.54, df = 11, p < 0.028). In mutant mice, CS+ lever 
responding tended to be decreased following 10 mg/kg cocaine (10 mg/kg vs. 
vehicle, t = 2.17, df = 10, p = 0.056), while CS+ lever responding was significantly 
decreased following 20 mg/kg cocaine (t = 2.88, df = 10, p = 0.016). 
  
138 
 
 
Figure 3.5 Group 1: Conditioned reinforcement and cocaine potentiation (a) Both 
genotypes preferentially responded on a novel lever that led to presentation of the 
food-paired stimulus (CS+) than an alternate control lever on which responding 
had no consequence (Ctrl). This effect was more robust in WT than KD mice. §p < 
0.1, within-genotype comparison of CS+ and Ctrl lever responding (n=12/12, 
WT/KD) (b) Cocaine (10 mg/kg i.p.) facilitated responding for CRf in WT mice, but 
not KD mice. *p < 0.05, within-genotype comparison of CS+ lever responding 
following 10 mg/kg cocaine and vehicle (n = 12/11, WT/KD)  
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3.3.2 Group 2 
3.3.2.1 Pavlovian conditioning 
Group 2 received identical Pavlovian conditioning to Group 1 and, in agreement, 
wild-type and mutant mice from this group also acquired Pavlovian conditioning 
(Fig 3.6a-d). For the sake of brevity, analyses of Pavlovian conditioning data are 
summarized in table (Table 3.1). Across conditioning sessions, findings for each of 
the four measures of Pavlovian conditioning were near identical to that observed in 
Group 1. The only notable differences were that, in Group 2, overall rates of 
magazine entries (magazine entries / min) during the CS+ and ITI periods and 
overall retrieval latencies were not significantly reduced in mutant mice, in 
comparison to wild-types. However, the overall proportion of magazine entries 
made during CS+ presentations (% Magazine entries) was lower in mutant mice, in 
comparison to wild-types (Table 3.1). 
 
 Session 
F(10,220) 
Session x Genotype 
F(10,220) 
Genotype 
F(1,22) 
Magazine entries/ min    
CS+ period 10.79*** 0.28 0.32 
ITI period 30.23*** 1.65 1.24 
% Magazine entries 73.97*** 0.68 8.75** 
Discriminated 
approach 
3.33* 1.51 0.70 
Retrieval latency 31.06*** 0.92 0.17 
 
Table 3.1 Group 2: ANOVAs for Pavlovian conditioning. Factors: Session 
(1-11); Genotype (WT, KD). ***p < 0.001, **p < 0.01, *p < 0.05 
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Figure 3.6 Group 2: Pavlovian conditioning. Figures show (a) magazine entry 
rates, across conditioning sessions, during presentation of the stimulus paired with 
food (CS+) and the no-stimulus period (ITI), (b) The proportion of total magazine 
entries made during CS+ presentations, (c) The number of magazine entries made 
in the 5 sec interval following CS+ onset but before food delivery, (d) The average 
time of the first entry into the food magazine following CS+ onset (retrieval latency) 
(n = 12/12, WT/KD)  
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3.3.2.2 Conditioned reinforcement 
In group 2, responding for CRf was observed in wild-type mice, but not mutant 
mice (Fig. 3.7a). Analysis of lever responding in both genotypes identified that 
responding varied depending on the lever identity (main effect of Lever, F(1,22)= 
10.33, p < 0.01). However, lever responding also varied between genotypes (Lever 
x Genotype interaction, F(1,22) = 4.61, p < 0.05) and overall responding was 
reduced in mutant mice (main effect of Genotype, F(1,22) = 12.51, p < 0.01). Post-
hoc comparisons of CS+ and control lever responding confirmed robust CRf in 
wild-type mice (t = 3.38, df = 11, p < 0.01), but not mutant mice (t = 0.873, t = 11, p 
= 0.40). In comparison to WT mice, post-hoc comparisons confirmed that CS+ 
lever and control lever responding was significantly reduced in mutant mice (CS+ 
lever, t = 3.11, df = 22, p < 0.01; Control lever, t = 3.28, df = 22, p < 0.01). 
 
A time-course plot of lever responding and magazine entries during the 45 minute 
CRf test (Fig. 3.7b-c) revealed that CS+ lever responding was steady across the 
duration of the test in both genotypes (main effect of Period, NS; Period x 
Genotype interaction, NS). CS+ lever responding was reduced in mutant mice over 
the duration of the session (main effect of Genotype, F(1,22) = 7.26, p < 0.05). 
Similarly, control lever responding (Fig. 3.7c) was steady in both genotypes (main 
effect of Period, NS; Period x Genotype interaction, NS) and was reduced overall 
in mutant mice (main effect of Genotype, F(1,22) = 10.085, p < 0.01). In contrast, 
entries into the food magazine (Fig. 3.7d) declined in both genotypes over the test 
(main effect of Period, F(2,44) = 18.19, p < 0.001; Period x Genotype interaction, 
NS) and did not differ overall between genotypes (main effect of Genotype, NS).  
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Figure 3.7 Group 2: Conditioned reinforcement. (a) Responding for CRf was 
present in wild-type, but not mutant mice. **p < 0.01, within-genotype comparison 
of CS+ and Ctrl lever responding. ##p < 0.01, between-genotype comparison of 
CS+ or Ctrl lever responding. (b) A time-course plot shows that CS+ paired lever 
responding was reduced in mutant mice over the duration of the 45 minute test. (c) 
Responding on the control (Ctrl) lever was also reduced in mutant mice over the 
test duration (d) Entries into the food magazine decreased over the course of the 
session, but did not differ between genotypes (n = 12/12, WT/KD).  
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3.3.2.3 The effect of MTEP on conditioned reinforcement 
In wild-type mice, CRf was present over repeated tests that were preceded by 
injections of 0-20 mg/kg MTEP (main effect of Lever, F(1,10) = 104.24, p < 0.001). 
However, MTEP did not affect overall lever responding (main effect of Dose, NS; 
Dose x Lever interaction, NS). Analysis of responding on each lever separately 
across all MTEP doses confirmed that MTEP did not affect responding on the CS+ 
lever (main effect of Dose, NS), nor reliably on the inactive lever (main effect of 
Dose, F(3,30) = 2.76, p = 0.11). Magazine entries were unaffected by MTEP 
treatment (Friedman test, df = 3, p = 0.60). 
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Figure 3.8 Group 2: MTEP on conditioned reinforcement in wild-type mice. (a) 
Injections of MTEP (1-20 mg/kg i.p.) 20 minutes prior to the CRf test did not disrupt 
responding for CRf in WT mice. (b) Magazine entries during the CRf test were 
similarly unaffected following injections of MTEP (n = 11). 
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3.3.2.4 Discriminated approach 
Multiple tests of discriminated approach were undertaken in group 2 to determine 
whether mice were using the light stimulus and/or perhaps another cue (such as 
the noise of food pellet delivery) to guide magazine entries. Analyses of these data 
were undertaken for each genotype separately due to different training and test 
histories. Discriminated approach during a particular trial type (e.g. „CS/US‟ or 
„noise‟ test) was identified by comparing magazine entry rates during trials to entry 
rates in the interval between trials (ITI). 
 
In wild-type mice (Fig. 3.9a), magazine entry rates during the two periods (trial, ITI) 
varied among the five different test conditions (main effect of Period, F(1,11) = 
39.52, p < 0.001; Test,  F(4,44) = 15.76, p < 0.001; Test x Period interaction, 
F(4,44) = 15.19, p < 0.001). Post hoc comparisons of magazine entry rates 
between trial and ITI periods, in each test, identified that rates were significantly 
increased (that is, discriminated approach was present) during trial periods for the 
CS+, US test (t = 10.93, df = 11, p < 0.001), the CS+, noise test (t = 4.28, df = 11, 
p = 0.001) and the CS+ test (t = 3.17, df = 11, p < 0.01). 
 
In mutant mice, findings from the discriminated approach tests were near identical 
to those of wild-type controls. Magazine entry rates (Fig. 3.9b) during the trial 
period or the no-stimulus period between trials (ITI) also varied among the five test 
conditions (main effect of Period, F(1,11) = 54.31, p < 0.001; Test,  F(4,44) = 
13.63, p < 0.001; Test x Period interaction, F(4,44) = 18.23, p < 0.001). Post-hoc 
comparisons of magazine rates between trial and ITI periods, in each test, 
identified that rates were significantly increased during the trial period for the CS+, 
US test (t = 7.80, df = 11, p < 0.001), CS+, noise test (t = 5.72, df = 11, p = 0.001), 
the CS+ test (t = 4.44, df = 11, p = 0.001) and the noise test (t = 3.77, df = 11, p < 
0.01). 
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Figure 3.9 Group 2: Discriminated approach (a) WT and (b) KD mice received 5 
different tests of discriminated approach.  Each test consisted of 8 x 10 sec trials, 
each separated by a 100 sec ITI. The type of trial in each test was either 1) CS+, 
US: CS+ presentation and food delivery, 2) CS+, Noise: CS+ presentation and 
noise of food delivery only, 3) CS+: CS+ presentation only, 4) Noise: noise of food 
delivery only 5) No: no stimuli were presented in each 10 sec trial period. Due to 
the different training and test histories, data from WT and KD mice are presented 
on two different panels. Discriminated approach in each test was identified by a 
significant difference in magazine entry rates between trial periods and the ITI. ***p 
< 0.001, **p < 0.01, within-genotype comparison of trial and ITI magazine entry 
rates in each test (n = 12/12, WT/KD).  
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3.3.3 Group 3 
3.3.3.1 Pavlovian conditioning 
When mice were trained a Pavlovian association between a stimulus paired with 
food (CS+) and a second stimulus unpaired with food (CS-), mice from both 
genotypes came to enter the food magazine almost exclusively during presentation 
of the CS+ and largely ignored the magazine when the CS- was presented. As for 
Group 1 and 2, four different measures of conditioning performance are reported 
(Fig. 3.10a-d). Again, for brevity, analyses of these measures are summarised in 
table format (Table 3.2). Notably, in both genotypes, magazine entry rates 
increased during presentation of the CS+, and decreased during CS- presentations 
(Fig. 3.10a). Overall rates of responding were reduced during CS- presentations in 
mutant mice (Fig. 3.10a). The proportion of total magazine entries made during 
CS+ presentations increased across sessions in both genotypes, although % CS+ 
magazine activity tended to be reduced overall in wild-type mice (Fig. 3.10b). 
Discriminated approach responses increased over conditioning sessions in both 
genotypes, and to a similar extent (Fig. 3.10c). In both genotypes, the mean 
retrieval latency decreased over conditioning sessions, approaching the time of 
food delivery (Fig. 3.10d). The decrease in retrieval latency over conditioning 
sessions was less pronounced in wild-type mice than mutants, although this effect 
did not reach statistical significance (Table 3.2).  
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Figure 3.10 Group 3: Pavlovian conditioning. Figures show (a) magazine entry 
rates, across conditioning sessions, during presentation of the stimulus paired with 
food (CS+) and stimulus unpaired with food (CS-), (b) the proportion of total 
magazine entries made during CS+ and CS- presentations, (c) the number of 
magazine entries made in the 5 sec interval following CS+ onset but before food 
delivery and (d) the average time of the first entry into the food magazine following 
CS+ onset (retrieval latency) (n = 9/12, WT/KD).  
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Session 
F(10,190) 
Session x Genotype 
F(10,190) 
Genotype 
F(1,19) 
Magazine entries / min    
CS+ period 8.74** 0.72 0.14 
CS- period 3.12* 0.76 5.18* 
% Magazine entries 
CS+ 
CS- 
 
29.66*** 
5.57*** 
 
0.93 
0.58 
 
3.51§ 
1.43 
Discriminated approach 7.57** 0.17 0.004 
Retrieval latency 19.26*** 2.10§ 0.06 
 
Table 3.2 Group 3: ANOVAs for Pavlovian conditioning, Group 3. Factors: Session 
(1-11); Genotype (WT, KD). ***p < 0.001, **p < 0.01, *p < 0.05, §p < 0.10 
  
150 
 
3.3.3.2 Conditioned reinforcement 
In group 3, the CRf test was conducted such that responses on one lever were 
reinforced by the CS+ and responses on the alternate lever led to CS- 
presentations. Responding for CRf was observed in both genotypes, but was 
reduced in mutant mice (Fig. 3.11a). Analysis of lever responding in both 
genotypes identified that responding varied depending on the lever identity (main 
effect of Lever, F(1,19) = 24.38, p < 0.001). However, lever responding also varied 
between genotypes (Lever x Genotype interaction, F(1,19) = 5.57, p < 0.05) and 
overall responding was reduced in mutant mice (main effect of Genotype, F(1,19) = 
7.23, p < 0.05). Post hoc analyses showed that more responses were made on the 
CS+ lever than the CS- lever in both wild-type (t= 3.52, df = 8, p < 0.01) and 
mutant (t = 3.285, df = 11, p < 0.01) mice. However, mutant mice made 
significantly fewer CS+ lever responses than KD mice (t= 2.36, df = 19, p < 0.05), 
while responding on the CS- lever did not differ between genotypes (t = 1.47, df = 
19, p = 0.158). 
 
A time-course plot of lever responding during the 45 minute CRf test revealed that 
CS+ lever responding (Fig. 3.11b) tended to increase over the duration of the test 
(main effect of Period, F(2,38) = 2.96, p = 0.083 ), in both genotypes (Period, x 
Genotype interaction, NS). CS+ lever responding was reduced in mutant mice over 
the duration of the session (main effect of Genotype, F(1,19) = 6.92, p < 0.05). CS- 
lever responding (Fig. 3.11c) was steady in both genotypes over the test duration 
(main effect of Period, NS; Period x Genotype interaction, NS) and did not differ 
overall between genotypes (main effect of Genotype, NS). An analysis of a time-
course plot of food magazine entries (Fig. 3.11d) indicated that the profile of 
magazine entries over the session varied between genotypes (Period x Genotype 
interaction, F(2,38) = 3.31, p < 0.05), Post hoc comparisons indicated that mutant 
mice tended to make fewer head entry responses in the final 15 minute period of 
the session than WT controls, although this effect did not reach statistical 
significance (t = 1.73, df = 19, p = 0.10).  
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Figure 3.11 Group 3: Conditioned reinforcement (a) Both genotypes responding 
for CRf, however CS+ reinforced lever responding was significantly reduced in KD 
mice in comparison to WT mice. There was no between-genotype difference in 
lever responding reinforced by the stimulus unpaired with food (CS-). **p < 0.01, 
within-genotype comparison of CS+ and Ctrl lever responding. #p < 0.05, between-
genotype comparison of CS+ lever responding. (b) A time-course analysis shows 
that CS+ paired lever responding was reduced in mutant mice over the duration of 
the 45 minute test. (c) CS- paired lever responding did not differ between 
genotypes over the test duration (d) Magazine entries tended to be reduced in 
mutant mice in the final 15 minute period of the test (n = 9/12, WT/KD).  
0
100
200
300
400
WT KD
CS+
CS-**
**
#
Genotype
L
e
v
e
r 
re
s
p
o
n
s
e
s
0
50
100
150
1 2 3
WT
KD
15 min Bin
C
S
- 
le
v
e
r 
re
s
p
o
n
s
e
s
0
50
100
150
1 2 3
WT
KD
15 min Bin
C
S
+
 l
e
v
e
r 
re
s
p
o
n
s
e
s
0
50
100
150
1 2 3
WT
KD
15 min Bin
M
a
g
a
z
in
e
 e
n
tr
ie
s
ba
c d
152 
 
3.3.3.3 The effect of satiety on discriminated approach responses 
In both genotypes from group 3, mice in the „devalued‟ condition made fewer 
magazine entries during presentation of the CS+ in a test of discriminated 
approach than mice in the „valued‟ condition (Fig 3.12). Analysis of these data was 
first performed by mixed-factor ANOVA with Stimulus (CS+, CS-) and Test 
(Valued, Devalued) as within-subjects factors. Discriminated approach was 
confirmed by higher rates of magazine entries during the CS+ than the CS- across 
all conditions (main effect of Stimulus, F(1,19) = 35.52, p < 0.001) in both 
genotypes (Stimulus x Genotype interaction, NS). Magazine entries varied with the 
test identity (main effect of Test, F(1,19) = 23.34, p < 0.001). An analysis of CS+ 
magazine entries only, in both genotypes across the two tests, confirmed that 
entries were decreased in the devalued condition (main effect of Test, F(1,19) = 
32.59, p < 0.001), but this effect did not differ between genotypes (main effect of 
Genotype, NS ; Genotype x Test interaction, NS). Post hoc comparisons confirmed 
that CS+ magazine entries were significantly reduced in the devalued condition in 
both WT (t = 3.68, df = 8, p < 0.01) and KD mice (t = 4.40, df = 11, p = 0.001), in 
comparison to the valued condition. In contrast, CS- magazine entries were 
unaffected by the test condition (main effect of Test, NS), and did not differ 
between genotypes (main effect of Genotype, NS; Genotype x Test interaction, 
NS). 
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Figure 3.12 Group 3: Devaluation of discriminated approach. In both genotypes, 
magazine entries during presentation of the food-paired stimulus (CS+) were 
significantly reduced when mice were allowed ad libitum access to the food used 
for conditioning (Devalued), in comparison to mice given ad libitum access to a 
different food (Valued). Magazine entries during presentation of the unpaired 
stimulus (CS-) were unaffected by the test condition. ***p < 0.001, **p < 0.01, 
within-genotype comparison of CS+ magazine entries between the two feeding 
conditions (n = 9/12, WT/KD) 
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3.3.4 Group 4 
3.3.4.1 Pavlovian conditioning 
In preparation for the PIT test, when mice were trained a Pavlovian association 
between a stimulus paired with food delivery (CS+) and a second stimulus 
unpaired with food (CS-), both genotypes entered the food magazine during CS+ 
presentations and largely avoided the magazine during CS- presentations (Fig. 
3.13a). In the first portion of conditioning, when only the CS+ was presented, 
magazine entries increased over the twelve conditioning sessions (main effect of 
Session, F(11,154) = 4.0, p < 0.01), in both genotypes (Session x Genotype 
interaction, NS; main effect of Genotype, NS). When the CS- was introduced, 
magazine entry rates were higher during the CS+ period over the six conditioning 
sessions (main effect of Stimulus, F(1,14) = 113.15, p < 0.001), in both genotypes 
(Session x Genotype interaction, NS, Stimulus x Session x Genotype interaction, 
NS). An analysis of CS+ magazine entries over these six conditioning sessions 
indicated that entry rates did not significantly vary over the sessions (main effect of 
Session, NS), and did not differ between genotypes (Genotype x Session 
interaction, NS; main effect of genotype, NS). Magazine entry rates during the CS- 
period neither varied across the six conditioning sessions (main effect of Session, 
NS), nor between genotypes (Genotype x Session interaction, NS; main effect of 
Genotype, NS). 
 
The proportion of total magazine entries made during CS+ presentations increased 
over the first twelve conditioning sessions (main effect of Session, F(11,154) = 
9.16, p < 0.001) in both genotypes (Session x Genotype interaction, NS; main 
effect of Genotype, NS; Fig. 3.13b). When the CS- was introduced for a further six 
conditioning sessions, a greater proportion of magazine entries occurred during 
CS+ presentations than CS- presentations (main effect of Stimulus, F(1,14) = 
192.73, p < 0.001), in both genotypes (Stimulus x Genotype interaction, NS; main 
effect of genotype, NS). An analysis of magazine entry distribution during each 
stimulus period, separated, for both genotypes confirmed that the distribution of 
entries did not significantly differ between genotypes during the CS+ period 
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(Stimulus x Genotype interaction, NS; main effect of Genotype, NS), or the CS- 
period (Stimulus x Genotype interaction, NS; main effect of Genotype, NS). 
 
3.3.4.2 Instrumental training 
Both genotypes acquired instrumental responding reinforced by food delivery (Fig. 
3.13c). Analysis of lever responding was performed by mixed-factor ANOVA, with 
Lever (active, inactive) and Session (1-4) included as within-subjects factors. 
Analysis was restricted to the first four and last four sessions of instrumental 
responding to compare the initial acquisition of instrumental responding and 
performance of the well learned instrumental response between-genotypes, 
respectively. Over the first four sessions of responding, under an FR1 schedule, 
responding was preferential for the lever that resulted in food delivery (active lever) 
over the alternate lever on which responding had no consequence (inactive lever; 
main effect of Lever, F(1,14) = 54.84, p < 0.001). This response profile did not 
differ between genotypes (Lever x Genotype interaction, NS; main effect of 
Genotype, NS). Similarly, over the final four instrumental training sessions, under a 
VI60s schedule, responding was preferential for the active lever (main effect of 
Lever; F(1,14) = 40.35, p < 0.001), and lever response rates did not differ between 
genotypes (Lever x Genotype interaction, NS; main effect of Genotype, NS). 
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Figure 3.13 Group 4: Pavlovian conditioning and instrumental training. (a) Mice 
from both genotypes made more magazine entries during the presentation of a 2 
min stimulus paired with food (CS+), than during presentations of a 2 min stimulus 
unpaired with food (CS-). (b) In both genotypes, the majority of magazine entries 
occurred when the CS+ presented, while only a small proportion of entries 
occurred during CS- presentations. (c) Responses on a lever that resulted in food 
delivery (the active lever) increased over training, initially under a fixed-ratio 1 
(FR1) schedule then under variable interval (VI) schedules of reinforcement. A 
second lever was present during instrumental training on which responding had no 
consequence (the inactive lever). Inactive lever response rates are not presented 
as these were low (< 2 responses/ min) in both genotypes over the duration of 
training (n = 7/9, WT/KD).  
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3.3.4.3 Pavlovian-instrumental transfer 
Responses on a lever that previously led to the delivery of food significantly 
increased during presentations of the previously food-paired stimulus (CS+), in 
comparison to a decrease in responding during CS- presentations (Fig. 3.14a; 
main effect of Stimulus, F(1,14) = 20.93, p < 0.001). There was no difference in PIT 
between genotypes (Stimulus x Genotype, NS; main effect of Genotype, NS). Post-
hoc comparisons of CS+ and CS- elevation scores confirmed that lever responding 
was significantly increased during CS+ presentations, in comparison to responding 
during CS- presentations, in both WT (t = 3.18, df = 6, p = 0.019) and KD mice (t= 
3.46, df = 8, p = 0.009). 
 
A plot of elevation scores over the four trials in WT mice (Fig. 3.14b, panel i) 
revealed that lever responding was increased during CS+ presentations, in 
comparison to responding during CS- presentations (main effect of Stimulus, F(1,6) 
= 10.015, p < 0.05) over all trials (main effect of Trial, NS; Stimulus x Trial 
interaction, NS). An identical profile of elevation scores over trials was observed for 
mutant mice (Fig. 3.14b, panel ii; main effect of Stimulus, F(1,8) = 9.05, p < 0.05; 
main effect of Trial, NS; Stimulus x Trial interaction, NS). 
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Figure 3.14 Group 4: Pavlovian-instrumental transfer test (a) In both genotypes, 
presentation of the previously food-paired stimulus (CS+) elevated responding on 
the lever previously associated with food, in comparison to a decrease in 
responding observed during presentations of the stimulus unpaired with food (CS-). 
The elevation score is calculated as responses during CS minus responses pre 
CS. (b) The elevation scores for each stimulus presentation trial in the PIT tests for 
WT (panel i) and KD (panel ii) mice are shown. **p < 0.01, *p < 0.05, within-
genotype comparison of CS+ and CS- elevation scores (n = 7/9, WT/KD). 
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3.3.4.4 The effect of satiety on extinction responding 
In both genotypes from group 4, mice in the devalued condition made fewer 
responses of the active lever in a test of extinction than mice in the valued 
condition (Fig. 3.15a). Analysis of these data was first performed by mixed-factor 
ANOVA with Lever (active, inactive) and Test (valued, devalued) as within-subjects 
factors. Preferential active lever responding across all tests was confirmed (main 
effect of Lever, F(1,14) = 106.51, p < 0.001), in both genotypes (Lever x Genotype 
interaction, NS). Lever responding varied with the test condition (Lever x Test 
interaction, F(1,14) = 38.36, p < 0.001), so further analyses were performed, first 
for active lever responding in both genotypes and tests. This analysis confirmed 
that active lever responding was significantly reduced in the devalued condition 
(main effect of Test, F(1,14) = 46.67, p < 0.001), but this effect did not differ 
between genotypes (main effect of Genotype, NS; Genotype x Test interaction, 
NS). Post hoc comparisons confirmed that active lever responding was reduced in 
the devalued condition, in comparison to the valued condition, in both WT (t = 3.12, 
df = 6, p < 0.01) and KD mice (t = 6.014, df = 8, p < 0.001). In contrast, inactive 
lever responses were unaffected by the test condition (main effect of Test, NS) and 
did not reliably differ between genotypes (main effect of Genotype, NS; Genotype x 
Test interaction, F(1,14) = 3.19, p = 0.10). 
 
Finally, an analysis of magazine entry rates during these extinction tests (Fig 
3.15b), indicated the entry rates were also reduced under the devalued test 
condition (main effect of Test, F(1,14)=31.46, p < 0.001), in both genotypes (main 
effect of Genotype, NS; Genotype x Lever interaction, NS). Post-hoc comparison of 
magazine entry rates between tests in confirmed that entry rates were significantly 
reduced in KD mice (t = 10.97, df = 8, p < 0.001) and tended to be reduced in WT 
mice (t = 2.07, df = 6, p = 0.084).  
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Figure 3.15 Group 4: Devaluation on instrumental responding. (a) In both 
genotypes, responses on the active lever were significantly reduced when mice 
were allowed ad libitum access to the food used for instrumental conditioning prior 
to test of extinction responding (Devalued), in comparison to mice that were not 
given access to food prior to the test (Valued). (b) In both genotypes, magazine 
entries were reduced in the devalued test condition. ***p < 0.001, **p < 0.01, §p < 
0.1, within-genotype comparison of active lever responding, or magazine entries, 
between test conditions (n = 7/9, WT/KD).  
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3.4 Discussion 
 
The present chapter examined distinct features of appetitive learning in mGluR5KD-
D1 and wild-type mice. Both genotypes readily learned about the predictive 
properties of the food-paired CS. Thus, presentation of the CS elicited entries into 
the food hopper, even when food was not delivered (discriminated approach). Both 
genotypes were also able to adjust responding to the CS, based on the current 
value of the CS triggered US representation (devaluation on discriminated 
approach). However, assessments of incentive learning revealed specific deficits in 
mGluR5KD-D1 mice. First, the ability of the CS to serve as a „motivational magnet‟ 
(Berridge and Robinson, 2003) and elicit approach toward it (sign-tracking) was 
impaired. Second, the acquisition of a novel response reinforced by the reward-
paired CS (CRf) was also impaired in mGluR5KD-D1 mice. Further tests of CRf 
revealed that cocaine potentiated CRf responding in wild-type, but not mGluR5KD-D1 
mice. In addition, blockade of mGluR5 in wild-type mice with a selective antagonist 
(MTEP) failed to disrupt responding for CRf. In contrast to deficits in sign-tracking 
and CRf, incentive learning necessary for a reward-paired CS to motivate ongoing 
goal-directed actions (generalised PIT) was intact in mutant mice. Finally, although 
this thesis primarily concerns Pavlovian appetitive learning, it is worthwhile to note 
that mGluR5KD-D1 mice readily acquired an instrumental response reinforced by a 
food reward and instrumental responding remained sensitive to variation in the 
outcome value in both genotypes (devaluation on instrumental responding). Taken 
together, these data indicate mGluR5 on D1R expressing cells as necessary for 
specific Pavlovian incentive learning processes. 
 
Different conditioning procedures were used in the present report, including the 
pairing of a short duration (10 sec) stimulus with the delivery of a single food pellet 
(Groups 1, 2 and 3; CRf experiments), and the pairing of a longer duration (2 min) 
stimulus with the delivery of multiple food reinforcers (Group 4; PIT experiment). 
Since PIT was normal in mGluR5KD-D1 mice, but CRf was disrupted, could it be that 
mGluR5KD-D1 mice simply failed to acquire any CS-US association (incentive or 
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predictive) because a short duration CS was used, or that a longer duration CS 
was more permissive for incentive learning in mGluR5KD-D1 mice? To address this 
question empirically would require that both genotypes were tested for CRf and PIT 
after receiving conditioning with the longer duration and short duration CS, 
respectively. Although this experiment would be interesting, this overall proposal 
seems unsatisfactory. First, mGluR5KD-D1 mice readily acquired a predictive CS-US 
association under both conditioning parameters, as indexed by the different 
measures of discriminated approach recorded during conditioning. Discriminated 
approach performance in mGluR5KD-D1 mice typically approached or reached 
asymptotic levels at the end of conditioning and was largely indistinguishable from 
wild-type mice. In some groups, overall rates of magazine entries were lower in 
mGluR5KD-D1 mice (for example, Group 1, magazine entries/min and %magazine 
entries; Fig. 3.3a-b). However, a subsequent between-genotype comparison of the 
slopes of these measures, which perhaps provides a better measure of the rate of 
learning, indicated no difference in the rate of change of each measure across 
conditioning sessions (data not shown). Second, the use of different Pavlovian 
conditioning procedures for CRf and PIT studies was in recognition of data 
indicating that these procedures were most suitable for supporting subsequent CRf 
or PIT behaviour in mice (Crombag et al., 2008a). Longer-duration CSs are more 
likely to establish „drive‟ conditioned responses that exert more modulatory 
influence over behaviours (this effect being fundamental to PIT) (Konorski, 1967; 
Wagner and Brandon, 1989; Holland and Gallagher, 2003). In contrast, short-
duration CSs are more likely to establish specific „consummatory‟ conditioned 
responses (Konorski, 1967; Wagner and Brandon, 1989; Holland and Gallagher, 
2003). Thus, the conditioning parameters used in the present report should have 
been optimal for promoting learning necessary for supporting CRf and sign-
tracking in mGluR5KD-D1 mice. 
 
In the sign-tracking test, mGluR5KD-D1 mice made fewer approaches toward the 
food-paired CS than wild-type mice, but overall rates of nose-poking in the period 
between CS presentation trails (the ITI) were also reduced in mGluR5KD-D1 mice. A 
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finding of impaired sign-tracking in mGluR5KD-D1 mice may have simply been an 
artefact of reduced exploratory activity. Arguing against this possibility is that the 
latency to the first nose-poke response did not differ between genotypes (data not 
shown) and, in a separate test of spontaneous activity (Chapter 2, section 2.2.6.2), 
no difference in spontaneous nose-poking was found between genotypes. One 
possibility is that presentation of the CS+ may have been more effective in 
stimulating conditioned activity (or general behavioural activation) in wild-type 
mice, leading to an increase in overall rates of nose-poking. The presentation of 
food-paired CSs can trigger a variety of conditioned responses (Holland, 1977) but, 
in the current preparation, we were unable to record activity levels (beyond nose-
poking) in the operant chamber during Pavlovian conditioning and the test. 
 
It must also be considered whether impaired responding for CRf in mGluR5KD-D1 
mice was due to a general reduction in activity and/or impairment in ability to 
acquire a lever response. These possibilities can be ruled out on a number of 
accounts. First, magazine entries elicited during the CRf tests did not reliably differ 
between genotypes, providing some evidence that overall activity levels in the CRf 
tests were comparable between mGluR5KD-D1 and wild-type mice. Second, there 
was no difference between genotypes in the latency to the first lever press (data 
not shown), providing evidence that mGluR5KD-D1 mice did explore the response 
levers. Third, mGluR5KD-D1 mice readily acquired an instrumental response that 
was reinforced by food and could respond at high rates, indistinguishable from their 
wild-type counterparts. Similarly, mGluR5KD-D1 mice also learned to lever press for 
cocaine in identical fashion to wild-type mice (Novak et al., 2010). Taken together, 
these data support a dissociable role for mGluR5 on D1R expressing cells in the 
primary versus secondary (that is, conditioned) reinforcing effects of both natural 
and drug reinforcers. 
 
Although CS reinforced responding in mGluR5KD-D1 was generally reduced in 
comparison to wild-type mice in both the sign-tracking and CRf tests, mGluR5KD-D1 
mice could nevertheless discriminate between CS+ and control nose-pokes (sign-
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tracking test) or CS+ and CS- paired levers (CRf test). This profile of responding 
mirrors that reported in an autoshaping procedure following lesions of the NAcc 
core or its dopamine depletion, which are characterized by decreased approach 
toward the CS+ (Parkinson et al., 1999) and/or a more global reduction in 
approach responses (Parkinson et al., 2002). In contrast, lesions of the anterior 
cingulate cortex resulted in a general disruption of autoshaping by increasing 
approaches made toward the CS- (Bussey et al., 1997a; but see; Cardinal et al., 
2002b). The findings reported here suggest that mGluR5 on D1R expressing 
neurons may be particularly important for determining the „vigour‟ of the CS 
controlled response output, while having less influence over the „direction‟ of the 
behavioural response and without disrupting „drive‟ conditioned responses that are 
fundamental to PIT. 
 
In the first two tests of CRf (Group 1 and 2), mice were presented with one lever 
reinforced by the food-paired CS (a light) and a second lever on which responses 
had no consequence. Under these conditions, mGluR5KD-D1 mice did not 
demonstrate reliable CRf (Group 1 and 2) or responding for CRf was reduced in 
comparison to wild-type mice (Group 2). Criticism of this test design has been 
raised, suggesting that responding for „sensory reinforcement‟  (that is, responding 
for stimuli without acquired reinforcing properties) may underlie a large component 
of CS reinforced responding (Winterbauer and Balleine, 2007). This issue is 
particularly pertinent for the current thesis, given a recent report indicating that the 
acquisition of an instrumental response reinforced solely by a novel visual stimulus 
is impaired in mGluR5 knock-out mice (termed, operant sensation seeking; Olsen 
et al., 2010). While a „sensory reinforcement‟ or „operant sensation seeking‟ 
account cannot be ruled out with regards to findings from the first two CRf tests, 
responding for CRf was also impaired in mutant mice in the third CRf test that 
employed proper control procedures (Rescorla, 1967). Thus, where responses on 
one lever were reinforced by a food-paired stimulus (CS+) and responses on the 
second lever by a stimulus unpaired with food (CS-), mutant mice demonstrated 
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reduced responding for CRf in comparison to wild-types, supporting our initial 
assertion of a specific incentive learning deficit in mGluR5KD-D1 mice. 
 
When cocaine was injected prior to tests of CRf, responding for CRf was 
potentiated in wild-type mice. In contrast, cocaine did not facilitate CS+ reinforced 
responding in mutant mice. One possible account for the absence of cocaine 
facilitation of CRf in mutant mice is that preference for the CS+ reinforced lever 
was simply reduced in mGluR5KD-D1 mice during this test. Thus, perhaps there was 
no real CRf response to facilitate in these mice. However, psychostimulants can 
markedly potentiate the incentive effects of a reward-paired CS, even when the 
baseline effects of the CS alone are small (e.g. amphetamine on PIT; Wyvell and 
Berridge, 2001) or have been reduced due to lesioning (e.g. BLA lesions on CRf; 
Burns et al., 1993). The present data suggest that loss of mGluR5 on D1 
expressing neurons may play a critical role in the „gain-amplification‟ process that 
depends heavily upon dopamine and glutamate innervation in the ventral striatum 
(Taylor and Robbins, 1986; Wolterink et al., 1993; Burns et al., 1994), and integrity 
of the ventral subiculum (Burns et al., 1993), NAcc shell (Parkinson et al., 1999) 
and CeN (Robledo et al., 1996). 
 
If mGluR5 on D1R expressing cells are necessary for CRf, one might have 
expected blockade with a selective mGluR5 antagonist (MTEP) in wild-type mice to 
similarly impair CS reinforced responding. This was not the case, as MTEP failed 
to significantly alter responding for CRf in wild-type mice. One possibility is that the 
doses of MTEP used were too low to cause a sufficient block of mGluR5. However, 
3 mg/kg i.p. MTEP was reported to achieve >75% receptor occupancy for at least 
15 min post-dosing in mice (Anderson et al., 2003) and doses of 30 mg/kg i.p. 
MTEP or higher reduced locomotor activity in mice (Cowen et al., 2007). In the 
current chapter, MTEP was injected prior to the test, thereby examining the role of 
mGluR5 in the expression of control over responding by the CS. Alternatively, 
mGluR5 may be critically involved in the acquisition of incentive value by a CS. 
Some support for this proposal is provided from studies of conditioned fear. Thus, 
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MTEP impaired the acquisition (and the expression) of hippocampus-dependent 
contextual fear conditioning, but impaired the expression (but not the acquisition) of 
hippocampus-independent auditory fear conditioning (Gravius et al., 2006). 
 
Not all appetitive behaviours were impaired in mGluR5KD-D1 mice. Mice were able to 
use the CS as a predictive signal of food delivery, as indicated by the discriminated 
approach tests. A satiety-induced devaluation test indicated that mGluR5KD-D1 mice 
were able to adjust responding to the CS, based on the current value of the CS 
triggered US representation. In the „devalued‟ condition, mice were given access to 
the same food used for conditioning (sucrose pellets), while in the „valued‟ 
condition, mice were given access to a different food (chow). At first sight, the 
reduction in discriminated approach responses in the devalued vs. the valued 
condition might suggest that the CS triggered a specific representation of the 
outcome (i.e. sucrose pellets). However, mice from both genotypes ate significantly 
more sucrose pellets than chow in the 1 hour period before the devaluation test 
(data not shown). Thus, the data from the current experimental preparation can be 
used only to support a notion that mice had encoded a CS representation of the 
US, but not the nature (general or specific) of that representation. 
 
The finding that a reward-paired CS was able to motivate ongoing goal-directed 
actions in mGluR5KD-D1 mice highlights an important dissociation in the role of 
mGluR5 on D1R expressing neurons for incentive learning processes. Since the 
underlying neural circuitry of the behavioural models used is relatively well 
characterised (see General Introduction for review), this dissociation can be used 
to propose neural „node(s)‟ in which mGluR5 loss on D1R expressing neurons 
could contribute to the present findings. For now, I wish to speculate about the role 
of mGluR5 on D1R expressing neurons (i.e. D1-MSNs) within the ventral striatum, 
given the contribution of this structure to responding for CRf (Parkinson et al., 
1999; Ito et al., 2004), the development of sign-tracking responses (Parkinson et 
al., 2000b; Di Ciano et al., 2001) and PIT (Hall et al., 2001). Notably, the NAcc is 
not required for CRf per se but can influence the vigour (NAcc shell) and direction 
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(NAcc core) of CS-reinforced behaviour (Cardinal et al., 2002a). In addition, lesions 
of the NAcc core, but not the shell abolish PIT (Hall et al., 2001). The mGluR5KD-D1 
mouse would therefore appear similar to NAcc shell lesioned animals, and one 
might speculate that glutamatergic signalling from cortical limbic inputs onto D1-
MSNs in the NAcc shell may be disrupted in mGluR5KD-D1 mice. However, lesions 
of the NAcc core, but not the NAcc shell abolish autoshaping in rats (Parkinson et 
al., 2000b). Thus, if mGluR5KD-D1 mice were completely analogous to NAcc shell 
lesioned animals (and moreover NAcc shell lesioned rats) we ought to have seen 
normal sign-tracking in mutant mice, which was not the case. The effects of 
lesioning will be far more disruptive for node function than a cell-type specific 
manipulation and the findings reported with mGluR5KD-D1 mice may underline 
further functional dissociations within the ventral striatum, not only between the 
core and shell regions, but also within the distinct MSN populations in each region. 
Finally, it is worthwhile noting that post-training intra-NAcc infusions of an NMDA 
and D1R antagonist, but not a D2R antagonist, impaired the consolidation of 
appetitive Pavlovian learning necessary for supporting autoshaping (Dalley et al., 
2005). While infusions in this study were primarily targeted at the NAcc core 
region, a small number of injector tips were located in the ventrolateral shell region 
(Dalley et al., 2005), suggesting that dopamine and glutamate signalling in this 
region may contribute, in part, to incentive learning necessary for sign-tracking. 
Whether in the NAcc core or shell, the findings reported here with mGluR5KD-D1 
mice suggest that glutamate and dopamine signalling in the ventral striatum, 
particularly though cells that express the dopamine D1R, are necessary for specific 
incentive learning processes. 
 
In summary, the experiments reported here identify a necessary role of mGluR5 on 
D1R expressing neurons for incentive learning processes that endow a reward-
paired CS with the ability to both reinforce and attract motivated behaviours. A 
critical question outstanding from the current chapter is whether mGluR5 in 
necessary for the acquisition of conditioned incentive value by reward-paired CSs 
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or the expression of control over responding by a conditioned incentive. This issue 
will be addressed in the next chapter.  
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4 The role of mGluR5 in the acquisition and 
expression of incentive learning 
 
4.1 Introduction 
 
In the previous chapter, mGluR5 on D1R expressing neurons was revealed as 
necessary for incentive learning that enables a reward-paired CS to both attract 
and directly reinforce behaviour. In contrast, mGluR5 on D1R expressing neurons 
was not necessary for learning about the predictive properties of the reward-paired 
CS. These experiments employed a mutant mouse line in which mGluR5 was 
constitutively knocked-down on D1R expressing cells. As such, it was not possible 
to determine whether mGluR5 was necessary for the acquisition of the incentive 
association, or for the expression of control over behaviour by the reward-paired 
CS. Using the selective mGluR5 antagonist MTEP, in wild-type mice, the following 
experiments will explore the role of mGluR5 in the acquisition and/or expression of 
predictive (discriminated approach or goal-tracking; Boakes, 1977) and incentive 
(conditioned reinforcement; Mackintosh, 1994) properties of a reward-paired CS. 
 
There are numerous examples where neural nodes or molecular substrates play 
dissociable roles in the acquisition and expression of an appetitive Pavlovian 
association. For example, the BLA is required for the attribution of cues with 
incentive properties of outcomes, but may not (under some conditions) be required 
for maintaining these CS-US representations in memory or updating them with new 
information (Setlow et al., 2002; Blundell et al., 2003; Pickens et al., 2003; Johnson 
et al., 2009). With respect to the sign-tracking CR, lesion studies have indicated 
that the CeN plays a specific role in the acquisition of this CR, but not in the 
performance of it (Parkinson et al., 2000a; Cardinal et al., 2002b). Lesion studies 
have also indicated that some neural nodes are involved in both the acquisition 
and performance of a CR, but pharmacological approaches can reveal further 
acquisition/expression dissociations within these nodes. For example, the NAcc 
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core and its dopaminergic innervation contribute both to the acquisition and 
performance of a sign-tracking CR (Parkinson et al., 2000a; Cardinal et al., 2002b; 
Parkinson et al., 2002). However, dopamine and NMDA receptors within the NAcc 
core contribute selectively to the acquisition (but not the expression) of a sign-
tracking CR, while AMPA/KA receptors in the NAcc core are necessary for the 
expression (but not the acquisition) of this response (Di Ciano et al., 2001). The 
role of NAcc core dopamine (presumably acting at D1Rs rather than D2Rs; Dalley 
et al., 2005) and NMDA receptors in the consolidation of appetitive learning is in 
agreement with the role of these receptors in LTP and other forms of synaptic 
plasticity hypothesised to underlie associative learning (Pennartz et al., 1993; 
Kombian and Malenka, 1994; Kelley et al., 2003; Kelley, 2004). In contrast, AMPA 
receptors are particularly important for maintaining synaptic strength at excitatory 
synapses (Malenka, 2003; Kessels and Malinow, 2009), which is in broad 
agreement with their role in the performance of CS controlled appetitive 
behaviours. 
 
With regards to mGluR5, there is much evidence to suggest that it contributes to 
the expression of control over behaviours by reward paired-CSs. For example, 
cue-induced reinstatement of cocaine seeking, which is largely analogous to 
responding for CRf, is significantly attenuated by the mGluR5 antagonist, MPEP 
(Backstrom and Hyytia, 2006). In the Pavlovian-instrumental transfer procedure, 
MPEP attenuates the ability of a food-paired CS to motivate ongoing instrumental 
responding (George et al., 2009). In the conditioned place preference model, 
mGluR5 antagonism blocks the expression of place preference established with 
drugs, including morphine (Herzig and Schmidt, 2004) and amphetamine (Herzig et 
al., 2005). Few studies have directly examined the possibility that mGluR5 may be 
involved in the acquisition of an incentive CS-US association. There is some 
evidence that mGluR5 could play a role here, since MPEP given during 
conditioning with cocaine or morphine, attenuated the subsequent establishment of 
place preference (Popik and Wrobel, 2002; McGeehan and Olive, 2003). However, 
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whether the expression of CPP requires incentive learning processes is 
questionable (Stephens et al., 2010). 
 
More robust support for a role of mGluR5 in the acquisition of conditioned 
associations can be found in studies of conditioned fear. Using the fear potentiated 
startle paradigm in rats, MPEP dose dependently blocked the acquisition of fear 
and, at a higher dose, also blocked the expression of fear (Schulz et al., 2001). 
When infused into the lateral-amygdala (LA), MPEP blocked the acquisition, but 
not the expression, of auditory and contextual fear conditioning in rats (Rodrigues 
et al., 2002). The role of mGluR5 in conditioned fear appeared restricted to the 
acquisition phase, since post-training intra-LA infusions had no effect on the 
consolidation of fear conditioning (Rodrigues et al., 2002). Moreover, bath 
application of MPEP disrupted LTP at thalamic input synapses to the LA, indicating 
that mGluR5 has a central role in establishing plasticity in the amygdala that may 
be necessary for aspects of emotional learning (Fendt and Schmid, 2002; 
Rodrigues et al., 2002). 
  
As previously discussed (see section 1.4), incentive learning involves a fairly well 
circumscribed forebrain circuitry involving cortical limbic and striatal regions (Everitt 
et al., 1999). Within many components of this circuitry, mGluR5 is implicated in the 
associative strengthening of neural connections during learning (reviewed in 
Bellone et al., 2008; Anwyl, 2009). For instance, blockade of mGluR5 disrupts 
hippocampal LTP (Bashir et al., 1993), and mice lacking mGluR5 show a reduction 
in LTP in NMDA-receptor dependent pathways, including the CA1 region and 
dentate gyrus of the hippocampus (Lu et al., 1997). In dopaminergic cells of the 
VTA, the AMPA/NMDA EPSC ratio is reduced in mice lacking mGluR5 (Bird et al., 
2010). In the striatum, mGluR5 regulates excitability of MSNs (D'Ascenzo et al., 
2009), and is necessary for the induction of synaptic plasticity in the NAcc core that 
occurs following stimulation of glutamatergic cortical inputs (Schotanus and 
Chergui, 2008), but may not be so critical for the maintenance of corticostriatal 
plasticity following its induction (Sung et al., 2001; Gubellini et al., 2003). Taken 
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together, there is ample evidence to suggest that mGluR5 could contribute to the 
formation of appetitive CS-US associations. 
 
In this chapter, the role of mGluR5 in the acquisition and/or expression of 
Pavlovian incentive learning is explored in mice using the mGluR5 antagonist, 
MTEP. By administering MTEP to mice during the learning of this stimulus-reward 
association (Pavlovian conditioning), we were able to examine the contribution of 
mGluR5 to the acquisition of predictive properties by the food-paired CS that serve 
to signal the availability of reward at its location (goal-tracking test), and incentive 
properties necessary to reinforce an entirely novel instrumental response (CRf 
test). To determine whether mGluR5 was necessary for the expression of control 
over behaviours by the CS, we administered MTEP during the tests of goal-
tracking and CRf to mice that had received vehicle during Pavlovian conditioning 
sessions. Critically, tests of goal-tracking and CRf were performed under extinction 
conditions, therefore allowing the predictive and incentive motivational features of 
the CS to be examined without interference from presentation of the primary 
reward.   
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4.2 Materials and methods 
 
4.2.1 Animals 
Mice (n = 62; male C57BL6 x Sv129; derived in house; minimum 8 weeks old) 
were housed in groups of two or three and allowed to habituate to the holding room 
for one week prior to beginning the experiment. Animals were maintained on a 
12:12 h light-dark cycle (lights on at 0700 hours) under controlled temperature (21 
± 2 °C) and humidity conditions (50 ± 5%). Body weights were maintained at 
approximately 85% of free-feeding weight by the provision of a limited amount of 
standard lab chow (B&K Feeds, Hull, UK) approximately 2 hours after daily 
experiment completion. Experiments took place during the light-phase between 
0900 and 1500 hours. All procedures were performed in accordance with the 
United Kingdom 1986 Animals (Scientific Procedures) Act, following institutional 
ethical review. 
 
4.2.2 Drugs 
All injections were administered at a volume of 10 ml/kg i.p. The non-competitive 
mGluR5 antagonist, 3-((2-methyl-1,3-thiazol-4-yl)ethynyl)pyridine (MTEP; Sequoia 
Research Products, Pangbourne, UK), was dissolved in 10% v/v Tween 80 : 90% 
water. 
 
4.2.3 Apparatus 
Behavioural training and testing were performed in eight standard mouse operant 
chambers (as described in section 3.2.3) 
 
4.2.4 Procedure 
A summary of the experimental design is shown in Figure 4.1. Mice were allocated 
to one of three Pavlovian conditioning (PC) treatment groups that received 
injections of either vehicle (PC: Veh group; n = 22), 3 mg/kg (PC: 3; n = 19) or 10 
mg/kg (PC: 10; n = 21) i.p. MTEP prior to each Pavlovian conditioning session 
(Phase 1). Following conditioning, each conditioning treatment group (PC: Veh, 3 
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and 10) was exposed to two tests of CRf (CRf; Phase 2). Mice from each 
conditioning treatment group were injected with vehicle during one CRf test and 
MTEP during the other CRf test, the order of CRf test treatment (i.e. Veh or MTEP) 
being counterbalanced. Specifically, group PC: Veh received 10 mg/kg MTEP 
during one CRf test, while groups PC: 3 and PC: 10 received 3 and 10 mg/kg 
MTEP during one CRf test, respectively. Each conditioning treatment group was 
then exposed to two tests of goal-tracking (GT; Phase 3). As described for the CRf 
tests, each conditioning treatment group was injected with MTEP during one of the 
GT tests and vehicle during the other test; the order of GT test treatments being 
counterbalanced. Two further Pavlovian conditioning sessions were conducted 
between each CRf test and each GT test. Mice received injections of vehicle (PC: 
Veh group) or 3 or 10 mg/kg MTEP (PC: 3 and 10 groups, respectively) prior to 
each reconditioning session to ensure that learning conditions were identical to 
those experienced during the initial conditioning phase. All drug injections were 
made 20 min prior to the start of the experimental sessions. The doses of MTEP 
used have previously been shown to not affect locomotor activity in mice (Cowen 
et al., 2007), and 3 mg/kg i.p. MTEP was reported to achieve >75% receptor 
occupancy for at least 15 min post-dosing in mice (Anderson et al., 2003). 
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Figure 4.1 Experimental design summary. Mice were allocated to one of three 
groups that received injections of vehicle (PC: Veh), 3 mg/kg (PC: 3) or 10 mg/kg 
(PC: 10) MTEP prior to eleven, once daily, Pavlovian conditioning sessions (Phase 
1). Two tests of conditioned reinforcement (CRf; Phase 2) and goal-tracking (GT; 
Phase 3) were subsequently undertaken in each group. Injections of vehicle or 
MTEP were given before each test, the order of treatments being counterbalanced. 
Two Pavlovian conditioning sessions were conducted between each test (block 
arrows). See methods section for further details.  
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4.2.4.1 Magazine training 
To familiarize mice with the food reinforcer used in Pavlovian conditioning 
sessions, a small amount of the food was provided to mice in their home cage. The 
following day, mice received a single 30 min magazine training session in which 
food pellets were delivered once every 60 sec, on average (range of 25-95 sec). 
No drug injections were made prior to the magazine training session and no stimuli 
or response levers were presented. 
 
4.2.4.2 Phase 1: Pavlovian conditioning 
Commencing 24 h after the magazine training session, mice received eleven, once 
daily, Pavlovian conditioning sessions. Each 60 min session consisted of 16 trials 
in which presentation of a stimulus was paired with food delivery (CS+) and 16 
trials in which presentation of an alternative stimulus was not paired with food (CS-
). The order of stimulus presentations was randomly determined and each stimulus 
trial was separated by a variable, no-stimulus, inter-trial interval (ITI; range of 80-
120 sec; M = 100 sec). For half of the mice a constant 10 sec tone served as the 
CS+ and the 10 sec flashing (1 Hz) of both cue lights served as the CS-. This 
contingency was reversed for the remaining mice. A single food pellet was 
delivered 5 sec after CS+ onset. The total number of entries made into the food 
magazine during each stimulus trial (CS+ or CS-) was recorded and expressed as 
a percentage of total magazine entries made during the session (% magazine 
entries). Food magazine entries that occurred in the first five seconds following 
CS+ onset (i.e. prior to food delivery) were recorded to provide a preliminary 
assessment of the acquisition of goal-tracking responses. The latency to enter the 
food magazine following onset of the CS+ (retrieval latency) was also measured. 
 
4.2.4.3 Phase 2: Conditioned reinforcement 
The 60 min CRf test commenced with insertion of both response levers into the 
operant chamber. A single response on one lever resulted in a 1.5 sec 
presentation of the CS+, whereas a single response on the alternate lever resulted 
in a 1.5 sec presentation of the CS-. For half of the mice, the left lever was 
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designated the CS+ lever and the right lever the CS- lever. This contingency was 
reversed for remaining mice. No food was delivered during the test. The ability of 
the CS+ to serve as a conditioned reinforcer is demonstrated by a greater number 
of responses on the CS+ lever than on the CS- lever. 
 
4.2.4.4 Phase 3: Goal-tracking 
The GT test was 30 min in duration and consisted of 8 trials of the CS+, and 8 trials 
of the CS-. The order of stimulus presentations was randomly determined and 
each stimulus trial was separated by a 100 sec fixed, ITI, during which no stimuli 
were presented. No food was delivered during the test. The total number of entries 
made into the food magazine during each stimulus trial was recorded. Four mice 
died before completion of the GT tests, reducing the size of groups PC: 3 and PC: 
10 to n = 17 and n = 19, respectively. 
 
4.2.5 Statistical analysis 
Data were initially analysed by mixed-factor analysis of variance (ANOVA), where 
the three conditioning treatment groups (PC: Veh, 3 or 10) were represented by the 
between-subjects factor of PC treatment. The drug treatment (Veh or MTEP) 
administered to each of the three conditioning treatment groups during subsequent 
CRf and GT test sessions was included in analyses as a within-subjects factor of 
CRf treatment or GT treatment, respectively. Where a significant (p ≤ 0.05) main 
effect or interaction term was found, further analysis was performed using ANOVA 
and post-hoc comparisons by two-tailed t-tests. To permit analysis by parametric 
tests, appropriate transformations were undertaken to transform skewed 
distributions closer to a normal distribution and to reduce heterogeneity of variance 
(Cardinal and Aitken, 2006). Specifically, for analysis of % magazine entries 
(Phase 1), data were arcsine transformed (Y‟ = arcsin√(Y)). For analysis of 
magazine entries made during the first five seconds of CS+ presentations in 
conditioning sessions (Phase 1), lever responses and magazine entries in the test 
of CRf (Phase 2) and magazine entries in the test of goal-tracking (Phase 3), data 
were square root transformed (Y‟ = √Y). For within-subjects ANOVA, the 
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Greenhouse-Geisser correction was used where the assumption of sphericity was 
violated. All figures show group mean (± SEM). 
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4.3 Results 
 
4.3.1 Phase 1: Pavlovian conditioning 
Pavlovian conditioning performance did not differ among groups of mice that 
received vehicle (PC: Veh group), 3 mg/kg (PC: 3) or 10mg/kg (PC: 10) MTEP 
prior to each conditioning session. Across conditioning sessions, mice from all 
three conditioning treatment groups (PC: Veh, 3 or 10) directed a greater 
proportion of total session entries into the food magazine (% magazine entries; Fig. 
4.2a) during presentations of the food-paired stimulus (CS+) than during 
presentations of the unpaired stimulus (CS-). This finding was confirmed by a 
mixed-factor ANOVA, which included Stimulus (CS+ or CS-) and Session (1-11) as 
within-subjects factors. A significant difference in responding to the two stimuli 
across conditioning sessions was identified (main effect of Stimulus, F(1,59) = 
1432.62, p < 0.001; Stimulus x Session interaction, F(10,590) = 83.26, p < 0.001). 
However, there was no difference between the three conditioning treatment groups 
in % magazine entries directed toward the stimuli (Stimulus x Session x 
Conditioning treatment interaction, not significant (NS)). 
 
The number of magazine entries made during the first five seconds of CS+ 
presentations (i.e. before delivery of the food reward; Fig. 4.2b) increased across 
conditioning sessions (main effect of Session, F(10,590) = 22.01, p < 0.001), but 
did not differ among the conditioning treatment groups (Session x Conditioning 
treatment interaction, NS). In contrast, the total number of magazine entries made 
during CS- presentations decreased across conditioning sessions (main effect of 
Session, F(10,590) = 43.91, p < 0.001), but also did not differ among the 
conditioning treatment groups (Session x Conditioning treatment interaction, N.S; 
data not shown). 
 
Mice came to enter the food magazine at 4-5 sec after CS+ onset (retrieval latency; 
Fig.4.2c), corresponding with the time of food delivery. The mean retrieval latency 
to enter the food magazine following activation of the CS+ significantly decreased 
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across conditioning sessions (main effect of Session, F(10,590) = 43.23, p < 
0.001), and there was no difference in retrieval latencies among the three 
conditioning treatment groups (Conditioning treatment x Session interaction, NS). 
 
Stability of conditioning performance (indicated by asymptotic responding) prior to 
the first test of CRf was observed from the eighth conditioning session. % 
magazine entries (Fig. 4.2a) did not differ across sessions 8-11 (main effect of 
Session, NS), and there was no difference between conditioning treatment groups 
(Stimulus x Session x Conditioning treatment interaction, NS). Similarly, magazine 
entries made in first five seconds of CS+ presentations (Fig. 4.2b) and mean 
retrieval latencies (Fig. 4.2c) did not differ across sessions 8-11 (main effect of 
Session, NS), nor between conditioning treatment groups (Session x Conditioning 
treatment interaction, NS). No further change in conditioning performance was 
observed during any of the subsequent Pavlovian reconditioning sessions that 
occurred between the CRf and GT tests. 
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Figure 4.2 Measures of food magazine entry activity during eleven Pavlovian 
conditioning sessions (Phase 1) in which mice received presentations of a stimulus 
paired with food delivery (CS+) and a second, unpaired stimulus (CS-). Mice were 
injected with either vehicle or 3 or 10 mg/kg i.p. MTEP (PC: Veh, 3, or 10) 20 min 
prior to each conditioning session. (a) Magazine entries during presentation of the 
CS+ and CS-, expressed as a percentage of total session entries (% magazine 
entries), did not differ between conditioning treatment groups and stabilized from 
session 8 onward. (b) Magazine entries made during the first five seconds of the 
CS+ presentation (i.e. prior to food delivery) increased across conditioning 
sessions and were unaffected by treatment with MTEP. (c) The mean retrieval 
latency to enter the food magazine following CS+ activation stabilized at 4-5 sec, 
which corresponded with the time of food (US) delivery. Retrieval latencies did not 
differ among the three groups.  
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4.3.2 Phase 2: Conditioned reinforcement 
Conditioned reinforcement was influenced by the MTEP treatment given prior to 
Pavlovian conditioning sessions, but not by the MTEP treatment given during the 
CRf tests (Fig. 4.3a). An initial mixed-factor ANOVA, which included Lever (CS+ or 
CS- paired) as a within-subjects factor, confirmed that lever responding 
significantly differed as a result of the treatment received during conditioning 
sessions (Lever x Conditioning treatment interaction, F(2,59) = 3.80, p < 0.05). 
However, lever responding did not reliably differ as a result of the MTEP treatment 
received during the CRf test (Lever x CRf treatment interaction, NS). 
 
Within-subjects ANOVA comparisons of CS+ and CS- lever responding, which 
included both CRf treatment conditions (Veh or MTEP), were undertaken to 
determine whether each conditioning treatment group demonstrated CRf (i.e. more 
responding on the CS+ lever than the CS- lever). Conditioned reinforcement was 
demonstrated in the PC: Veh group (main effect of Lever, F(1,21) = 26.53, p < 
0.001) and in the PC: 3 group (main effect of Lever, F(1,18) = 8.55, p < 0.01). 
However, the PC: 10 group failed to show any difference in CS+ and CS- lever 
responding (main effect of Lever, NS). 
 
The impairment in responding for CRf in the PC: 10 group was due to a specific 
reduction in responding for the food-paired stimulus (CS+), rather than a general 
reduction in the ability of these mice to perform an instrumental response. A mixed-
factor ANOVA, performed for each stimulus-paired lever, demonstrated that CS+ 
lever responding was significantly influenced by the treatment received during 
conditioning (main effect of Conditioning treatment, F(2,59) = 3.59, p < 0.05). By 
contrast, CS- lever responding was unaffected by the treatment received during 
conditioning (main effect of Conditioning treatment, NS). Post-hoc comparisons 
indicated that CS+ lever responding was significantly reduced in the PC: 10 group, 
in comparison to the PC: Veh group during CRf tests that were preceded by 
injection of vehicle (t = 2.68, df = 41, p < 0.05) and by 10 mg/kg MTEP (t = 2.70, df 
= 41, p < 0.05). Consistent with a dose-related effect of MTEP, there were no 
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differences in CS+ lever responding between the PC: Veh and PC: 3 groups or the 
PC: 3 and PC: 10 groups in either the CRf test (t-test comparisons, NS). 
 
Although CRf was not impaired by pre-test administration of 10 mg/kg MTEP in the 
PC: Veh group, a possibility existed that the temporal profile of lever responding 
may have been altered by acute 10 mg/kg MTEP treatment. Further analysis was 
therefore performed to determine whether administration of 10 mg/kg MTEP in the 
test of CRf had any effect on the temporal profile of lever responding (Fig. 4.3b). 
Conditioned reinforcement (i.e. greater responding on the CS+ lever) was evident 
in each 15 min time period of the 60 min CRf test in the PC: Veh group (main effect 
of Lever, F(1,21) = 25.81, p < 0.001), but not in the PC: 10 group (main effect of 
Lever, NS). In the PC: Veh group, 10 mg/kg MTEP during the test of CRf did not 
alter the temporal profile of either CS+ lever responding (Period x CRf treatment 
interaction, NS), or CS- lever responding (Period x CRf treatment interaction, NS). 
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Figure 4.3 Lever responding in tests of conditioned reinforcement (a) Responding 
for CRf was observed in mice that received vehicle or 3 mg/kg MTEP during 
Pavlovian conditioning (PC: Veh and 3, respectively). CRf was significantly 
impaired in mice that received 10 mg/kg MTEP during conditioning (PC: 10). In 
contrast, 10 mg/kg MTEP during the CRf test did not impair CRf in mice that 
received vehicle during conditioning (PC-CRf: Veh-10). *p < 0.05 Post-hoc, t-test 
comparison between Veh-Veh and 10-Veh CS+ lever responses; #p < 0.05 Post-
hoc, t-test comparison between Veh-10 and 10-10 CS+ lever responses. (b) 10 
mg/kg MTEP did not alter the temporal profile of lever responding in mice that 
received vehicle during conditioning (PC: Veh). Mice that received 10 mg/kg MTEP 
during conditioning (PC: 10) failed to show any significant difference in CS+ and 
CS- lever responding in any 15 min period of each CRf test.  
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Magazine entry activity during CRf tests was also examined (Table 4.1), as this 
could provide further indication of whether MTEP administration had any gross 
effects on activity. A mixed-factor ANOVA of mean total magazine entries, 
indicated that entries were significantly increased during CRf tests in which MTEP 
was administered (main effect of CRf Treatment, F(1,59) = 11.19, p < 0.01), but 
that the effect of MTEP on magazine entries did not differ among conditioning 
treatment groups (CRf treatment x Conditioning treatment interaction, NS). 
Analysis of the time course of magazine entries during the CRf tests indicated that 
entries decreased over the course of the test session (main effect of Period, 
F(3,177) = 7.0, p < 0.01), but the effects of MTEP given during the CRf test did not 
reach statistical significance (CRf treatment x Period interaction, NS). 
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Group Magazine 
Entries 
15 min Period 
(PC-CRf) Total 1 2 3 4 
Veh-Veh 
Veh-10 
 
3-Veh 
3-3 
 
10-Veh 
10-10 
62.5 (8.5) 
77.7 (11.0) 
 
61.5 (13.4) 
71.8 (13.6) 
 
51.8 (7.7) 
81.5 (13.1) 
23.0  (3.4) 
23.0  (3.8) 
 
13.3 (2.6) 
16.9 (2.6) 
 
17.2 (3.4) 
28.7 (3.5) 
11.9 (2.2) 
16.9 (3.3) 
 
14.7 (3.0) 
17.3 (4.5) 
 
14.5 (3.0) 
19.0 (3.9) 
12.5 (3.5) 
18.5 (3.7) 
 
13.6 (4.0) 
20.2 (4.5) 
 
9.5 (2.0) 
19.8 (3.6) 
15.2 (3.2) 
19.2 (3.0) 
 
19.9 (7.4) 
17.4 (4.3) 
 
10.6 (2.9) 
14.0 (4.0) 
 
Table 4.1 Head entries into the food magazine during tests of Conditioned 
Reinforcement (CRf). Total magazine entries were significantly increased when 
MTEP was administered during the CRf test; however this effect did not differ 
between Pavlovian conditioning (PC) treatment groups. Magazine head entries 
decreased across each of the 15 min periods (1-4) of the 60 minute CRf test. Table 
shows group mean (±SEM). 
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4.3.3 Phase 3: Goal-tracking 
Presentation of the food-paired stimulus (CS+), in the absence of food delivery, 
elicited approach responses into the food magazine (i.e. towards the goal). Mice 
made fewer head entry responses into the magazine during presentation of the 
unpaired stimulus (CS-), indicating that the CS+ was able to serve as a predictor of 
food availability (Fig. 4.4a). There was no effect of MTEP given during the 
Pavlovian conditioning phase, or MTEP given during the GT test, on goal-tracking 
responses. These findings were confirmed by a mixed-factor ANOVA, which 
included Stimulus (CS+, CS-) as a within-subjects factor. Mean total magazine 
entry responses significantly differed depending on the identity of the stimulus 
(main effect of Stimulus, F(1,55) = 200.51, p < 0.001), but there was no effect of 
either the treatment received during conditioning (Stimulus x Conditioning 
treatment interaction, NS) or during the GT test (Stimulus x GT treatment 
interaction, NS) on goal-tracking responses. 
 
Analysis of magazine entries made during each stimulus trial was performed to 
determine whether acute 10mg/kg MTEP treatment altered the profile of goal-
tracking responses in the PC: Veh group and whether response profiles differed 
between the PC: Veh and PC: 10 groups (Fig. 4.4b). For both PC: Veh and PC: 10 
groups, the number of magazine entries made during each CS+ trial decreased 
across the course of the GT test and few responses were made across all CS- 
trials. Analysis of magazine entries during CS+ trials was performed using a mixed-
factor ANOVA, which included Trial (1-8) as a within-subjects factor. This analysis 
confirmed that magazine entries made during each CS+ trial significantly 
decreased with successive trials (main effect of Trial, F(7,273) = 17.215, p < 0.001 
), but that this profile of responding was unaffected by the treatment received 
during conditioning (Trial x Conditioning treatment interaction, NS), or the 
treatment received during the GT test (Trial x GT treatment interaction, NS). 
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Figure 4.4 Food Magazine entries in tests of goal tracking (GT), which examines 
the ability of a CS to elicit approach responses to the place of food delivery. No 
food was delivered during each GT test. (a) Mice that received vehicle, 3 or 10 
mg/kg i.p. MTEP during conditioning sessions (PC: Veh, 3 and 10, respectively) 
made more entries into the food magazine during presentation of the food-paired 
stimulus (CS+) than during presentation of the unpaired stimulus (CS-). There was 
no difference in magazine activity between the conditioning treatment groups, and 
magazine activity was not altered by the MTEP treatment received during the GT 
test. (b) Magazine entries made in each CS+ stimulus trial decreased across 
successive trials. The number of magazine entries made during each CS+ stimulus 
trial was unaffected by the treatment (vehicle or 10 mg/kg MTEP) received during 
the GT test in PC: Veh and PC: 10 groups.  
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4.4 Discussion 
 
The present study explored the effects of the selective mGluR5 antagonist, MTEP, 
on the acquisition of a Pavlovian association that enables a food-paired stimulus to 
acquire predictive properties that signal reward availability (goal-tracking) and 
incentive properties necessary to reinforce a novel instrumental response 
(conditioned-reinforcement). We report that MTEP did not affect performance 
during Pavlovian conditioning sessions, indicating that the overall motivation to 
obtain food and the ability of mice to discriminate between the food-paired stimulus 
and the stimulus not paired with food was unaffected by blockade of mGluR5. In 
addition, mGluR5 function was not required for the acquisition of predictive 
properties necessary for the control over goal-tracking responses by the food-
paired stimulus. However, mGluR5 function was critical for the associative learning 
processes necessary for the acquisition of properties by the CS that allow the CS 
to serve as a conditioned reinforcer, i.e. providing the CS with incentive value. 
Once incentive learning had taken place, mGluR5 function was not required for the 
expression of this CS-reinforced behaviour, which has been proposed to depend 
upon CS elicited representations of general affect (Parkinson et al., 2005; Burke et 
al., 2007). These findings add important new information regarding the function of 
mGluR5 in the control over appetitive behaviours by reward-paired stimuli. 
 
A potential explanation for the findings reported here is that impaired CRf in mice 
that had received MTEP during conditioning sessions (PC: 10 group) was due to a 
state-dependent learning process (Stephens et al., 2000). That is, MTEP may have 
induced an interoceptive state during conditioning sessions and the subsequent 
retrieval of the CS memory during the CRf test may have been disrupted due to the 
presence of a different interoceptive state, namely the absence of MTEP. However, 
this account is unlikely since CRf responding was also impaired in the PC: 10 
group when 10 mg/kg MTEP was given during the CRf test to induce the same 
state that existed during conditioning sessions. 
 
190 
 
That we found contrasting effects of MTEP on responding for CRf and goal-
tracking responses may have been due to mice having experienced relatively more 
stimulus-food (CS-US) pairings prior to the GT tests than the CRf tests. Thus, goal-
tracking responses may have been less susceptible to the effects of MTEP due to 
strengthened CS-US associations. At variance with this possibility is the 
observation that mice came to use the CS+ as a predictor of food delivery even 
during Pavlovian conditioning sessions that preceded the first CRf test (Fig. 4.2b-
c). Critically, the acquisition of these goal-tracking responses were unaffected by 
administration of MTEP, thereby supporting our proposition that mGluR5 plays a 
dissociable role in the acquisition of predictive and incentive motivational properties 
by CSs. 
 
Our findings that CRf was not impaired by administration of 10 mg/kg MTEP, 
during the test only, in mice that had received vehicle prior to conditioning sessions 
(PC: Veh group) is in apparent contrast to behavioural studies of cue-induced 
reinstatement that have reported a role of mGluR5 in the expression of control over 
responding maintained by both natural- and drug-paired CSs (Tessari et al., 2004; 
Bespalov et al., 2005; Backstrom and Hyytia, 2006; Schroeder et al., 2008; Gass et 
al., 2009; Kumaresan et al., 2009; Martin-Fardon et al., 2009). Since it is possible 
that higher doses of MTEP would have reduced the expression of CRf in our study, 
our findings do not exclude a role of mGluR5 in the control over appetitive 
behaviours by reward-paired stimuli. Alternatively, subtle methodological 
differences may have contributed to this apparent contrast in findings. Firstly, in our 
study, the CS reinforced an instrumental response that had not previously been 
associated with primary reinforcement. Secondly, mice were trained a purely 
Pavlovian (stimulus-outcome) association, while an instrumental (response-
outcome) component is embedded in the acquisition of associations between 
environmental stimuli and reward in studies of self-administration and cue-induced 
reinstatement. Finally, we examined instrumental responding supported by a CS 
immediately following the conditioning phase, while extinction learning or periods of 
withdrawal are commonly employed in studies of cue-induced reinstatement and 
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which may contribute to neural changes mediating the subsequent expression of 
control over appetitive behaviours by CSs (Grimm et al., 2003; Lu et al., 2005; 
Conrad et al., 2008; Ghasemzadeh et al., 2009b). 
 
Our finding that mGluR5 antagonism was effective in reducing a CS-reinforced 
behaviour when administered during the acquisition of a Pavlovian association 
shares some similarity with studies examining the role of mGluR5 in conditioned 
place preference (CPP) learning. Administration of the mGluR5 antagonist 6-
methyl-2-(phenylethynyl)pyridine (MPEP), during conditioning (i.e. the acquisition 
phase), reduced the development of cocaine CPP in mice while having no effect on 
the development of amphetamine, ethanol, morphine or nicotine CPP (McGeehan 
and Olive, 2003). Another study reported that higher doses of MPEP attenuated 
both the acquisition and expression of morphine CPP in mice (Popik and Wrobel, 
2002). In rats, the expression of cocaine CPP was unaffected by a dose of MPEP 
that reduced the expression of morphine CPP (Herzig and Schmidt, 2004). Thus, 
mGluR5 can contribute to the acquisition of associations that enable reward-
paired, contextual stimuli to mediate CPP and can also influence the expression of 
CPP, a finding that may depend on the extent of mGluR5 blockade and/or the 
primary reward experienced during conditioning. However, the expression of CPP 
may be due to either predictive or incentive motivational associations formed 
between the contextual cues and the paired outcome (Stephens et al., 2010). 
While acknowledging that substantial differences exist between contextual vs. 
discrete cue conditioning, our findings may provide further insight into the 
psychological mechanisms underlying these earlier CPP reports by identifying a 
specific role of mGluR5 in the acquisition of incentive associations between an 
environmental stimulus and reward, while the ability of a reward-paired stimulus to 
acquire predictive properties is unaffected by mGluR5 antagonism. 
 
What is surprising about the present findings is the degree of overlap between the 
response profile of mGluR5KD-D1 mice in the CRf test, and that seen in wild-type 
mice that had received 10 mg/kg MTEP injections prior to conditioning sessions. In 
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both cases, a reduction in CS+ reinforced responding was observed, however 
discrimination between the CS+ and CS- lever was maintained. Thus, mGluR5 
seems to have a particular contribution to the vigour of the response that is under 
the control of the reward-paired CS, rather than the direction of the behavioural 
output. The similarity of these results is also particularly surprising since MTEP 
was administered systemically in the present study, and therefore lacks any cell-
type selectivity afforded by the mGluR5KD-D1 mouse model. These findings suggest 
at least two possibilities. First, that knock-down of mGluR5 is not actually cell-type 
specific in the mutant mouse model or, second, that only mGluR5 located on D1R 
expressing cells contribute to the acquisition of incentive learning necessary for 
CRf. 
 
The first suggestion mentioned above seems unlikely, given the extensive 
characterisation of the mGluR5KD-D1 model (Novak et al., 2010). The second 
possibility would be remarkable, but not entirely inconceivable when considering 
some other reports that have explored the neural mechanisms of appetitive 
Pavlovian learning. For example, systemic administration of an NMDA antagonist 
in mice blocked the acquisition and expression of nicotine (Papp et al., 2002) and 
cocaine CPP (Maldonado et al., 2007). Similarly, mice with inactivation of NMDA 
receptors specifically in dopamine neurons (NR1-KO) or mutation of NMDA 
receptors specifically on dopamine D1R expressing neurons (DR1-NR1m) also 
show impaired nicotine (Wang et al., 2010) and cocaine CPP (Heusner and 
Palmiter, 2005), respectively. These reports confirm that systemic drug treatments 
can produce the same behavioural phenotype as cell-type specific mutations, but 
whether these manipulations are working through the same processes (e.g. 
incentive or predictive learning or something entirely different) to disrupt CPP is not 
clear. Indeed, there is a dearth of literature that allows for comparison of systemic 
drug treatments and cell-type specific mutations in more rigorously defined 
appetitive learning preparations such as CRf, sign-tracking and PIT. This likely 
reflects the compromising side-effect profiles and/or receptor subtype selectivity of 
many drugs that target receptors implicated in incentive learning processes (e.g. 
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NMDA, AMPA, and dopamine D1Rs), rather than a scarcity of the genetic mouse 
models. 
 
Until an inducible cell-type specific knock-out model is generated that allows for 
temporal control of mGluR5 expression on dopamine-D1R neurons, it will be 
impossible to formally determine the contribution of mGluR5 on D1R expressing 
neurons for the acquisition and/or expression of specific incentive learning 
processes. However, the findings reported in this chapter, together with a failure of 
20 mg/kg i.p. MTEP to disrupt the expression of responding for CRf in wild-type 
mice (reported in Chapter 3, section 3.3.2.3), strongly favours a role of mGluR5 on 
D1R expressing neurons in neural adaptations that are necessary for the 
acquisition, rather than the expression, of an incentive CS-US association. A 
pertinent question that arises from the studies reported thus far is, what role might 
mGluR5 on D1R expressing neurons play in behavioural effects of addictive drugs, 
such as cocaine, which are thought to reflect the ability of such drugs to engage 
with the neural systems that mediate the learning of incentive associations 
(Stewart et al., 1984; Robinson and Berridge, 1993; Everitt et al., 2001). This issue 
will be addressed in the next chapter 
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5 Some behavioural effects of cocaine in 
mGluR5KD-D1 mice 
 
5.1 Introduction 
 
The previous chapters have established that glutamate signalling through mGluR5, 
on cells that also receive dopaminergic input, is necessary for the formation of 
incentive associations between environmental stimuli and natural rewards. In the 
striatum, the interaction of glutamate and dopamine is critical for long-term 
plasticity underlying a variety of adaptive learning and memory processes, but 
which may also subserve the behavioural effects of addictive drugs (Nestler, 2001; 
Kelley, 2004; Malenka and Bear, 2004; Hyman et al., 2006). The following 
experiments will explore the contribution of mGluR5 on dopaminoceptive neurons 
to cocaine conditioned reward and behavioural sensitisation; two behavioural 
effects of cocaine that reflect drug induced neuronal adaptations within cortical 
limbic striatal networks (Wolf, 1998; Vanderschuren and Kalivas, 2000; Girault et 
al., 2007). 
 
Acute exposure to psychostimulants, such as cocaine, can increase extracellular 
dopamine and glutamate in defined brain regions, such as the ventral striatum 
(Reith et al., 1986; Di Chiara and Imperato, 1988; Reid et al., 1997), resulting in 
augmented locomotor activity (Kelly et al., 1975; Clarke et al., 1988; Delfs et al., 
1990) and the induction of intracellular signalling cascades (Graybiel et al., 1990; 
Valjent et al., 2005). With repeated intermittent psychostimulant exposure, long 
lasting neuronal adaptations can occur, including changes in synaptic strength 
(Thomas et al., 2001b; Borgland et al., 2004) and dendritic morphology (Robinson 
and Kolb, 2004). Such neuronal changes are mirrored by a persistent, sensitised 
locomotor response to cocaine in animals (Segal et al., 1980; Robinson and 
Becker, 1986) and are proposed to contribute to behavioural changes underpinning 
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addiction in humans (Robinson and Berridge, 1993; Nestler, 2001; Kauer and 
Malenka, 2007; Thomas et al., 2008). 
 
There is ample evidence that glutamatergic signalling, particularly at ionotropic 
NMDA and AMPA receptors, is involved in the acute psychomotor activating 
effects of psychostimulants (Witkin, 1993) and induction and expression of 
neuroplastic changes that follow repeated intermittent psychostimulant exposure 
(Wolf, 1998; Vanderschuren and Kalivas, 2000; Kalivas, 2009; Schmidt and Pierce, 
2010). For example, glutamatergic signalling at NMDA is necessary for the 
induction of cocaine sensitisation (Karler et al., 1989; Kalivas and Alesdatter, 1993; 
Stewart and Druhan, 1993; Wolf and Jeziorski, 1993; Haracz et al., 1995; Khan 
and Shoaib, 1996), while AMPA receptors contribute to both the induction and 
expression of sensitisation (Karler et al., 1990; Karler et al., 1991). Repeated 
cocaine exposure also leads to changes in the expression of these ionotropic 
glutamate receptors in both the VTA (Fitzgerald et al., 1996) and ventral striatum 
(Boudreau and Wolf, 2005). In addition, after repeated cocaine exposure, basal 
extracellular glutamate is depressed in the NAcc (Baker et al., 2003) and VTA 
(Kozell and Meshul, 2003), but the amount of glutamate released in the NAcc is 
significantly increased following an injection of cocaine (Pierce et al., 1996; 
McFarland et al., 2003). With respect to the metabotropic receptor, mGluR5, both 
its mRNA and protein are augmented in the NAcc of cocaine-sensitised animals 
(Ghasemzadeh et al., 1999; Ghasemzadeh et al., 2009a) and mGluR5 appears 
necessary for the expression of behavioural sensitisation to morphine (Kotlinska 
and Bochenski, 2007), cocaine (Kotlinska and Bochenski, 2009) (but see, 
Dravolina et al., 2006) and nicotine (Tessari et al., 2004). Only recently has a 
necessary role for mGluR5 in the induction of behavioural sensitisation to cocaine 
(but not morphine) been reported using the mGluR5 antagonist, MTEP, in rats 
(Veeneman et al., 2010). In consideration of these pharmacology studies, the 
mGluR5KD-D1 mouse provides an ideal tool to further probe the contribution and 
neuroanatomical location of mGluR5 in cocaine sensitisation. 
 
196 
 
In addition to behavioural sensitisation, animals can learn to associate the effects 
of cocaine with the environment in which cocaine was administered and will 
demonstrate preference for that place (Spyraki et al., 1982b). Conditioned place 
preference (CPP) relies on the formation of a Pavlovian association between a 
biologically relevant stimulus with neutral contextual cues and has been 
established with a variety of “natural” reinforcers, including food (Spyraki et al., 
1982a) and conspecifics interaction (Calcagnetti and Schechter, 1992), but also 
many addictive drugs (Tzschentke, 2007). Although the precise psychological 
basis of CPP has not yet been established (Stephens et al., 2010), its 
neurobiological substrates clearly overlap with those required for other appetitive 
Pavlovian conditioning tasks. Thus, the BLA and NAcc core and their serial 
connectivity are necessary for discrete-cue based CPP (Everitt et al., 1991; Fuchs 
et al., 2002; Ito et al., 2006), while the HPC and NAcc shell and serial connectivity 
between these two structures are necessary for idiothetic spatial-cue based CPP 
(Ito et al., 2008). The acquisition of CPP has also been shown to involve the 
ventral pallidum and medial dorsal thalamus (McAlonan et al., 1993) and 
specifically the dorsal, but not ventral, hippocampus (Meyers et al., 2003). 
 
There is also ample evidence pointing to glutamate transmission at the ionotropic 
NMDA and AMPA receptors as important for the acquisition and expression of 
cocaine-CPP (Cervo and Samanin, 1995; Kaddis et al., 1995; Kim et al., 1996; 
Mead and Stephens, 1999; Harris and Aston-Jones, 2003; Dong et al., 2004; 
Maldonado et al., 2007). However, the role of mGluR5 in CPP supported by natural 
or drug reinforcers is not at all clear. Using mGluR5 knock-out mice, mGluR5 has 
been proposed as necessary for cocaine reinforcement in one study (Chiamulera 
et al., 2001), but not required for cocaine reward in another (Olsen et al., 2010). 
Using the mGluR5 antagonist, MPEP, both a “necessary role” and “no role” of 
mGluR5 have been proposed for CPP established with morphine (Popik and 
Wrobel, 2002; McGeehan and Olive, 2003), ethanol (McGeehan and Olive, 2003; 
Lominac et al., 2006), nicotine (McGeehan and Olive, 2003; Yararbas et al., 2010), 
amphetamine (McGeehan and Olive, 2003; Herzig et al., 2005) and cocaine 
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(McGeehan and Olive, 2003; Herzig and Schmidt, 2004). These conflicting findings 
could be due to any number of procedural differences but, where MPEP has been 
effective in drug-CPP, it is not known whether the effects of MPEP on drug-CPP 
are due to disruption of drug reinforcement (Paterson et al., 2003; Kenny et al., 
2005), discriminative drug effects (Lee et al., 2005; Zakharova et al., 2005; 
Besheer et al., 2006) or more general spatial learning impairments (Balschun and 
Wetzel, 2002; Naie and Manahan-Vaughan, 2004). In addition, there is now 
substantial evidence that MPEP is itself reinforcing (van der Kam et al., 2009b, a; 
Rutten et al., 2010) and the effects, or lack thereof, of MPEP on drug-CPP could 
be due to a potentiation, rather than an attenuation, of any rewarding drug effects 
(Rutten et al., 2010). Given this confound, the examination of food- and cocaine-
CPP in mGluR5KD-D1 may provide some additional clarity on the role of mGluR5 in 
conditioned reward. Moreover, mGluR5KD-D1 mice may provide valuable insight to 
the psychological basis of CPP. Incentive learning necessary for CRf is clearly 
impaired in these mice, but CRf has been suggested as one mechanism whereby 
contextual stimuli may support instrumental locomotor responses necessary for 
approaching and contacting the paired compartment during the test of place 
preference (Everitt et al., 1991). If CRf was necessary for CPP, one could predict 
that CPP would be impaired in mGluR5KD-D1 mice. 
 
The following experiments will first examine the effects of acute and repeated 
intermittent cocaine exposure on locomotor activity in mGluR5KD-D1 mice. The 
development of behavioural sensitisation may result from an additive effect of 
unconditioned locomotor activity to the drug and conditioned locomotor activity 
induced by the formation of Pavlovian associations to the drug-paired context 
(Stewart, 1983; Pert et al., 1990; Crombag et al., 1996; Le Merrer and Stephens, 
2006). Thus, a test will be undertaken to explore the ability of the environment in 
which cocaine is experienced to augment activity in the absence of cocaine 
(termed, conditioned activity; Stewart, 1983). The second series of experiments 
reported in this chapter will see mGluR5KD-D1 mice exposed to tests of food- and 
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cocaine-CPP to examine the contribution of mGluR5 on dopaminoceptive neurons 
to learning about conditioned food- and drug-reward, respectively.  
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5.2 Materials and methods 
 
5.2.1 Animals 
Mice (n = 27/28, WT/KD; male and at least 8 weeks old prior to experiment start) 
were maintained on a 12:12 h light-dark cycle (lights on at 0700 hours) under 
controlled temperature (21 ± 2 °C) and humidity conditions (50 ± 5%). Animals 
were housed in groups of two or three in polycarbonate cages. Water was 
available ad libitum in the holding room. At least 7 days prior to the experiment 
start, mice were placed onto a restricted feeding regime designed to maintain body 
weights at ~85% of free-feeding weight. Experiments took place during the light-
phase. All procedures were performed in accordance with the United Kingdom 
1986 Animals (Scientific Procedures) Act, following institutional ethical review. 
 
5.2.2 Drugs 
Cocaine hydrochloride (Macfarlan Smith, Edinburgh, Scotland, UK) was dissolved 
in 0.9% saline. Injections were administered at a volume of 10 ml/kg i.p. 
 
5.2.3 Apparatus 
Conditioned place preference: Behavioural training and testing were performed in 
eight identical, three-compartment conditioned place preference chambers (Fig. 
5.1a). Each chamber consisted of two „outer‟ compartments (ea. 20 x 20 x 20 cm), 
adjoined by a smaller „middle‟ compartment (20 x 5 x 20 cm). Access amongst the 
three compartments was controlled by a removable panel (5 x 20 cm) in the 
partitioning walls of the outer compartments and middle compartment. Each outer 
compartment was differentiated by tactile and visual cues. One outer compartment 
(context A) consisted of black and white walls (each wall split along the diagonal 
with the top half white and the bottom half black) and a smooth Perspex floor. The 
second compartment (context B) consisted of white walls and a perforated steel 
floor. The activity and location of mice was recorded using five infra-red beams 
distributed amongst the three compartments (Fig. 5.1b), which interfaced with a PC 
running data collection and analysis software (written by A.N. Mead). 
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Figure 5.1 Conditioned place preference apparatus. (a) Two CPP chambers are 
shown. Each apparatus consists of two outer compartments (context A and B) 
differentiated by tactile (floor material) and visual (wall pattern) cues. Access 
between the outer compartments is made through a smaller middle compartment. 
(b) Overview of one CPP chamber. The red dots indicate the position of infra-red 
beams used to detect the location of mice and which also provide a measure of 
activity.  
a b
Context A
Middle
Context B
IR Detector
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Locomotor activity: Locomotor activity experiments were performed using nine 
circular runways, as described previously (see Chapter 2, section 2.2.6.1). 
 
5.2.4 Experiment 1: Locomotor activity 
Procedural note: Initially, 9 mice per genotype were assigned to this study. One 
wild-type mouse showed high levels of activity during the sham injection test (> 2 x 
S.D. from group mean). This mouse was excluded from testing, reducing group 
sizes to n = 8 and n = 9 for knock-down and wild-type mice, respectively. The 
remaining mice were used for all the following locomotor activity experiments 
reported here. Mice were assigned to the same circular runway for all sessions. 
Multiple groups of mice were run in the locomotor apparatus each day, although 
each group contained mice from both genotypes. The circular runways and 
Perspex platform were cleaned between each group. 
 
5.2.4.1 Habituation to a novel environment and sham injection 
Mice were habituated to the circular runways across five, once-daily, 1 h sessions. 
On the sixth day, following 30 min of activity recording, mice were removed from 
the circular runways and were injected with vehicle (10 ml/kg saline i.p.), in order to 
acclimatize them to the injection procedure. Activity was recorded for a further 60 
min post-vehicle injection. 
 
5.2.4.2 Cocaine-locomotor dose-response (pre-sensitisation) 
Mice were habituated to the circular runways for 30 min, removed and then 
injected with cocaine (1, 3 or 10 mg/kg i.p.) or vehicle. Activity was recorded for a 
further 60 min post-injection. Each mouse received each dose, separated by 48 h 
intervals, in a Latin-square design. 
 
Because activity was not markedly increased by 10 mg/kg cocaine in mutant mice, 
a second cocaine-locomotor test was performed using a higher cocaine dose. As 
before, mice were habituated to the circular runways for 30 min, removed and then 
injected with cocaine (20 mg/kg i.p.) or vehicle. Activity was recorded for a further 
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60 min post-injection. These two additional tests were separated by 48 h and the 
order of injections (cocaine or vehicle) was counterbalanced. 
 
5.2.4.3 Cocaine-locomotor sensitisation 
Mice received repeated, intermittent injections of 10 mg/kg cocaine at 3-4 day 
intervals over 12 sessions. During each session, mice were habituated to the 
circular runways for 30 min, removed and then injected with cocaine. Activity was 
recorded for a further 60 min post-cocaine injection. 
 
5.2.4.4 Conditioned activity 
Three days after the final sensitisation session, mice were habituated to the 
circular runways for 30 min, removed and then injected with vehicle. Activity was 
recorded for a further 60 min post-vehicle injection. A comparison of activity 
following the post-sensitisation vehicle injection was made with activity following 
the pre-sensitisation (sham) vehicle injection (5.2.4.1). 
 
5.2.4.5 Cocaine-locomotor dose-response (post-sensitisation) 
Mice were habituated to the circular runways for 30 min, removed and then 
injected with cocaine (3, 10 or 20 mg/kg i.p.) or vehicle. Activity was recorded for a 
further 60 min post-injection. Each mouse received each dose, separated by 48 h 
intervals, in a Latin-square design. 
 
5.2.4.6 Cocaine-locomotor dose-response (2 months post-sensitisation) 
Commencing two months after the final post-sensitisation dose-response test, a 
second test was performed (as described 5.2.4.5.) to examine the persistence of 
cocaine-locomotor sensitisation. 
 
5.2.4.7 Statistical Analysis 
All locomotor activity data were first analysed by mixed-factor analysis of variance 
(ANOVA), with genotype (WT, KD) as a between-subjects factor. Details of the 
within-subjects factors used for each ANOVA are provided in the results section. 
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Where significant (p ≤ 0.05) main effects or interaction terms were found, further 
analysis was performed using ANOVA and individual between- or within-genotype 
comparisons by t-test. Findings were considered indicative of a trend where p ≤ 0.1 
and Bonferroni corrections were applied for multiple comparisons. For within-
subjects ANOVA, the Greenhouse-Geisser correction was used where the 
assumption of sphericity was violated (Mauchly‟s test, p ≤ 0.05). 
 
5.2.5 Experiment 2: Conditioned place preference (CPP) 
Procedural note: An equipment malfunction meant that the location of two mutant 
mice from the food CPP study and one wild-type mouse from the cocaine CPP 
study were not recorded during the pre-conditioning session. These mice were 
excluded from further testing, leaving group sizes of n = 10 and n = 9 for WT and 
KD mice, respectively in the food CPP study, and n = 7 and n = 8 for WT and KD 
mice, respectively in the cocaine CPP study. 
 
5.2.5.1 Food CPP 
On day 1 (pre-conditioning), mice were placed into the apparatus and allowed to 
explore all three compartments for 20 min. Mice were then assigned one outer 
compartment (A or B) as food-paired and the other compartment as food-unpaired. 
The assignment of compartments as food-paired or food-unpaired was 
counterbalanced. For the next 8 days (conditioning), mice received access to 20 
mg food pellets (5TUL, Cat no. 1811142; Test Diets, Indiana, USA) presented in a 
small dish in the food-paired compartment, or access to an empty dish in the 
unpaired compartment. Each 30 min, once-daily, conditioning session was 
alternated between food-paired and food-unpaired compartments, but the order of 
exposure to each compartment was counterbalanced. Mice were confined to the 
outer compartment during each conditioning session. On day 10 (post-
conditioning), mice were placed into the apparatus and allowed to explore all three 
compartments for 20 min to determine post-conditioning preference. No food was 
presented during the post-conditioning test. 
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5.2.5.2 Cocaine CPP 
Because data from the food CPP study suggested that baseline compartment 
preference tended to differ between the genotypes, mice for the cocaine CPP 
study were first allowed to explore the entire the apparatus during two, once-daily, 
20 min sessions in an effort to reduce any baseline compartment preference. The 
following day, a 20 min pre-conditioning test of preference was conducted (as 
described above). Mice were then assigned one outer compartment (A or B) as 
cocaine-paired and the other compartment as the vehicle-paired. The assignment 
of compartments as cocaine-paired or vehicle-paired was counterbalanced. For the 
next 8 days (conditioning), mice were injected with 10 mg/kg cocaine or vehicle (10 
ml/kg saline) immediately prior to placement in one compartment (cocaine- or 
vehicle-paired, respectively). Each 30 min, once-daily, conditioning session was 
alternated between cocaine-paired and vehicle-paired compartments, but the order 
of exposure to each compartment was counterbalanced. During each conditioning 
session, mice were confined to the outer compartment. Twenty four hours after the 
final conditioning session, mice were placed into the apparatus and allowed to 
explore all three compartments for 20 min to determine post-conditioning 
preference. No injections were given on the post-conditioning test. 
 
5.2.5.3 Statistical Analysis 
Comparison of pre-conditioning or post-conditioning preference between 
genotypes (that is, time spent in each outer compartment) was performed by 
mixed-factor ANOVA, with genotype (WT, KD) as a between-subjects factor and 
compartment (two levels: A, B or food-paired, food-unpaired or cocaine-paired, 
vehicle-paired) as a within-subjects factor. Compartment preference was also 
indexed by a preference score calculation (post-conditioning time minus pre-
conditioning time) to inform about the change in place preference following 
conditioning. Preference scores were also compared between genotypes by 
mixed-factor ANOVA, with compartment (two levels: food-paired, food-unpaired or 
cocaine-paired, vehicle-paired) as a within-subjects factor. Where significant (p ≤ 
0.05) main effects or interaction terms were found, comparisons of the time spent 
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in either compartment were made by t-test to determine any place preference in 
each genotype. 
 
In both the food- and cocaine-CPP studies, a between-genotype comparison of 
activity in the two outer chambers during pre- and post-conditioning preference 
tests (indexed by beam breaks in the compartments) was performed by mixed-
factor ANOVA, including conditioning (Pre, Post) and compartment (food-paired, 
unpaired or cocaine-paired, vehicle-paired) as a within-subjects factor. For the 
cocaine CPP study, a comparison of activity between genotypes during 
conditioning sessions, following injections of cocaine or vehicle, was performed by 
mixed-factor ANOVA, including conditioning session (1-4) and compartment 
(cocaine-paired, vehicle-paired) as within-subjects factors. Where significant (p ≤ 
0.05) main effects or interaction terms were found, further analysis was performed 
by ANOVA. All figures show mean ± SEM. 
  
206 
 
5.3 Results 
 
5.3.1 Experiment 1: Locomotor activity 
5.3.1.1 Habituation to a novel environment 
The findings for habituation in mGluR5KD-D1 and wild-type mice have been reported 
previously (see Chapter 2, section 2.3.4.1). For the cohort of mice used in the 
present studies, upon exposure to the novel circular runway environment, activity 
(indexed by the distance travelled; m) was greatest during the first 10 min period of 
the 1 h session and declined over each subsequent 10 min period (Fig. 5.2a; main 
effect of Period, F(5,75) = 7.66, p = 0.001; Period x Genotype interaction, NS). 
Notably, activity in KD mice during this first session tended to be reduced in 
comparison to their wild-type counterparts (main effect of Genotype, F(1,15) = 
3.04, p = 0.10). Both genotypes habituated to the apparatus with repeated 
exposure to the runway over five, once-daily, 1 h sessions (Fig. 5.2b). Habituation 
was confirmed by a significant reduction in mean total activity over the five 
sessions (main effect of Session, F(4,60) = 8.57, p < 0.01), in both genotypes 
(main effect of Genotype, NS; Genotype x Session interaction, NS). During the fifth 
session (Fig. 5.2c), activity declined across each 10 min period of the session in 
both genotypes (main effect of Period, F(5,75) = 5.03, p < 0.01; Period x Genotype 
interaction, NS), but there was no overall difference in activity between genotypes 
(main effect of Genotype, NS). 
 
On the sixth day, when mice were given a sham-vehicle injection (Fig. 5.2d), 
activity did not differ between genotypes over the 30 min habituation period (main 
effect of Genotype, NS; Genotype x Period interaction, NS) or the 60 min post-
injection period (main effect of Genotype, NS; Genotype x Period interaction, NS).  
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Figure 5.2 Cocaine-locomotor studies: Habituation and sham-vehicle injection. (a) 
Locomotor activity was reduced in KD mice during the first session. (b) Both 
genotypes habituated to the circular runways over five, once-daily, 1 h sessions. 
(c) Activity did not differ between genotypes over each 10 min period of the fifth 
session. (d) Mice were given a sham-injection (10 ml/kg saline; ▲) after a period of 
30 min in the locomotor apparatus and activity recorded for 1 h post sham-
injection. Activity did not differ between genotypes either pre- or post-sham 
injection. (n = 8/9, WT/KD; except for the 30 min habituation period in the sham 
dose test, where a data collection error resulted in group sizes of n = 6 and n = 7 
for wild-type and mutant mice, respectively).  
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5.3.1.2 Cocaine-locomotor dose-response (pre-sensitisation) 
In the first test, the effect of 0-10 mg/kg cocaine on locomotor activity was 
examined (Fig. 5.3a). Overall activity varied with cocaine dose (main effect of 
Dose, F(3,45) = 2.46, p < 0.05), but the effect of cocaine on activity also varied 
between genotypes (Dose x Genotype interaction, F(3,45) = 3.90, p < 0.05; main 
effect of Genotype, NS). Analysis of activity, for each genotype separately, 
indicated that cocaine increased activity in wild-type mice (main effect of Dose, 
F(3,21) = 10.24, p < 0.001), but not mutant mice (main effect of Dose, NS). Post-
hoc comparisons of activity between each cocaine dose and vehicle confirmed that 
10 mg/kg cocaine significantly increased mean total activity in wild-type mice (t = 
8.46, df = 7, p < 0.017). 
 
In the second test, the effect of 0-20 mg/kg cocaine on locomotor activity was 
examined (Fig. 5.3b). Overall activity varied with dose (main effect of Dose, F(1,15) 
= 51.67, p < 0.001) but the effect of cocaine on activity also tended to vary 
between genotypes (Dose x Genotype interaction, F(1,15) = 4.51, p = 0.051; main 
effect of Genotype, F(1,15) = 3.015, p = 0.10). Individual comparisons of activity 
between cocaine and vehicle confirmed that 20 mg/kg cocaine increased activity in 
wild-type mice (t = -5.47, df = 7, p < 0.01) and mutant mice (t = -4.48, df = 8, p < 
0.01). Post hoc between-genotype comparisons of activity at each dose confirmed 
that the psychomotor activating effects of 20 mg/kg cocaine tended to be 
attenuated in mutant mice (t = 1.96, df = 15, p = 0.069), but activity did not differ 
between genotypes following vehicle (t = 0.102, df = 15, p = 0.92). 
 
The effects of cocaine on locomotor activity were most pronounced immediately 
following injection, as revealed by activity time-course plots (Fig. 5.3d). For brevity, 
analyses of activity time-course data from both dose-response tests are 
summarised in table format (Table 5.1). Notably, the activity profile differed 
between genotypes following 20 mg/kg cocaine (Table 5.1: Test 2 and Fig. 5.3d). 
Subsequent analysis confirmed that activity varied over the post-injection period 
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following 20 mg/kg cocaine in wild-type mice (main effect of Period, F(5,35) = 
15.58, p < 0.001) but not in mutant mice (main effect of Period, NS).  
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Figure 5.3 Cocaine-locomotor dose-response test (pre-sensitisation). (a) 10 mg/kg 
cocaine increased mean total locomotor activity during a 1 h session in wild-type 
mice, but not mutant mice. *p < 0.017, Bonferroni t-test comparison, between 
vehicle and 10 mg/kg cocaine (WT mice only) (b) 20 mg/kg cocaine increased 
mean total activity in both genotypes. The psychomotor stimulating effects of 20 
mg/kg cocaine were attenuated in KD mice. **p < 0.01, Individual t-test 
comparisons between vehicle and 20 mg/kg cocaine. (c-d) Activity time-course 
plots from the second dose-response test. Note the distinct activity profiles 
between mutant and wild-type mice, following 20 mg/kg cocaine (n = 8/9, WT/KD).  
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Time course 
analysis 
Period 
F(5,75) 
Period x Genotype 
F(5,75) 
Genotype 
F(1,15) 
Test 1    
Vehicle 2.19 0.82 4.09§ 
1 mg/kg cocaine 
3 mg/kg cocaine 
1.74 
2.64* 
0.45 
1.75 
0.22 
2.18 
10 mg/kg cocaine 0.91 0.68 2.21 
Test 2    
Vehicle 7.00*** 1.12 0.01 
20 mg/kg cocaine 14.17*** 7.82*** 3.83§ 
 
Table 5.1 ANOVAs for cocaine-locomotor dose-response time-course profiles (pre-
sensitisation). Factors: Period (1-6); Genotype (WT, KD). ***p < 0.001, *p < 0.05, 
§p < 0.10  
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5.3.1.3 Cocaine-locomotor sensitisation 
In both genotypes, mean total activity increased by a similar extent over 12 
sessions of repeated, intermittent cocaine (Fig 5.4a; main effect of Session, 
F(11,165) = 6.12, p < 0.001; Genotype, NS; Session x Genotype interaction, NS). 
Restricting the analysis to the first 10 min period post-cocaine injection (i.e. where 
the locomotor activating effects of cocaine were greatest) also confirmed that 
activity increased in both genotypes to a similar extent over the 12 sessions (Fig. 
5.4b; main effect of Session, F(11,165) = 10.31, p < 0.001; Genotype, NS; Session 
x Genotype interaction, NS). 
 
In order to compare the rate of sensitisation between the two genotypes, linear 
regression analysis was performed for mean total activity data and slope 
coefficients compared between genotypes by t-test. Sensitisation is indicated by a 
positive slope (slope coefficient > 0), and the greater the slope co-efficient, the 
greater the rate of sensitisation (Crombag et al., 1999; Mead et al., 2004). 
Sensitisation was present in wild-type mice (mean slope co-efficient = 7.40 ± 2.38) 
and mutant mice (mean slope co-efficient = 3.30 ± 1.45) and the slope co-efficients 
did not significantly differ between genotypes (t = 1.51, df = 15, p = 0.15).  
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Figure 5.4 Cocaine locomotor sensitisation (a) Repeated, intermittent 10 mg/kg 
cocaine augmented mean total locomotor activity, during 60 min sessions, in both 
WT and KD mice. (b) Activity during the first 10 min period following repeated, 
intermittent 10 mg/kg cocaine is shown. The acute locomotor response to 10 mg/kg 
cocaine, obtained during the dose-response test, is shown in both figures (DR) (n = 
8/9, WT/KD).  
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5.3.1.4 Conditioned activity 
The comparison of activity following the post-sensitisation vehicle injection with 
activity following the pre-sensitisation vehicle injection was restricted to the first 30 
min post-injection because of unstable activity in the pre-sensitisation test at 30-60 
min post-injection (Fig. 5.5a). Mean total activity in this period (Fig. 5.5b) was 
significantly increased following sensitisation (main effect of Sensitisation, F(1,15) 
= 9.64, p < 0.01), and did not differ between genotypes (main effect of Genotype, 
NS; Genotype x Session interaction, NS).  
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Figure 5.5 Conditioned activity in the runways in which cocaine was experienced. 
(a) The complete activity time-course is shown for a session before any cocaine 
was experienced (Pre) and during a session after cocaine sensitisation (post). In 
both sessions, mice were injected with saline (▲) after a 30 min habituation period 
and activity recorded for a further 60 min post-injection. The comparison of activity 
pre- and post-sensitisation was restricted to mean total activity from the first 30 min 
post-injection period (shaded area). (b) In both genotypes, mean total activity 
during the first 30 min period following a post-sensitisation saline injection (Post) 
was increased in comparison to activity during the same period following a pre-
sensitisation saline injection (Pre) (n = 8/9, WT/KD).  
0
20
40
60
WT KD
Pre
Post
Genotype
D
is
ta
n
c
e
 t
ra
v
e
ll
e
d
 (
m
)
0
5
10
15
20
WT
KD
Pre Post
10 min Bin
D
is
ta
n
c
e
 t
ra
v
e
lle
d
 (
m
)
a b
216 
 
5.3.1.5 Cocaine-locomotor dose-response (post-sensitisation) 
Mean total locomotor activity was increased by cocaine (Fig. 5.6a; main effect of 
Dose, F(3,45) = 107.25, p < 0.001) and by a similar extent in both genotypes (main 
effect of Genotype, NS; Genotype x Dose interaction, NS). Post-hoc comparisons 
of activity between each cocaine dose with vehicle confirmed that cocaine 
significantly increased activity at the 10 mg/kg (WT, t = -5.81, df = 7, p < 0.017; KD, 
t = -6.46, df = 8, p < 0.017) and 20 mg/kg (WT, t = -8.68, df = 8, p < 0.017; KD: t = -
8.23, df = 8, p < 0.017) doses. Activity time-course profiles following cocaine and 
vehicle injections were plotted (Fig 5.6b) and, for brevity, analyses of these data 
are summarised in table format (Table 5.2: Time-course analysis). Most notably, 
the effect of acute 20 mg/kg cocaine on locomotor activation was attenuated in 
mutant mice, in comparison to wild-types. 
 
The effect of sensitisation on the acute locomotor response to cocaine was 
examined by comparing activity following post-sensitisation cocaine injections, with 
activity following pre-sensitisation cocaine injections (Fig. 5.6c). This comparison 
was restricted to the activity from the first 10 min post-injection period (i.e. where 
the locomotor stimulating effects of cocaine were greatest) and also included post-
vehicle injection activity, to provide an additional measure of conditioned activity. 
Analyses of these data are summarised in table format (Table 5.2: Pre vs. Post 
analysis). Notably, following sensitisation, activity was significantly increased in 
both genotypes by all cocaine doses (including vehicle). However, at 20 mg/kg 
cocaine, the locomotor stimulating effect of cocaine was attenuated in mutant mice, 
relative to their wild-type counterparts. Subsequent between-genotype 
comparisons confirmed that psychomotor activation following 20mg/kg cocaine 
was attenuated in mutant mice pre-sensitisation (t = 3.93, df = 15, p < 0.01) and 
tended to be attenuated post-sensitisation (t = 1.88, df = 15, p = 0.08). 
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Figure 5.6 Cocaine-locomotor dose-response tests (post-sensitisation). (a) In both 
genotypes, cocaine significantly increased mean total activity at the 10 and 20 
mg/kg doses. *p < 0.017, within-genotype, Bonferroni t-test comparison between 
each cocaine dose and vehicle (b) Time-course plots of activity at each dose. 
There was a trend for an overall reduction in activity in mutant mice at the 20 
mg/kg cocaine dose. (c) In the first 10 min period post-injection, activity was 
significantly increased in both genotypes at all doses after cocaine sensitisation 
(Post), in comparison to the same period before sensitisation (Pre). At the 20 
mg/kg cocaine dose, activity was reduced in mutant mice both pre- and post-
sensitisation. **p < 0.01, §p < 0.10, between-genotype t-test comparisons of activity 
pre- or post- sensitisation.  
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Time-course 
analysis 
Period 
F(5,75) 
Period x Genotype 
F(5,75) 
Genotype 
F(1,15) 
Vehicle 9.69*** 0.73 0.02 
3 mg/kg cocaine 
10 mg/kg cocaine 
39.71*** 
116.91*** 
1.35 
0.99 
0.15 
1.55 
20 mg/kg cocaine 53.65*** 0.94 3.08§ 
Pre vs. Post 
analysis 
Sensitisation 
F(1,15) 
Sensitisation x 
Genotype F(1,15) 
Genotype 
F(1,15) 
Vehicle 16.98*** 0.26 0.87 
3 mg/kg cocaine 45.43*** 0.008 0.66 
10 mg/kg cocaine 216.82*** 1.98 2.72 
20 mg/kg cocaine 43.76*** 0.72 11.1** 
 
Table 5.2 ANOVAs for cocaine-locomotor dose-response tests (post-sensitisation). 
Factors: Period (1-6); Sensitisation (Pre, Post); Genotype (WT, KD). ***p < 0.001, 
**p < 0.01, §p < 0.10  
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5.3.1.6 Cocaine-locomotor dose-response (2 months post-sensitisation) 
Mean total locomotor activity was increased by cocaine (Fig. 5.7a; main effect of 
Dose, F(3,45) = 73.77, p < 0.001), although the effect of cocaine on activity tended 
to vary between genotypes (Dose x Genotype interaction, F(3,45) = 3.17, p = 
0.077). In addition, overall activity was significantly lower in mutant mice than wild-
types (main effect of Genotype, F(1,15) = 5.97, p < 0.05). In both genotypes, post-
hoc comparisons of activity between each cocaine dose with vehicle confirmed that 
cocaine significantly increased activity at the 10 mg/kg (WT, t = -8.22, df = 7, p < 
0.017; KD, t = -6.30, df = 8, p < 0.017) and 20 mg/kg (WT, t = -7.44, df = 8, p < 
0.017; KD: t = -6.22, df = 8, p < 0.017) doses. Individual between-genotype 
comparisons at each dose confirmed that, in comparison to wild-type mice, 
psychomotor activation was significantly attenuated in mutant mice following 
vehicle (t = 2.93, df = 15, p < 0.05) and 20 mg/kg cocaine (t = 2.25, df = 15, p < 
0.05), and tended to be attenuated following 10 mg/kg cocaine (t = 1.97, df = 15, p 
= 0.067). Activity time-course profiles following cocaine and vehicle injections were 
plotted (Fig 5.7b) and, for brevity, analyses of these data are summarised in table 
format (Table 5.3: Time-course analysis). Most notably, the locomotor activating 
effects of 20 mg/kg cocaine were significantly attenuated in mutant mice and 
tended to be attenuated at the 10 mg/kg cocaine dose (Table 5.3: Time-course 
analysis and Fig 5.7b) in comparison to wild-type mice. 
 
The persistence of sensitisation was examined by comparing activity following 2 
month post-sensitisation cocaine injections, with activity following pre-sensitisation 
cocaine injections (Fig 5.7c). This comparison was restricted to the activity from the 
first 10 min post-injection period and also included post-vehicle injection activity, to 
provide an additional measure of conditioned activity. Analyses of these data are 
summarised in table format (Table 5.3: Pre vs. 2 months Post analysis). Notably, 2 
months following repeated cocaine, activity was significantly increased in both 
genotypes at all doses, although this effect was not quite significant in the vehicle 
condition. In comparison to wild-type mice, the locomotor activating effects of 
cocaine were significantly attenuated in mutant mice at the 10mg/kg and 20 mg/kg 
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cocaine doses. Following 10 mg/kg cocaine (Fig. 5.7c) activity in mutant mice was 
attenuated, in comparison to wild-type mice, at 2 months post-sensitisation (t = 
2.21, df = 15, p < 0.05). Following 20 mg/kg cocaine (Fig. 5.7c), activity in mutant 
mice was attenuated, in comparison to wild-type mice, both pre-sensitisation (t = 
3.93, df = 15, p < 0.01) and 2 months post-sensitisation (t = 2.83, df = 15, p < 
0.05).  
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Figure 5.7 Cocaine-locomotor dose-response tests (2 months post-sensitisation). (a) 
Cocaine increased mean total activity in both genotypes, although overall activity was 
reduced in mutant mice. *p < 0.017, within-genotype, Bonferroni t-test comparison 
between each cocaine dose and vehicle (b) Time-course plots of activity at each dose. 
Overall activity was reduced in mutant mice at the vehicle, 10 and 20 mg/kg cocaine 
doses. (c) In the first 10 min period post-injection, activity was increased at all doses after 
cocaine sensitisation (Post), in comparison to the same period before sensitisation (Pre). 
At the 10 and 20 mg/kg cocaine doses, activity was reduced pre and/or 2 months post-
sensitisation in mutant mice, in comparison to wild-types. **p < 0.1, *p < 0.05, between-
genotype t-test comparisons of activity pre- or 2 months post-sensitisation   
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Time-course 
analysis 
Period 
F(5,75) 
Period x 
Genotype F(5,75) 
Genotype 
F(1,15) 
Vehicle 6.55*** 0.26 8.59** 
3 mg/kg cocaine 
10 mg/kg cocaine 
23.38*** 
48.56*** 
0.92 
1.91 
0.42 
3.90§ 
20 mg/kg cocaine 37.43*** 0.59 5.04* 
Pre vs. 2 months 
Post analysis 
Sensitisation 
F(1,15) 
Sensitisation x 
Genotype F(1,15) 
Genotype 
F(1,15) 
Vehicle 3.38§ 1.87 0.39 
3 mg/kg cocaine 31.17*** 0.20 1.15 
10 mg/kg cocaine 91.48*** 3.70§ 5.77* 
20 mg/kg cocaine 40.97*** 0.00 18.19*** 
 
Table 5.3 ANOVAs for cocaine-locomotor dose-response tests (2 months post-
sensitisation). Factors: Period (1-6); Sensitisation (Pre, Post); Genotype (WT, KD). 
***p < 0.001, **p < 0.01, *p < 0.05, §p < 0.10.  
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5.3.2 Experiment 2: Conditioned place preference 
5.3.2.1 Food CPP 
In the 20 min pre-conditioning session, base-line preference for the outer 
compartments (A and B) differed between the two genotypes (Fig. 5.8a; 
Compartment x Genotype interaction; F(1,17) = 5.66, p < 0.05). Mutant mice spent 
significantly more time in compartment A than wild-type mice (t = -2.59, df = 17, p < 
0.05) and, conversely, tended to spend less time in compartment B than their wild-
type counterparts (t = 1.81, df = 17, p = 0.088). However, once these 
compartments had been assigned as food-paired or food-unpaired, there was no 
overall difference in pre-conditioning preference between genotypes (Fig. 5.8b; 
main effect of Compartment, NS; Genotype, NS; Genotype x Compartment 
interaction, NS). 
 
In the 20 min post-conditioning session, mice from both genotypes spent more time 
in the food-paired than the food-unpaired compartment (Fig. 5.8c; main effect of 
Compartment, F(1,17) = 8.13, p < 0.05; Genotype, NS; Genotype x Compartment 
interaction, NS). Subsequent within-genotype comparisons confirmed preference 
for the food-paired compartment, although the effect did not reach statistical 
significance in wild-type (t = 2.15, df = 9, p = 0.06) or mutant (t = 1.89, df = 8, p = 
0.095) mice. Calculating a preference score indicated that, following conditioning, 
the amount of time spent in the food-paired compartment increased while the 
amount of time spent in the food-unpaired compartment decreased in both 
genotypes (Fig. 5.8d; main effect of Compartment; F(1,17) = 15.25, p < 0.01; 
Genotype, NS; Genotype x Compartment interaction, NS). Subsequent within-
genotype comparisons confirmed that, following conditioning, preference for the 
food-paired compartment increased relative to a decrease in preference for the 
food-unpaired compartment, in both wild-type (t = 3.10, df = 9, p < 0.05) and 
mutant (t = 2.45, df = 8, p < 0.05) mice.  
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Figure 5.8 Conditioned place preference for food. (a) During a 20 min test of 
baseline preference (BL), both genotypes spent most time in the outer 
compartments (A and B) than the adjoining middle compartment (Mid). *p < 0.05, 
§p < 0.1, between-genotype t-test comparison of time spent in compartment A or B 
(b) Prior to conditioning (Pre), there was no between genotype difference in the 
time spent in each compartment assigned as food-paired (Food) or food-unpaired 
(Non) (c) Post-conditioning (Post), both genotypes spent more time in the food-
paired compartment, than the food-unpaired. §p < 0.10, within-genotype t-test 
comparisons of time spent in the food-paired and unpaired compartments. (d) The 
preference score (post-conditioning time minus pre-conditioning time) shows that 
time in the food-paired compartment increased, while time in the food-unpaired 
context decreased, following conditioning. *p < 0.05, within-genotype t-test 
comparisons of food-paired and unpaired preference scores (n = 10/9, WT/KD).  
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In both genotypes, post-conditioning activity in the food-paired compartment was 
increased in comparison to post-conditioning activity in the food-unpaired 
compartment (Fig. 5.10a). An initial analysis of activity during pre- and post-
conditioning preference tests, in both genotypes, revealed only that activity in the 
compartments varied with conditioning (Conditioning x Compartment interaction, 
F(1,17) = 18.29, p = 0.001), and further ANOVAs were performed to explore this 
effect. First, analysis of pre-conditioning activity in the two compartments in both 
genotypes confirmed that activity in the compartments did not differ depending 
upon the compartment identity (main effect of Compartment, NS), nor between 
genotypes (main effect of Genotype, NS; Genotype x Compartment interaction, 
NS). A similar analysis of post-conditioning activity confirmed that activity was 
greater in the food-paired compartment (main effect of Compartment, F(1,17) = 
6.93), p < 0.05) and to a similar extent in both genotypes (main effect of Genotype, 
NS; Genotype x Compartment interaction, NS). 
 
5.3.2.2  Cocaine CPP 
In the 20 min pre-conditioning session, there was no overall base-line preference 
for the two outer compartments (A and B) in either genotype (Fig. 5.9a; main effect 
of Compartment, NS; Genotype, NS; Genotype x Compartment interaction, NS). 
Once the outer compartments had been assigned as cocaine- or vehicle-paired, 
there was a tendency for an overall pre-conditioning preference for the cocaine-
paired compartment (Fig. 5.9b; main effect of Compartment, F(1,13) = 3.85, p = 
0.072; Genotype, NS; Genotype x Compartment interaction, NS). However, 
subsequent within-genotype comparisons did not identify a significant pre-
conditioning preference for the cocaine-paired compartment in either wild-type (t = 
1.81, df = 6, p = 0.12) or mutant (t = 0.71, df = 7, p = 0.50) mice. 
 
In the 20 min post-conditioning session, mice from both genotypes spent more time 
in the cocaine-paired compartment than the vehicle-paired compartment (Fig. 5.9c; 
main effect of Compartment, F(1,13) = 21.60, p < 0.001; Genotype, NS; Genotype 
x Compartment interaction, NS). Subsequent within-genotype comparisons 
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confirmed significant preference for the cocaine-paired compartment in both wild-
type (t = 3.20, df = 6, p < 0.05) and mutant (t = 3.37, df = 7, p < 0.05) mice. 
Calculating a preference score indicated that, following conditioning, the amount of 
time spent in the cocaine-paired compartment increased while the amount of time 
spent in the vehicle-paired compartment decreased in both genotypes (Fig. 5.9d; 
main effect of Compartment; F(1,13) = 10.71, p < 0.01; Genotype, NS; Genotype x 
Compartment interaction, NS). Subsequent within-genotype comparisons 
confirmed that, following conditioning, preference for the cocaine-paired 
compartment increased relative to a decrease in preference for the vehicle-paired 
compartment, in mutant mice (t = 3.26, df = 7, p < 0.05) but not wild-type mice (t = 
1.51, df = 6, p = 0.18). 
 
In both genotypes, post-conditioning activity in the cocaine-paired compartment 
was increased in comparison to post-conditioning activity in the vehicle-paired 
compartment (Fig. 5.10b). An initial analysis of activity during pre- and post-
conditioning preference tests, in both genotypes, revealed that activity in the 
compartments varied with conditioning (Conditioning x Compartment interaction, 
F(1,13) = 10.75, p < 0.01), and further ANOVA were performed to explore this 
effect. First, analysis of pre-conditioning activity in the two outer compartments in 
both genotypes confirmed that activity in the compartments did not differ 
depending upon the compartment identity (main effect of Compartment, NS), nor 
between genotypes (main effect of Genotype, NS; Genotype x Compartment 
interaction, NS). A similar analysis of post-conditioning activity confirmed that 
activity was greater in the cocaine-paired compartment (main effect of 
Compartment, F(1,13) = 14.57, p < 0.01) and to a similar extent in both genotypes 
(main effect of Genotype, NS; Genotype x Compartment interaction, NS).  
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Figure 5.9 Conditioned place preference for cocaine. (a) During a 20 min test of 
baseline (BL) preference, both genotypes spent most time in the outer 
compartments (A and B) than the adjoining middle compartment (Mid) (b) Prior to 
conditioning (Pre), there was no significant genotype difference in the time spent in 
compartments assigned as cocaine-paired (Coc) or vehicle-paired (Veh) (c) Post-
conditioning (Post), both genotypes spent more time in the cocaine-paired than the 
vehicle-paired compartment. *p < 0.05, within-genotype t-test comparisons of time 
spent in the cocaine-paired and vehicle-paired compartments (d) The preference 
score (post-conditioning time minus pre-conditioning time) shows that time in the 
cocaine-paired compartment increased, while time in the vehicle-paired 
compartment decreased, following conditioning. *p < 0.05, within-genotype t-test 
comparison of cocaine-paired and vehicle-paired preference scores (n = 7/8, 
WT/KD).  
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Figure 5.10 Activity during pre- and post-preference tests for the food and cocaine 
CPP studies. (a) For food CPP, in the post-conditioning test of preference (Post), 
activity in both genotypes was greater in the food-paired compartment (Food) than 
the food-unpaired compartment (Non), in both genotypes. Activity in the pre-
conditioning test of preference (Pre) did not significantly differ between genotypes 
or compartments (n=10/9, WT/KD). (b) For cocaine-CPP, activity in the post-
conditioning test of preference (Post) was greater in the cocaine-paired 
compartment (Coc) than the vehicle-paired compartment (Veh), in both genotypes. 
Activity in the pre-conditioning test of preference (Pre) did not significantly differ 
between genotypes or compartments (n = 7/8, WT/KD).  
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Activity in the cocaine and vehicle-paired compartments was also recorded over 
the eight 30 min conditioning sessions (Fig. 5.11). Overall activity was higher in the 
cocaine-paired compartment in both wild-type mice (main effect of Compartment, 
F(1,6) = 13.19, p < 0.05) and mutant mice (main effect of Compartment, F(1,7) = 
69.23, p < 0.001). In addition, the profile of activity in the two outer compartments 
differed over conditioning sessions in mutant mice (Compartment x Session 
interaction, F(3,21) = 7.12, p < 0.05), but not wild-type mice (Compartment x 
Session interaction, NS). In mutant mice, activity in the cocaine-paired 
compartment increased over conditioning sessions (main effect of Session, F(3,21) 
= 6.83, p < 0.05), while activity in the vehicle-paired compartment did not change 
(main effect of Session, NS).  
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Figure 5.11 Activity during conditioning sessions in the cocaine CPP study. In both 
genotypes, overall activity (indexed by interruptions of two infra-red beams located 
in each compartment) was higher in the cocaine-paired (Coc) than the vehicle-
paired compartment (Veh). In mutant mice, activity in the cocaine-paired 
compartment increased over conditioning sessions while activity in the vehicle-
paired compartment did not change. In wild-type mice, activity in both 
compartments did not significantly change over the course of conditioning (n = 7/8, 
WT/KD)  
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5.4 Discussion 
 
The present data indicate that knock-down of mGluR5, on cells that receive 
dopaminergic input via D1Rs, results in a marked attenuation of the acute 
psychomotor activating effects of cocaine. However, repeated intermittent cocaine 
does induce behavioural sensitisation in mGluR5KD-D1 mice that persists for at least 
two months after the final cocaine injection. In the CPP studies, mGluR5KD-D1 mice 
showed preference for an environment paired with food availability and non-
contingent cocaine, indicating that mGluR5 on dopaminoceptive neurons are not 
required for learning about natural or drug rewards that supports place preference. 
 
As reported previously (Chapter 2), mGluR5KD-D1 mice showed reduced activity in a 
novel environment, relative to wild-type mice, which is in agreement with studies 
showing that the mGluR5 antagonist MPEP reduces spontaneous locomotor 
activity in rats (Spooren et al., 2000a; Herzig and Schmidt, 2004), but does 
contrast with spontaneous hyperlocomotion reported in mGluR5 knock-out mice 
(Bird et al., 2010; Olsen et al., 2010). Notably, the group I mGluR agonist (S)-
DHPG elevated motor activity after micro-injection into either the VTA or NAcc 
(Swanson and Kalivas, 2000) and, in the NAcc, the group I mGluR antagonist S-4-
CPG prevented increases in locomotor activity produced by the D1-like receptor 
agonist SKF 38393, while having no effect when injected alone (David and Abraini, 
2001). In contrast, S-4-CPG had no effect on locomotor responses produced by 
the selective D2-like receptor agonist LY17155 (David and Abraini, 2001). Taken 
together, our data with mGluR5KD-D1 mice provides further evidence that 
spontaneous activity in a novel environment may require the integrity of dopamine 
and glutamate signalling on neurons that project monosynaptically to the 
substantia nigra pars reticulata (SNr) and which constitute the „direct‟ striatonigral 
pathway (Alexander and Crutcher, 1990). 
 
A critical finding in the present series of experiments was that the acute locomotor 
activating effects of cocaine were attenuated in mGluR5KD-D1 mice, both before and 
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following the induction of sensitisation. The psychomotor effects of stimulants are 
often strongly dependent on the novelty of the environment in which the stimulant 
drug was administered (Badiani et al., 1995), and perhaps the decreased 
locomotor response of mGluR5KD-D1 mice to acute cocaine was due, in part, to the 
reduced response to the novelty of the test environment. Although mutant mice 
were thoroughly habituated to the apparatus before the cocaine-locomotor dose-
response test was conducted, differences in baseline locomotor activity were still 
occasionally apparent between mGluR5KD-D1 and wild-type mice (for example, Fig 
5.7a, but see Fig. 5.3b & 5.6a), suggesting that an interaction between the drug 
and environment could contributing to differences in the locomotor activating 
effects of cocaine between genotypes. It would certainly be of interest to examine 
the effect of cocaine in mGluR5KD-D1 mice while situated in their home cages. 
Against this general idea is the finding that mGluR5 knockout mice are hyper-
responsive in a novel environment, yet show a blunted locomotor response to 
acute cocaine (Chiamulera et al., 2001; Olsen et al., 2010), indicating that mGluR5 
may be integral for the acute psychomotor activating effects of cocaine. 
 
The locomotor activating effects of psychostimulants, such as cocaine, are typically 
attributed to their enhancement of dopamine neurotransmission in mesolimbic 
brain regions (Swerdlow et al., 1986; Delfs et al., 1990; Neisewander et al., 1995; 
Giros et al., 1996). There is much evidence to suggest that striatal mGluRs, 
including mGluR5, interact with dopamine to regulate the locomotor response to 
stimulant drugs (Meeker et al., 1998; Verma and Moghaddam, 1998). For example, 
although systemic MPEP is without effect on basal extracellular striatal dopamine 
(Golembiowska et al., 2003; Tronci and Balfour, 2011), it can block increases in 
extracellular striatal dopamine produced by nicotine (Tronci and Balfour, 2011). It is 
also noteworthy that extracellular striatal dopamine is increased by intra-striatal 
infusions of MPEP (Golembiowska et al., 2003), but not by a group I mGluR 
agonist (Hu et al., 1999; although see Canales et al., 2003). Taken together, these 
data might suggest that loss of mGluR5 on striatal D1-MSNs may result in altered 
dopaminergic transmission in response to psychostimulants which, in turn, results 
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in a reduction of locomotor activity. Although glutamate spillover from corticostriatal 
synapses can depress DA transmission, this effect is most likely attributable to pre-
synaptic group I mGluR receptors (Zhang and Sulzer, 2003). How loss of (post-
synaptic) mGluR5 on D1R expressing neurons may translate to disrupted 
dopaminergic signalling in response to psychostimulants at a synaptic level is not 
clear but, at a network level, could involve altered input of GABAergic MSNs onto 
the ventral midbrain. 
 
In addition to elevating extracellular striatal dopamine, cocaine also results in 
elevated glutamate in the ventral striatum (Smith et al., 1995; Reid and Berger, 
1996; Reid et al., 1997; Zhang et al., 2001) and block of glutamate receptors in the 
NAcc disrupts the acute locomotor activating effects of psychostimulants (Pulvirenti 
et al., 1989, 1991). Although mGluR5 is typically located post-synaptically on 
MSNs in the striatum (Tallaksen-Greene et al., 1998), it can influence pre-synaptic 
glutamate release (Thomas et al., 2001a) through retrograde endocannabinoid 
signalling (Robbe et al., 2001). Thus, in addition to the potential for disrupted 
dopaminergic transmission in mGluR5KD-D1 mice, loss of mGluR5 in MSNs may 
have also translated to disrupted glutamatergic transmission in response to 
cocaine. Further studies (for example, microdialysis or voltammetry) are required to 
directly test whether the (pre-synaptic) dopaminergic and/or glutamatergic 
response to cocaine is attenuated in mGluR5KD-D1 mice, but it is interesting to note 
that mGluR5 knockout mice show elevations in cocaine induced extracellular 
striatal dopamine that are comparable to wild-type mice (Chiamulera et al., 2001), 
which perhaps favours a glutamatergic dysregulation account. 
 
Finally, a third, but not entirely incongruent hypothesis that could explain the 
attenuated psychomotor response to cocaine in mGluR5KD-D1 mice comes from 
recognising that the locomotor activating effects of psychostimulants typically 
require a substantial D1-like receptor, but not D2-like receptor component 
(Moratalla et al., 1996a; Fritts et al., 1997; Badiani et al., 1999; O'Neill and Shaw, 
1999; Kim et al., 2001). As mentioned above, intra-NAcc antagonism of group I 
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mGluRs alters motor responses arising from stimulation of NAcc D1-like receptors, 
but not D2-like receptors (David and Abraini, 2001), but also suppresses the acute 
locomotor activating effects of intra-NAcc amphetamine (David and Abraini, 2003). 
When our present data with mGluR5KD-D1 mice are placed in the context of these 
reports, there is compelling evidence to propose that the acute locomotor activating 
effects of cocaine are critically dependent upon the (post-synaptic) interaction of 
mGluR5 with D1-like, but not D2-like receptors on striatonigral MSNs. 
 
With repeated intermittent cocaine infusions the locomotor response (measured by 
distance travelled) to cocaine was augmented in both genotypes. Thus, mGluR5KD-
D1 mice did show behavioural sensitisation to cocaine. This finding is surprising on 
a number of accounts. First, a role of mGluR5 in the induction and expression of 
cocaine sensitisation has been demonstrated using an mGluR5 antagonist 
(Kotlinska and Bochenski, 2009; Veeneman et al., 2010) (but see, Dravolina et al., 
2006). Second, the role of glutamate transmission through ionotropic NMDA and 
AMPA receptors in the induction and expression of psychostimulant sensitisation is 
well established (e.g. Karler et al., 1989; Karler et al., 1990; Karler et al., 1991; 
Kalivas and Alesdatter, 1993; Stewart and Druhan, 1993) and mutation of NMDA 
on D1R expressing neurons (i.e. non-dopaminergic neurons) prevents the 
induction of cocaine sensitisation (Heusner and Palmiter, 2005), while knock-out of 
NMDA on dopaminergic neurons is without effect (Engblom et al., 2008). Because 
mGluR5 can powerfully modulate NMDA-mediated responses (Pisani et al., 2001) 
and can also influence AMPA receptor expression (Zhang et al., 2008), these 
reports would predict that mGluR5, particularly on D1R expressing neurons, should 
play a role in behavioural sensitisation. Finally, the propensity to to attribute 
incentive salience to environmental stimuli associated with reward experience has 
been associated with susceptibility to behavioural sensitisation (Flagel et al., 2008). 
Thus, given clear incentive learning deficits in mGluR5KD-D1 mice (Chapter 3), 
impaired behavioural sensitisation might have been expected. 
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Could it be that the experimental design in the present study was not sufficient for 
detecting differences in sensitisation between genotypes? Locomotor activity is 
often considered as a relatively insensitive indicator of behavioural sensitisation 
(Ferrario et al., 2005; Flagel and Robinson, 2007; Flagel et al., 2008) and it would 
be valuable to examine more detailed motor behaviours in mice during the 
induction of sensitisation, such as stereotypy, rearing or head bobbing (Tolliver and 
Carney, 1994). In addition, it has been proposed that the relative degree of 
sensitisation (that is, the change in activity over sessions) may be a critical 
measure of neurobehavioural plasticity, rather than whether or not a drug produces 
sensitisation per se (Ferrario et al., 2005; Flagel and Robinson, 2007; Flagel et al., 
2008). The degree of sensitisation was lower in mGluR5KD-D1 mice (see 
comparison of slopes over sessions 1-11), but did not significantly differ from wild-
type mice. However, it was clear that a robust sensitised response was seen in 
both genotypes following the first 10mg/kg cocaine injection of the sensitisation 
test, indicating that exposure to the cocaine-locomotor dose-response test had 
produced some neural adaptations necessary for supporting sensitisation. Thus, 
the comparison of slopes in the present study was unable to take into account the 
initial induction period of sensitisation. Thus, while the present data suggest no 
differences in behavioural sensitisation between genotypes, additional studies are 
warranted to assure this finding. 
 
Sensitisation involves both unconditioned drug effects on motor activity and 
conditioned responses to the context in which the animals receive the drug (Pert et 
al., 1990; Crombag et al., 1996; Stephens, 2006). Thus, the environment in which 
the drug was experienced can act as a CS, causing behavioural activation even in 
the absence of the drug (Stewart, 1983). In the present report, conditioned activity 
was observed in both genotypes, and to a similar extent, when mice were injected 
with saline and placed into the runway in which cocaine had previously been 
experienced. A potential confound of the conditioned activity test is that 
conditioned activity was determined by comparing activity in the chambers after 
cocaine had been experienced with activity in the same animals, but before 
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cocaine was first experienced (i.e. activity in the sham vehicle injection session). It 
could be conditioned activity was simply a reflection of a sensitised stress 
response as a result of repeated injections in the runway, rather than due to 
acquired associations between the runway and the effects of cocaine. Although 
this possibility cannot be ruled out, it seems unlikely given that repeated injections 
failed to give rise to hyperlocomotion during the four saline conditioning trials in the 
CPP test. 
 
The second series of experiments examined food- and cocaine-CPP. In both CPP 
tests, mutant mice displayed preference for the environment previously associated 
with the reward. Thus, mGluR5 on D1R expressing neurons is not necessary for 
learning that supports performance in the place preference test. But, what learning 
is required to support place preference? The ability of the paired context to 
generate approach behaviour in a CPP test of preference could reflect any number 
of distinct psychological processes (Robbins and Everitt, 2002). Contextual stimuli 
may acquire the ability to elicit simple Pavlovian approach (i.e. sign-tracking) 
responses (Tomie, 1996; Krank, 2003; Mead et al., 2005; Cunningham and Patel, 
2007), or may act as conditioned reinforcers that strengthen the instrumental 
locomotor response of approaching and contacting the paired compartment during 
the CPP choice test (Everitt et al., 1991). Alternatively, the reward associated 
stimuli may acquire incentive motivational properties that energize the sign-tracking 
response or the instrumentally reinforced approach response. Indeed, despite CPP 
being described as a measure of conditioned reward, it is plausible that incentive 
learning is not required for CPP and the reward-paired compartment simply acts as 
a predictor of reward availability. Any or all of these processes may be contributing 
to the development and expression of place preference, and deficits in any one 
learning strategy may be compensated for by another. Nevertheless, that food- and 
cocaine-CPP are normal in mGluR5KD-D1 mice suggests that incentive learning 
necessary for CRf and sign-tracking is not necessary for performance in the CPP 
choice test. This proposal garners some support from studies identifying distinct 
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neuronal nodes involved in the reconsolidation of CPP and CRf related memories 
(Theberge et al., 2010). 
 
A potential concern over the CPP paradigm is that, since animals typically prefer a 
novel context over a familiar one (Hughes, 1968), place preference may be 
influenced by novelty exploration during the choice test. This may occur in one of 
two ways. First, in the three-compartment CPP procedure used in the present 
report, the middle choice compartment remains relatively novel as animals are only 
exposed to this compartment during tests of preference. Exploration of the central 
compartment during a test of preference may further enhance food- or drug-CPP, 
by reducing time spent in the relatively less novel unpaired compartment, whilst 
having less of an effect on time spent in the reward-paired compartment (Bardo et 
al., 1995). In the current CPP studies, preference was determined by comparing 
time spent in the two outer compartments, and it is plausible that exploration of the 
central compartment differentially contributed to place preference seen in both 
genotypes. However, in both CPP tests, a comparison of time spent in the middle 
compartment before and after conditioning failed to find any significant difference 
between genotypes (data not shown), indicating that enhanced exploration of the 
middle compartment did not contribute to CPP in the present studies. Second, an 
argument based on state-dependency, would propose that the drug-paired 
compartment is more novel on the test day because the compartment is 
experienced in a drug-free state. Although this account cannot be ruled out in the 
present study, since we did not look at preference when animals were in a drugged 
state, other studies have shown that animals prefer the drug-paired compartment 
regardless of whether they are tested with or without drug (Mucha and Iversen, 
1984), which provides some evidence to discount this novelty effect. 
 
In the cocaine CPP study, preference for the cocaine-paired compartment was not 
particularly robust in wild-type mice when assessed using a preference score (that 
is, post- minus pre- conditioning preference). This study used a non-biased CPP 
design, in which no preference for either outer compartment existed prior to, or 
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following the assignment of compartments as cocaine-paired or vehicle-paired. 
However, a small (albeit non-significant) bias for the cocaine-paired compartment 
was present in wild-type mice during the pre-conditioning test. A pre-conditioning 
bias may influence the development of CPP in two ways. First, a “motivational 
interaction hypothesis” would suggest that a drug interacts with some 
unconditioned motivational state reflected in the initial compartment bias 
(Cunningham et al., 2003). Thus, a drug might support CPP by reducing „fear‟ 
associated with a non-preferred environment or, conversely, potentiate the 
motivational value of a preferred environment (Schenk et al., 1985; Cunningham et 
al., 2003). Second, pairing a drug with an initially non-preferred compartment may 
simply provide a greater window to measure CPP and, conversely, pairing the drug 
with an initially preferred compartment may obscure any conditioning properties of 
the drug due to a ceiling effect (Cunningham et al., 2003). This second idea seems 
more probable in explaining the weak cocaine CPP in wild-type mice, when 
assessed by calculation of a preference score, since CPP was clearly robust when 
comparing only post-conditioning preference between the vehicle- and cocaine-
paired compartments.  
 
One advantage of the CPP apparatus used here is that locomotor activity during 
preference tests and conditioning trials can be measured. Confirming findings from 
the cocaine behavioural sensitisation study, mutant mice displayed a sensitised 
locomotor response to cocaine over conditioning trials. Cocaine did augment 
locomotor activity in wild-type mice, but did not produce locomotor sensitisation 
over conditioning trials. It is unlikely that the lack of robust sensitisation in wild-type 
mice explains the weak cocaine-CPP in these animals, since locomotor 
sensitisation and CPP can be considered as dissociable phenomena (Shimosato 
and Ohkuma, 2000). During the food-CPP study, activity tended to be reduced in 
the food-paired compartment relative to the food-unpaired compartment during 
conditioning trials in both genotypes (data not shown), which probably reflects the 
occurrence of food consumption competing with exploratory behaviour during 
these conditioning trials. It is also important to note that, in both genotypes, post-
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conditioning activity in the cocaine-paired and food-paired compartments was 
increased in comparison to the non-reward-paired compartments. These data 
confirm and extend the findings of the cocaine conditioned activity study above by 
demonstrating that both a food and cocaine-paired environment can stimulate 
conditioned activity in mGluR5KD-D1 mice in a manner indistinguishable from wild-
type mice. 
 
Although a role for glutamate signalling through ionotropic NMDA and AMPA 
receptors in the acquisition and/or expression of cocaine-CPP has been 
established (e.g. Cervo and Samanin, 1995), previous studies exploring the role of 
mGluR5 in conditioned drug reward using MPEP have produced conflicting results. 
Thus MPEP has been found to reduce the acquisition of cocaine CPP in rats in one 
study (McGeehan and Olive, 2003), but not in another (Herzig and Schmidt, 2004). 
These findings may be explained, in part, by the intrinsic reinforcing properties of 
MPEP producing drug-substitution like effects (van der Kam et al., 2009b, a; 
Rutten et al., 2010). Our data with mGluR5KD-D1 mice indicate that mGluR5 on D1R 
expressing neurons are not necessary for learning that supports cocaine-CPP and 
this result is in agreement with a recent study using mGluR5 KO mice in which 
cocaine CPP was normal (Olsen et al., 2010). It has been proposed that loss of 
mGluR5 may potentiate the rewarding properties of (Rutten et al., 2010) or 
increase behavioural sensitivity to (Bird et al., 2008) some addictive drugs. Our 
cocaine-CPP study does not exclude the possibility that cocaine reward is 
potentiated in mGluR5KD-D1 mice (i.e. a leftward-shift of the minimal effective dose 
required to induce CPP). However, it is worthwhile noting that in a self-
administration preparation the fixed-ratio cocaine dose-response profile in 
mGluR5KD-D1 mice is indistinguishable from wild-type mice (Novak et al., 2010), 
suggesting that mGluR5KD-D1 mice do not show enhanced sensitivity to the primary 
reinforcing effects of cocaine. 
 
Finally, our findings do not exclude the possibility that mGluR5 on D1R expressing 
neurons may be involved in other behavioural effects of cocaine. For example, this 
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population of mGluR5 could contribute to extinction learning in the CPP paradigm 
(but not extinction of instrumental responding; Novak et al., 2010), or the 
reinstatement of CPP. Some evidence for this first hypothesis comes from 
appreciating the importance of glutamate in extinction learning. Thus, 
enhancement of glutamate transmission with an NMDA partial agonist (D-
cycloserine) can facilitate the extinction of conditioned fear and drug-associated 
memories (Botreau et al., 2006; Davis et al., 2006). In mice lacking GluR1 or NR1 
selectively in dopamine neurons, both cocaine CPP and sensitisation was normal, 
but extinction of cocaine CPP and reinstatement of CPP by cocaine were 
abolished in GluR1DATCre and NR1DATCre mice, respectively (Engblom et al., 2008). 
Similarly, GluR1 knock-out mice show extinction deficits, despite normal cocaine 
self-administration (Mead and Stephens, 2003b) and viral over-expression of 
GluR1 and GluR2 in the NAcc facilitates extinction learning (Sutton et al., 2003). 
Because mGluR5 is closely linked to NMDA and AMPA (see discussion above), it 
would seem plausible that activation of mGluR5 could facilitate the extinction of 
cocaine-CPP memories. In addition, knock-out of neuronal activity regulated 
pentraxin (NARP), a neuronal IEG that encodes a secreted protein which may 
influence AMPA trafficking or clustering (O'Brien et al., 1999), also interferes with 
inhibitory learning necessary for extinction, but does not disrupt the initial 
acquisition of a conditioned association (Crombag et al., 2009). This observation is 
interesting with respect to this thesis, since neuronal pentraxins play a necessary 
role in LTD induced by group I mGluR stimulation (Cho et al., 2008). More direct 
evidence for a role of mGluR5 in extinction learning comes from a recent study by 
Gass and Olive (2009), who demonstrated that a positive allosteric modulator of 
mGluR5, CDPPB, facilitated extinction of cocaine-CPP. This effect was reversed 
by MTEP and MK801, suggesting a contribution of both mGluR5 and NMDA 
receptors. The authors noted that the neuroanatomical regions that mediate these 
effects are not clear, but likely include the infra-limbic prefrontal cortex (Zavala et 
al., 2003; Hsu and Packard, 2008), BLA (Fuchs et al., 2002) or hippocampus 
(Meyers et al., 2003), given the role of these structures in extinction learning, 
stimulus-reward learning and drug-context associations in CPP, respectively. It 
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would be of great interest to examine extinction learning in mGluR5KD-D1 mice to 
further probe the potential neuroanatomical location of mGluR5 involved in this 
effect. 
 
In summary, the present study identifies an important role of mGluR5 on neurons 
that receive dopamine input in the acute psychomotor activating effects of cocaine. 
In contrast, this population of mGluR5 is not required for neuroplastic changes that 
support learning about cocaine conditioned reward, measured by CPP, and are not 
necessary for cocaine sensitisation. However, this latter finding should be 
interpreted with caution given the potential for differences in the degree of 
sensitisation to be revealed using more sensitive measures of motor activity. 
Whether the reduced locomotor effects of cocaine can be ascribed to altered pre-
synaptic glutamate and/or dopamine transmission in the striatum and/or disrupted 
output of neurons that constitute the direct nigrostriatal pathway remains to be 
determined. However, psychostimulants, such as cocaine are known to produce 
robust neurochemical changes in the striatum (Reith et al., 1986; Di Chiara and 
Imperato, 1988; Reid et al., 1997), which in turn lead to the induction of post-
synaptic signalling cascades (Graybiel et al., 1990; Young et al., 1991; Valjent et 
al., 2005). If mGluR5KD-D1 mice have impaired regulation of pre- or post-synaptic 
signalling in the striatum, then this may be revealed by examining activation of 
intra-cellular signalling cascades in this brain region in response to acute cocaine 
challenge. This possibility will be explored in the next and final experimental 
chapter. 
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6 Some neurobiological effects of cocaine in 
mGluR5KD-D1 mice 
 
6.1 Introduction 
 
The most notable finding of the previous chapter was that the acute psychomotor 
activating effects of cocaine were significantly attenuated in mice lacking mGluR5 
on cells that receive dopamine input via D1Rs. If some behavioural effects of 
cocaine, which involve glutamate and dopamine signalling in the striatum, are 
diminished, it may be expected that some neurobiological effects of cocaine in the 
striatum are also disrupted in mutant mice. The following experiments will explore 
the ability of acute cocaine to produce rapid changes in synaptic function in the 
striatum and to activate an intracellular signalling cascade in striatal MSNs, which 
may be required for cocaine to produce long lasting changes in synaptic structure 
and function.  
 
As stated in the preceding chapter, cocaine, like many addictive drugs, can 
increase levels of extracellular dopamine and glutamate in the accumbens (Di 
Chiara and Imperato, 1988; Reid et al., 1997; McKee and Meshul, 2005). Elevated 
dopamine and glutamate can augment locomotor activity (Kelly et al., 1975; Clarke 
et al., 1988; Delfs et al., 1990) and trigger intracellular signalling cascades in MSNs 
and alter the expression of immediate early genes (IEGs) (Young et al., 1991; 
Hope et al., 1992; Moratalla et al., 1993; Berke et al., 1998; Valjent et al., 2000). 
Some of these IEGs encode transcription factors (for example, c-fos, JunB, zif268) 
that may be associated with long lasting changes in synaptic structure and function 
(Bai and Kusiak, 1997; Thomas et al., 2003; Kim et al., 2009; Ren et al., 2010). 
Since MSNs provide the sole striatal output to motivational and motor systems 
(Goto and Grace, 2008), cocaine-induced adaptations in these neurons are likely 
to be of considerable importance for the development and maintenance of 
behavioural responses related to addictive processes (Berke and Hyman, 2000). 
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The mitogen-activated protein kinase/extracellular signal-regulated kinase 
(MAPK/ERK) pathway is a major effector of signal transduction from the neuronal 
cell surface to the nucleus (Grewal et al., 1999; Valjent et al., 2001; Adams and 
Sweatt, 2002) and may be a critical component enabling drug-induced adaptations 
in striatal MSNs (Girault et al., 2007). Inactive ERK1 (44KDa) and ERK2 (42KDa) 
are found mainly in somatic and dendritic compartments of neurons (Ortiz et al., 
1995). Activated ERKs can phosphorylate a wide range of substrates within the 
cytoplasm, including membrane associated proteins such as EGF receptors, 
phospholipase A2 and cytoskeletal proteins, including microtubule associated 
proteins and neurofilaments (Grewal et al., 1999). In this way, ERKs can contribute 
to rapid changes in synaptic efficacy that underlie the induction of plasticity and 
short term memory formation. Activated ERKs can also translocate to the nucleus 
(Chen et al., 1992) and phosphorylate major transcriptional regulators, including 
ELK-1 and CREB (cyclic AMP response element binding protein), which bind to 
promoters SRE (serum response elements) and/or CRE (cAMP-response 
elements) of IEGs (Sgambato et al., 1998; Vanhoutte et al., 1999; Davis et al., 
2000; Choe and McGinty, 2001; Valjent et al., 2001; Choe et al., 2002; Mattson et 
al., 2005; Radwanska et al., 2005; Valjent et al., 2005). This ERK1/2-mediated 
burst of gene transcription likely drives long term changes in synaptic function 
necessary for establishing and maintaining long term memories (Adams and 
Sweatt, 2002; Mazzucchelli et al., 2002; Selcher et al., 2002; Sweatt, 2004). 
 
In striatal MSNs, one well characterised mechanism of ERK1/2 control involves 
convergent dopamine and glutamate signalling at D1Rs and NMDARs, 
respectively, and co-operative intracellular signalling pathways (Valjent et al., 2000; 
Valjent et al., 2005; Pascoli et al., 2011). One pathway involves a D1R-PKA 
mediated inhibition of PP-1, requiring phosphorylation of DARPP-32 at Thr-34 and 
resulting in de-phosphorylation of STEP46, thus preventing de-phosphorylation of 
ERKs (Valjent et al., 2005). This first pathway likely potentiates activity in a second 
pathway of ERK1/2 control that requires NMDAR-Ca2+-Ras mediated activation of 
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MEK, resulting in activation of ERKs by phosphorylation at Thr202 and Tyr204 
residues (Valjent et al., 2005; Pascoli et al., 2011). The requirement for both 
dopamine and glutamate signalling for ERK1/2 activation points to this pathway as 
a key element in plasticity of striatal neurons triggered by activity of glutamatergic 
neurons encoding behavioural choice and stimulus properties (Kalivas and Volkow, 
2005) together with dopaminergic signals providing reward error prediction signals 
(Schultz et al., 1997) and/or influencing attention (Mackintosh, 1975; Roesch et al., 
2010). Given that psychostimulants strongly activate ERK1/2 the striatum (Choe et 
al., 2002; Rajadhyaksha et al., 2004; Valjent et al., 2004; Zhang et al., 2004) with 
resultant induction of IEGs (Valjent et al., 2000; Choe et al., 2002; Salzmann et al., 
2003; Zhang et al., 2004; Brami-Cherrier et al., 2005), the ERK1/2 pathway would 
also appear critical for influencing transcriptional regulation proposed to underlie 
the long term effects of addictive drugs (Hope et al., 1994; Moratalla et al., 1996b; 
Nestler, 2001; Zhang et al., 2004; Lu et al., 2006). 
 
More recently, evidence has been provided for a role of mGluR5 in activating 
ERK1/2. Thus, in addition to glutamate signalling through ionotropic NMDARs and 
AMPARs activating ERKs (Sgambato et al., 1998; Mao et al., 2004), stimulation of 
group I mGluRs leads to ERK1/2 activation in the spinal cord (Karim et al., 2001), 
glial cell cultures (Peavy and Conn, 1998), cultured striatal neurons (Voulalas et 
al., 2005) and the striatum (Choe and Wang, 2001). Moreover, stimulation of 
mGluR5 appears sufficient for ERK1/2 activation in cultured striatal neurons with 
resultant phosphorylation of Elk-1, CREB and IEG expression (Mao et al., 2005). In 
this system, activation of at least two distinct intracellular signalling pathways is 
required. The first pathway involves Ca2+-dependent kinase activation of ERK1/2, 
triggered by the „conventional‟ mGluR5 derived PLCβ1/IP3/ Ca
2+ cascade (Mao et 
al., 2005). A second dominant pathway involves the Homer family of scaffold 
proteins, homer1b/c, which directly couple with mGluR5 to enable ERK1/2 
activation through a currently undefined mechanism (Mao et al., 2005). Other 
studies provide evidence for mGluR5-dependent ERK activation in mediating 
responses to addictive drugs. Thus, antagonism of mGluR5 in vivo blocks 
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amphetamine-induced ERK1/2 activation and IEG (P-CREB, P-ELK-1 and Fos) 
induction in the dorsal striatum (Choe et al., 2002) and mGluR5 antagonism blocks 
cue-induced reinstatement of alcohol seeking and associated ERK1/2 activation in 
the NAcc shell and BLA (Schroeder et al., 2008). 
 
In summary, ERKs likely play an important role in both short and long term 
changes in drug-induced synaptic plasticity. Striatal ERK1/2 activation requires 
glutamate and dopamine signalling through NMDA and D1Rs, respectively, but 
mGluR5 stimulation may also be sufficient. Since psychostimulants are known to 
trigger ERK1/2 activation almost exclusively in those MSNs that express 
predominantly D1Rs (that is, MSNs of the direct pathway) (Bertran-Gonzalez et al., 
2008), the mGluR5KD-D1 model provides an excellent tool to assess the contribution 
of mGluR5 on this population of MSNs to cocaine-induced striatal ERK activation. 
The following experiments will use immunohistochemistry and immunoblotting to 
examine activation of ERK1/2 in areas of the dorsal and ventral striatum following a 
single injection of cocaine in wild-type and mGluR5KD-D1 mice. 
 
In addition to ERK1/2 activation, drug-induced alterations of AMPA receptors at 
glutamatergic corticostriatal synapses are considered important for neuroplastic 
changes underlying addiction-related behaviours, including control over drug-
seeking by drug-associated stimuli (Di Ciano and Everitt, 2001; Shepherd and 
Huganir, 2007; Conrad et al., 2008; Wolf and Ferrario, 2010). Stimulation of group I 
mGluRs, including mGluR5, can produce changes in synaptic plasticity through 
trafficking of AMPA receptors (Snyder et al., 2001; Bellone and Luscher, 2005; 
Mameli et al., 2007; Jo et al., 2008; Waung et al., 2008; Zhang et al., 2008; Kelly et 
al., 2009) and recent evidence suggests that, at least in the hippocampus, 
stimulation of group 1 mGluRs can drive internalisation of AMPA receptors, in part, 
requiring activation of ERK1/2 and the subsequent rapid translation of STEP61 
(Zhang et al., 2008). Phosphorylation of AMPA receptors, which can result to 
altered receptor conductance, subunit composition and/or trafficking (Wang et al., 
2005), provides an additional mechanism through which addictive drugs, such as 
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cocaine, can influence neuronal plasticity and addiction-related behaviours (Snyder 
et al., 2000; Famous et al., 2008). In the striatum, activation of mGluR5 appears 
necessary for phosphorylation of GluR1-Ser845 (Ahn and Choe, 2009), a PKA and 
cGMP-dependent protein kinase II phosphorylation site (Roche et al., 1996; Serulle 
et al., 2007), GluR1-Ser831 (Ahn and Choe, 2009), a PKC and CAMKII 
phosphorylation site (Roche et al., 1996; Mammen et al., 1997) and GluR2-Ser880 
(Ahn and Choe, 2010), also a PKC site (Chung et al., 2000). Taken together, these 
studies suggest that glutamate signalling through striatal mGluR5 may play an 
important role in cocaine-induced alterations of AMPA receptor-mediated neuronal 
plasticity by influencing AMPA receptor trafficking and/or phosphorylation state. To 
examine this possibility, the following immunoblotting experiments will also 
examine STEP protein expression and alterations in AMPA receptor 
phosphorylation state in areas of the dorsal and ventral striatum following acute 
cocaine challenge in mGluR5KD-D1 and wild-type mice.  
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6.2 Materials and methods 
 
6.2.1 Animals 
Mice (n = 20/21, WT/KD; male and at least 8 weeks old prior to experiment start) 
were bred in house and housed in groups of two or three. Animals were maintained 
on a 12:12 h light-dark cycle (lights on at 0700 hours) under controlled temperature 
(21 ± 2°C) and humidity (50 ± 5%) conditions. Body weights were maintained at 
approximately 85% of free-feeding weight by the provision of a limited amount of 
standard lab chow (B&K Feeds, Hull, UK) approximately 2 h after daily experiment 
completion. Food restriction was used in these animals to match the conditions of 
other studies reported in this thesis, such that effects of cocaine could be 
paralleled between studies without confounds arising from the use of different 
feeding conditions (Deroche et al., 1993). Experiments took place during the light-
phase between 1200 and 1900 hours. All procedures were performed in 
accordance with the United Kingdom 1986 Animals (Scientific Procedures) Act, 
following institutional ethical review. 
 
6.2.2 Drugs 
Cocaine hydrochloride (C17H21NO4·HCl; MacFarlan Smith, Edinburgh, UK) was 
dissolved in 0.9% saline. All injections were administered at a volume of 10 ml/kg 
i.p.  
 
6.2.3 Locomotor apparatus and behavioural procedure 
Locomotor activity was recorded using nine circular runways, as previously 
described (see Chapter 2, section 2.2.6.1). Mice were first habituated to the 
locomotor apparatus during five, once-daily, 1 h sessions. On the sixth day, 
following 30 min of activity recording, mice received a vehicle sham injection (10 
ml/kg saline i.p.) designed to acclimatize them to the injection procedure. Activity 
was monitored for 10 min post-sham injection. On the seventh day, locomotor 
activity was again recorded for 30 min. Mice were then injected with either cocaine 
(20 mg/kg i.p.) or vehicle and activity recorded for a further 10 min post-injection. 
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Mice were then immediately removed from the locomotor apparatus and used for 
either immunohistochemistry or immunoblotting, as described below. Five blocks of 
locomotor sessions were run each day, with each block containing mice from both 
genotypes. The assignment of treatment condition (cocaine or saline) and study 
destination (immunohistochemistry or immunoblotting) was counterbalanced within 
each genotype and each block. 
 
6.2.4 Immunohistochemistry  
6.2.4.1 Tissue preparation 
Saline (n = 5/6, WT/KD) and cocaine (n = 5/6, WT/KD) treated mice were injected 
with pentobarbital (0.2 ml of 200 mg/ml stock; Euthatal; Merial Animal Health, 
Harlow, Essex) and perfused transcardially with 4% (w/v) paraformaldehyde (PFA) 
in 0.1 M sodium phosphate buffer (Na2HPO4/NaH2PO4, pH 7.5). PFA was delivered 
rapidly (20 ml/min) with a peristaltic pump for 5 min (as reported in Bertran-
Gonzalez et al., 2008). Brains were post-fixed overnight in the same solution at 4ºC 
and then blocked, sectioned and placed in cassettes (Tissue-Tek Uni-Cassettes; 
Sakura, Torrance, California, USA) to process for paraffin fixation (Tissue-Tek VIP 
5; Sakura). In brief, brain sections were dehydrated in increasing concentrations of 
ethanol (70% for 1 h, 80% for 1 h and 5 x 100% each for 1 h), cleaned in xylene (2 
x 1 h and 1 x 2 h) and incubated in molten paraffin (4 x 1 h; Richard-Allan Scientific 
Histoplast IM; Thermo Scientific, Waltham, Massachusetts, USA), before being 
embedded in paraffin blocks (Tissue-Tek TEC 5; Sakura). From these blocks, 4 µm 
sections of medial striatum (corresponding to 1.18 mm from bregma; Franklin and 
Paxinos, 2008) were cut with a microtome (RM2255; Leica, Milton Keynes, Bucks, 
UK), placed on charged slides (SuperFrost Plus; Menzel-Gläser, Brunswick, 
Germany), air-dried overnight at 37°C and stored at room temperature prior to 
staining. 
 
6.2.4.2 Staining 
Immunohistochemistry was performed using a Discovery XT Autostainer (Ventana 
Medical Systems, Tucson, Arizona, USA). Sections underwent de-paraffinization, 
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heat-induced epitope retrieval (CC1 solution, mild protocol; Ventana Medical 
Systems) and staining using a heat protocol. Sections were incubated for 1 h with 
primary antibodies raised against DARPP-32 (1:100, mouse monoclonal, 611520, 
lot 58902; BD Biosciences, Franklin Lakes, New Jersey, USA) and phospho-
Thr202-Tyr204-ERK1/2 (P-ERK1/2; 1:200, 9101, lot 26; Cell Signaling Technology, 
Danvers, Massachusetts, USA). For detection of P-ERK1/2 and DARPP-32, slides 
were incubated for 30 min with goat anti-rabbit Cy3-conjugated (1:200, A10520; lot 
771575, Invitrogen) and goat anti-mouse Cy5-conjuated (1:200, A10524, Lot 
731500; Invitrogen) secondary antibodies, respectively. All antibodies were diluted 
in a Tris-based diluent (PSS diluent, 760-212, Ventana Medical Systems). On 
completion of staining, slides were removed from the Autostainer, washed in warm 
soapy water and cover slipped using ProLong® Gold anti-fade reagent (P36930; 
Invitrogen). Sections for P-ERK1/2 detection were cover slipped using the same 
reagent supplemented with 4‟,6-diamidino-2-phenylindole (DAPI; P36931; 
Invitrogen), a DNA intercalating fluorescent molecule. 
 
6.2.4.3 Controls 
As a negative control, the same immunohistochemical protocol was performed 
except that primary antibodies were omitted and replaced by fractions of rabbit IgG 
(for P-ERK1/2; V0415; Vector laboratories, Burlingame, California, USA) or mouse 
IgG2a (for DARPP-32; X0943; Dako, Ely, Cambridgeshire, UK), used at identical 
concentrations to the respective primary antibodies. In addition, primary antibodies 
were preadsorbed for at least 1 h with varying dilutions of the control peptide for 
DARPP-32 (1081, lot 1; Cell Signaling Technology) or P-ERK1/2 (1150, lot 4; Cell 
Signaling Technology). 
 
6.2.4.4 Imaging and analysis of fluorescence 
Images (375 x 375 µm; see panel b in Figs. 6.3-6.6 for illustration of sample area)  
from the dorsomedial (DM) and ventrolateral (VL) striatum, NAcc core and NAcc 
shell of the medial striatum were obtained bilaterally using sequential laser 
scanning confocal microscopy (SP5; Leica; using 40x dry objective, APO, 0.85 
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N.A.). For quantification of P-ERK1/2 +ve neurons, the Cy3 immunofluorescent 
nuclei were counted bilaterally from two sections from each mouse. Cell counts 
were performed by an observer unaware of the treatment condition (cocaine or 
saline) or the genotype (WT or KD) of mice. 
 
6.2.5 Immunoblotting 
6.2.5.1 Sample preparation 
Saline (n = 5/5, WT/KD) and cocaine (n = 5/5, WT/KD) treated mice were 
decapitated and their brains rapidly (30-60 sec) extracted and snap-frozen in 
chilled isopentane (-50ºC). Using a cryostat (CM3050S; Leica) frozen brains were 
cut in the coronal plane until the rostral striatum was exposed (Fig. 6.1b; equivalent 
to 1.54 mm from bregma; Franklin and Paxinos, 2008). A ~1 mm section that 
encompassed rostral, medial and caudal parts of the striatum was manually cut 
(Fig. 6.1a), from which bilateral punches (1.5 mm dia. dermal biopsy punch; Kai 
Medical, Honolulu, Hawaii) of the dorsal and ventral striatum were taken (for 
example see Fig. 6.1c) and stored at -80ºC. 
 
Frozen samples were briefly sonicated in ~100 µl of ice cold RIPA lysis buffer (1x 
of 10x stock: 0.5 M Tris-HCl, pH 7.4, 1.5 M NaCl, 2.5% deoxycholic acid, 10% NP-
40, 10 mM EDTA: 20-188; Millipore, Temecula, California, USA) supplemented 
with phosphatase inhibitors (1x phosSTOP; Roche Diagnostics, Burgess Hill, West 
Sussex, UK) and protease inhibitors (1x cOmplete mini, EDTA free; Roche 
Diagnostics). Lysate protein concentrations were determined by Bradford assay. 
Specifically, 5 µl of each sample was added to 250 µl of Bradford Reagent (B6916; 
Sigma, Saint Louis, Missouri, USA) and incubated at room temperature for a 
minimum of 5 min. Each lysate was assayed in duplicate. Protein concentrations 
were determined by comparing mean assay absorbance values measured at 590 
nm (PowerWave HT Microplate Spectrophotometer; Biotek, Winooski, Vermont, 
USA) against a standard curve generated using known concentrations of Bovine 
Serum Albumin (BSA, A/1278/46; Fisher Scientific, Loughborough, Leicestershire, 
UK) dissolved in the same lysis buffer. 
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Equal amounts of lysates were prepared for gel electrophoresis by the addition of 
protein loading buffer (1x of 4x stock: 125 mM Tris-HCl, pH 6.8, 50% glycerol, 4% 
SDS, 0.2% (w/v) Orange G: 928-40004; Li-Cor Biosciences, Lincon, Nebraska, 
USA) and reducing agent (1x of 10x stock: 500 mM dithiothreitol: NP0004; 
Invitrogen, Paisley, UK), made to volume (15 µl per well) with deionized water 
(Milli-Q, Millipore). Loading samples were heated at 70ºC for 10 min prior to 
charging gels.  
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Figure 6.1 Punches for immunoblotting. Frozen brains were cut until the rostral 
striatum was visualised (panel b; corresponding to 1.54 mm from Bregma; Franklin 
and Paxinos, 2008). A 1 mm slice was then manually cut that encompassed 
rostral, medial and caudal striatum (shaded area of panel a). From this slice, 1.5 
mm dia. bilateral punches of dorsal and ventral striatum were taken for 
immunoblotting. (c) Brain section (15 µm thick, equivalent to 1.10 mm from 
Bregma), stained with haematoxylin and eosin, illustrating dorsal and ventral 
punches taken from a single hemisphere. CPu: Caudate Putamen, C: NAcc core, 
S: NAcc shell, VP: Ventral Pallidum. Scale bar, 500 µm 
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6.2.5.2 Electrophoresis 
Protein gel electrophoresis was undertaken with the NuPage® pre-cast gel system 
(all reagents and equipment from Invitrogen unless otherwise stated) using Novex 
4-12% Bis-Tris gels (NP0322) and MOPS SDS running buffer (1x of 20x stock, 
NP0001-02) with added Antioxidant (NP0005). Molecular weight markers (Two-
Color Protein Molecular Weight Marker, 928-40001; Li-Cor Biosciences; or 
SeeBlue Plus2 Pre-stained Standard, LC5925) were run alongside samples to 
confirm antibody specificity. Gels were run for 50 min at 200 v (PowerEase500) 
and proteins transferred to a 0.2 μm nitrocellulose membrane (IB3010-01) using 
iBlot (IB1001UK). 
 
6.2.5.3 Western blotting 
Blots were blocked in Li-Cor blocking buffer (927-40000; Li-Cor Biosciences) for 1 
h at room temperature and incubated overnight at 4°C with primary antibodies 
raised against STEP (1:500, mouse monoclonal, 4396, lot 1; Cell Signaling 
Technology), ERK1/2 (1:1000, rabbit polyclonal, 9102, lot 20; Cell Signaling 
Technology), phospho-Thr202-Tyr204-ERK1/2 (P-ERK1/2; 1:500, rabbit polyclonal, 
9101, lot 26; Cell Signaling Technology), GluR1 (1:500, rabbit monoclonal 
recombinant, 05-855R, lot NG1683901; Millipore), phospo-Ser831-GluR1 (P-
GluR1-s831; 1:200, rabbit polyclonal, ab5847, lots NG1731388, JC1676088; 
Millipore), phospho-Ser845-GluR1 (P-GluR1-s845; 1:200, rabbit monoclonal, 2491-
1, lots YH011804C, YF052719C; Epitomics, Burlingame, California, USA), GluR2 
(1:500, goat polyclonal, N-19, sc-7661, lot B1908; Santa Cruz Biotechnology, 
Santa Cruz, California, USA) and phospho-Ser880-GluR2 (P-GluR2-s880; 1:200, 
rabbit polyclonal, 07-294; Millipore). All antibodies were diluted in fresh Li-Cor 
blocking buffer supplemented with 0.1% Tween 20. 
 
After four 5 min washes in DPBS/0.1 % Tween 20, blots were incubated for 1 h at 
room temperature with appropriate donkey anti-mouse (680, 926-32222, lot 
B81023-03; 800, 926-32212, lot B70820-02), anti-rabbit (680, 926-32223, lot 
C00118-0; 800, 926-32212, lot B90713-02) and/or anti-goat (680, 926-32224, lot 
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C00426-06) secondary antibodies labelled with IRDyes 680 or 800 (Li-Cor 
Biosciences). Blots were washed and then imaged with an Odyssey infrared 
fluorescence scanner (Li-Cor Biosciences). 
 
To control for sample loading variation, membranes were stripped (10 min 
incubation with 1x of a 5x NewBlot Nitro stripping buffer stock; 928-40030; Li-Cor 
Biosciences) and incubated for 1 h at room temperature with an antibody raised 
against β-actin (1:5000, mouse monoclonal, clone AC-15, A1978, lot 056K4796; 
Sigma; or 1:1000, rabbit monoclonal, clone 13e5, 4970, lot 3; Cell Signaling 
Technology). After washing, blots were incubated for 1 h at room temperature with 
donkey anti-mouse or anti-rabbit secondary antibodies labeled with IRDye 800 (Li-
Cor Biosciences). Following a final wash step, blots were again imaged for 
fluorescence detection. 
 
Band intensity was determined using Odyssey v2.1 software. Quantification was 
performed by subtracting background readings from the relative intensity of each 
sample band and normalizing band intensity with that of actin. The band intensity 
for each sample in a gel was divided by the mean band intensity for the control 
sample condition in the same gel (i.e. WT mice treated with saline) to provide a „% 
of Control‟ value (100% of Control value would indicate no change in band intensity 
between the treatment group and the control condition). 
 
6.2.6 Statistical Analysis 
All test data were initially assessed for normality (Shapiro-Wilk test; assumption 
violated when p ≤ 0.05) and homogeneity of variance (Levene‟s test, assumption 
violated when p ≤ 0.05). To permit analysis by parametric tests, appropriate 
transformations were undertaken to transform skewed distributions closer to a 
normal distribution and to reduce heterogeneity of variance (Cardinal and Aitken, 
2006). Specifically, for P-ERK1/2 +ve cell counts in the immunohistochemistry 
study, all data were square root transformed (Y‟ = √Y). 
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For the locomotor habituation phase and sham-injection day, data were analysed 
by mixed-factor analysis of variance (ANOVA), with genotype (WT, KD) as a 
between-subjects factor and session (1-5) as a within-subjects factor. Where 
significant (p ≤ 0.05) main effects or interaction terms were found, further analysis 
was performed using ANOVA and post-hoc comparisons by t-test, with Bonferroni 
corrections applied for multiple comparisons. For within-subjects ANOVA, the 
Greenhouse-Geisser correction was used where the assumption of sphericity was 
violated (Mauchly‟s test, p ≤ 0.05). 
 
For the cocaine/vehicle injection day, immunohistochemistry and immunoblotting 
studies, the effect of treatment (cocaine or vehicle) and genotype (WT or KD) on 
the respective dependent variables (distance travelled, P-ERK1/2 +ve cell counts 
or % of control) was analysed by univariate ANOVA. Where a significant (p ≤ 0.05) 
main effect or interaction term was found, between-group comparisons were 
performed by independent samples t-test. Findings were considered indicative of a 
trend where p ≤ 0.1 and all figures show group means (± SEM). Statistical analysis 
was performed with SPSS Statistics v.17 (IBM, Somers, New York, USA).  
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6.3 Results 
 
6.3.1 Locomotor activity 
As has been reported previously (Chapter 2, section 2.3.4.1), activity of KD mice 
was reduced in a novel environment (Fig. 6.2a, session 1, post-hoc Bonferroni t = 
2.76, df = 40, p < 0.01). Following a period of habituation there was no difference in 
locomotor activity between WT and KD mice (Fig. 6.2a, session 5, post-hoc 
Bonferroni t-test comparison, NS). Locomotor activity in the first 10 min period 
following the vehicle sham-injection (Fig. 6.2b) did not differ between genotypes (t-
test comparison, NS). When injected with cocaine, locomotor activity significantly 
increased in both WT and KD mice (Fig. 6.2c; main effect of Treatment, F(1,37) = 
35.56, p < 0.001). However, the locomotor response to cocaine was significantly 
attenuated in KD mice (Treatment x Genotype interaction; F(1,37) = 11.79, p = 
0.001; t-test comparison of WT cocaine vs. KD cocaine, t = 3.70, df = 19, p < 0.01). 
Locomotor activity following injection with vehicle did not differ between genotypes 
(t-test comparison, NS). The locomotor response to either treatment did not differ 
depending on the fate of mice (immunoblotting or immunohistochemistry; data not 
shown).  
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Figure 6.2 Locomotor activity (a) Activity was reduced in mutant mice when 
exposed to the novel locomotor apparatus (session 1), but activity did not differ 
between genotypes following a period of habituation (session 5). Each data point 
represents mean total activity (distance travelled) from once-daily 1 h sessions. *p 
< 0.01, between-genotype Bonferroni t-test comparison (b) During the sixth 
session, a vehicle sham injection (▲) was given after a 30 min habituation period. 
Locomotor activity did not differ between genotypes either prior to or following the 
injection. (c) Activity significantly increased in both genotypes during the 10 min 
period following 20 mg/kg cocaine (Coc), but was attenuated in KD mice. Activity 
following a vehicle injection (Veh) did not differ between genotypes. ***p < 0.001, 
within-genotype t-test comparison of vehicle and cocaine activity, ##p < 0.01, 
between-genotype t-test comparison of cocaine activity (n = 20/22, WT/KD; except 
for 30 min habituation period before the sham injection where n = 17/21 due to 
data recording error).  
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6.3.2 Immunohistochemistry 
6.3.2.1 P-ERK1/2 
Striatal ERK1/2 activation following cocaine and saline injections in wild-type and 
mutant mice was assessed by counting P-ERK1/2 +ve cells in the dorsal and 
ventral compartments of the medial striatum (a summary of the analyses is 
provided in Table 6.1). In the dorsomedial part of the striatum (Fig. 6.3a-c), cocaine 
did not increase P-ERK1/2 +ve cell counts (main effect of Treatment, NS), but 
overall P-ERK1/2 +ve cell counts were reduced in mutant mice (main effect of 
Genotype: F(1,18) = 5.59, p < 0.05). In the ventrolateral part of the medial striatum 
(Fig. 6.4a-c), cocaine did not reliably increase P-ERK1/2 immunoreactivity (main 
effect of Treatment, NS) and there was no overall difference between genotypes in 
P-ERK1/2 +ve cell counts (main effect of Genotype, NS). In the NAcc core (Fig. 
6.5a-c), cocaine did increase P-ERK1/2 +ve cell counts, although this effect was 
not quite significant (main effect of treatment: F(1,18) = 3.50, p = 0.078). The effect 
of cocaine on P-ERK1/2 immunoreactivity in the NAcc core did not differ between 
genotypes (main effect of Genotype, NS; Genotype x Treatment interaction, NS). 
In the NAcc shell (Fig. 6.6.a-c), cocaine produced a robust increase in P-ERK1/2 
immunoreactivity (main effect of Treatment, F(1,18) = 11.01, p < 0.01) and overall 
P-ERK1/2 immunoreactivity tended to be reduced in mutant mice (main effect of 
Genotype, F(1,18) = 3.85, p = 0.065). However, the effect of cocaine on P-ERK1/2 
+ve cell counts did not reliably differ between genotypes (Treatment x Genotype 
interaction, NS). Subsequent within-genotype comparisons indicated that cocaine 
significantly increased P-ERK1/2 +ve cell counts in WT mice (t = -2.48, df = 8, p < 
0.05), although this effect was not so robust in mutant mice (t = -2.11, df = 10, p = 
0.061). 
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Figure 6.3 Immunohistochemistry of P-ERK1/2 in the dorsomedial striatum. (a) P-
ERK1/2 immunoreactivity (red) was detected together with DAPI (white; a marker 
of DNA) and DARPP-32 (blue; a marker of MSNs) in the dorsomedial part of the 
striatum (red dot in panel b; equivalent to 1.18 mm from Bregma; Franklin and 
Paxinos, 2008) of wild-type and mGluR5KD-D1 (KD) mice in a triple-fluorescence 
analysis. Arrows indicate the position of P-ERK1/2 +ve neurons. Merged images 
show that P-ERK1/2 +ve neurons are also MSNs. Scale bars, 50 μm. (c) Cocaine 
did not increase P-ERK1/2 immunoreactivity in either genotype, although P-ERK 
immunoreactivity was reduced overall in mutant mice in this striatal region.  
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Figure 6.4 Immunohistochemistry of P-ERK1/2 in the ventrolateral striatum. (a) P-
ERK1/2 immunoreactivity (red) was detected together with DAPI (white) and 
DARPP-32 (blue) in the ventrolateral part of the striatum (red dot in panel b; 
equivalent to 1.18 mm from Bregma; Franklin and Paxinos, 2008) of wild-type and 
mGluR5KD-D1 (KD) mice. Arrows indicate the position of P-ERK1/2 +ve neurons. 
Scale bars, 50 μm. (c) Cocaine did not reliably increase P-ERK1/2 +ve cell counts 
in either genotype in this striatal region.  
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Figure 6.5 Immunohistochemistry of P-ERK1/2 in the NAcc core. (a) P-ERK1/2 
immunoreactivity (red) was detected together with DAPI (white) and DARPP-32 
(blue) in the NAcc core of the medial striatum (red dot in panel b; equivalent to 
1.18 mm from Bregma). Arrows indicate the position of P-ERK1/2 +ve neurons. 
Scale bars, 50 μm. (c) Cocaine increased P-ERK1/2 immunoreactivity in the NAcc 
core, although this effect was not quite statistically significant (main effect of 
Treatment, p = 0.065).  
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Figure 6.6 Immunohistochemistry of P-ERK1/2 in the NAcc shell. (a) P-ERK1/2 
immunoreactivity (red) was detected together with DAPI (white) and DARPP-32 
(blue) in the NAcc shell of the medial striatum (red dot in panel b; equivalent to 
1.18 mm from Bregma). Arrows indicate the position of P-ERK1/2 +ve neurons. 
Scale bars, 50 μm. (c) Cocaine increased P-ERK1/2 immunoreactivity in both 
genotypes, although this effect was not so robust in mutant mice *p < 0.05, §p < 0.1 
within-genotype t-test comparison between vehicle and cocaine.  
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6.3.2.2 Controls 
No cell-type specific fluorescent signal was detected when IgG fractions were 
replaced for respective primary antibodies (images not shown). In the 
preadsorption assays, the control peptide for DARPP-32 blocked DARPP-32 
immunoreactivity in a concentration dependent manner (Fig. 6.7). Although the 
control peptide for P-ERK1/2 blocked P-ERK1/2 immunoreactivity, no 
concentration dependent block of P-ERK1/2 was demonstrated (i.e. the peptide 
was still effective at the lowest dilution tested; 0.3 μg of peptide per 1 μg of P-
ERK1/2 antibody; images not shown). 
  
 
 
F-IHC: P-ERK1/2 
Treatment 
F(1,18) 
Genotype 
F(1,18) 
Treatment x 
Genotype 
F(1,18) 
Dorsomedial 
striatum 
0.180 5.59* 0.036 
Ventrolateral 
striatum 
2.48 2.33 0.20 
NAcc core 3.50§ 1.58 0.50 
NAcc shell 11.01** 3.85§ 0.58 
 
Table 6.1 ANOVAs for fluorescence immunohistochemistry (F-IHC) of P-
ERK1/2 cell counts. Factors: Treatment, (Cocaine, vehicle); Genotype (WT, 
KD), **p < 0.01, *p < 0.05, §p < 0.1 
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Figure 6.7 DARPP-32 preadsorption control. DARPP-32 immunoreactivity was 
blocked by its control peptide in a concentration dependent manner. Each 375 x 
375 µm panel indicates the ratio of control peptide preadsorbed to DARPP-32 
primary antibody. Note that all images are of the same brain region in the same 
wild-type mouse. Images were captured with identical confocal settings and 
brightness adjusted for display purpose to the exact same extent.  
3:1 1:1 0.3:1 0.01:1
Control peptide : DARPP-32 primary Ab
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6.3.3 Immunoblotting 
Tissue from one animal was lost during punch collection, reducing group sizes to n 
= 5/5 (WT/KD) for the saline injected animals and n = 4/5 (WT/KD) for the cocaine 
treated mice. In addition, two samples intended for detection of total ERK1/2 in the 
dorsal striatum did not run correctly in the gel, reducing the group sizes for this 
particular condition to n = 5/4 (WT/KD) for the saline condition and n = 4/4 (WT/KD) 
for the cocaine condition. 
 
Bands for GluR2, GluR1, P-GluR1-s845 and P-GluR1-s831 were observed at ~100 
KDa (Fig. 6.8). The antibody used for detection of P-GluR2-s880 was not of 
sufficient quality to permit reliable identification of the target phosphorylated protein 
(not shown), and thus no data for GluR2 or P-GluR2-s880 will be reported in this 
thesis. Consistent with reported identification of STEP isoforms (Lombroso et al., 
1993; Sharma et al., 1995), two major bands at 61 and 46 KDa were observed for 
STEP, with additional minor bands at 37, 33, and 20 KDa (Fig. 6.8). For total 
ERK1/2 and P-ERK1/2, two bands were observed at 44 and 42 KDa corresponding 
with ERK1 and ERK2, respectively (Fig. 6.8). Both actin antibodies detected a 
single band, observed at 42 KDa (A1978; Sigma shown in Fig. 6.8). It is worthwhile 
to note that, under the same immunoblotting conditions described above, little 
success was had with other antibodies raised against GluR1 (sc-13152, lot H1109; 
Santa Cruz), phospho-Ser845-GluR1 (AB5849, lot JC1650292; Millipore), phospo-
Ser831-GluR1 (04-823, lot DAM1557561; Millipore), and GluR3 (mab5416, lot 
JC1629918; Millipore). In addition, antibodies for ERK1/2 (06-182, lot 
DAM1644549; Millipore) and phospho-Tyr204-ERK1/2 (sc-7383, Lot H0409; Santa 
Cruz) did produce bands at the predicted size, but were not used in the present 
report. 
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Figure 6.8 Example western blots. Full blots are shown for antibodies raised 
against GluR1, P-GluR1-s845 (P-s845), P-GluR1-s831 (P-s831), GluR2, ERK1/2 
(ERK), P-ERK1/2 (P-ERK), STEP and β-Actin. Arrow heads indicate bands 
selected for analysis, based on predicted protein weight. 
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6.3.3.1 Total ERK1/2 and P-ERK1/2 
No differences in either total ERK1/2 or P-ERK1/2 were found in the dorsal 
striatum of WT and KD mice treated with cocaine or vehicle (Fig. 6.9a-b, DStr; for 
each ERK and P-ERK isoform: main effect of Genotype, NS; Treatment, NS; 
Genotype x Treatment interaction, NS). Similarly, in the ventral striatum, total 
ERK1/2 levels did not differ between genotypes or as a function of treatment (Fig 
6.9a-b, VStr; for each ERK: main effect of Genotype, NS; Treatment, NS; 
Genotype x Treatment interaction, NS). Although P-ERK1/2 levels in the ventral 
striatum were elevated overall in KD mice (P-ERK1: main effect of Genotype, 
F(1,15) = 4.93, p < 0.05; P-ERK2: main effect of Genotype, F(1,15) = 5.16, p < 
0.05), P-ERK1/2 levels were unaffected by cocaine (for each P-ERK isofrom: main 
effect of Treatment, NS; Genotype x Treatment interaction, NS). A summary of the 
analyses is provided in Table 6.2. 
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Figure 6.9 Immunoblotting of total ERK1/2 and P-ERK1/2 (a) 20 mg/kg cocaine did 
not alter total ERK1/2 protein or its active form P-ERK1/2 in either the dorsal (DStr) 
or ventral (VStr) striatum of wild-type or mGluR5KD-D1 mice. Overall levels of P-
ERK1 and P-ERK2 showed a small but significant increase in mGluR5KD-D1 mice in 
comparison to wild-types (n = 4-5 per group). (b) Example blots are shown from 
wild-type or mGluR5KD-D1 (bold line) mice injected with vehicle (V) or 20 mg/kg 
cocaine (C).  
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6.3.3.2 STEP 
Total STEP46 protein did not differ in mice given cocaine or saline, in either the 
dorsal or ventral striatum (Fig. 6.10a-b; in each area: main effect of Genotype, NS; 
Treatment, NS; Genotype x Treatment interaction, NS). Although STEP61 protein 
was not altered in the ventral striatum of mice in either treatment condition (Fig. 
6.10a-b; main effect of Genotype, NS; Treatment, NS; Genotype x Treatment 
interaction, NS), expression of this isoform in the dorsal striatum showed a small 
but significant variation depending on the genotype and treatment condition 
(Treatment x Genotype interaction, F(1,15) = 6.81, p < 0.05; main effect of 
Genotype, F(1,15) = 3.11, p = 0.098). Subsequent comparisons revealed a trend 
for increased STEP61 expression in WT mice given cocaine, in comparison to WT 
mice injected with saline (t = -1.92, df = 8, p = 0.09). In contrast, STEP61 
expression was significantly reduced in KD mice given cocaine, in comparison to 
WT mice injected with cocaine (t = -3.38, df = 8, p = 0.01). A summary of the 
analyses is provided in Table 6.2. 
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Figure 6.10 Immunoblotting of STEP. (a) Following 20 mg/kg cocaine, STEP61 
expression tended to increase in the dorsal striatum (DStr) of WT mice, while 
STEP61 expression was significantly decreased in KD mice injected with cocaine 
compared to WT mice. There were no between group differences in expression of 
either STEP isoform in the ventral striatum (VStr). §p < 0.1 within-genotype t-test 
comparison of cocaine and vehicle, ##p < 0.01 between-genotype t-test comparison 
of cocaine (n = 4-5 per group) (b) Example blots are shown from wild-type or 
mutant (bold line) mice injected with vehicle (V) or 20 mg/kg cocaine (C).  
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6.3.3.3 P-GluR1-s845 and P-GluR1-s831 
In the dorsal striatum, P-GluR1-s845 levels were significantly increased following 
20 mg/kg cocaine (Fig. 6.11a-b, DStr; main effect of Treatment, F(1,15) = 13.19, p 
< 0.01) but this effect differed between genotypes (Treatment x Genotype 
interaction, F(1,15) = 7.77, p < 0.05). Subsequent comparisons revealed that 
cocaine significantly increased P-GluR1-s845 levels in WT mice in comparison to 
WT mice injected with vehicle (t = -4.2, df = 8, p < 0.01), but no similar change was 
found in KD mice (t-test comparison, NS). Moreover, P-GluR1-s845 levels 
significantly differed between WT and KD mice injected with cocaine (t = 2.83, df = 
8, p < 0.05). In the ventral striatum, cocaine again increased P-GluR1-s845 levels 
(Fig. 6.11a-b, VStr; main effect of Treatment, F(1,15) = 5.39, p < 0.05), although 
this effect did not differ between genotypes (Treatment x Genotype interaction, 
NS). In marked contrast, P-GluR1-s831 levels did not vary in either the ventral or 
dorsal striatum region as a function of drug treatment, nor between genotypes (in 
both regions: main effect of Treatment, Genotype and Treatment x Genotype 
interaction, NS). A summary of the analyses is provided in Table 6.2. 
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Figure 6.11 Immunoblotting of P-GluR1-s845 and P-GluR1-s831 (a) 20 mg/kg 
cocaine significantly increased levels of P-GluR1-s845 in the dorsal striatum (DStr) 
in wild-type mice, but not mutant mice. In the ventral striatum (VStr), P-GluR1-s845 
was increased by cocaine, but this effect did not differ between genotypes. Levels 
of P-GluR1-s831 did not differ following cocaine in either brain region. **p < 0.01 
within-genotype t-test comparison of vehicle and cocaine, #p < 0.05 between-
genotype t-test comparison of cocaine (n = 4-5 per group). (b) Example blots are 
shown from wild-type or mutant (bold line) mice injected with vehicle (V) or 20 
mg/kg cocaine (C).  
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Immunoblotting 
Treatment 
F(1,15) 
Genotype 
F(1,15) 
Treatment x 
Genotype 
F(1,15) 
Dorsal Striatum    
P-ERK1 2.32 0.96 0.00 
P-ERK2 0.037 0.028 0.51 
Total ERK1# 0.003 1.92 0.58 
Total ERK2# 
STEP61 
STEP46 
P-GluR1-s845 
P-GluR1-s831 
0.001 
0.142 
1.72 
13.19** 
0.43 
0.40 
3.11§ 
0.12 
5.04* 
1.31 
0.68 
6.81* 
1.79 
7.77* 
0.20 
Ventral Striatum    
P-ERK1 
P-ERK2  
Total ERK1 
Total ERK2 
STEP61 
STEP46 
P-GluR1-s845 
P-GluR1-s831 
0.004 
0.13 
0.47 
0.92 
0.046 
0.035 
5.39* 
0.36 
4.93* 
5.16* 
0.026 
0.003 
0.63 
0.12 
1.88 
0.063 
0.43 
0.13 
0.57 
0.58 
0.005 
0.079 
0.56 
0.81 
 
Table 6.2 ANOVAs for immunoblotting studies. Factors: Treatment (Cocaine, 
vehicle); Genotype (WT, KD), **p < 0.01, *p < 0.05. #For total ERK1/2 in the dorsal 
striatum, F(1,14).  
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6.4 Discussion 
 
In the present chapter, immunohistochemistry and immunoblotting techniques were 
used to explore some neurobiological effects of acute non-contingent cocaine in 
wild-type and mGluR5KD-D1 mice. The immunohistochemistry study revealed that a 
single cocaine injection was sufficient to produce a robust activation of ERK1/2 in 
the NAcc shell, with some activation also seen in the NAcc core. Moreover, at least 
in the NAcc shell, the effect of cocaine on ERK1/2 activation tended to be 
attenuated in mGluR5KD-D1 mice. In the dorsal striatum, cocaine did not reliably 
increase ERK1/2 activation in either the dorsomedial or ventrolateral regions; 
although overall levels of ERK1/2 activation in the dorsal striatum were reduced in 
mGluR5KD-D1 mice when compared to their wild-type counterparts. In contrast to 
the immunohistochemistry study, immunoblotting did not identify increased ERK1/2 
activation in either the dorsal or ventral striatum in response to a cocaine injection. 
However, immunoblotting did reveal that translation of STEP61 and levels of P-
GluR1-s845 were increased following a cocaine injection in the dorsal striatum of 
wild-type mice, but not mutant mice. In the ventral striatum, cocaine increased 
levels of P-GluR1-s845 in both genotypes to a similar extent. By contrast, cocaine 
had no effect on levels of P-GluR1-s831 in the ventral or dorsal striatum of either 
genotype. Taken together, these data suggest that regulation of basal levels of 
ERK1/2 activation in the dorsal striatum and activity of this pathway in response to 
acute cocaine challenge in the ventral striatum may involve glutamate signalling 
through mGluR5 located on D1-MSNs. In addition, mGluR5 on D1-MSNs may play 
an important role in regulating AMPA receptor trafficking and/or phosphorylation 
state of AMPA receptors in the striatum following acute cocaine experience. 
 
A general limitation of the immunohistochemistry approach is that only cells which 
show robust activation of ERK1/2 are counted and it is not possible to distinguish 
between the degree of ERK1/2 activation amongst neurons. It is possible that less 
robust ERK1/2 activation occurred in other neurons of wild-type and mGluR5KD-D1 
mice, which may still have important physiological consequences (Valjent et al., 
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2004). Oppositely, it is not known whether ERK1/2 activation observed in either 
genotype in the present study was sufficient to activate associated transcriptional 
regulators, such as ELK-1 and CREB (Konradi et al., 1994; Yang et al., 2004). In 
future studies, examining the induction of such regulators and associated 
immediate early genes (for example, c-fos) would be highly valuable to further 
understand the role of mGluR5 on D1-MSNs in gating neuronal adaptations that 
occur following exposure to psychostimulants. 
 
In the immunohistochemistry study, cocaine had no significant effect on ERK1/2 
activation in the dorsal striatum, which contrasts with other reports (most notably 
those of Valjent and colleagues; Valjent et al., 2005; Bertran-Gonzalez et al., 
2008). The lack of more robust and widespread ERK1/2 activation could reflect a 
number of factors. First, it may be that the time of sampling after the cocaine 
injection in the present study (mice were perfused immediately after the 10 min 
locomotor session) was not optimal. The time course of striatal ERK1/2 activation 
in response to cocaine has been characterised and varies between the dorsal and 
ventral striatum (Bertran-Gonzalez et al., 2008). Thus, activation of ERK1/2 was 
greatest in all striatal regions measured (dorsal striatum, NAcc core and shell) 2 
min after cocaine injection, declined rapidly from 15 min post-cocaine, but was 
prolonged in the dorsal striatum compared to the ventral striatum (Bertran-
Gonzalez et al., 2008). Although we did observe robust ERK1/2 activation in the 
ventral striatum, but not the dorsal striatum, it would still be valuable to examine 
additional time points post-cocaine injection in future studies. Second, ERK1/2 
activation was assessed only in the medial part of the striatum and it is possible 
that more robust effects of cocaine would have been recorded in more rostral 
striatal regions, since, at least in the ventral striatum, a rostro-caudal gradient for 
cocaine induced ERK1/2 activation has been described (Bertran-Gonzalez et al., 
2008). Third, mice experienced only one vehicle sham-injection prior to the test day 
and it may be that stress arising from the injection procedure contributed to 
ERK1/2 activation, which masked the effects of cocaine (particularly in the dorsal 
striatum where basal levels of ERK1/2 activation were greater than that seen in the 
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ventral striatum). Stress has been noted to activate ERK1/2 in many brain regions, 
including the striatum (Shen et al., 2004) and it is notable that in a study of Bertran-
Gonzalez and colleagues (2008), mice received vehicle injections in each of the 
three, 2 hour, once-daily habituation sessions that occurred before the actual 
experiment in which the effect of cocaine on striatal P-ERK1/2 was assessed. 
 
A final procedural difference that may contribute to the differences in ERK1/2 
activation observed in our current report with those reported by Valjent and 
colleagues was the use of food restriction in our current protocol, while mice in 
studies reported by Valjent and colleagues were provided with ad libitum access to 
food (Valjent et al., 2005; Bertran-Gonzalez et al., 2008). Numerous studies have 
identified wide ranging influences of food restriction on behavioural responses to 
cocaine and other addictive substances. For example, in rats, food restriction 
increased sensitivity to the locomotor-stimulating effects of cocaine (Cabeza de 
Vaca and Carr, 1998; Stamp et al., 2008), amphetamine (Campbell and Fibiger, 
1971; Deroche et al., 1993; Stuber et al., 2002) and morphine (Deroche et al., 
1993) and increased the expression of CPP mediated by cocaine (Bell et al., 1997) 
and amphetamine (Stuber et al., 2002). At the neurobiological level, food restriction 
in drug naïve rats produced a small but significant enhancement of expression of 
35-37 KDa isoforms of Delta-FosB in the NAcc, but not the CPu (Stamp et al., 
2008). However, dopamine release in the NAcc following a single amphetamine 
injection was comparable between ad libitum fed and food deprived rats (Stuber et 
al., 2002), suggesting that alterations in behavioural responses to 
psychostimulants mediated by food deprivation are unlikely to be determined by 
the level of extracellular dopamine in the striatum. More convincingly, a clear role 
for endogenous corticosterone secretion in modulating responses to addictive 
drugs by food restriction has been demonstrated (Deroche et al., 1993; Stamp et 
al., 2008). Thus, one possibility is that hyper secretion of corticosterone as a result 
of food restriction in the present studies may have masked some of the effects of 
cocaine on ERK1/2 activation. This idea would require further study, but evidence 
for a role of corticosterone in regulating ERK1/2 activation in limbic regions and the 
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dorsal striatum has been provided (Gourley et al., 2008) and food restriction results 
in enhanced sensitivity to ERK1/2 activation under basal conditions in rats (Pan et 
al., 2006). 
 
There is much evidence that activation of ERK1/2 in response to psychostimulants 
occurs almost exclusively in MSNs of the direct striatonigral pathway although, 
under certain behavioural (e.g. home vs. novel environment) or genetic (e.g. ERK1 
knock-out mice) manipulations, some activation of ERK1/2 in response to 
psychostimulants in the indirect striatopallidal pathway has been observed (Valjent 
et al., 2000; Mazzucchelli et al., 2002; Ferguson and Robinson, 2004; Valjent et al., 
2005; Ferguson et al., 2006; Bertran-Gonzalez et al., 2008). In the present study, 
ERK1/2 activation did occur almost exclusively in MSNs (identified with DARPP-
32), and it would have been valuable to formally distinguish between ERK1/2 
activation in MSNs of the striatonigral or striatopallidal pathway. Striatonigral 
neurons are typically characterised by enriched expression of substance P and 
dynorphin, while striatopallidal neurons contain enkephalin (Chesselet and 
Graybiel, 1983; Beckstead and Kersey, 1985). In pilot studies (not reported here), 
antibodies raised against prepro-dynorphin (guinea pig polyclonal, GP10110; 
Neuromics Inc, Minneapolis, Minnesota, USA) and substance-P (guinea pig 
polyclonal, ab10353, lot 866742; Abcam) showed little cell-type specificity, despite 
some reports to the contrary (Martella et al., 2009). To date, it would appear that 
the most reliable segregator of MSNs by immunohistochemistry is provided by 
antibodies raised against enkephalin (e.g. Novak et al., 2010). Unfortunately, anti-
enkephalin antibodies (produced in rabbit) were not compatible with the 
combination of antibodies used in the present report to identify P-ERK1/2 
(produced in rabbit) and DARPP-32 (produced in mouse). Although it is tempting to 
propose that loss of mGluR5 on D1-MSNs was concomitant with an attenuation of 
ERK1/2 activation specifically in D1-MSNs in response to cocaine, it will be of 
critical importance for any future studies to determine whether cocaine induced 
ERK1/2 activation in wild-type and mGluR5KD-D1 mice occurred in the same 
population of MSNs. 
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While the immunohistochemistry study identified increased ERK1/2 activation in 
the ventral striatum following cocaine, this finding was not replicated in the 
immunoblotting studies. These findings are perhaps disconcerting, but not entirely 
unexpected; others have reported increased ERK1/2 activation in the ventral 
striatum following cocaine when measured with immunohistochemistry but not 
immunoblotting (Marin et al., 2009). The total number of P-ERK1/2 +ve cells in the 
immunohistochemistry study only ever represented a small minority of total cells in 
each region of interest. In the immunoblotting experiments, homogenate samples 
incorporated rostral, medial and caudal striatum and could not distinguish between 
sub-regions in the ventral (that is, NAcc core and shell) or dorsal striatum (e.g. 
dorsomedial and ventrolateral striatum). Moreover, punches of the ventral striatum 
likely incorporated dorsal parts of the striatum and some part of the ventral 
pallidum. Thus, it is likely that small changes in ERK1/2 activation were obscured 
in the immunoblotting studies by unaltered or even decreased ERK1/2 
phosphorylation levels in the majority of neurons within the homogenate sample. 
Even so, most reports do identify robust increases in P-ERK1/2 with 
immunoblotting following cocaine, suggesting that there is some room for 
optimising the experimental protocol used in the present report with respect to the 
time of sampling, habituation procedures and the use of food restriction (as 
discussed above). 
 
If future studies confirm disrupted ERK1/2 signalling in the striatum of mGluR5KD-D1 
mice, then what might be the implications for neuronal function and behavioural 
responses to cocaine? First, ERK1/2 is closely involved in synaptic plasticity 
(reviewed in Thomas and Huganir, 2004; Thomas et al., 2008). For example, in 
mice lacking the ERK1 isoform, striatal LTP induced by cortical stimulation is 
dramatically enhanced (Mazzucchelli et al., 2002). The ERK1/2 pathway has also 
been directed linked to alterations in AMPA receptor surface expression (Boudreau 
et al., 2007; Zhang et al., 2008) and regulation of AMPA by ERK1/2 may be critical 
for the induction of LTP at excitatory synapses (Patterson et al., 2010). Thus, it 
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seems reasonable to propose that plasticity at excitatory corticostriatal synapses 
may be disrupted in mGluR5KD-D1 mice, in part, because of impaired activation of 
ERK1/2. Second, given the proposed role of corticostriatal plasticity in certain 
addiction-related behaviours, including drug seeking under the control of drug-
associated cues (Kalivas, 2009; Wolf and Ferrario, 2010), it would also be 
reasonable to propose that such behaviours could also be impaired in mGluR5KD-D1 
mice. Indeed, recent data has provided direct support for this proposal, since 
mGluR5KD-D1 mice show deficits in cue-induced reinstatement of cocaine seeking 
(Novak et al., 2010). Whether corticostriatal plasticity is impaired in mGluR5KD-D1 
and whether this is linked to disruption in ERK1/2 signalling requires further 
empirical study, but there is considerable evidence to implicate ERK1/2 as a 
central signalling pathway involved in the learning and expression of control over 
behaviours by environmental stimuli associated with drug reinforcement (Lu et al., 
2005; Valjent et al., 2006). 
 
The immunoblotting studies reported here also examined the role of mGluR5 on 
D1R expressing neurons in regulating STEP, a family of proteins expressed in 
dopaminoceptive neurons of the CNS and enriched in the basal ganglia and 
related structures (Lombroso et al., 1991; Lombroso et al., 1993). STEP family 
members are produced by alternative splicing with variants including STEP61, a 
membrane associated protein, and STEP46, a cytosolic protein (Sharma et al., 
1995; Bult et al., 1996; Bult et al., 1997). The role of STEP proteins in synaptic 
plasticity has been reviewed by others (Braithwaite et al., 2006a), but notably, at 
least in the hippocampus, stimulation of group I mGluRs causes rapid translation of 
STEP61 protein, which is necessary for the endocytosis of AMPA receptors (Zhang 
et al., 2008). Moreover, data would suggest that STEP61 translation in the 
hippocampus requires mGluR5-, not mGluR1-, mediated ERK1/2 activation (Zhang 
et al., 2008). This report is particularly interesting with respect to findings of the 
current chapter, because an increase in total STEP61 protein was found in the 
dorsal striatum of wild-type mice injected with cocaine, but not mGluR5KD-D1 mice. 
If STEP61 translation promotes AMPAR receptor internalisation in the striatum, as 
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has been reported in the hippocampus (Zhang et al., 2008), it would be exciting to 
propose that AMPA receptor trafficking in MSNs in response to acute cocaine 
challenge necessitates translation of STEP61 following stimulation of mGluR5 on 
D1-MSNs. However, the increase in STEP61 protein levels following cocaine in 
wild-type mice was small and further studies would be required to explore whether 
AMPA receptor trafficking was disrupted in mGluR5KD-D1 mice because of 
alterations in STEP translation. 
 
At least two further functions of STEP in regulating neuronal activity warrant further 
investigation in mGluR5KD-D1 mice. First, STEP associates with the NMDA complex 
in postsynaptic terminals, constitutively inhibits NMDA channel function (Oyama et 
al., 1995; Pelkey et al., 2002) and can regulate LTP, in part, through modulation of 
NMDA trafficking (Snyder et al., 2005; Braithwaite et al., 2006b). Thus, it would be 
of interest to explore the extent to which NMDA channel function is altered, if at all, 
in mGluR5KD-D1 mice. Second, through direct protein-protein interactions, active 
(dephosphorylated) STEP can inhibit the duration of ERK1/2 activation by 
dephosphorylating the tyrosine residues in the ERK1/2 activation loop (Pulido et 
al., 1998; Paul et al., 2000; Paul et al., 2003). STEP activation is under the 
opposing control from dopamine and glutamate signalling in the striatum. Thus, in 
MSNs, dopamine signalling through D1 receptors and activation of cAMP-
dependent PKA inactivates STEP by phosphorylation and thus prevents STEP 
from dephosphorylating ERK (Pulido et al., 1998; Paul et al., 2000). The 
maintenance of inactive (phosphorylated) STEP by dopamine likely involves a PKA 
mediated phosphorylation of DARPP-32 at Thr34 and subsequent inhibition of PP-
1, which would normally serve to activate STEP (Svenningsson et al., 2004; Valjent 
et al., 2005). Oppositely, glutamate mediated activation of NMDA receptors leads 
to activation of STEP, by dephosphorylation, which in turn limits the duration of 
ERK1/2 activation (Paul et al., 2003). Since the present immunohistochemistry 
studies suggest that activation of ERK1/2 in response to cocaine is attenuated in 
mutant mice, it would be of interest to further explore the contribution of STEP to 
this finding; the hypothesis being that reduced ERK1/2 activation could be due to 
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increased levels of active (dephosphorylated) STEP in mGluR5KD-D1 mice, possibly 
arising from loss of PKA-mediated inactivation of STEP. On measuring the 
phosphorylation state of STEP, it is noteworthy that others have reported STEP 
phosphorylation to be observed by an increase in the apparent molecular weight of 
the 46KDa STEP isoform (Valjent et al., 2005; Sun et al., 2007). No such shift in 
STEP46 was found in the present immunoblotting studies, suggesting that 
optimisation of the immunoblotting protocol (with respect to the primary antibody, 
gel concentration and electrophoresis conditions) will be required to fully 
understand any changes in STEP activity in the striatum of mGluR5KD-D1 mice. 
 
Phosphorylation of the GluR1 subunit of AMPA at Ser845 was increased in the 
dorsal striatum of wild-type mice following cocaine but, remarkably, no such 
change was found in mGluR5KD-D1 mice. Phosphorylation of GluR1-s845 by 
cocaine necessitates activation of dopamine D1R/cAMP-dependent PKA (Snyder 
et al., 2000; Valjent et al., 2005) and GluR1-s845 phosphorylation is often used as 
a surrogate measure for PKA activity. That levels of P-GluR1-s845 were not 
increased by cocaine in mGluR5KD-D1 mice, at least in the dorsal striatum, provides 
critical support for the proposal that ERK1/2 signalling, and indeed regulation of 
DARPP-32 and STEP activity, could well be disrupted in mGluR5KD-D1 mice due to 
loss of PKA activity. The GluR1-Ser845 site is also functionally important, since its 
phosphorylation results in enhanced current of GluR1 containing AMPA receptors 
and thus promotes increased neuronal activity (Banke et al., 2000). In the 
hippocampus, phosphorylation of GluR1-s845 is modulated during LTP and LTD 
and may affect membrane insertion of GluR1-containing AMPA receptors (Lissin et 
al., 1999; Lee et al., 2003). Moreover, mice with point-mutations of GluR1-s845 
show impaired memory deficits in spatial learning tasks (Lee et al., 2003). By 
analogy, it is tempting to propose that impaired corticostriatal plasticity and 
associated learning impairments in mGluR5KD-D1 may be due, in part, to disrupted 
PKA activation and regulation of GluR1-s845 phosphorylation. 
 
282 
 
An important limitation of the immunoblotting studies is that levels of 
phosphorylated protein (e.g. P-GluR1-s845) were not corrected for levels of total 
protein (i.e. total GluR1). It is therefore possible that changes in P-GluR1-s845 
simply reflected a change in total GluR1 protein. Arguing against this possibility is 
that P-GluR1-s831 levels did not change following cocaine, which would have been 
expected had total GluR1 protein been altered. It is noteworthy that others have 
also reported no change in P-GluR1-s831 protein, which necessitates activation of 
PKC and CAMKII, in the striatum of cocaine treated animals (Roche et al., 1996; 
Mammen et al., 1997; Snyder et al., 2000). Nevertheless, cocaine is well known to 
modulate cell surface expression of AMPA receptor subunits in many brain regions 
(reviewed in Wolf and Ferrario, 2010)  (but see Lu et al., 2002) and it would be 
imperative that any future studies applied this control measure. However, even if 
phosphorylated proteins had been corrected against total protein, it must be 
recognized that AMPA receptor subunits can rapidly cycle between intracellular 
pools and the cell surface (Shepherd and Huganir, 2007) and even total protein 
levels may provide a poor control measure. Thus, under ideal conditions, 
phosphorylated and total protein levels in these distinct cellular compartments 
would be analysed separately by the use of cross-linking (e.g. Boudreau and Wolf, 
2005) or subcellular fractionation (e.g. Ghasemzadeh et al., 2009a) techniques. 
 
In summary, the present data suggest that neuroplastic changes triggered by acute 
non-contingent cocaine experience, including ERK activation and AMPA receptor 
trafficking and phosphorylation state, may be disrupted in mice lacking mGluR5 on 
D1-MSNs. Whether disruption of these neuroplastic events reflects the necessity 
for glutamate signalling through mGluR5 on D1-MSNs per se, interactions between 
mGluR5 and NMDARs or D1Rs, or generally disrupted dopaminergic signalling in 
mGluR5KD-D1 mice remains to be determined. This question will be touched upon 
again in the general discussion, but it is interesting to note that mGluR5 KO mice 
show a normal increase in extracellular dopamine in the accumbens following 
acute cocaine challenge (Chiamulera et al., 2001). Many further studies are 
required to formally confirm or disprove the present findings and suggestions for 
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how to optimise such studies have been provided. The early neurobiological effects 
of cocaine assessed in the present chapter can have important long term 
consequences for neuronal function, including altered strength of corticostriatal 
synapses (Thomas et al., 2001b; Borgland et al., 2004) and changes in dendritic 
morphology (Robinson and Kolb, 2004; Crombag et al., 2005; Ren et al., 2010). 
Thus, given the present findings, it will also be valuable to assess 
electrophysiological and morphological characteristics of striatal MSNs in 
mGluR5KD-D1 mice both following acute and repeated cocaine exposure and 
following a period of cocaine withdrawal, ideally from response-contingent (i.e. self-
administration) cocaine experience.  
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7 General discussion 
 
7.1 Review of general aims 
 
The ability to learn about and subsequently use environmental stimuli associated 
with reward experience to guide our behaviour has clear adaptive value. Addictive 
drugs are proposed to closely interact with neural mechanisms of learning and 
memory, enabling environmental stimuli associated with drug experience to 
promote drug-seeking, drug-taking and to trigger relapse (Stewart et al., 1984; 
Robinson and Berridge, 1993; Everitt et al., 2001; Kelley, 2004; Hyman et al., 
2006). Uncovering the neural mechanisms of reward-related learning may 
therefore provide valuable insight into the basis of clinical disorders like drug 
addiction. The group I metabotropic glutamate receptor, mGluR5, is particularly 
interesting in this respect. It is densely located within brain regions that contribute 
to reward-related learning (Shigemoto et al., 1993; Romano et al., 1995; Tallaksen-
Greene et al., 1998) and electrophysiology and biochemistry studies point to 
mGluR5 as a key regulator of synaptic plasticity (e.g. Mao et al., 2005; Bellone et 
al., 2008; Anwyl, 2009), considered as the cellular correlate of learning and 
memory. Using a novel mouse line in which mGluR5 is selectively knocked-down 
on cells that express the dopamine D1R (Novak et al., 2010), the present thesis 
aimed to further understand the role of mGluR5 located on dopaminoceptive 
neurons in Pavlovian incentive learning processes for a natural reward and in 
some behavioural and neurobiological effects of one addictive drug, cocaine. 
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7.2 Summary of key findings 
 
A summary of the key findings of this thesis is provided in Table 7.1. Before 
undertaking more complex behavioural assessments, it first was necessary to 
understand the basic phenotype of mGluR5KD-D1 mice (Chapter 2). On casual 
observation, mGluR5KD-D1 mice were indistinguishable from their wild-type 
counterparts, but the experiments of Chapter 2 identified two interesting traits in 
this novel mouse line. First, mGluR5KD-D1 mice displayed a reduced anxiety-like 
phenotype in tests of unconditioned anxiety-related behaviours, although this effect 
was not particularly robust across the three different tests employed. Second, in 
comparison to their wild-type counterparts, mutant mice showed a clear reduction 
in exploratory locomotor activity when placed into a novel inescapable 
environment. However, after a period of habituation, basal locomotor activity did 
not differ between genotypes. 
 
Studies on Pavlovian incentive learning in mGluR5KD-D1 mice (Chapter 3) identified 
mGluR5 on dopaminoceptive neurons as critically important for incentive learning 
that enables an environmental stimulus associated with reward to became 
attractive and elicit approach toward it (sign-tracking) and to support the learning of 
a new instrumental response (CRf). It is also noteworthy that a psychostimulant 
failed to facilitate responding for CRf in mGluR5KD-D1 mice; a phenomenon that is 
critically dependent upon dopamine and glutamate signalling within the ventral 
striatum (Taylor and Robbins, 1986; Wolterink et al., 1993; Burns et al., 1994; 
Parkinson et al., 1999). In contrast to these select deficits in Pavlovian incentive 
learning processes, mGluR5 on dopaminoceptive neurons appeared to play no role 
in learning about the predictive relationship between the reward-paired stimulus 
and the reward itself (discriminated approach), the acquisition of a simple food-
reinforced instrumental response, or incentive learning that allows the food-paired 
CS to motivate ongoing, goal-directed actions (PIT). Studies using wild-type mice 
injected with the selective mGluR5 antagonist, MTEP, (Chapter 4) indicated that 
mGluR5 was particularly important for the acquisition of an incentive Pavlovian 
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association necessary to support CRf, rather than the expression of the acquired 
incentive association. 
 
In Chapter 5, I examined the possibility that some behavioural effects of cocaine, 
which involve neural components implicated in Pavlovian incentive learning 
processes, might also be disrupted in mGluR5KD-D1 mice. Mutant mice 
demonstrated normal performance in a test of learning about cocaine and food 
conditioned reward (i.e. CPP). The psychological processes involved in CPP are 
not fully understood (see discussion of Chapter 5), but data from this Chapter 
suggested that learning and/or performance in this task does not require Pavlovian 
incentive learning processes that are necessary for sign-tracking and conditioned-
reinforcement responses. In a series of locomotor studies reported in Chapter 5, 
the acute psychomotor activating effects of cocaine were found to be attenuated in 
mGluR5KD-D1 mice, in comparison to wild-type animals. Notably, mGluR5KD-D1 mice 
did develop a sensitised locomotor response to cocaine, which persisted for at 
least 2 months after its induction. However, it is important to note that the rate of 
sensitisation was slightly reduced in mutant mice (although not significant) and the 
possibility remains that more robust differences in sensitisation between genotypes 
may have been uncovered had sensitisation been performed in animals without 
prior cocaine experience and/or by the inclusion of other measures of activity, 
including the development of stereotypies. 
 
Finally, in Chapter 6, a series of experiments were undertaken to explore some 
neurobiological effects of acute cocaine exposure in mGluR5KD-D1 mice. The 
purpose of these experiments was twofold. First, to understand the role of mGluR5 
on dopaminoceptive neurons in neuroplastic changes that may contribute to long 
term behavioural effects of cocaine and second, to highlight any deficits in 
neuroplasticity that could have contributed to incentive learning deficits observed in 
mGluR5KD-D1 mice. Notwithstanding the technical limitations raised in the 
discussion of Chapter 6, it appeared that activation of the ERK1/2 intracellular 
signalling cascade was disrupted in the ventral striatum of mGluR5KD-D1 mice 
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following cocaine (immunohistochemistry studies), and some evidence pointed to 
disruption of AMPA receptor trafficking and/or regulation of its phosphorylation by 
PKA at the GluR1-s845 site, at least in the dorsal striatum (immunoblotting 
studies).  
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Test KD WT 
Chapter 2   
Basic observations (body weight, reflexive 
responses) 
  
Sucrose consumption   
Locomotor activity in a novel environment   
Time in middle zone of open-field   
Chapter 3   
Discriminated approach   
Sign-tracking   
Conditioned reinforcement    
Cocaine facilitation of CRf   
Instrumental responding for food   
Pavlovian instrumental-transfer   
Chapter 4   
MTEP on the acquisition of incentive learning   
MTEP on the expression of incentive learning   
Chapter 5   
Acute cocaine locomotor response   
Cocaine sensitisation   / ?  
Conditioned activity   
Is cocaine sensitisation persistent?   
Food CPP   
Cocaine CPP   
Chapter 6 (In response to acute cocaine...)   
ERK1/2 activation in the ventral striatum   
STEP61 translation in the dorsal striatum   
P-GluR1-s845 in the dorsal striatum   
 
Table 7.1 Summary of key findings from each chapter. Normal performance () 
and altered performance () in mGluR5KD-D1 mice (KD) relative to wild-type (WT) 
littermates is indicated. Studies in Chapter 4 were conducted only in wild-type 
mice, and comparisons here are made with wild-type mice treated with vehicle. For 
the cocaine sensitisation study, a question mark is given; see comment in main 
text above. 
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7.3 Is mGluR5 on D1R expressing neurons involved in specific sensory or 
general preparatory conditioning processes?  
 
In the introduction of this thesis I introduced two accounts of motivation; a 
„Konorskian‟ model (Konorski, 1967; Dickinson and Balleine, 2002; Balleine, 2005) 
and an „incentive salience‟ model (Robinson and Berridge, 1993; Berridge, 1996; 
Berridge and Robinson, 1998; Berridge, 2004), both of which described how 
environmental stimuli associated with reward experience could come to influence 
behaviours through Pavlovian learning processes. According to the incentive 
salience model, mGluR5KD-D1 mice show impaired incentive salience attribution 
necessary for the acquisition of sign-tracking and CRf CRs, but a valuable question 
to consider is whether impaired learning in mGluR5KD-D1 mice relates more to 
specific consummatory or general motivational conditioning processes, as 
described in the Konorskian model. 
 
In answering this question, it is first necessary to consider whether the three tests 
of Pavlovian incentive learning represent specific consummatory or general 
motivational conditioning processes. Conditioned reinforcement may be mediated 
by activation of both general motivational or specific outcome representations, 
which are proposed to operate in concert under normal conditions (Burke et al., 
2007, 2008). Sign-tracking responses often acquire a topography that resembles 
that of the UR directed at the US (Wolin, 1968; Jenkins and Moore, 1973), 
indicating that sign-tracking is partly a reward-specific mechanism. The 
conditioning parameters used for PIT in the present thesis likely favoured the 
formation of a more general motivational CS-US association due, in part, to the 
longer duration CS (Konorski, 1967; Dickinson and Balleine, 1994; Holland and 
Gallagher, 2003; Crombag et al., 2008a), but also because only one CS-US 
outcome was trained. Taken together, it would appear that mGluR5KD-D1 mice fail to 
acquire more specific consummatory associations (Fig. 7.1). As such, it may be 
predicted that other Pavlovian learning processes that involve sensory specific 
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learning, such as outcome-selective PIT, would also be disrupted in mGluR5KD-D1 
mice. 
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Figure 7.1. mGluR5KD-D1 mice show impaired specific consummatory conditioning. 
Both sign-tracking and CRf processes employ a short duration CS (10 sec CS) and 
may require the formation of specific consummatory associations to activate the 
appetitive system (Ap) through increased affect (red arrows indicate impairment in 
mGluR5KD-D1). In contrast, Pavlovian-instrumental transfer was normal in 
mGluR5KD-D1 mice, which employs a long duration CS (2 min CS) and depends 
upon the formation of more general preparatory CS-US associations that give rise 
to arousal. A connection between sensory specific (Se) and motivational (M) 
features is thought not functional for the role of reward-related cues on activating 
instrumental performance (adapted from Balleine, 2005).  
2 min
CS
Se
M
Ap
Affect
Arousal
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7.4 Does Pavlovian incentive learning involve mGluR5-mediated regulation of 
plasticity in D1-MNSs? 
 
Deficits in the acquisition of sign-tracking and CRf in mGluR5KD-D1 mice and a 
failure of cocaine to facilitate CRf in mutant animals closely echo results from 
studies in rats that received selective excitotoxic lesions of the ventral striatum, or 
in which glutamatergic signalling in this region was blocked (Burns et al., 1994; 
Parkinson et al., 1999; Parkinson et al., 2000b; Di Ciano et al., 2001; Di Ciano and 
Everitt, 2001; Cardinal et al., 2002b; Ito et al., 2004; Dalley et al., 2005; Backstrom 
and Hyytia, 2007). Such studies (reviewed more extensively in the general 
introduction), have led a number of reviewers to propose that neuroplastic changes 
on MSNs in the ventral striatum during reward-related learning may be key for 
determining how these neurons subsequently respond to salient events (e.g. 
reward-associated CSs), and that glutamatergic mechanisms, acting in partnership 
with dopamine, may be critical for initiating and maintaining these neuroplastic 
changes (Kelley et al., 2003; Svenningsson et al., 2004; Dalley et al., 2005; Valjent 
et al., 2005; Meredith et al., 2008; Wolf and Ferrario, 2010). Findings in the present 
thesis suggest that mGluR5 on D1-MSNs in the ventral striatum may play a critical 
role in controlling neuroplastic changes that are necessary for supporting the 
acquisition of specific Pavlovian incentive learning processes. A key question is 
through which cellular mechanisms does mGluR5 exert such control? 
 
In the general introduction (Chapter 1), studies were highlighted that identified an 
important role of group I mGluRs in mediating LTD at excitatory synapses in the 
dorsal and ventral striatum, which likely involves a retrograde-endocannabinoid 
signalling mechanism (Robbe et al., 2002; Kreitzer and Malenka, 2007; 
Uchigashima et al., 2007; Shen et al., 2008). It is possible that this „post-synaptic 
induction/pre-synaptic expression‟ mechanism of mGluR-LTD could be disrupted in 
mGluR5KD-D1 mice and could account for observed incentive learning deficits. 
There is also evidence that mGluR5 can contribute to corticostriatal LTP (Gubellini 
et al., 2003; Schotanus and Chergui, 2008) and „post-synaptic induction/post-
293 
 
synaptic expression‟ mechanisms of neuroplasticity could also account for 
incentive learning deficits in mGluR5KD-D1 mice. Two such mechanisms, although 
not mutually exclusive, can be proposed; one involving mGluR5-mediated 
regulation of AMPA receptor activity and a second involving regulation of the 
ERK1/2 signalling cascade. These intracellular interactions are illustrated in Figure 
7.2. 
 
Stimulation of group I mGluRs, including mGluR5, can produce changes in the 
post-synaptic expression of AMPA receptors (Snyder et al., 2001; Bellone and 
Luscher, 2005; Mameli et al., 2007; Jo et al., 2008; Waung et al., 2008; Zhang et 
al., 2008; Kelly et al., 2009) and, in the striatum, activation of mGluR5 is required 
for phosphorylation of striatal GluR1-Ser831 and -Ser845 (Ahn and Choe, 2009), 
and GluR2-Ser880 residues (Ahn and Choe, 2010). Such changes in AMPA 
receptor trafficking and/or activity may be critical for experience-dependent 
alterations in synaptic plasticity and which subsequently determine the sensitivity to 
control over appetitive behaviours by reward-paired CSs (Di Ciano et al., 2001; 
Mead and Stephens, 2003b, a; Conrad et al., 2008; Crombag et al., 2008b; 
Crombag et al., 2008c). Whether mGluR5 is important for regulating trafficking 
and/or phosphorylation of AMPA receptors during Pavlovian incentive learning 
processes requires further empirical study, but some support for the proposal that 
this processes is disrupted in mGluR5KD-D1 mice is offered by the immunoblotting 
experiments reported in Chapter 6 (see Table 7.1 for summary). 
 
Group I mGluRs can positively link to the extracellular signal-regulated kinase 
(ERK) cascade (Peavy and Conn, 1998; Thandi et al., 2002), which has numerous 
functions in experience-dependent plasticity (Adams and Sweatt, 2002; Boudreau 
et al., 2007; Patterson et al., 2010; Shiflett and Balleine, 2011). Activation of 
ERK1/2 in the striatum requires co-stimulation of D1R and NMDARs (Valjent et al., 
2005) and it is noteworthy that both D1R and NMDA receptors in the accumbens 
were identified as critical for the early consolidation of appetitive Pavlovian 
memories (Dalley et al., 2005). These reports are particularly relevant in the 
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context of this thesis, given the close interactions between striatal mGluR5 and 
D1Rs (involving an enhanced cAMP response; Paolillo et al., 1998; Voulalas et al., 
2005; Schotanus and Chergui, 2008), and striatal mGluR5 and NMDA receptors 
(Pisani et al., 2001; Mao and Wang, 2002; Yang et al., 2004; Choe et al., 2006). 
Regarding the mGluR5-NMDA interaction, it is likely that this involves a PKC 
dependent mechanism (Kelso et al., 1992; Fitzjohn et al., 1996; Doherty et al., 
1997; Pisani et al., 1997; Awad et al., 2000; Skeberdis et al., 2001) in which PKC 
phosphorylates the ion channel associated with NMDA receptors that increases 
NMDA sensitivity and activity leading to enhanced Ca2+ influx  (Chen and Huang, 
1992; Lan et al., 2001; Skeberdis et al., 2001). Some reports have also proposed 
that stimulation of mGluR5 alone is sufficient for ERK1/2 activation in striatal 
neurons (Choe et al., 2002; Mao et al., 2005). Thus, whether through co-operative 
interactions between mGluR5 and D1Rs and/or NMDARs, or as a direct 
consequence of mGuR5 stimulation, activation of ERK1/2 involving mGluR5 on 
D1-MSNs in the ventral striatum may be a key component necessary for the 
formation of Pavlovian incentive associations. Some support for the proposal that 
activation of ERK1/2 is disrupted in mGluR5KD-D1 mice is offered from 
immunohistochemistry studies of Chapter 6 (see Table 7.1 for summary).  
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Figure 7.2 Post-synaptic induction/post-synaptic expression mechanisms of mGluR5 
signalling in striatal neurons. In a simplified and largely hypothetical post-synaptic D1-MSN 
synapse, stimulation of perisynaptic mGluR5 may result in activation of PKC and PKA, the 
latter involving endogenous release of calcium. Activity of a number of substrates is 
dependent upon phosphorylation regulated by PKA (red dots; note STEP46 and ERK are 
not direct substrates of PKA, but lie downstream of PKA phosphorylation of DARPP-32 at 
Thr34) and PKC (green dots). Phosphorylation of AMPA receptor subunits can lead to 
alterations in activity and/or trafficking. Activation of ERK by phosphorylation may result in 
the rapid synthesis of STEP61 protein, at least in the hippocampus, which promotes 
internalisation of AMPA receptors. Coupling between mGluR5 and the ERK cascade is 
also achieved by the scaffolding protein Homer1b/c. (image based on findings reported by; 
Snyder et al., 2001; Mao et al., 2005; Ossowska, 2005; Valjent et al., 2005; Zhang et al., 
2008; Ahn and Choe, 2009, 2010). 
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7.5 Does Pavlovian incentive learning require a balance of output between 
direct and indirect pathways? 
 
In the classical model of basal ganglia function, the D1R-expressing „direct‟ 
pathway and D2R-expressing „indirect‟ pathway act in opposition to balance 
behavioural output (Albin et al., 1989; Gerfen, 1992). Thus, activation of the direct 
pathway increases locomotor activity and activation of the indirect pathway exerts 
a tonic inhibitory tone. A disruption in the balance of activity in these two pathways 
is a central feature of motor disturbances in Parkinson‟s disease and in 
Parkinsonian models, an absence of mGluR-LTD on the D2R indirect pathway has 
been reported, which appears to shift the balance of plasticity in this pathway 
toward LTP (Kreitzer and Malenka, 2007; Shen et al., 2008). The resulting 
enhancement of activity of the indirect pathway is proposed to give rise to 
excessive inhibition of movement (Kreitzer and Malenka, 2007; Shen et al., 2008; 
Luscher and Huber, 2010). Dysregulation in the balance of activity between D1- 
and D2-MSNs has also been proposed to contribute to maladaptive learning 
processes in addictions (Shen et al., 2008). Thus, one account to explain findings 
in the present thesis is that loss of mGluR5 on D1R-expressing neurons of the 
direct pathway results in a dysregulation in the balance of output from the striatum, 
which clearly would stem from a failure to appropriately integrate dopamine and 
glutamate signalling as discussed in section 7.4. 
 
Some recent evidence provides support for this proposal. Bateup and colleagues 
(2010) generated mice in which DARPP-32, a central signalling protein, was 
selectively knocked out in D1R or D2R expressing neurons. In mice lacking 
DARPP-32 in D1R striatonigral neurons, spontaneous locomotor activity was 
reduced in comparison to controls and so too were the acute psychomotor 
activating effects of cocaine (Bateup et al., 2010). In mice lacking DARPP-32 in 
D2R striatopallidal neurons, spontaneous locomotor activity and the psychomotor 
activating effects of cocaine were both increased (Bateup et al., 2010). Durieux 
and colleagues (2009) reported that selective ablation of D2R MSNs in the entire 
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striatum resulted in hyperlocomotion, while ablation of D2R MSNs solely in the 
ventral striatum increased amphetamine CPP. Similarly, Lobo and colleagues 
(Lobo et al., 2010) reported that optogenetic stimulation of D1+ve neurons in the 
ventral striatum enhanced cocaine CPP, while stimulation of D2+ve neurons 
inhibited this measure of cocaine conditioned reward. Taken together, it seems 
plausible that disrupted activity in neurons of the D1R direct pathway of mGluR5KD-
D1 mice could account for a reduction in both spontaneous locomotor activity and 
the psychomotor activating effects of cocaine. Moreover, it is tempting to propose 
that the appropriate integration of dopaminergic and glutamatergic signals in the 
direct pathway, involving mGluR5, and the resultant balance of activity between 
direct and indirect MSNs, may be a critical for appropriately responding to reward-
associated CSs (Fig. 7.2). Notably, this model would predict a reduction of activity 
in the D1R direct pathway of mGluR5KD-D1 mice (either dominant LTD and/or a loss 
of LTP), but further studies would clearly be required to explore this hypothesis. 
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Figure 7.3 Disruption of output from the basal ganglia accounts for features of 
mGluR5KD-D1 mice. (a) When the function of GABAergic D1-MSNs (green) of the 
direct striatonigral pathway is disrupted (dotted line), spontaneous motor output 
diminishes and so too do the effects of cocaine on locomotor activity (Bateup et al., 
2010). Such behaviours are also found in mGluR5KD-D1 mice, and thus loss of 
mGluR5 on D1-MSNs may well result in a disruption of D1-MSN function. Further, 
loss of mGluR5 from D1-MSNs in the ventral striatum may account for deficits 
observed in specific Pavlovian incentive learning processes. (b) When function of 
D2-MSNs (red) of the indirect striatopallidal pathway is disrupted, spontaneous 
motor output increases, and so too do the psychomotor activating effects of 
cocaine (Durieux et al., 2009; Bateup et al., 2010).  
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7.6 Implications for drug addiction 
 
Early neuroplastic changes in response to addictive drugs, while in no way 
constituting the complete picture of addiction, may represent critical first steps in 
the remodelling of reward-related brain areas that underlie the development of 
more persistent addiction-related behaviours (Nestler, 2001; Valjent et al., 2001; 
Hyman et al., 2006; Kauer and Malenka, 2007). In this regard, mGluR5 on D1-
MSNs may play a role, since activation of ERK1/2 and activity and/or trafficking of 
AMPA receptors appeared disrupted in striatal regions of mGluR5KD-D1 mice 
following a single cocaine challenge (Chapter 6). It is beyond the scope of this 
thesis to cover the literature on the role of ERK1/2 signalling and AMPA receptor 
function in addiction-related behaviours but, needless to say, both components are 
thought to play central roles in enabling environmental stimuli associated with drug 
experience to exert influence over addiction-related behaviours (Wolf, 1998; 
Thomas and Huganir, 2004; Wolf et al., 2004; Lu et al., 2006; Wolf and Ferrario, 
2010). 
 
Behavioural sensitisation is often used as a surrogate measure of the ability of 
repeated cocaine experience to produce long-lasting changes in brain systems that 
mediate incentive salience attribution (Robinson and Berridge, 1993, 2000, 2001). 
Since incentive salience attribution was disrupted in mGluR5KD-D1 mice, it was 
predicted that behavioural sensitisation would also have been disrupted in mutant 
animals, in accordance with similar correlations reported elsewhere (Flagel et al., 
2008). However, this was not the case; mutant mice developed a persistent, 
sensitised cocaine-locomotor response (Chapter 5). It must be stressed that more 
sensitive measures of behavioural activity may have revealed differences in the 
rate of sensitisation between wild-type and mGluR5KD-D1 mice, which may be a 
critical component of neurobehavioural plasticity (Flagel and Robinson, 2007; 
Flagel et al., 2008). Thus, based on the present data, we cannot entirely exclude 
the possibility that mGluR5 on D1R expressing neurons play an important role in 
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drug-induced neuroplastic changes that are proposed to result in a sensitisation of 
incentive salience attribution. 
 
That mGluR5KD-D1 mice were impaired in sign-tracking and CRf, suggests that such 
incentive learning processes may also be disrupted in mGluR5KD-D1 mice during 
learning about drug-associated CSs. Cocaine self-administration studies in 
mGluR5KD-D1 mice provide direct confirmation of this proposal (Novak et al., 2010). 
Mutant mice were observed to self-administer cocaine under a fixed-ratio schedule 
of reinforcement, but cue-induced reinstatement of drug-seeking, considered as an 
animal model of relapse vulnerability (Shaham et al., 2003; Sanchis-Segura and 
Spanagel, 2006; Stephens et al., 2010), was attenuated in mutant mice (Novak et 
al., 2010). This finding mirrors the failure of mGluR5KD-D1 mice to respond for CRf 
(Chapter 3) and supports a common notion that the cue-induced reinstatement 
model is heavily influenced by CRf related learning processes. A valuable series of 
future experiments would be to test mGluR5KD-D1 mice in second-order schedules 
of reinforcement and also in approach toward a drug-paired CS (e.g. Uslaner et al., 
2006). These models are thought to reflect aspects of drug-seeking and taking and 
the ability of drug-CSs to attract drug addicts toward places where drugs can be 
found (reviewed in the General Introduction, section 1.6). Here, the expectation 
would be that responding under second-order schedules and approach toward a 
drug-paired CS would be disrupted in mGluR5KD-D1 mice. 
 
In summary, our present findings, together with self-administration studies in 
mGluR5KD-D1 mice (Novak et al., 2010), suggest that mGluR5-mediated 
neuroplastic events on D1-MSNs are crucial for the formation of psychologically 
distinct associations between environmental stimuli and rewards that endow 
reward-paired stimuli with the subsequent ability to both reinforce and attract 
motivated behaviours. Furthermore, recent reports have revealed that mGluR5-
mediated striatal plasticity is involved in, or affected by, cocaine experience 
(Fourgeaud et al., 2004; Moussawi et al., 2009; Hao et al., 2010). Data from 
mGluR5KD-D1 mice provide a psychobiological context for these findings by pointing 
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to glutamate signalling at mGluR5 on striatal D1-MSNs as a key mediator through 
which repeated cocaine experience (and presumably exposure to other drugs of 
abuse) produces a persistent increase in the susceptibility to relapse triggered by 
environmental stimuli associated with drug use.  
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7.7 Limitations 
 
In generating mGluR5KD-D1 mice, cell-type specific knock-down of mGluR5 was 
achieved by driving the expression of artificial micro-RNAs that targeted mGluR5 
mRNA with a D1R promoter (Novak et al., 2010). Thus, mGluR5 knock-down was 
restricted to cells that express the D1R. The percentage of striatal MSNs that 
exclusively express D1Rs or D2Rs or express both D1Rs and D2Rs has been the 
focus of much debate (for review see Bertran-Gonzalez et al., 2011), with some 
reports indicating little overlap (Gerfen et al., 1990), and others suggesting many if 
not all MSNs contain both D1Rs and D2Rs (Surmeier et al., 1992; Aizman et al., 
2000). Key arguments of this thesis rest on the position that there is some degree 
of segregation, which is supported by the characterisation of mGluR5KD-D1 mice in 
which mGluR5 transcript and protein levels are reduced to ~40 and ~50%, 
respectively, of wild-type levels (Novak et al., 2010). However, if there is a high 
degree of overlap it cannot be concluded that some MSN populations are more 
important than others for Pavlovian incentive learning. Nevertheless, our data do 
highlight the importance of glutamate signalling through mGluR5, on cells that also 
receive dopamine input, for Pavlovian incentive learning processes and some 
behavioural and neurobiological effects of cocaine. 
 
Much of this thesis has focused on the role of mGluR5 in the ventral striatum, in 
part because of the large volume of corroborating literature that identifies this 
region as important for Pavlovian incentive learning processes, but also because 
little characterisation has yet been performed to understand the extent of mGluR5 
loss within other brain regions in mGluR5KD-D1 mice. The possibility remains that 
mGluR5 loss outside the ventral and dorsal striatum could have contributed to 
findings reported in this thesis. For example, group I mGluRs function at multiple 
levels within the subcortical nuclei that constitute the basal ganglia to regulate 
locomotor activity (DeLong and Wichmann, 2007). In the STN, activation of 
mGluR5 on postsynaptic neurons results in a switch from a characteristic single-
spike firing mode to a burst-firing mode (Awad et al., 2000); a firing state commonly 
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observed in Parkinsonian rats and non-human primates (Hollerman and Grace, 
1992; Bergman et al., 1994). Similarly, mGluR5 is distributed throughout the SNr 
(Hubert et al., 2001) and activation of mGluR5 mediates depolarization of these 
neurons, albeit only under conditions of dopamine blockade (Marino et al., 2002). 
In the mGluR5KD-D1 mouse model, whether mGluR5 is knocked-down in these 
regions will depend upon whether D1R receptors are expressed in the same 
neuronal populations, and further characterisation is warranted. For example, while 
there is some evidence to suggest that the D1R promoter may be active in the 
STN, its pre- or post-synaptic location is debated (Fremeau et al., 1991; Mansour 
et al., 1992; Smith and Kieval, 2000; Smith and Villalba, 2008). 
 
Another structure that should not be overlooked within the context of this thesis is 
the amygdala, which provides a key link between brain regions processing sensory 
information and those involved in more fundamental motivational aspects of 
reward-processing. In particular, the BLA and its interactions with the NAcc appear 
critical for turning associative information into goal-directed actions (Cador et al., 
1989; e.g. Burns et al., 1993; Di Ciano and Everitt, 2004b), while the CeN may 
influence the impact of the motivational value of a CS via its connections with the 
ventral midbrain (Robledo et al., 1996). Could mGluR5 loss from D1R expressing 
neurons in the amygdala account for findings reported in this thesis? In the 
amygdala, mGluR5 has been found on dendritic shafts and spines in the lateral 
nucleus, post-synaptic to auditory thalamic inputs, and contributes to plasticity in 
this thalamo-amygdala pathway (Fendt and Schmid, 2002; Lee et al., 2002; 
Rodrigues et al., 2002). A retrograde endocannabinoid mechanism involving 
mGluR5 has been identified in isolated BLA neurons with GABAergic input neurons 
attached (Zhu and Lovinger, 2005) and mGluR5 also contributes to plasticity at 
BLACeN synapses (Neugebauer et al., 2003; Kolber et al., 2010). Further work 
is required to understand the extent of mGluR5 and D1R co-localisation in 
amygdala neurons and the studies mentioned here have only considered the role 
of mGluR5-mediated plasticity in the amygdala with respect to anxiety- (e.g. 
Rodrigues et al., 2002) and pain- (Kolber et al., 2010) related behaviours. Few 
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studies have explored the role of mGluR5 in the amygdala in appetitive learning 
tasks. One notable exception is from Schroeder and colleagues (2008), who 
reported that cue-induced reinstatement of alcohol seeking behaviour was 
associated with a robust increased in P-ERK1/2 in the BLA and NAcc shell, and 
both reinstatement and ERK1/2 activation was blocked by systemic MPEP 
administration. Thus, there is some evidence that mGluR5 in the amygdala may be 
play an important role in responding to reward-paired CSs, but further 
investigations are clearly required. 
 
Only one mutant mouse line was used for experiments on the present thesis, and 
we cannot exclude the possibility that behavioural effects in mGluR5KD-D1 mice 
were due to compensatory effects and/or interactions between the genetic 
manipulation and the background strain used (Crawley et al., 1997). Indeed, this 
idea also extends to pharmacology studies (Chapter 4) where the effect of mGluR5 
antagonism may vary amongst strains and between species. For example, 
published reports reveal little consistency in the role of mGluR5 in locomotor 
activity in a novel environment. Antagonism of mGluR5, which can be considered 
analogous to an mGluR5 knock-out model, reduces locomotor activity in rats 
(Spooren et al., 2000a; Varty et al., 2005) and C57BL/6J mice (Cowen et al., 
2007), but can also result in hyperactivity in DBA/2J (McGeehan et al., 2004) and 
C57BL/6J mice (Halberstadt et al., 2010). In genetic models, complete knock-out of 
mGluR5 in mice results in hyperactivity in a novel environment (Gray et al., 2009; 
Bird et al., 2010; Halberstadt et al., 2010; Olsen et al., 2010). Thus, it would be 
highly valuable to examine the effect of mGluR5 knock-down on D1R expressing 
cells in different strains. 
 
Phenotyping tests (Chapter 2) were selected to determine whether deficits existed 
in mutant mice that could affect performance during subsequent behavioural 
experiments. A number of parameters were not measured in mGluR5KD-D1 mice 
which could have contributed to deficits in learning reported here. For example, we 
did not assess parental behaviours, nor did we examine feeding in terms of meal 
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size, rate of consumption, meal frequency, nutrient preference, taste aversion, 
circadian rhythms and orofacial motor components of ingestion; considered to 
reflect hedonic aspects of reward experience (Berridge, 1996; Berridge and 
Kringelbach, 2008). Social behaviours, including exploratory social interactions, 
aggressive behaviours and juvenile play were not formally assessed. Emotional 
responses including conditioned fear, depression- and schizophrenia-related 
behaviours were also not assessed. Thus, while no overt differences were reported 
in mGluR5KD-D1 and wild-type mice, a host of subtle factors remain unexplored that 
may reveal important functional roles for mGluR5 on D1R-expressing neurons. 
 
In experiments that assessed Pavlovian incentive learning (Chapter 3-4), the main 
measures of activity were lever pressing and nose-poking into the food magazine 
or into nose-poke holes. How animals respond to cue activation can result in 
important differences in conditioning and the conditioned response that develops 
(e.g. Holland, 1980) and simple frequency measures are not sensitive to 
differences in the topography of the response and only account for behaviour in a 
tiny proportion of the entire session. It would be highly valuable to closely monitor 
behaviour of mGluR5KD-D1 mice, with video capturing, to see whether further 
behavioural differences could be identified that could account for impaired learning 
in these animals. Similarly, in locomotor studies (Chapter 5-6), the main measure 
of activity was distance travelled, which fails to capture the variety of spontaneous 
behaviours that may be emitted during the course of these sessions (as assessed 
in Chapter 2). Again, video monitoring of locomotor activity would be valuable to 
more closely examine how activity, particularly in response to cocaine, differs 
between mGluR5KD-D1 mice and wild-type mice.  
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7.8 Future research 
 
To test the idea that mGluR5 on D1R expressing neurons are involved in more 
sensory specific consummatory conditioning, further tests could be undertaken in 
mGluR5KD-D1 mice that more closely examine and compare sensory specific 
learning with more general forms of conditioning. Notably, Corbit and Balleine 
(2005) have developed a PIT procedure in which both the general motivational and 
the specific sensory effects of Pavlovian CSs can be examined in the same rat. 
The testing of selective PIT would be valuable in mGluR5KD-D1 mice and some 
studies indicate that testing of outcome-selective PIT is possible in mice, although 
the effect sizes tend to be rather small (Yin et al., 2006a; Johnson et al., 2007a). 
Burke and colleagues (2007, 2008) have used reinforcer devaluation and 
transreinforcer blocking procedures to generate CSs that are considered to evoke 
representations of general affect (that are devaluation-insensitive) or outcome-
specific representations (that are devaluation-sensitive), and both CS forms 
support CRf. To further explore whether Pavlovian learning in mGluR5KD-D1 mice 
can support the formation of outcome-specific associations, it would be valuable to 
attempt such procedures in mGluR5KD-D1 mice. 
 
One of the main proposals of this thesis is that incentive learning deficits arose due 
to loss of mGluR5 on D1R expressing neurons, resulting in disrupted plasticity in 
D1-MSNS in the ventral striatum. A number of options exist to further investigate 
this possibility, beyond the obvious need for extensive electrophysiological 
characterisation of mutant mice. First, targeted disruption of mGluR5 solely in the 
ventral striatum during the learning and/or performance of the CRf task would be 
valuable to confirm that mGluR5 in this brain region was primarily responsible for 
deficits in the acquisition of incentive learning following systemic MTEP treatment 
(Chapter 4). The need for repeated intracerebral administration of MTEP during 
conditioning sessions would undoubtedly cause confounding damage to the 
infused brain region and thus an alternate approach could be to use virally 
mediated knock-down of mGluR5. Alternatively, displacement of mGluR5 from 
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Homer scaffolding proteins regions using a TAT decoy peptide may offer a viable 
alternate approach to disrupt mGluR5 mediated signalling in specific brain regions 
(e.g. Tronson et al., 2010). Second, if loss of a post-synaptic LTP-like expression 
mechanism in the ventral striatum, involving a reduction in activity of AMPA 
receptors, was responsible for impaired incentive learning in mGluR5KD-D1 mice, 
one prediction might be that administration of a positive allosteric modulator of 
AMPA receptors (i.e. an ampakine) into the accumbens could restore performance 
deficits in CRf and/or sign-tracking in mGluR5KD-D1 mice. In this respect, it is 
interesting that the ampakine CX546 was found to restore prepulse inhibition and 
latent inhibition deficits in mGluR5 knock-out mice (Lipina et al., 2007). Third, if 
mGluR5-mediated ERK1/2 signalling in D1-MSNs is particularly important for the 
formation of Pavlovian incentive associations, then manipulations that disrupt 
ERK1/2 signalling in the ventral striatum of wild-type mice during conditioning trials 
would be expected to mimic the phenotype of mGluR5KD-D1 mice. Support for this 
proposal can be taken from a study of Dalley and colleagues (2005), in which post-
training infusions of a D1R and NMDA antagonist into the accumbens (i.e. blocking 
receptors that are critical for ERK1/2 activation) disrupted the formation of 
Pavlovian incentive memories. Fourth, if STEP protein is critically involved in 
mGluR5-mediated neuroplastic changes, then disruption of STEP signalling in the 
ventral striatum during conditioning may also give similar rise to deficits reported in 
mGluR5KD-D1 mice. It is noteworthy that Tashev (2009) and colleagues reported 
that a substrate trapping form of STEP (TAT-STEP) blocked the induction of LTP 
and potentiated LTD in acute striatal slices. Finally, if co-operative signalling 
between mGluR5 and D1Rs and/or NMDARs are important for determining 
appropriate cellular responses in the ventral striatum, then determining a 
locomotor-dose effect profile in mGluR5KD-D1 mice following intra-accumbens 
infusions of a D1R agonist (e.g. SKF 38393) or NMDA antagonist (e.g. PCP) may 
provide a useful starting point to understand whether the function of these 
receptors is disrupted following mGluR5 loss. 
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To test the proposal that a dysregulation in the balance of D1R direct and D2R 
indirect striatal output pathways may be important for incentive learning processes, 
optogenetic tools may prove useful (e.g. Lobo et al., 2010) where pharmacology 
experiments may be precluded by damage associated with repeated intracerebral 
infusions and further limited by a lack of regional and/or cell-type specificity. In this 
scenario, optogenetic stimulation of D1-MSNs during Pavlovian conditioning would 
be predicted to result in enhanced performance during a subsequent test of CRf 
and/or sign-tracking. Oppositely, selective stimulation of D2-MSNs during 
conditioning would be predicted to result in impaired performance during a 
subsequent test of the incentive motivational value of a reward paired CS. A critical 
question remains as to how such manipulations of striatal outputs (and indeed 
impairments in striatal signalling proposed in mGluR5KD-D1 mice) may influence 
output from the ventral midbrain that may, in turn, be a central feature in the 
attribution of incentive value to reward-associated CSs (Flagel et al., 2010). In this 
respect, microdialysis studies following acute cocaine challenge and/or fast-scan 
cyclic voltammetry during conditioning sessions would be valuable to understand 
whether dopamine signalling is disrupted in mGluR5KD-D1 mice.  
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7.9 Conclusion 
 
The acquisition of incentive associations is necessary for many aspects of adaptive 
behaviours, but conditioned incentives are also proposed to contribute to 
compulsive drug seeking and relapse observed in drug addiction (Stewart et al., 
1984; Robinson and Berridge, 2000; Everitt et al., 2001). The findings of the 
present thesis identify glutamate signalling through mGluR5, on cells that also 
receive dopamine input, as critical for the attribution of incentive motivational value 
to environmental stimuli associated with reward experience. Together with cocaine 
self-administration studies conducted in mGluR5KD-D1 mice (Novak et al., 2010), 
our data suggest that mGluR5-mediated plasticity on D1-MSNs in the ventral 
striatum may be critical in the attribution of incentive value to drug-paired cues that 
enable them to support drug seeking and trigger relapse.  
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